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recombinant XGPRTase produced by cell-free expression.
Bioinformatics was employed to analyze the phylogeny of
XGPRTase, to compare it to equivalent prokaryotic and eukaryotic
enzymes and to build a structural model of the enzyme using
threading techniques. The model served to identify key residues of
the enzyme involved in catalysis. The interactions of purine
phosphoribosyltransferases with inhibitors were used to assess
their potential against the H. pylori XGPRTase.
It was demonstrated that the gpt gene of H. pylori encodes
a functional XGPRTase enzyme. Analyses of the XGPRTase
sequence revealed that the enzyme is significantly divergent from
equivalent mammalian enzymes. A XGPRTase model revealed that
while parts of the enzyme were similar to those observed of other
PRTase enzymes, there were significant differences between
H. pylori XGPRTase and purine salvage PRTases. Understanding
of these differences will be an important contribution to the
development of therapeutic agents against H. pylori XGPRTase.

Abstract no.: 01.01*
DNA Transfer from Coccoid to Bacillary Forms
of Helicobacter pylori
8Abstract
Microbiology

A. Maillet,* M. Garnier,* N. Quellard,† B. Fernandez,†
J. Fauchère* and C. Burucoa*
*EA 3807 Université de Poitiers – Laboratoire de Microbiologie A,
CHU La Milétrie, Poitiers, France, †Service d’Anatomie et Cytologie
Pathologiques, CHU La Milétrie, Poitiers, France

Helicobacter pylori is a bacillary bacterium that converts into coccoid
form under various stress conditions. Coccoid forms are eliminated
in feces, and can be present in drinking water. So they may transit in
gut of an individual that already carries another strain. The signification
of coccoid forms remains unclear: they are viable, nonculturable,
and their infectivity is still under debate. Their DNA is a potential
source of exogenous DNA for an implanted strain.
The aim of this work was to test the possibility of DNA transfer
from nonculturable coccoid forms and to characterize this transfer.
We compared the frequency of clarithromycin resistance transfer
by in vitro natural transformation between a resistant donor strain
under spiral or coccoid form and a susceptible receiver strain.
We enumerated culturable and nonculturable bacteria using a
quantitative real-time polymerase chain reaction (qPCR) method
calibrated with a traditional viable count method. We studied by
electron microscopy the morphological aspects of the transfer.
Our results show that the transfer of clarithromycin resistance is
possible from nonculturable-resistant coccoid forms to culturable
bacillary susceptible strain. The fragmented DNA of coccoid form
still transfers even after several weeks of culture and the transfer
rate is the same whatever the age and the form of the bacteria. TEM
data suggest that the transfer requires a contact between the
coccoid donor cell and the bacillary receiver. Nonculturable
coccoid forms represent therefore a source of DNA for acquisition
of antibiotic resistance and genetic diversity of H. pylori.
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Abstract no.: 01.03
Disulphide Reductases of Campylobacterales:
Are They Involved in Drug Resistance and
Response to Environmental Stresses?
N. O. Kaakoush and G. L. Mendz
University of New South Wales, Sydney, Australia
Disulphide reductases of pathogenic bacteria are involved in the
resistance to drugs and the elimination of compounds toxic to the
pathogen, functions that are crucial to the success of infections.
CXXC- or CXXC-derived motifs characterize disulphide reductases
and are involved in the catalysis of redox reactions.
Genome searches of CXXC- and CXXC-derived motifs were
performed to identify putative disulphide reductases in the epsilonproteobacteria Campylobacterales Campylobacter jejuni, Helicobacter
pylori, and Wolinella succinogenes. Genes encoding thioredoxin,
ferredoxin, and methionine sulphoxide reduction were identified
in the genomes of the three species, with the exception of genes
encoding methionine sulphoxide reduction in W. succinogenes.
Phylogenetic trees of the three reductases suggested common clades
for these enzymes. For instance, peptide methionine sulphoxide
reductase A and ferredoxin oxidoreductase subunit A were significantly closer to one another than to their respective B proteins.
In addition, the thioredoxin reductases of Campylobacterales
were more closely related to those of Firmicutes than to the
corresponding proteins of other proteobacteria.
The enzyme activities of the three Campylobacterales species were
measured employing proton nuclear magnetic resonance spectroscopy
and spectrophotometry. This was the first time that several of these
activities were measured in C. jejuni and W. succinogenes.
These investigations demonstrated that the disulphide reductases
of Campylobacterales have characteristic phylogenetic features and
enzyme activities. Features that support a special role for these
reductases in the physiology of these bacteria, and their response to
environmental stresses, such as resistance to drugs and detoxication
of xenobiotics.
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The Potential of Helicobacter pylori XGPRTase as
a Therapeutic Target: An In Silico Investigation
M. Duckworth,* A. Ménard,† F. Mégraud† and
G. L. Mendz*
*University of New South Wales, School of Biotechnology and
Biomolecular Sciences, Sydney, Australia, †Université Victor Segalen,
Bordeaux II, Laboratoire de Bactériologie, Bordeaux, France

The xanthine–guanine phosphoribosyltransferase (XGPRTase) is
an enzyme of purine nucleotide salvage synthesis. The glutamicpyruvic transaminase (gpt) gene of Helicobacter pylori has been
annotated as encoding an XGPRTase and proposed as essential for
survival of the bacterium in vitro. The aims of this work were to
establish the role of gpt in the bacterium, and to assess the potential
of the H. pylori XGPRTase as a therapeutic target by investigating
bioinformatically the effects of known inhibitors of purine PRTases.
XGPRTase activity was measured in the cytosolic fraction of
five H. pylori strains by 31P-NMR spectroscopy, and also in
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Abstract no.: 01.04
Non-Animal-Derived Medium for Transport and
Growth of Helicobacter pylori
C. M. Dierikx,* J. Martodihardjo,† J. G. Kusters,*
C. M. H. Hensgens,† A. H. M. van Vliet,* N. de Groot†
and E. J. Kuipers*
*Erasmus

MC, Rotterdam, the Netherlands, †MucoVax B.V., Leiden,
the Netherlands

Introduction. The fastidious nature of Helicobacter pylori burdens
the simple exchange of H. pylori isolates between laboratories. In
addition, all media that are commonly used for the shipment of live
H. pylori strains contain animal-derived materials, and as this is
linked with the risk of spreading infectious diseases (like bovine
spongiform encephalopathy), their use may be subject to regulations
preventing the spread of such diseases.
Aim. The formulation of a transport and growth medium for
H. pylori that does not contain animal-derived components
associated with the transfer of infectious agents.
Methods. Non-animal-derived medium (NADM) was based on
Columbia medium. Beef extract and peptic digest of animal tissue
were replaced by soja pepton, serum components were replaced by
β-cyclodextrin, and pancreatic digest of casein was replaced by
acid-hydrolyzed casein.
Results. 1, Growth: NADM-supported growth of 4/4 reference
strains and 16/16 clinical isolates to similar optical densities as
obtained with brucella media. In addition, urease activity, protein
profiles, and cellular morphology of the reference strains were
also similar when compared to strains grown in brucella media;
2, transport: NADM with 0.5% agar supported transport and storage
of strains as 4/4 tested reference strains and 11/11 tested H. pylori
strains were successfully cultured from vials stored for 3 days at
room temperature.
Conclusion. NADM can be used both as transport and as growth
medium for H. pylori. The formulation of NADM may allow
future certification allowing international transport of H. pylori
and other bacterial pathogens.
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Abstract no.: 01.05
Helicobacter pylori Amplifies Intracellular, but
not Extracellular Production of Toxic Oxygen
Species In Vitro
V. G. Zhukhovitsky,* A. A. Barsukov† and
E. G. Shcherbakova‡
*Botkin

Hospital, Moscow, Russian Federation, †BINAR Research
Center, Moscow, Russian Federation, ‡Russian Academy of
Postgraduate Medical Education, Moscow, Russian Federation
Objective. Helicobacter pylori induces oxidative burst of
polymor-phonuclear leukocytes (PMN) and subsequent release of
toxic oxygen species.
Methods. Broth and agar cultures of H. pylori NCTC 11639
cultivated during 48 hours in microaerobic conditions onto
brucella broth with normal horse serum (NHS) and Columbia agar
with lyzed horse blood were used. H. pylori- or opsonized
zymosan-induced chemiluminescence of PMN from health
volunteers in presence of luminol (Aldrich Chem. Co.) or lucigenin
(Sigma) was measured using chemiluminometer LKB-1251
(Wallak, Sweden). Optical density of zymosan suspension was

© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556

equalized with optical density of 1.0 × 109 cfu/ml H. pylori
suspension. Integral chemiluminescence response (ICR) was
estimated in mV/20 minutes/100 PMN.
Results. In presence of luminol agar H. pylori NCTC 11639
culture induced on the average 61.0 ± 0.4 mV ICR whereas
zymosan induced 14.2 ± 0.7 mV ICP only ( p < .001). In contrast, in
the presence of lucigenin these indices accounted for 2.1 ± 0.1 mV
and 4.3 ± 0.4 mV, respectively ( p < .01). Broth H. pylori NCTC 11639
culture also induced reduced ICR in the presence of lucigenin, but
not in the presence of luminol: 2.2 ± 0.2 mV versus 4.4 ± 0.3 mV by
zymosan and 13.2 ± 0.4 mV versus 14.6 ± 0.4 mV by zymosan,
respectively ( p < .01).
Discussion. As long as luminescence of luminol reflects intracellular
events of oxygen metabolism during phagocytosis, mainly associated
with myeloperoxidase, while lucigenin records extracellular
superoxide anion generation, H. pylori exerts double influence
upon PMN. Possibly, bacterial cells from agar culture and bacterial
cells from broth culture opsonized by NHS interact with different
receptors of PMN.
Conclusion. H. pylori amplifies intracellular and suppresses
extracellular generation of toxic oxygen species.
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Abstract no.: 01.06
Ciprofloxacin–Bismuth Complexation:
A Novel Approach for Helicobacter Therapy
A. R. Shaikh,* M. R. Yadav* and V. S. Velingkar†
*Department

of Pharmacy, M.S. University, Baroda, India,
College of Pharmacy, Mumbai, India

†K. M. Kundnanai

Helicobacter pylori is a curved, spiral Gram-negative motile
organism. It infects the gastric antrum and causes gastritis.
H. pylori infection results in an acute, then chronic inflammation of
the gastric mucosa. The inflammation regresses following
antimicrobial treatment.
Bismuth Compounds for Eradication of Helicobacter pylori.
Helicobacter pylori is highly susceptible to bismuth, a heavy metal
with antimicrobial activity linked to its effect on bacterial iron
uptake. Despite these findings, bismuth monotherapy often fails to
completely eradicate these bacteria. A number of studies have
linked the antimicrobial activities of many heavy metals, including
bismuth, against Helicobacter.
Fluoroquinolones posses a broad spectrum of activity. They
show activity against a wide variety of aerobic Gram-negative and
Gram-positive bacteria. The mechanism of their action involves
inhibition of bacterial DNA gyrase, which is essential for DNA
replication, and it has been proposed that metal complex
intermediates are involved in this process.
Experimental Work. Present work involved the synthesis of an
organometallic complex of iprofloxacin with bismuth. The
previously mentioned complex was purified and characterized by
various spectral techniques like UV, IR, NMR, DSC, AAS.
Preliminary antimicrobial evaluation confirmed the activity of
the synthesized complex against various Gram-negative and
Gram-positive organisms.
In vitro anti-H. pylori studies were performed and the MIC
values for the complex was determined. The complex was found to
be active against H. pylori with a MIC value of less than 0.25 µg/l.
Also, the activity was compared against the standard drugs
(ciprofloxacin alone and also with the bismuth salt alone).
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Abstract no.: 01.07
The Lectin Cascade and Killing of
Helicobacter pylori
8Abstract
Abstracts

C. Basset, J. Holton, R. O’Mahony and I. Roitt
University College London, London, UK
Introduction. Helicobacter pylori survives in the stomach despite
a good systemic response but also manages to circumvent the
innate immune defenses by coating itself with host CD59, which is
anticomplementary. The role of mannose-binding lectin (MBL) in
killing H. pylori has not been investigated. Thus, we have studied
the effect of serum components including MBL on H. pylori
survival using an in vitro system.
Material and Methods. Anti-H. pylori antibody positive and
negative normal serum, serum heated at 50 °C or 56 °C for
30 minutes, C2-deficient serum and three sera deficient in MBL
were tested against six clinical isolates of H. pylori and NCTC
strain 11637. A suspension of H. pylori (1.0 × 107 final
concentration) was mixed with sera or sera supplemented with 100
microg/ml purified MBL and samples taken every 15 minutes for
1 hour and dilutions plated on Colombia blood agar with 5% horse
blood and incubated for 4 days at 37 °C in CO2.
Results. Five percent antibody-positive and -negative sera killed
H. pylori within 15 minutes. Sera heated at 50 °C or 56 °C and sera
deficient in C2 or MBL did not kill H. pylori. MBL alone had no
activity on the viability of H. pylori. C2-deficient sera with added
MBL did not kill H. pylori. The three MBL-deficient sera with
added MBL did kill H. pylori to the same level as the control sera.
Conclusion. H. pylori activates the lectin cascade resulting in
killing.
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Abstract no.: 01.08
Sodium Deoxycholic Acid and Native Pig Bile
Tolerance of Helicobacter pylori and
Enterohepatic Helicobacter Species
T. A. Rodionova, H. Nilsson, Å. Ljungh and
T. Wadström
Department of Laboratory Medicine, Lund University, Lund, Sweden
Helicobacter pylori and enterohepatic Helicobacter species (EHS)
have been associated with hepatic diseases in man. Previous reports
demonstrated antibacterial activity of bile acids against H. pylori.
H. pylori as well as EHS tolerance to native bile has not been
reported.
We determined survival and growth kinetics of H. pylori
(CCUG 17874), H. pullorum (CCUG 33838), and H. bilis (CCUG
38995) using brucella blood agar (BA), brucella broth (BB), and a
defined (F12) liquid medium with or without supplementation
with various concentrations of sodium deoxycholic acid (Sdoc) and
native pig bile (sterile filtered pool from healthy pigs).
The Helicobacter strains were cultured on BA, harvested,
suspended in PBS (OD540 1.0), and inoculated onto BA
supplemented with pig bile or Sdoc. Aliquots of exponential phase
F12- or BB-cultures were supplemented with pig bile or Sdoc and
CFU determined at different time-points.
H. pylori grew on BA and in BB with up to 15% of native bile or
0.05% of Sdoc. Supplements prolonged the lag-phase at higher
concentrations. Bacteria grown in F12 were more sensitive to both
bile and Sdoc; growth was possible in 0.5% bile and survival

Microbiology
(24 hours) in 3% bile. H. pullorum was extremely tolerant to bile
and Sdoc and grew in pure bile and in BB or BA containing 1.25%
Sdoc. Cultivation in F12 decreased the tolerance to Sdoc (0.25%),
but not to native bile. Growth of H. bilis in BB was not inhibited
by supplementation with 60% of native bile. H. pylori and EHS
survive and replicate in natural bile.
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Abstract no.: 01.09
Inhibition of Helicobacter pylori by Probiotic and
Dairy Lactobacillus Strains
A. Haukioja,* V. Loimaranta† and J. Tenovuo†
*Institute

of Dentistry, PeGaSOS, University of Turku, Turku, Finland,
of Dentistry, Department of Cariology, University of Turku,
Turku, Finland

†Institute

In recent decades, much attention has been paid on healthpromoting probiotic properties of lactobacilli. Our aim was to
investigate the growth inhibitory activity of seven probiotic and
three dairy Lactobacillus strains against Helicobacter pylori.
Lactobacilli were grown overnight in MRS broth in anaerobic
atmosphere. The bacteria were collected and resuspended in fresh
MRS broth to 109 cfu/ml. H. pylori ATCC 43504 grown on
brucella–horse blood agar was collected in PBS and 107 cfu was
plated on the brucella–horse blood plates. Three filter paper discs
(diameter 0.5 cm) were set on the plate and 25 µl of MRS broth,
1/100 diluted Lactobacillus suspension or undiluted Lactobacillus
suspension was added on discs. After 3 days cultivation in a
microaerophilic atmosphere, the diameters of the inhibition zones
were measured.
Of the 10 tested lactobacilli, five (2 dairy and 3 probiotic)
inhibited the growth of H. pylori. The diameters of the inhibition
zones varied between 0.8 and 1.7 cm. Two probiotic strains caused
a very narrow (< 1 mm) inhibition zone around the filter paper.
The rest of the tested lactobacilli (one dairy and two probiotic) did
not have any effect on H. pylori growth.
To conclude, there were both probiotic and dairy strains that
inhibited the H. pylori growth. The inhibitory activity was strainspecific – strains of same species behaved differently. Half of the
tested strains showed potential in H. pylori growth inhibition in
these preliminary in vitro experiments and are therefore interesting
for further characterization.
Supported by the Turku University Central Hospital.
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Abstract no.: 01.10
HYPERCHEM RELEASE 6.0, A Novel Approach for

the Design of Helicobacter pylori Inhibitors
A. R. Shaikh,* M. R. Yadav* and V. S. Velingkar†
*Department

of Pharmacy, M.S. University of Baroda, Baroda, India,
College Of Pharmacy, Mumbai, India

†K.M. Kundnani

The explosive development of computer technology and of
methodology to calculate molecular properties have increasingly
made it possible to use computer techniques to aid the drug
development process with the aim of making it more rational.
Objectives. To explain how the software tools (hyperchem
release 6.0) help in designing some novel organometallic
compounds, which were found to be specifically active against
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556
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Helicobacter pylori, a prevalent human pathogen responsible for
more than 90% of the cases for ulcer.
Experimental Computation and Model Build. Quantitative
structure–activity relationship (QSAR) properties like atomic partial
charges, Vander Waal’s, solvent accessible surface area, Vander Waal’s
surface bounded molecular volume, mass, log p, molar refractivity,
and polarizability were computed for the previously mentioned
compounds using hyperchem release 6.0. Atom-wise contribution for the QSAR properties was carried out to find the role
of each atom for the change in physicochemical parameters. Model
build studies were performed to find the most stable confirmation
of the synthesized compounds. Bond-length comparison was
performed as a basis for drug receptor studies in details.
Also antimicrobial and anti-Helicobacter (in vitro) studies were
performed.
Conclusion and Achievements. These calculations suggest that
hydration energy in the range of −22.0 to −28.0 kcal/mol, log p,
1.004–0 2.07, refractivity, 86 –214A3, polarizability, 46–89 A3 are
the minimum requirements for exhibiting anti-H. pylori activity.
Model build studies suggest that the compounds have achieved
energy minima and the most stable confirmation.
Thus, hyperchem release 6.0 has been found to play a major
role in the development of some new generation anti-ulcer agents.
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Abstract no.: 01.11
Effect of Probiotic Lactic Acid Bacteria Isolated
from Foods Against Helicobacter pylori
Y. Moreno, C. Parra, A. Jiménez, A. González and
M. A. Ferrús
Universidad Politécnica de Valencia,Valencia, Spain
Helicobacter pylori is an etiological agent of gastritis and peptic ulcer
disease. Lactobacilli bacteria present in foods have been reported to
exhibit antimicrobial activities against human pathogens. Even
the oral administration of lactobacilli as supplements has been
successfully used for pathogen eradication.
Objective. To evaluate the in vitro antimicrobial effects of
lactobacilli isolated from commercial fermented products on
H. pylori strains.
Methods. Eighteen commercial food samples, four probiotic
lyophilised concentrates, and seven milk samples were analyzed
after enrichment in MRS broth. Isolates were identified by CH50
API system. Two reference and two H. pylori clinical strains were
used for inhibition assays. Inhibitory activity was assayed with a
well test by adding 100 µl of the lactobacilli culture in each well,
and by directly using agar discs with lactobacilli on a solid H. pylori
culture. Antibiotic resistance was measured by E-test system.
Urease activity was detected with a urease media containing phenol
red and measured by spectrophotometric analysis at 550 nm.
Results. H. pylori NCTC 11637 was inhibited by all the
lactobacilli tested. The different isolates belonging to L. casei,
L. paracasei, L. plantarum, L. acidophilus, L. johnsonii, L. rhamnosus,
and L. pentosus species presented antimicrobial activity against all
H. pylori strains. Probiotic products containing species different
from the previously mentioned were not active against H. pylori.
Urease activity was affected by lactobacilli presence. The inhibitory
activity was present always when lactobacilli cells were confronted
to H. pylori cells, whereas supernatants without lactobacilli cells
did not inhibit H. pylori growth.

© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556

Abstract no.: 01.12
Comparison of DNA Fingerprints of SingleColony Isolates of Helicobacter pylori from
Corpus and Antrum by RAPD–PCR
8Abstract
Abstracts

F. Siavoshi,* M. Shokuhfard,* R. Malekzadeh,†
N. Dinparast Jaded‡ and S. Massarrat†
*Microbiology

Department, Faculty Science, Tehran University, Tehran,
Islamic Republic of Iran, †Digestive Diseases Research Center, Tehran
University of Medical Science, Tehran, Islamic Republic of Iran,
‡Biotechnology Department, Pasteur Institute of Iran, Tehran, Islamic
Republic of Iran
Background. Chronic infection of Helicobacter pylori leads to
gastric ulcer and cancer. Bacterial genetic profile is one important
factor that determines the consequences of the infection. Genetic
fingerprinting of H. pylori isolates indicates remarkable heterogeneity
within H. pylori populations worldwide. In this study, genetic
fingerprints of H. pylori isolates cultured from corpus and antrum
of two cancer patients were compared.
Methods. Gastric biopsies from corpus and antrum of two
patients with adenocarcinoma were cultured on brucella blood agar
and incubated microaerobically at 37 °C. Twelve single colonies
from corpus and antrum of each patient were subcultured for DNA
extraction. Random amplified polymorphic DNA–polymerase chain
reaction (RAPD–PCR) was optimized using designed primers.
The generated DNA fingerprints were analyzed on agarose gel.
Results. DNA fingerprints of 12 colonies from corpus and antrum
of each patient showed identical band profiles with 100%
homology. Although isolates from two patients exhibited totally
different genetic fingerprinting.
Discussion. The results of this study suggest that cancer patients
under study were infected with a genetically predominant strain
throughout the stomach. It appears that young individuals are commonly colonized with multiple strains of H. pylori, whereas adults
become predominantly infected with one strain. These changes might
convert a chronic benign to a malignant and detrimental malady.
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Abstract no.: 01.13
Two-Phase Medium for Long-Term Storage
of Helicobacter pylori Cultures
L. G. Bajenov,*† E. V. Rizaeva* and E. V. Artemova*
*Republican
†Uzbek

Specialized Centre of Surgery, Tashkent, Uzbekistan,
Helicobacter Study Group, Tashkent, Uzbekistan

The purpose of the work: To elaborate an effective and accessible
medium permitting sustained vitality of the Helicobacter pylori
cultures in laboratory conditions for long periods.
Medium consisting of semifluid and dense phases was elaborated.
A semifluid phase is prepared of brain–heart broth (“HiMedia”,
India) with addition of hemin, vitamin K, and agar (0.75 g/l). The
dense phase represents egg emulsion coagulated at 85 °C. In each
test tube with a dense phase we pour out 2 ml of a semifluid phase.
If it is necessary, for addition of selective properties to medium we
add amphotericin B, vancomycin, and nalidixic acid in the generally
accepted concentrations. Then in test tubes with medium, we inoculate
the H. pylori cultures or gastric juice or gastric biopsies. After
incubation within 3–4 days at 37 °C, we study the grown microorganisms by microscopy of gram preparation, doing urease and
other tests and if it is necessary reinoculate them on other mediums.

462
The H. pylori cultures in a given medium remain viable without
reinoculation for not less than 20 days, and with weekly
reinoculations – up to 2 years and more with maintainance of basic
biological properties.
Thus, elaborated medium allows storing H. pylori cultures in
laboratory conditions for a long time, at their regular reinoculations
from one test tube to another. The combination of dense and
semifluid mediums permits to grow microorganisms without the
use of anaerostats, mineral oil, and shakers, etc., that essentially reduce
complexity and financial costs at work with H. pylori cultures.

Abstract no.: 01.14
Probiotics Against Helicobacter pylori.
Is There Any Effect?
Abstracts
8Abstract

J. Díaz-Regañón Vilches, T. Alarcón, S. Abanades,
A. Pérez de Ayala, D. Domingo and M. López-Brea
Hospital de La Princesa, Servicio de Microbiología, Madrid, Spain
Objective. To determine the effect of six probiotics against 16
Helicobacter pylori clinical strains.
Methods. A prospective study was made from January 2004 to
January 2005. H. pylori strains were isolated from 16 gastric
biopsies. They were plated on blood and pylori agar and incubated
under microaerobic atmosphere at 37 °C for 3–5 days. Identification
was made by Gram stain and by the presence of oxidase, catalase,
and urease. Probiotics were obtained from five commercial
products and one blood culture and were identified by Gram stain
and Api (BioMérieux).We also tested them for susceptibility to
vancomycin by disc diffusion. We obtained three Lactobacillus spp.
vancomycin-resistant, one Lactobacillus reuteri vancomycin-resistant,
one Lactobacillus acidophilus vancomycin-susceptible, and one
Lactococcus lactis lactis vancomycin-susceptible. To determine the
effect of these probiotics we made the “striation” method. On a
blood agar plate we made a striation with the maximum colonies of
H. pylori that was crossed by another one of the probiotic after a
0.5 MacFarland suspension. Plates were incubated at 37 °C for
3–5 days under microaerobic conditions.
Results. Three H. pylori strains were inhibited by three probiotics.
Two were Lactobacillus spp. and one Lactococcus lactis lactis and
they had an inhibitory effect. After incubating the plates we could
see no growth of the H. pylori but it was clear for the probiotics.
Conclusions. We found an inhibitory effect of three probiotics on
three clinical H. pylori strains. This effect needs confirmation by
other techniques, but keeps the possibility to an adjuvant treatment
against H. pylori.

Abstract no.: 01.15
The Growth Inhibitory Effects of Cranberry
Extract on Helicobacter pylori – In Vitro Analyses
8Abstract
Abstracts

M. Matsushima, T. Suzuki, A. Masui, T. Shirai and
T. Mine
Department of Internal Medicine,Tokai University School of Medicine,
Isehara, Japan
Background and Aim. Cranberry is a fruit that originated in
North America, and had been used for bacterial infection by the
native people. Recent studies revealed that it is effective for

Microbiology
preventing refractory urinary infections, and also suggested
possible roles in the eradication of Helicobacter pylori from human
and mice. Besides, the cranberry high-molecular-constituent was
shown to have anti-adhesion activity to human gastric cells. The
aim of this paper was to investigate the growth inhibitory effects of
cranberry on H. pylori in vitro and getting the basic backgrounds
before possible clinical application.
Method. The H. pylori strains used were NCTC11637 and 11638
that were cultured in brain–heart infusion (BHI) or on BHI/horse
blood plasma plates with or without the cranberry hot-water
extract supplied by Kikkoman Co. The concentrations of the
bacteria were estimated by measuring OD660, and the bacteria
proliferating were titrated using HelicoBlue plates. The shapes of
the bacteria were analyzed by a scanning electron microscope.
Results. The cranberry extract suppressed the bacterial proliferation
in a dose-dependent manner and did almost completely at
concentration of 1 mg/ml and 3.3 mg/ml in liquid and on plate
culture, respectively. The shapes of the bacteria after incubation
with the cranberry extract showed the tendency of more coccoid,
shortened, L-shaped appearance, and clustering formation.
Conclusion. The cranberry extract inhibits H. pylori proliferation
and seems inducing unhealthy condition of the bacteria in vitro.
Further basic studies on the mechanisms and the effective
ingredients of the growth inhibiting function, as well as in vivo
studies, will be necessary.
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Abstract no.: 01.16
Optimization of Culture Conditions for Isolation
and Recovery of Helicobacter pylori Strains
L. Zamaninia, M. Mohammadi, M. Esmaieli,
F. Mahmoudi and A. Oghalaie
Biotechnology Research Center, Pasteur Institute of Iran, Tehran,
Islamic Republic of Iran
Helicobacter pylori is regarded as a highly fastidious organism that
typically requires 5 and 10 days for passage and isolation from
gastric biopsies, respectively.
The aim of this study was to optimize the isolation and freezing
procedures in order to obtain and maintain H. pylori strains at their
most viable form under most time and cost-effective conditions.
H. pylori growth response to different plating media; brucella blood
agar and H. pylori special peptone agar (HPSPA) supplemented with
10% defibrinated blood was determined, and significant differences
were observed. Gastric biopsies cultured on HPSPA medium
resulted in larger and separated colonies, leading to easier isolation
of single colonies from otherwise contaminated clinical samples.
To identify the optimum gas composition that enhances the
growth rate as well as colony size, four different conditions were
compared: 1, 5% CO2; 2, 10% CO2; 3, 85% N2, 10% O2, 5% CO2;
and 4, 85% N2, 10% CO2, 5% O2. Mixed composition of 85% N2,
10% CO2, and 5% O2 yielded the highest rate of strain recovery
and larger colony size.
Chances of strain recovery following deep freezing is influenced
by enrichment of freezing media and initial load of bacterium. The
optimized freezing media in this study was determined as 25%
glycerol, 25% fetal bovine serum, and 50% bacterial wash in brain–
heart infusion media.
Collectively, the mentioned optimized conditions reduced the required time of incubation by half and doubled the rate of strain recovery.
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Abstract no.: 01.17
Performance of Serologic Assays for Helicobacter
pylori in European and Asian Populations
H. T. T. Hoang,*† A. Rehnberg,‡ T. Wheeldon,‡
C. Bengtsson,* C. Phung,† R. Befrits,‡ M. Sorberg‡
and M. Granstrom*
*Karolinska

Institute, Stockholm, Sweden, †National Institute of
Hygiene and Epidemiology, Hanoi,Vietnam, ‡Karolinska University
Hospital, Stockholm, Sweden

Aims. To investigate the performance of commercial kits in
Western (Swedish) and Asian (Vietnamese) population and to find
commercial test alternatives for Asian populations.
Methods. Serum samples were collected from 91 Swedish gastric
ulcer patients and 270 Vietnamese peptic ulcer disease patients
(PUD); control samples came from 141 Swedish healthy individuals,
positive for Helicobacter pylori by urea breath test and 429
Vietnamese population controls of unknown H. pylori status.
The assays used were Pyloriset EIA-GIII, HM-CAP, Helicoblot
2.1 and an in-house ELISA with Swedish and Vietnamese strains,
respectively.
Results. All four assays had high sensitivities of 96.7–100% in the
Swedish populations and in the Vietnamese PUD patients, but
HM-CAP was significantly ( p < .001) less sensitive. In the Vietnamese
population controls, with immunoblot as reference, the in-house
ELISA and the Pyloriset EIA-GIII showed good performances,
whereas the HM-CAP was both less sensitive and less specific. The
performance of the Pyloriset could be further improved in the
Vietnamese population controls by lowering the cut-off level to 19,
whereas HM-CAP performed poorly even at the indicated optimal
cut-off level of 1.8. For the immunoblot, the only difference noted
was the response to the 35 kDa antigen, significantly ( p < .001) less
common in the Vietnamese as compared to the Swedish study
populations. The immunoblot performed, however, equally and
well in both populations.
Conclusion. Asian populations were found to have lower antibody
concentrations to H. pylori strains used in commercial kits than
Western populations. The Pyloriset EIA-GIII and Helicoblot 2.1
performed well in both populations.
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Abstract no.: 01.18
Is Helicobacter hepaticus Antigen of New
Monoclonal Antibodies Related to Strain
Diversity of the Bacteria?
R. Takahashi,* Y. Fukuda,† T. Sakagami,† K. Murakami,‡
T. Shimoyama,§ Y. Sano,* N. Nakabayashi,* T. Ohmura*
and T. Fujioka‡
*Wakamoto Pharmaceutical Co. Ltd. Sagami Research Laboratories,
378 Oimachi, Ashigarakamigun, Kanagawa 258-0018, Japan,
†Departments of Internal Medicine, Hyogo College of Medicine, 1-1
Mukougawa, Nishinomiya, Hyogo 663-8501, Japan, ‡Oita University
Faculty of Medicine, 1-1 Hasama-Machi, Oita 879-5593, Japan, §First
Department of Internal Medicine, Hirosaki University School of
Medicine, 5 Zaifu, Hirosaki 036-8562, Japan

for ELISA corresponding to the polymerase chain reaction (PCR)
result. As one of the reasons, we speculate that the mutagenesis of
H. hepaticus may be easily induced. This study investigated
whether one strain’s H. hepaticus antigen could be detected in
other strains.
Methods. Monoclonal antibodies were prepared from H. hepaticus
(A. Lee strain) antigen immunized spleen cells and myeloma cells
(P3-X63-Ag8.653), and selected noncross reactivity with other
bacteria (Helicobacter five species and five bacteria). The sonicated
whole cells of H. hepaticus strains (ATCC, JG Fox strain, A. Lee
strain) was estimated by Western blot analysis with the selected
monoclonal antibody.
Results. The selected monoclonal antibodies were reacted to
H. hepaticus antigen with the molecular mass of 13–15 kDa. The
antigen could be detected in A. Lee strain but undetectable in the
ATCC strain and GJ Fox strain. The A. Lee strain’s antigen (Lee
antigen) was gradually diminished because of the passage culture
under the same condition and was shown in an irreversible
expression. Several sera of patients with chronic liver disease were
reacted to the Lee antigen.
Conculusion. Strain diversity of H. hepaticus may be easily
induced with the change of environments. The Lee antigen might
be strongly implicated in the strain diversity of H. hepaticus and is
diminished easily by the fine change of environment factors.

Abstract no.: 01.19
Extraction and Separation of LPS from Outer
Membrane of Helicobacter pylori by SDS_PAGE
and Silver Nitrate Staining
8Abstract
Abstracts

J. Zavarreza,* M. Doosti,* S. Ariabarzin,* F. Siavoshi†
and S. Masserrat‡
*Department

of Medical Biochemistry, Faculty of Medicine, Tehran
University of Medical Science, Tehran, Islamic Republic of Iran,
†Department of Medical Microbiology, Faculty of Science, Tehran
University, Tehran, Islamic Republic of Iran, ‡Digestive Disease
Research Center – Shariati Hospital, Tehran, Islamic Republic of Iran
Helicobacter pylori is a microaerophilic, Gram-negative, spiral-like,
unease positive, and motile bacterium resistant to the acid. One of
the properties of this bacterium is its special lipopolysaccharides
(LPS).
LPS of the bacterium is responsible for its high resistance against
gastric acid and escape from the human immune system. This
property of LPS makes it a target for further research or diagnostic
goals. For this research to be conducted, its extraction, separation,
and purification from outer membrane is required. In this study,
LPS from the outer membrane or envelope of H. pylori is extracted
from bacteria, obtained from patients who suffer from gastritis,
gastric ulcer, and gastric cancer. LPS extraction was carried out by
both proteinase K and hot-phenol methods. SDS-PAGE and silver
staining were applied to investigate the electrophoretical pattern of
LPS. Finally, the obtained pattern was compared with that of
Escherichia coli serotype O111: B4 and Salmonella serotype ATCT
14028.
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Aims. Several studies have suggested Helicobacter hepaticus was
involved in the pathogenesis of chronic liver disease in humans.
However, nobody has succeeded in the isolation of H. hepaticus
from the human samples and has found out H. hepaticus antigen
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556
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Abstract no.: 01.20
The Novel Helicobacter pylori Cadmium, Zinc,
and Nickel Resistance Determinants CznA
(HP0971), CznB (HP0970), and CznC (HP0969)
are Required for Urease Modulation and Gastric
Colonization
F. Stähler,* S. Odenbreit,† R. Haas,† B. Waidner,*
A. H. M. van Vliet,‡ J. G. Kusters,‡ M. Kist* and
S. Bereswill*§
*Department of Microbiology and Hygiene, Institute of Medical
Microbiology and Hygiene, University Hospital Freiburg, Freiburg,
Germany, †Ludwig–Maximilians University Munich, Max von
Pettenkofer Institute for Hygiene and Medical Microbiology, Munich,
Germany, ‡Department of Gastroenterology and Hepatology, Erasmus
MC – University Medical Center, Rotterdam, the Netherlands,
§Humboldt University, Charité University Medicine Berlin, Charité
Campus Mitte, Institute for Microbiology and Hygiene, Berlin,
Germany

Maintaining proper metal ion metabolism plays a crucial role in
the adaptation of Helicobacter pylori to the changing gastric
environment. The nickel-cofactored urease is essential for survival
in the gastric mucosa and it has been demonstrated that iron, copper,
and nickel homeostasis is required for H. pylori colonization in
animal models. Here we demonstrate that the HP0969-71 gene
cluster encodes a novel H. pylori metal resistance determinant,
which is essential for gastric colonization and modulation of urease
activity. The corresponding genes were designated cznA (hp0971),
cznB (hp0970), and cznC (hp0969), because individual hp0971,
hp0970, or hp0969 mutants displayed increased sensitivity to
cadmium, zinc, and nickel (czn). In the cznA mutant, accumulating
nickel ions led to a 8- to 10-fold increase in urease activity, indicating
that nickel export by the encoded H. pylori-specific protein is required
for urease modulation. Furthermore, the functions of H. pylori cznA,
cznB, and cznC in metal export are essential for survival in the
gastric mucosa, as the corresponding individual knockout mutants
were unable to colonize the gastric mucosa in a Mongolian gerbil-based
animal model. In summary, the phenotypes observed indicate that
the cznABC genes encode a novel H. pylori metal ion exporter and
underline the extraordinary importance of metal ion homeostasis
for the survival of H. pylori in the hostile gastric environment.
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Abstract no.: 01.21
A Novel Copper Regulation System in the
Gastric Pathogen Helicobacter pylori
8Molecular genetics and genomics
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B. Waidner,* F. Stähler,* M. Kist* and S. Bereswill†
*Department

of Medical Microbiology and Hygiene, Institute of
Medical Microbiology and Hygiene, University Hospital Freiburg,
Freiburg, Germany, †Humboldt University, Charité University
Medicine Berlin, Charité Campus Mitte, Institute for Microbiology
and Hygiene, Berlin, Germany
Ion metabolism plays an important role in the adaptation of
Helicobacter pylori to the changing gastric environment and it was
demonstrated that maintaining proper metal ion homeostasis is of
extraordinary importance for gastric colonization, as mutants
defective in maintaining proper iron, nickel, or copper metabolism
were unable to colonize in animal models. Here we describe that
the H. pylori sensor kinase HP1364 and response regulator
HP1365 designated CrdS and CrdR, respectively, are both required
for transcriptional copper-induction of the H. pylori copper
resistance protein CrdA, which is proposed to sequestrate copper
ions in the periplasmic space. H. pylori mutants deficient in CrdR
or CrdS production lacked copper-induction of crdA expression
and were copper-sensitive. A direct role of CrdR in transcriptional
regulation of crdA was confirmed by in vitro binding of CrdR to
the crdA upstream DNA region and a 21 nucleotide sequence
located nearby the crdA promoter was shown to be required for
CrdR binding. We conclude that the first description of a copper
regulator in H. pylori will give novel insights in the role of metal
homeostasis in the adaptation to the hostile gastric niche.
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Abstract no.: 02.01*
HP0906 Controls Flagellar Hook–Filament
Transition in Helicobacter pylori
K. A. Ryan,* N. Karim,† M. Worku,† C. W. Penn‡ and
P. W. O’Toole*
*University College Cork, Cork, Ireland, †Imperial College School of
Medicine, London, UK, ‡University of Birmingham, Birmingham, UK

Helicobacter pylori is dependent on motility for infection. The
H. pylori genome encodes a near-complete complement of flagellar

proteins compared to model enteric bacteria. One of the few
flagellar genes not annotated in H. pylori is that encoding FliK, a
hook-length control protein whose absence leads to a polyhook
phenotype in Salmonella enterica. We investigated the role of the
H. pylori gene HP0906 in flagellar biogenesis because of linkage to
other flagellar genes, its transcriptional regulation pattern, and
because of the properties of an ortholog in Campylobacter jejuni.
A nonpolar mutation of HP0906 in strain CCUG 17874 was
generated by insertion of a chloramphenicol resistance marker.
Cells of the mutant displayed impaired motility, and produced
sheathed, undulating polyhook structures. Expression of HP0906
in a Salmonella fliK mutant restored motility, confirming that
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556
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HP0906 is the H. pylori fliK gene. Mutation of HP0906 caused a
dramatic reduction in H. pylori flagellin protein production, and a
significant increase in production of the hook protein FlgE. The
HP0906 mutant showed increased transcription of the flgE and flaB
genes relative to the wild-type, down-regulation of flaA transcription,
and no significant change in the transcription of the flagellar
intermediate class genes flgM, fliD, and flhA. We conclude that the
H. pylori HP0906 gene product is the hook-length control protein
FliK, and that its function is required for turning off the sigma 54
regulon during the progression of the flagellar gene expression cascade.
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Abstract no.: 02.02*
The NikR Protein Mediates Nickel-Responsive
Regulation of the Helicobacter pylori Iron-Uptake
Genes fecA3 and frpB3
F. D. Ernst, J. M. Horrevoets, E. J. Kuipers, J. Stoof,
J. G. Kusters and A. H. M. van Vliet
Department of Gastroenterology and Hepatology, Erasmus
MC–University Medical Center, Rotterdam, the Netherlands
Objective. Intracellular homeostasis of the iron is a necessity for
most organisms, as both iron deficiency and iron overload will
result in cell death. The gastric pathogen Helicobacter pylori has
three copies of the fecA and frpB iron-uptake genes, of which the
fecA1/2 and frpB1/2 genes are regulated by the Fur protein.
Surprisingly, fecA3 and frpB3 are not Fur-regulated and thus were
thought to be constitutively expressed. H. pylori expresses a second
metal-regulatory protein, NikR, and in this study we have
investigated whether the fecA3 and frpB3 genes are regulated by
NikR.
Methods. H. pylori reference strain 26,695 and isogenic mutants
were grown in brucella broth supplemented with NiCl2. Gene expression was determined by Northern hybridization, primer extension
and SDS-PAGE.
Results. Expression of the fecA3 and frpB3 genes was nickelrepressed in wild-type H. pylori, but constitutively expressed in the
nikR mutant. However, the genes fecA1/2 and frpB1/2 did not
display any nickel or NikR-dependent regulation. On the
translational level the nickel- and NikR-dependent regulation was
confirmed for FrpB3. Mutation of frpB3 had no effect on growth in
nickel-supplemented medium, possibly due to the compensatory
expression of the two other copies of the fecA and frpB genes.
Conclusion. The NikR and Fur proteins each regulate the
expression of a subset of iron-transporter proteins, allowing
differential expression of iron-uptake systems depending on the
environmental conditions. This may help H. pylori to survive the
acidic conditions in the gastric mucosa.
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Abstract no.: 02.03
Fur Mediates Regulation of Iron-Uptake Genes in
Helicobacter mustelae
J. Stoof, E. J. Kuipers, J. G. Kusters and
A. H. M. van Vliet
Erasmus MC-University Medical Center, Rotterdam, the Netherlands
Objective. Iron restriction at mucosal surfaces by host is a
nonspecific defense mechanism against bacterial pathogens, and
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556

hence iron acquisition is considered to be an important virulence
factor. Helicobacter mustelae is a gastric pathogen of ferrets, and its
pathogenesis mimics many aspects of human infection with
Helicobacter pylori. However, relatively little is known about the
virulence factors of H. mustelae and their regulation. In this study,
we have determined the role of Fur in the regulation of iron
acquisition in H. mustelae.
Methods. The preliminary public release of the H. mustelae
genome sequence was screened for genes encoding putative ironaquisition proteins. An isogenic mutant was created in H. mustelae
ATCC 43772. Strains were grown in iron-restricted and ironsufficient conditions, and gene expression was monitored by
Northern hybridization and SDS-PAGE.
Results. Five genes were identified in the H. mustelae genome that
encode putative outer membrane receptors for iron uptake
(IROMPs). Transcription of the IROMPs FecA, FrpB1B, and
CfrA was repressed by iron and Fur, whereas expression of FrpB1a
and ChuA was not affected by either iron or Fur. Iron- and Furresponsive regulation of FecA, FrpB1B, and CfrA was confirmed
at the protein level.
Discussion. The H. mustelae genome encodes four different families
of iron-acquisition genes, which contrasts with the two families
encoded by the H. pylori genome. The Fur regulatory protein regulates
only three out of five H. mustelae iron-uptake genes, suggesting
either constitutive expression of the other two, or the presence of
an additional regulatory system controlling their expression.

Abstract no.: 02.04
Identification of Helicobacter pylori and Antrum
Erosion-Specific Gene Expression Patterns in
Gastric Biopsy Samples by Whole Genomic
Microarray Analysis
8Molecular genetics and genomics
Abstracts

O. Galamb, F. Sipos, B. Gyõrffy, B. Molnár and
Z. Tulassay
Second Department of Medicine, Semmelweis University, Budapest,
Hungary
Background. The high-density oligonucleotide microarray analysis
gives an opportunity for studying the genetic and gene expression
background of the diseases, even in small biopsy specimen.
Aims. Our aims were to identify Helicobacter pylori infection and
antrum erosion-associated gene expression patterns (GEP) and to
compare the gene expression profile of Hp+ and Hp– gastric
erosion to explain the possible role and effect of H. pylori infection.
Materials and Methods. Total RNA was extracted from frozen
gastric biopsy specimens of eight patients with Hp+ antrum erosion
and eight adjacent normal mucosa and eight patients Hp– antrum
erosion and eight adjacent normal mucosa. The mRNA fraction from
the extracted total RNA was amplified by T7 RNA amplification
method. Biotin-labeled cRNA probes were synthesized and
fragmented. The genome-wide mRNA expression profile was
evaluated by GeneChip U133 Plus 2.0 microarrays. Two
independent normalization methods (MAS 5.0, RMA), PAM
feature selection and hierarchical cluster analysis were performed.
The microarray results were confirmed by reverse transcriptasepolymerase chain reaction (RT-PCR).
Results. Significant overexpression of HLA-DMA, HLA-DQA1
antigen presentation genes, IL7R, ubiquitin D, CCR7 chemokine
receptor, killer cell lectin-like receptor, lactoferrin antimicrobial
immune response-related genes, and CXCL13 and CCL19
chemokine ligand genes were established in Hp+ patients compared
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to Hp- patients. In antrum erosion increased blood coagulation
(F2R,F3), apoptosis (p53-induced protein-3), proliferation (TNFR
superfamily 11a), and complement activation (DAF) were found,
whereas genes associated with angiogenesis (angiopoietin-like-3),
adhesion (alpha2-glycoprotein-1) and transport (Scf2/12, aquaporin4) were down-regulated.
Conclusions. The presented GEP can be used for multifunctional
mRNA-based classification of routine gastric biopsies. These genes
can be the targets of further DNA sequence-based studies.

Abstract no.: 02.05
Gastrokine 1 in Helicobacter pylori-Related
Gastric Carcinogenesis: A Genomic, Proteomic,
and Immunohistochemical Study
8Molecular genetics and genomics
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G. Nardone,* E. Rippa,† G. Martin,* A. Rocco,*
R. Siciliano,‡ A. Fiengo,§ G. Cacace,¶ A. Malorni,¶
G. Budillon,* T. E. Martin** and P. Arcari§
*Department of Clinical and Experimental Medicine, Gastroenterology
Unit, University Federico II, Naples, Italy, Napoli, Italy, †Department of
Biochemistry and Medical Biotechnologies; University Federico II,
Naples, Italy, Napoli, Italy, ‡Center of Proteomic and Biomolecular
Mass Spectrometry, CNR, Avellino, Italy, Napoli, Italy, §Department of
Biochemistry and Medical Biotechnologies, University Federico II,
Naples, Italy, Napoli, Italy, ¶Center of Proteomic and Biomelecular
Mass Spectrometry, CNR, Avellino, Napoli, Italy, **Department of
Molecular Genetics and Cell Biology, The University of Chicago,
Chicago, IL, USA

Helicobacter pylori infection is the most important etiological
factor responsible for the development of gastric cancer, a leading
cause of cancer-related deaths. Prevention is likely to be the most
effective strategy for reducing the incidence and mortality from
this disease. To be successful, a better understanding of the
molecular changes underlying gastric carcinogenesis is mandatory.
Proteomic technology is providing a rapid expansion of the basic
knowledge, particularly in the discovery of new biomarkers involved
in the tumorigenesis process. Our study was aimed to define new
molecular markers implicated in H. pylori-related carcinogenesis
by a genomic, proteomic, and immunohistochemical approach.
The study population comprised of 41 dyspeptic patients and 28
gastric cancer cases. Proteins extracted from gastric biopsies
were analyzed by 2D electrophoresis and identified by MALDI–
TOF–MS. Protein expression was evaluated by 2D gels and
monodimensional Western blot, semiquantitative RNA RT–PCR,
and immunohistochemistry. H. pylori infection was detected in
21/41 of the dyspeptic patients. In the H. pylori-positive group,
a lower expression of a protein about 18 kDa was observed that
corresponded to AMP-18 gastric protein currently referred as
Gastrokine-1. The expression of Gastrokine-1 was completely lacking
in the gastric cancer cases. Thus, our data suggest that Gastrokine-1
may play a key role in early phase of H. pylori-related gastric
carcinogenesis and provide in-depth information for a better
understanding of the GC risk of H. pylori-infected individuals
with chronic gastritis.
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Abstract no.: 02.06
Analysis of Gene Expression Profiles in Gastric
Cancer Cells According to Tyrosine
Phosphorylation Site of CagA Using Naturally
Occurring Isogenic Strains
Y. Lee,* Y. Youn,* I. Lee,† J. Pyo‡ and J. Chung*
*Department of Internal Medicine, Institute of Gastroenterology, Brain

Korea 21 Project for Medical Science, †Institute of Gastroenterology,
Brain Korea 21 Project for Medical Science, and ‡Institute of
Gastroenterology,Yonsei University College of Medicine, Seoul,
Republic of Korea
Background. Helicobacter pylori CagA protein is injected into
cells and undergoes tyrosine phosphorylation. The phosphorylated
tyrosine in CagA have various effects on cellular signal transduction,
proliferation, apoptosis, and cytoskelectal rearrangement. 147A
and 147C are a pair of naturally retrieved isogenic strains which
have difference in tyrosine phosphorylation of CagA ( J Infect Dis
2003;188:486–496). We analyzed the gene expression profiles in
gastric cancer cells stimulated with naturally occurring isogenic
strains in order to search for the host genes that are affected by the
phosphorylated tyrosine of CagA.
Methods. The AGS cells were stimulated for 24 hours by 147A
and 147C, respectively. The RNA was extracted and compared by
cDNA microarray for 8000 human genes in quadruple. The data
from microarray were analyzed and searched for the genes showing
at least a twofold difference in expression level. Differently
expressed genes identified on the microarray were validated by
reverse transcriptase-polymerase chain reaction (RT-PCR).
Results. Eighty genes showed significant changes in mRNA
expression according to difference in tyrosine phosphorylation of
CagA between 147A and 147C. There were nine genes (EGFR,
PTPRA, etc.) associated to signal transduction, 19 genes (AKAP13,
etc.) to cell growth and cytoskelecton, and three genes (FOSL2, etc.)
to cell death. Among 80 genes, up-regulations of five genes including
the AKAP13 and the PTPRA genes were analyzed by RT–PCR.
Conclusion. The differential expression of various genes in
relation to tyrosine phosphorylation in this experiment may
provide the genetic basis regarding the genofunctional role of cagA
gene and could give us the shortcut to the answer for gastric
carcinogenesis mediated by H. pylori CagA.
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Abstract no.: 02.07
Helicobacter pylori Genotyping in Gastric Lowgrade MALT Lymphoma and its Correlation with
Clinical Outcome
R. Schmelz,* D. Grossmann,* C. Thiede,* M. Dawel,†
S. Miehlke,* G. Ehninger,* M. Stolte‡ and
A. Morgner-Miehlke*
*Medical

Department I, Technical University, Dresden, Germany,
for Radiotherapy & Radiooncology, Technical University
Dresden, Germany, ‡Institute for Pathology, Klinikum Bayreuth,
Germany
†Department

Background. Helicobacter pylori has different factors of
pathogenicity, which can be associated with diseases like peptic ulcer
or gastric adenocarcinoma. Prevalence and influence of H. pylori
pathogenic factors in positive low-grade gastric mucosa-associated
lymphoid tissue (MALT) lymphoma and their potential influence
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556
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on clinical outcome after eradication of H. pylori have not been
investigated so far.
Aim and Methods. Genotyping of H. pylori for cagA, babA2,
iceA1, vacAm, vacAs, and JHP950 has been performed using
paraffin wax-embedded tissue from patients with H. pylori-positive
MALT lymphoma. The different genotypes were correlated with
time to complete remission. In addition, the lymphoma cells were
analyzed for monoclonality and translocation t (11; 18) to identify
potential risk factors for an unfavorable clinical outcome. Patients
with only partial remission 12 months after H. pylori eradication
were irradiated.
Results. So far, 24 patients have been included. Twenty-two (92%)
were tested positive for ureA. During clinical follow-up n = 4 were
drop outs, n = 3 (17%) had to be irradiated because of no complete
remission. Fifty percent of MALT lymphomas showed monoclonality, n = 2 (1%) had translocation t (11; 18). Genotyping revealed
positive results for cagA: 64%; babA2: 86%; iceA1: 50%; and
JHP950: 36%.
Conclusion. Percentage for babA2 and cagA were identical to
former reported results. IceA1 and the new marker JHP950 (Lehours
et al.) were less frequent than already published. Perhaps due to the
small number of genotyped H. pylori-positive patients there is no
correlation between an unfavorable outcome and a special genotype.
Still more patients have to be investigated. The genetic markers for
JHP1462, oipA, and sabA on-off-status are in work at the moment.
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Abstract no.: 02.08
Effect of Different Clarithromycin Resistance
Genotypes on Helicobacter pylori Eradication
Different Therapeutic Schemes
E. Ierardi,* V. De Francesco,† M. Margiotta,‡ A. Zullo,§
C. Hassan§ and C. Panella*
*Section

of Gastroenterology, Department of Medical Sciences, Foggia,
Italy, †Gastroenterology Unit Ospedali Riuniti, Foggia, Italy, ‡Section
of Gastroenterology, Department of Emergency and Organ
Translantation, Bari, Italy, §Gastroenterology Unit Ospedale Nuovo
Regina Elena, Roma, Italy
Helicobacter pylori clarithromycin resistance is caused by three-point
mutations (A2143G, A2142G, and A2142C), although their association with MIC is still controversial. This study aimed to evaluate
the role of these mutations on eradication success and to compare
standard triple therapy to sequential regimen according to resistance.
Genetic pattern of clarithromycin resistance at entry was assessed
by using a real-time polymerase chain reaction (PCR) on gastric
biopsies from H. pylori-infected patients (histology, rapid urease
test, 13C-urea breath test). Patients were treated with a 7-day triple
therapy including rabeprazole, clarithromycin, and amoxycillin
(75 patients) or a 10-day sequential regimen including rabeprazole
plus amoxycillin for 5 days and rabeprazole, clarithromycin, and
tinidazole for the remaining 5 days (81 patients). All drugs were
given twice daily. H. pylori status was checked 4 –6 weeks after
treatment as at entry.
Clarithromycin resistance was observed in 38 (24.3%) patients,
and A2143G was the most frequently detected point mutation
(55.3%). Overall, H. pylori eradication was achieved in 47.8% of
patients with the A2143G mutate strain and in 94.1% of those with
either A2142G or A2142C strains ( p = .0019). A significantly
higher cure rate in those patients infected with A2143G mutate
strains was achieved with the sequential regimen as compared to
triple therapy (69.2% versus 20%; p = .024). This is the first study
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556

showing that the A2143G mutation confers to H. pylori a crucial
clarithromycin resistance in vivo. The sequential regimen achieved
a significantly higher cure rate as compared to standard therapy
even in patients infected with A2143G mutate strains.

Abstract no.: 02.09
Molecular Detection of Host Cytokine
Expression in Cancer and Noncancer Patients via
Semiquantitative RT-PCR
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A. Oghalaie,* M. Mohammadi,* M. Eshagh Hosseini,†
M. Mohagheghi,‡ R. Ebrahimi,‡ B. Yazdizadeh‡ and
R. Sarrami*
*Biotechnology

Research Center, Pasteur Institute of Iran, Tehran,
Islamic Republic of Iran, †Endoscopy Unit, Amiralam Hospital, Tehran,
Islamic Republic of Iran, ‡Cancer Institute, Tehran Medical University,
Tehran, Islamic Republic of Iran
Introduction. The aim of this study was to determine the level of
IFN-γ (pro-inflammatory) and IL-4 (anti-inflammatory) cytokine
expression as indicators of Th1 and Th2 immune responses in gastric
cancer (GC) and nongastric cancer dyspeptic (non-GC) specimens
from Iranian patients by gene-specific reverse transcriptasepolemerase chain reaction (RT-PCR).
Materials and Methods. Biopsy specimens were collected from
three groups of gastric cancer patients (n = 18), non-ulcer dyspepsia
(NUD = 38), and ulcer patients (PUD = 20). Total RNA was extracted
from gastric tissue under RNase-free condition. Complementary DNA
was prepared from total RNA using reverse transcription system,
and PCR amplification was performed for HPRT, IFN-γ, and IL-4
cytokines and the intensity of each band was measured by densitometry
and normalized against HPRT expression as a housekeeping gene.
Results and Discussion. Comparison of results between different
groups of patients indicated that gene expression of IFN-γ was
similar in non-GC dyspeptic patients (NUD and PUD group;
3.4 ± 1.84, respectively; p < .01). Whereas, in GC cases, the IFN-γ
gene expression was significantly higher than that of non-GC
individuals (5.46 ± 0.65; p < .0001). This pronounced expression
indicates an association between TH1 response and cancer
development. There were no considerable differences between
NUD and cancer patients with regard to IL-4 gene expression,
whereas the expression rate of this cytokine was significantly
higher in PUD group (3.7 ± 0.1; p < .05). These data indicate an
association between Th2 immune response and ulcer development.
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Abstract no.: 02.10
The Association Between Asp299Gly
Polymorphism in TLR-4 Gene and the Risk of
Gastric Cancer in Korean Population
H. Y. Kim,* K. H. Kim,* J. Y. Park,* K. S. Lee,* C. J. Park,*
J. Y. Lee,* S. M. Kim,† M. K. Jang,* J. H. Lee* and
J. Y. Yoo*
*Department of Internal Medicine and †Digestive Disease Research
Laboratory, Kangdong Sacred Heart Hospital, Hallym University,
Seoul, Republic of Korea

Backgrounds/Aims. Toll-like receptor-4 (TLR-4) is a pattern recognition receptor involved in host defense against Gram-negative
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bacteria. It has been suggested to affect lipopolysaccharide
responsiveness and expression of pro-inflammatory cytokines.
Helicobacter pylori infection plays a crucial role in gastric
carcinogenesis and H. pylori LPS is one of the major virulence
factors. The recent report suggested that Asp299Gly polymorphism
in TLR-4 gene was associated with impaired LPS signaling and
increased susceptibility to Gram-negative bacteria. We evaluated
the association between the polymorphism of TLR-4 gene and the
risk of peptic ulcer and gastric cancer.
Methods. Blood were collected from patients with gastric cancer,
peptic ulcer disease, and healthy controls. We performed polymerase
chain reaction restriction length fragment polymorphism assay and
assessed Asp299Gly allele frequency.
Results. Atotal of 282 subjects (165 men and 117 women) were
enrolled. The numbers of enrolled subjects in gastric cancer, gastric
ulcer, duodenal ulcer, and control were 122, 58, 52, and 50,
respectively. There were no differences in mean age and sex ratio
among the groups. H. pylori infection rate had no significant
difference (66.4% in gastric cancer, 67.2% in gastric ulcer, 65.4% in
duodenal ulcer, and 66.0% in control subjects). The Asp299Gly
allele of TLR-4 gene was not detected in any patients with gastric
cancer, peptic ulcer disease, and controls.
Conclusions. The Asp299Gly allele of the TLR-4 gene was not
detected in any of the subjects. We suggest that it is very rare in the
Korean population and is not involved in the pathogenesis of
gastric cancer in the Korean population.
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Abstract no.: 02.11
DNA Fingerprinting of Single Colonies Isolates
of Helicobacter pylori from a Gastric Cancer
Patient by REP-PCR
S. Zabihinia,* F. Siavoshi,* R. Malekzadeh,†
N. Dinparast Djadid‡§ and S. Massarrat†
*Microbiology

Department, Tehran, Islamic Republic of Iran,
Diseases Research Center, Tehran, Islamic Republic of Iran,
‡MRG, Biotechnology Department, Tehran, Islamic Republic of Iran,
§Pasteur Institute of Iran, Tehran, Islamic Republic of Iran
†Digestive

Introduction. A large degree of heterogeneity among Helicobacter
pylori strains suggests that complex consequences of bacterial
infection such as ulcer or cancer might be due to infection with
specific strains of H. pylori. In this regard, DNA fingerprinting
methods are recruited (as powerful tools) to reveal genetic diversity
among H. pylori population and also to determine genetic changes
that H. pylori strains might undergo during colonization in the
stomach, one consequence of which might be cancer.
Methods. Biopsies from corpus and antrum of a cancer patient
were cultured on brucella agar and incubated under microaerobic
conditions at 37 °C. Twelve single colonies obtained from each
biopsy were subcultured and pure cultures were used for DNA
extraction. REP-PCR (repetitive extragenic palindromicpolymerase chain reaction) was performed after optimization with
designed primers. DNA fingerprints were analyzed on 1.5%
agarose gel.
Results. DNA fingerprints of single colonies from each corpus
and antrum contained similar band profiles. However, genetic
fingerprints of single-colony isolates from corpus exhibited only
66% homology with those isolates from antrum.
Discussion. The results of this study suggest that H. pylori strains
colonizing corpus or antrum could have different genetic
fingerprinting patterns. This difference might be the result of
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changes that H. pylori strains undergo to be able to adapt to
different loci of stomach.

Abstract no.: 02.12
Sequence Diversity of the cagA-3′′ Region in
Malaysian Helicobacter pylori Strains
8Molecular genetics and genomics
Abstracts

M. Ramelah,* H. Alfizah† and A. Aminuddin‡
*UKM

Medical Molecular Biology Institute (UMBI), Bandar Tun Razak,
Cheras, Kuala Lumpur, Malaysia, †Department of Medical Microbiology
& Immunology, Faculty of Medicine, UKM, Bandar Tun Razak, Cheras,
Kuala Lumpur, Malaysia, ‡Department of Medicine, Faculty of Medicine,
UiTM, Shah Alam, Selangor, D.E., Malaysia
Background. Variation in the cagA-3′ region of Helicobacter
pylori strains isolated from different geographic regions has been
observed.
Aim. To investigate the sequence variation in cagA-3′ of H. pylori
strains and determine their association with clinical outcome and
patient’s ethnicity.
Material and Method. DNA of 25 strains was randomly selected
from the DNA collection of Malaysian H. pylori isolates.
cagA-3′ region was amplified by polymerase chain reaction
(PCR) and cloned using pCR2.1 vector. The recombinant plasmids
were sequenced at both strands and sequence analysis was
performed.
Results. Four subtypes of cagA identified based on the strands of
cagA-3′ region were type A1, type A2, type B, and type C. Deduced
amino acid sequences showed that there are four different segments
present in the region named as α, β, γ, δ. The α segment is more
conserved among different genotypes whereas segments β, γ, and δ
showed variability in the sequence among strains. The sequence of
β1, γ1, and δ1 are similar to the East Asian CagA specific sequence
and β2, γ2, and δ2 are similar to the Western CagA. The number of
EPIYA motifs detected were three in cagA types A1 and A2, four in
cagA type B, and two in cagA type C. cagA type A1 was found to
be associated with patients of Chinese origin and also with peptic
ulcer disease.
Conclusion. It is observed that Malaysian strains of H. pylori
possess two types of CagA protein: the Western and the East Asian
CagA.

Abstract no.: 02.13
Determination of Genetic Diversity Among
Iranian and Danish Strains of Helicobacter pylori
via RAPD–PCR Fingerprinting
Abstracts
8Molecular genetics and genomics

D. Doroud,* M. Mohammadi,* L. Zamaninia,*
M. Feizabadi,† H. Colding‡ and L. P. Andersen§
*Biotechnology

Research Center, Pasteur Institute of Iran, Tehran,
Islamic Republic of Iran, †Microbiology Department,Azahra University,
Tehran, Islamic Republic of Iran, ‡Institute of Medical Microbiology and
Immunology, University of Copenhagen, Copenhagen, Denmark,
§Department of Clinical Microbiology, Rigshospitalet, Copenhagen,
Denmark
Genetically, Helicobacter pylori isolates are very diverse and this
phenomenon can be used to develop molecular markers for their
differentiation. After H. pylori single colonies isolation and
identification of 50 Iranian and 50 Danish H. pylori isolates,
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556
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RAPD–PCR was performed according to proposed methods to
asses its usefulness in categorizing isolates with geographically
diverse origins.
PCR experiments were double-checked to ensure the reproducibility of the technique. Thereafter, dendrograms were created
using phentree software and the diversity within and between the
two populations was studied accordingly.
The RAPD-generated profiles were composed of two to 10
major bands (average of three bands/isolates). The band size ranges
were 0.18–3 kbp. There was no common amplification band among
Iranian strains. Amplification bands sized 0.7– 0.8 kb were common
among Danish strains. Three separated dendrograms for Iranian,
Danish, and Iranian Danish strain were obtained. Cluster analysis
revealed a high degree of genetic heterogeneity among both H.
pylori populations. The mean genetic diversity for the Iranian and
Danish strains was calculated to be 0.302 and 0.236, respectively,
indicating less diversity for Danish strains. Dendrogram obtained
from the collection of Iranian Danish strains revealed no
geographic specific clusterization.
Despite the fact that this method was unable to categorize two
H. pylori populations into distinct clusters, Danish strains were
identified as less diverse.
These data further indicate that the Iranian strain population is a
combination from different races and as indicated by the present
genotyping study, Iranian H. pylori isolates appear to exhibit
nonrestricted diversity as apposed to the European strains.

Abstract no.: 02.14
Determination of Single versus Multistrain
Infection in Gastric Cancer versus Noncancer
Patients by Microbiologic Mapping and
Fingerprinting
8Molecular genetics and genomics
Abstracts

D. Doroud,* M. Mohammadi,* Y. Talebkhan,*
L. Zamaninia,* H. R. Vaziri,† M. A. Mohagheghi,‡
M. Ghaffarpour,* N. Mohajerani* and A. Nahvijoo‡
*Biotechnology

Research Center, Pasteur Institute of Iran, Tehran,
Islamic Republic of Iran, †Endoscopy Unit, Mofarrah Hospital, Tehran,
Islamic Republic of Iran, ‡Cancer Institute, Tehran Medical University,
Tehran, Islamic Republic of Iran

The causative role of Helicobacter pylori in the development of
gastric carcinoma risk factor is established. Unlike in developing
countries, H. pylori multiple strain infection is rare in developed
countries. In this study, RAPD–PCR fingerprinting has been used
to analyze H. pylori multiple strains to determine the correlation of
strain variation and degree of homogeneity of Iranian strains with
their disease outcomes. Thus, H. pylori strains were isolated from
different gastric sites of 14 cancer and 53 NUD subjects. Following
H. pylori identity confirmation, DNA was extracted and genetic
heterogeneity was evaluated via RAPD–PCR method using
published primers. A second primer was used to confirm the
results. Each profile was compared to determine single or multiple
strain colonization for each patient.
H. pylori multiple strain infection was found in 42.9% gastric
cancer and 26.4% noncancer patients. Among 14 non-GC and six
GC patients harboring > 1 H. pylori-infecting strain, 21.4% and
33.3% showed triple strain infection, respectively. The rest had
double strain infection.
This study reveals that in Iran, where H. pylori colonization is
relatively high, the rate of multiple strain infection is also higher
than that of developed countries and even some developing
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556

countries. Multiple strain infection may increase the risk of serious
clinical implications and decrease chances of antibiotic eradication
among the Iranian patients.
The etiology of multiple strain infections requires careful
analysis, which has serious implications on eradication regimens
and preventive and therapeutic vaccines design and development
that should possess polyvalent antigens to ensure lifelong and
effective protection.
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Abstract no.: 02.15
Genetic Characteristics of Helicobacter pylori in
Patients with Gastritis and Peptic Ulcer in
Lithuania
L. Kupcinskas,* J. Miciuleviciene,* G. Kiudelis,*
L. Jonaitis† and D. Berg†
*Kaunas University of Medicine, Kaunas, Lithuania, †Dept. of Molecular
Microbiology, Washington University, St. Louis, MO, USA

The aim of this study was to examine the genotypes of Helicobacter
pylori and putative virulence markers in Lithuanian patients with
chronic gastritis (CG) and peptic ulcer (PU).
Material and methods. H. pylori strains were isolated from
gastric biopsy samples of 81 consecutive patients (37 with PU, and
44 with CG) who underwent endoscopies in Kaunas Medical
University Hospital. The different genotypes of H. pylori were
analyzed with polymerase chain reaction (PCR).
Results. One-third (59.3%) of Lithuanian H. pylori strains carried
the cagPAI and 56.8% possessed potentially toxigenic vacA s1
alleles, independent of disease status. PCR type I DNA motifs were
present in 15 of 48 (31.2%) strains carrying the cagPAI, where
subtype Ia motifs predominated (12 of 15). Eighteen of 48 H. pylori
isolates (37.5%) were identified as type II and 12 (25%) as type III.
Subtype IIIa was detected in nine of 12 type III strains. vacA
s-region genotypes (s1, s2) were obtained with vacA specific primers.
Forty-six of 81 (56.8%) cultures yielded a 259-bp fragment,
indicating vacA s1 alleles, and 35 yielded a 286-bp fragment,
indicating vacA s2 alleles. Future analysis of the 46 strains with the
s1 genotype revealed that 44 (96.2%) were vacA s1a and two (3.8%)
were vacA s1b. Strains obtained from patients with PU more often
( p < .01) than patient with CG carried cag PAI + (75.7% and
45.5%, respectively) and vacA s1 (75.7% and 40.1%, respectively).
Conclusions. In the Lithuanian population, cagPAI- and vacA
s1-positive H. pylori strains are potentially ulcerogenic.
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Abstract no.: 03.01*
A Low-Molecular-Weight Protein of Helicobacter
pylori Inhibits Human T-cell Proliferation
C. Schmees,* T. Treptau,* L. Hengst,† R. Rad,*
P. Voland,* C. Prinz* and M. Gerhard*
*Klinikum Rechts der Isar, Munich, Germany, †Department of
Biochemistry, MPI, Munich, Germany

We have previously shown that Helicobacter pylori culture
supernatants and whole bacteria inhibit proliferation and induce
cell cycle arrest of human T cells. This effect was independent of the
known virulence factors cagA, vacA, or babA and not due to changes
in T-cell activation or T-cell response (Gastroenterology 2005).
Now we have further characterized the nature of the factor
responsible for the inhibition of cell proliferation and signal
transduction pathways involved in the effect.
Water extracts of H. pylori culture supernatants were analyzed
by gel filtration and cation-exchange chromatography. Gel
filtration indicated that the factor has a molecular weight (MW)
of 30–60 kDa, because fractions corresponding to this MW
inhibited proliferation of human T cells. After further purification
by cation-exchange chromatography, Jurkat T cells were incubated
with inhibiting fractions and analyzed for expression of several cell
cycle regulatory proteins by immunoblotting. These fractions
induced a significant up-regulation of p27 and a concurrent
down-regulation of cyclin D3 and c-myc protein levels. Nuclear
translocation of NFAT in Jurkat T cells was not affected by the
inhibiting fractions.
In comparison with wild-type mouse embryonic fibroblasts
(MEFs), MEFs deficient in p27 (p27–/–) exhibited significantly
reduced inhibition of proliferation when incubated with H. pylori
water extracts. This suggests a central role of p27 in mediating the
cell-cycle arrest induced by H. pylori.
Conclusion. Inhibition of T-cell proliferation is induced by a
secreted low-molecular-weight protein of H. pylori that induces
up-regulation of the cell-cycle inhibitor p27.
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Abstract no.: 03.02*
An Important New Determinant of vacA Toxicity
Is Prevalent Among Chinese Helicobacter pylori
Strains
J. L. Rhead,* D. P. Letley,* Y. Zhang* and J. C. Atherton*
*Institute of Infection, Immunity and Inflammation and the Wolfson
Digestive Diseases Centre, Nottingham, UK, †Division of
Gastroenterology, The Affiliated Hospital of Jiangsu University, Jiangsu,
China

Helicobacter pylori vacA s1m1 strains are more closely associated
with gastric adenocarcinoma than s1m2. Paradoxically, in China
where gastric cancer is common, most strains are vacA s1m2. vacA
s1m2 strains differ in toxicity. We aimed to define genetic
differences underlying differential toxicity, determine whether
Chinese strains were of the more toxigenic type, and develop a
simple polymerase chain reaction (PCR)-based typing system for
these more toxigenic strains.

Methods and Results. Comparing vacA between toxigenic (Tox+)
and nontoxigenic (Tox–) s1m2 strains revealed a polymorphic
region intermediate (i) between signal (s) and mid (m) regions with
two types, i1 and i2. We constructed vacA hybrids of strain 93–67
(s1/i1/m2; Tox+) containing either the first or second half of the
i-region from strain 93–72 (s1/i2/m2; Tox−); 93–67 i2-i1 and 93– 67
i1-i2, respectively. Both hybrids showed reduced vacuolation of
RK13 cells compared to 93–67 (93–67 i1-i2 < < 93–67 i2-i1). An
i1-i2 hybrid of 93–72 showed a similar vacuolating activity to
93–67 i1-i2. Next we developed an i-specific PCR typing system,
confirmed types by nucleotide sequencing, and assessed
vacuolating phenotype of strains on RK13 cells. All (8/8) of the
Western s1/i1/m2 strains vacuolated RK13 cells compared with
0/12 s1/i2/m2 strains ( p < 10−5). All (13/13) of the Chinese s1m2
strains typed as i1 and all vacuolated RK13 cells. All vacA s1m1
strains typed as i1.
Conclusion. We have identified a new region of vacA important
for toxigenicity. vacA s1/i1 strains are toxigenic in vitro; s1/i2 are
not. All Chinese s1m2 strains tested are type i1, perhaps
contributing to the high prevalence of gastric cancer in China.
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Abstract no.: 03.03*
Influence of Knockouts in HorB (HP1421) and
virB11 (HP0127) on O-chain Synthesis by
Lipopolysaccharide of Helicobacter pylori
A. P. Moran,* W. J. Snelling,† J. J. McGovern,*
P. W. O’Toole† and H. Annuk†
*Department

of Microbiology, National University of Ireland, Galway,
Galway, Ireland, †Department of Microbiology and Alimentary
Pharmabiotic Centre, University College Cork, Cork, Ireland
A second virB11 homologue (HP1421) occurs at a separate
location from that of the Helicobacter pylori cag pathogenicity
island and is genetically linked to the flagellar export ATPase, FliI.
Production of an outer membrane protein (OMP) HorB (HP0127)
is reduced in a virB11 knockout (KO) that influences colonization.
As preliminary studies indicated that the lipopolysaccharide (LPS)
in HP1421 and HP0127 KOs differed from that of the wild-type
strain, we undertook to characterize the LPSs of such mutants of
H. pylori CCUG 17874. Electrophoretic (SDS-PAGE) analysis of
purified LPS with silver staining showed that while the horBKO
expressed smooth LPS-like CCUG 17874, the amount of O-chain
was significantly reduced, whereas virB11KO expressed only
rough-LPS lacking an O-chain. Greater heterogeneity of core
structures was seen in the horBKO and virB11KO LPS profiles;
that of the horBKO was the most heterogeneous. Immunoblotting
indicated expression of Lewisx and Lewisy by horBKO LPS, but to
a lesser extent than wild-type LPS, whereas virB11KO LPS did not
exhibit reactivity consistent with the absence of an O-chain. A
whole-cell ELISA confirmed these findings. Complementation
restored production of the O-chains and Lewis expression.
Detailed structural analyses confirmed the occurrence, but lower
expression of O-chains in horBKO LPS like those of CCUG
17874. Lipid A structures were as expected for H. pylori roughand smooth-LPS, and the cores of horBKO and virB11KO LPSs
exhibited heterogeneity. Although LPS may play a role in OMP
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556
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assembly, this is the first evidence of OMP influence on LPS
O-chain assembly in H. pylori.
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Abstract no.: 03.04*
Reciprocal Regulation of NFAT Transcription
Factors by the Two Major Helicobacter pylori
Virulence Factors, CagA and VacA
M. Hatakeyama,* K. Yokoyama,* H. Higashi,*
S. Ishikawa,* T. Azuma,† T. Hirayama‡ and
H. Aburatani§
*Institute

for Genetic Medicine, Hokkaido University, Sapporo, Japan,
University Graduate School of Medicine, Kobe, Japan,
‡Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan,
§RCAST, University of Tokyo, Tokyo, Japan
†Kobe

Infection with cagA-positive Helicobacter pylori is associated with
the development of atrophic gastritis, peptic ulcers, and gastric
adenocarcinoma. The cagA gene product CagA is injected into
gastric epithelial cells and disturbs cellular functions by physically
interacting with and deregulating intracellular signaling
transducers through both tyrosine phosphorylation-dependent
and -independent mechanisms. To gain further insights into the
pathophysiologic activities of CagA, we performed a genomewide screening of CagA-responsive genes using DNA microarray
and identified NFAT transcription factors whose binding sites
were over-represented in the promoter regions of CagA-activated
genes. Expression of CagA in gastric epithelial cells elicited
translocation of NFATc3, a member of the NFAT family, from the
cytoplasm to the nucleus and activated NFAT-regulated gene.
CagA-mediated NFAT activation was abolished by inhibiting
calcineurin or phospholipase Cg activity. Furthermore, treatment
of cells with H. pylori VacA toxin, which has been shown to inhibit
NFAT in T lymphocytes, counteracted the ability of CagA to
activate NFAT in gastric epithelial cells. These findings indicate
that the two major H. pylori virulence factors inversely regulate
NFAT activity. Given the pleiotropic activities of NFAT in cell
growth and differentiation, deregulation of NFAT, either
positively or negatively depending on the relative exposure of cells
to CagA and VacA, may contribute to the diverged clinical
outcomes caused by H. pylori infection.
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Abstract no.: 03.05*
Evolution of the Helicobacter pylori cag
Pathogenicity Island (PaI) by Partial Deletion in
Strains from Relatives of Gastric Cancer Patients
R. H. Argent,* R. J. Thomas,* E. M. El-Omar† and
J. C. Atherton*
*University of Nottingham, Nottingham, UK, †University of Aberdeen,
Aberdeen, UK

Background. Helicobacter pylori strains possessing the cag
pathogenicity island (PaI) and vacuolating forms of VacA are
associated with the development of gastroduodenal diseases. The
cag PaI induces interleukin-8 secretion from epithelial cells and
delivers CagA into the host cell cytosol. We have recently shown
that evolution of vacA and cagA occurs commonly within
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556

individuals and within families from Scotland (Argent et al. Gut 54
(S2), A25; 2005). We now turn our attention to determining evolution
within the cag PaI in this population.
Methods/Results. Forty-three out of 45 individuals had singlestrain infections by random amplification of polymorphic
DNA-polymerase chain reaction (RAPD-PCR) of single colonies.
Twenty-nine strains were shared between at least two family
members. Two and five individuals had isolates with different vacA
and cagA alleles, respectively, despite identical RAPD patterns.
Within families with the same strain, two and eight members had
different vacA and cagA alleles, respectively. Single colonies
isolated for H. pylori strain AB9 possessed either s1/m1 or s1/m2
vacA. The s1/m2 form was not expressed. PCR amplification of
cagA, cagE, cagT (virB7), and cag10 (virD4) genes revealed that all
isolates possessed cagA and cag10. Some isolates possessing s1/m1
vacA and all with s1/m2 vacA, lacked cagE and cagT, indicating
partial deletion of the cag PaI. Coculture of isolates with AGS
gastric epithelial cells revealed that only those with all four genes
amplified had CagA phosphorylated within, and induced interleukin8 secretion from AGS cells.
Conclusions. Evolution of virulence factors occurs rapidly and
within the lifetime of individuals. This may increase or decrease
virulence and has important implications for pathogenesis.

Abstract no.: 03.06*
Iron-Repression of Urease Expression in
Helicobacter hepaticus is Mediated by the
Transcriptional Regulator Fur
8Virulence Factors and Pathogenesis
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C. Belzer, B. A. M. van Schendel, E. J. Kuipers,
J. G. Kusters and A. H. M. van Vliet
Erasmus MC-University Medical Center, Department of
Gastroenterology and Hepatology, Rotterdam, the Netherlands
The pathogen Helicobacter hepaticus colonizes the enteric and
hepatobiliary tract of rodents and causes inflammatory bowel lesions,
hepatitis, and hepatic malignancies. Urease is an environmentally
regulated key-virulence factor for gastric Helicobacter species,
but little is known about its role or regulation in nongastric
Helicobacter species. Low iron is often used by pathogenic bacteria
as a signal for entering the host. Here it is reported that urease
activity of H. hepaticus is iron-repressed, and this regulation is
mediated by the trancriptional regulator Fur.
Iron-depletion of growth medium resulted in a three-fold increase
in urease activity in wild-type H. hepaticus strain ATCC 51449. Using
Northern hybridization, it was demonstrated that iron-repression
of urease expression was mediated at the transcriptional level.
Mutation of the fur gene abolished the effect of iron-depletion,
suggesting a role for Fur in iron-repression of urease expression.
This was confirmed using a gel-shift assay, as recombinant Fur
displayed iron-dependent binding to the urease promoter region.
Conclusion. Iron and Fur are likely to contribute to H. hepaticus
virulence as they are both involved in the regulation of the urease
virulence factor. Iron-mediated urease regulation has not been
reported before and may be important in the colonization of the
hepatobilary tract by H. hepaticus.
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Abstract no.: 03.07
Effects of Bile on Helicobacter hepaticus
Expression of Virulence Factors
G. L. Mendz
School of Biotechnology and Biomolecular Sciences, Sydney, Australia
Helicobacter hepaticus causes chronic hepatitis and liver cancer in
mice. It colonizes the lower bowel, a habitat where it comes in
contact with bile, which has antimicrobial activities. To elucidate
habitat adaptation mechanisms of H. hepaticus, a study of its
response to bile was performed.
Strain ATCC 51449 was grown for 48 hours in media
supplemented with ox bile at concentrations 0 –5%. Growth–
response curves were obtained by determining the cfu/ml at 0 and
48 hours. The protein expression of bacteria grown at a sublethal
bile concentration of 0.1% was compared with those grown
without bile using 2D-PAGE. Identification of protein spots
unique to one growth condition or with differential intensities
greater than twofold between both conditions was performed
using tandem mass spectrometry.
Bacterial growth declined by an order of magnitude at 0.1% bile
concentration and did not grow at 5.0% bile concentration.
Proteins down-regulated in the presence of bile included cytolethal
distending toxin (Cdt), superoxide dismutase, major flagellin
subunit FlaA2, and glutamate dehydrogenase. Translation elongation
factor EF-Ts and the conserved hypothetical protein (HH1427)
were up-regulated in the presence of bile.
Cytolethal distending toxin is an important virulence factor of
H. hepaticus. Its down-regulation in the presence of bile opens the
possibility of alternative mechanisms through which the bacterium
causes hepatitis and liver cancer. However, the down-regulation of
superoxide dismutase and glutamate dehydrogenase, which protect
bacteria and Plasmodium falciparum against reactive oxygen
species, respectively, suggested that bile may serve to protect
H. hepaticus in host colonization.
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Abstract no.: 03.08*
Evaluating Proinflammatory and Adherence
Properties of the Helicobacter pylori Outer
Membrane Protein 13 (Omp13)
A. Dossumbekova,* W. Reindl,* A. Sarryeva,*
S. Backert,† J. Kusters,‡ C. K. Prinz* and R. Rad*
*II. Medical Department, Munich, Germany, †Institute for Medical
Microbiology, Magdeburg, Germany, ‡Department of
Gastroenterology, Rotterdam, the Netherlands

Background and Aims. Helicobacter pylori strains have a functional or nonfunctional omp13 (oipA) gene, depending on the number
of CT dinucleotide repeats in the coding region. We investigated
the influence of Omp13 on bacterial adherence, colonization, and
gastric inflammation.
Methods. A total of 60 antral biopsies from H. pylori-infected
patients were assessed in regard to the degree of granulocytic and
lymphocytic infiltration. The infecting H. pylori strain type was
characterized regarding cagA and omp13 status by polymerase
chain reaction (PCR) or sequencing. Bacterial colonization densities
were determined semiquantitatively after immunohistochemical
H. pylori staining. IL-8 mRNA expression in the gastric mucosa
was analyzed by real-time RT-PCR (reverse transcriptase-PCR).
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In vitro adherence assays and cytokine secretion assays were
performed with H. pylori wild-type, omp13-mutant, and omp13recomplemented strains on KATO-III and AGS gastric cancer cell
lines.
Results. Omp13-on status was strongly associated with presence
of the cagPAI. In vitro omp13-mutant strains showed reduced
adherence to epithelial cells compared to wild-type strains.
Complementation of omp13 completely restored the adherence
properties. In accordance with these results, bacterial colonization
densities were higher in patients infected with omp13-positive than
in patients harboring omp13-negative strains. However, the omp13
status did not significantly alter IL-8 secretion in vivo or in vitro.
Conclusion. Omp13 ameliorates the adherence properties of
H. pylori and thereby augments the density of bacterial colonization.
There is no direct effect of Omp13 on IL-8 secretion. In contrast
to previous reports, it appears that Omp13 is of smaller clinical
importance than originally anticipated.

Abstract no.: 03.09
Proteomic Characterization of an HpaANegative Helicobacter pylori Mutant and its
Colonization Ability in Mice
Abstracts
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J. K. Nyström,* E. Carlsohn,† I. Bölin,* C. L. Nilsson†‡
and A. Svennerholm*
*Department

of Medical Microbiology and Immunology and
of Medical Biochemistry, Göteborg University, Sweden,
‡National High Magnetic Field Laboratory, Tallahassee, FL, USA
†Department

Helicobacter pylori Adhesin A (HpaA) is an immunogenic surfacelocalized protein present in all H. pylori strains. Although
originally described as an adhesin, no concluding studies on the
function of HpaA have been performed. The aim of this study was
to study the importance of HpaA for colonization, by introducing
a mutation of the hpaA gene into the mouse-adapted H. pylori
strain SS1. To verify that the interruption of the hpaA gene did not
cause any polar effects of downstream genes or was associated with
a second site mutation, the protein expression pattern of the mutant
and wild-type strain was characterized by two different proteomic
approaches. Two-dimensional differential in-gel electrophoresis
(DIGE) analysis of whole cell extract and subcellular fractionation
combined with nano-LC–Fourier transform ion cyclotron resonance
(FT-ICR) MS for outer membrane protein profiling revealed that
only HpaA was absent in the mutant strain. Therefore, the mutant
strain was tested for its colonizing ability in a well-established
mouse model. Whereas the wild-type H. pylori strain readily
infected mice, the HpaA mutant strain was not able to establish
colonization. Thus, we conclude that HpaA is essential for
colonization of H. pylori in mice.
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Abstract no.: 03.10
Carcinogenetic Potential of the WSR cagA
Region
C. F. Zambon,* D. Basso,† A. Stranges,† A. Falda,†
M. Fasolo,† L. Del Giudice,‡ G. Guariso,‡ C. Belluco,§
F. Di Mario,¶ F. Navaglia,† E. Greco,† P. Fogar,*
M. Rugge,** G. Basso‡ and M. Plebani†
*Departments

of Medical and Surgical Sciences, †Laboratory Medicine,
and Surgical Sciences, University of
Padova, Padova, ¶Department of Gastroenterology University of
Parma, Parma, **Department of Pathology University of Padova,
Padova, Italy
‡Pediatrics, and §Oncological

Within CagA, a different number of repeats of the EPIYA, the tyrosine
phosphorylation site, might be found. Higher phosphorylated
CagA is suggested to worsen Helicobacter pylori infection outcome.
The aim of this study was to ascertain whether a different number
of the first (FR) or of the second (WSR) repeat region of the cagA
gene, encopassing the sequence encoding for the EPIYAs,
correlates with inflammation and outcome of cagA-positive
H. pylori infections. We studied cagA-positive Italian patients with
antral (n = 18) or diffuse (n = 16) gastritis, with duodenal ulcer
(n = 16), or with noncardia gastric cancer (NCGC, n = 25). The
number of repeats in FR and WSR regions were PCR-analyzed
from antral isolates. In a subset of 28 isolates, 14 from NCGC, the
whole 3′ cagA region was sequenced. In all patients the FR region
contained one repeat. The WSR repeats ranged from zero to three.
Twenty-two patients were coinfected by strains with a different
number of WSR repeats. H. pylori strains with less than two WSR
repeats had a more severe corpus activity (χ2 = 13.74, p < .005).
NCGC was correlated with H. pylori strains with two or more
WRS repeats, whereas those with less than two repeats were
correlated with duodenal ulcer (χ2 = 12.45, p < .05). Although
differences in nucleotide sequence of the 3′ cagA region were
found, none was associated with disease diagnosis or inflammatory
degree. In conclusion, in Italian patients cagA-positive infections
with less than two WSR repeats are correlated with duodenal ulcer,
those with two or more repeats with NCGC.

pathogenicity. Based on the peptide identity of published CagA
protein sequences, we developed degenerate polymerase chain
reaction (PCR) primers and subsequently sequenced and mapped
the EPIYA motifs in 124 Helicobacter pylori isolates (64 adults,
60 children). Strains were also typed with respect to vacA signal
and mid-region. A higher prevalence of EPIYA-negative strains in
children (20.0%) versus the adult (9.4%) population was observed,
although there was no real difference in H. pylori cagA-negative
strains (adults 14.1%, children 11.7%). The majority of strains
harbored the ABC (adults 53.1%, children 51.7%) and the ABCC
combination of TPMs (adults 15.6%, children 13.3%). Five strains
with additional TPM-C repeats (ABCCC) were detected exclusively
within the adult population (7.9%). A significant trend for a higher
number of TPM-C in adults (see table below, χ2 test, p = .045) was
observed. In addition, the presence of vacA s2m2 isotype was
associated with cagA-negative ( p < .0001), but not EPIYA-negative
strains. However, in children a strong association was observed
between EPIYA-negative strains ( p < .0001) and the least vacuolating
vacA s2m2 isotype. In conclusion, strains isolated from adults are
likely to harbor an increased number of phosphorylation TPM-C
repeats within the CagA protein, whereas in children a significant
trend for higher prevalence in EPIYA-negative vacA s2m2
H. pylori strains is observed.
TPM-C prevalence
Number of TPM-C
0
1
=2

Abstract no.: 03.11
Differences in the Prevalence of EPIYA Tyrosine
Phosphorylation Motifs in CagA Protein of
Helicobacter pylori Clinical Isolates from Children
and Adults
E. Panayotopoulou,* K. Papadakos,* A. Kalliaropoulos,*
K. Petraki,* S. Karagiannis,† F. Dimopoulos,†
S. Michopoulos,† E. Katsiyiannaki,‡ E. Roma,§
A. Archimandritis,¶ A. Mentis* and D. N. Sgouras*
*Laboratory

of Medical Microbiology, Institut Pasteur Hellenique,
Athens, Greece, †Gastroenterology Clinic, Alexandras General
Hospital, Athens, Greece, ‡Pediatric Gastroenterology Unit, Aghia
Sophia Childrens Hospital, Athens, Greece, §First Department of
Pediatrics, Athens University School of Medicine, Athens, Greece,
¶Second Department of Internal Medicine, Athens University School
of Medicine, Athens, Greece
The presence of tyrosine phosphorylation motifs (TPMs)
A:EPIYAKVNK, B:EPIYAQVAKK, and C:EPIYATIDDLG in
CagA protein have been proposed to enhance cagA-dependent
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556
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6
34
15

12
31
8

Abstract no.: 03.12
mtDNA Alterations in Helicobacter pylori
Chronic Gastritis and Gastric Carcinoma
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C. Figueiredo,*† V. Maximo,* P. Soares,*† S. Sousa,*
F. Carneiro,*† R. Seruca* and M. Sobrinho-Simoes*†
*IPATIMUP
†Faculty
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Adults

– Institute of Molecular Pathology and Immunology and
of Medicine of the University of Porto, Porto, Portugal

Mitochondrial DNA (mtDNA) alterations have been demonstrated
in various types of tumors, including gastric carcinoma. Our aim
was to elucidate the significance of mtDNA alterations in the
context of Helicobacter pylori chronic gastritis (CG) and gastric
carcinoma (GC).
A total of 160 H. pylori-infected patients (99 with CG and 61
with GC) were genotyped for vacA and cagA genes, and screened
for mtDNA alterations in ND1, ND3, ND4, ND5, COI, and
ATPase6 genes, and D-Loop regions D310 and D514.
Overall, mtDNA alterations were more frequent in GC (28/61,
46%) than in CG patients (20/99, 20%) ( p < .0001). D-loop
mutations were more frequently detected in GC (22/61, 36%) than
in CG patients (17/99, 17%) ( p = .008). Gastric carcinoma patients
harbored mutations in both D310 (19/61, 31%) and D514 (9/61,
15%) D-loop regions, whereas CG patients harbored mutations
only in D310 (17/99, 17%).
In coding genes, mutations were more frequent in GC (13/61,
21%) than in CG (5/99, 5%) ( p = .003). GC patients presented a
broader spectrum of mutations than CG patients. In the first group,
mutations were detected in all genes, except ND4. ND1 (5/13, 38%)
and ND5 (6/13, 46%) were the most frequently mutated genes. In
contrast, CG patients harbored mutations only in ND1 gene.
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There was a relationship between specific H. pylori genotypes
and mtDNA mutations.
These results suggest that mtDNA alterations are frequent
events in GC, and that these alterations may be mediated by
specific H. pylori strains.
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Abstract no.: 03.13
Positive Association Between the Presence of
CagA Protein EPIYA Motifs in Helicobacter pylori
Clinical Strains and the Severity of
Histopathologic Lesions
E. Panayotopoulou,* K. Petraki,* A. Kalliaropoulos,*
B. Martinez-Gonzalez,* K. Papadakos,* S. Karagiannis,†
F. Dimopoulos,† S. Michopoulos,† A. Archimandritis,‡
A. Mentis* and D. N. Sgouras*
*Laboratory of Medical Microbiology, Institut Pasteur Hellenique,
Athens, Greece, †Gastroenterology Clinic, Alexandras General
Hospital, Athens, Greece, ‡Second Department of Internal Medicine,
Athens University School of Medicine, Athens, Greece

We aimed to study the potential association between the presence of
EPIYA tyrosine phosphorylation motifs (TPMs) in CagA protein
of Helicobacter pylori clinical isolates with the clinical manifestation
of the disease and the observed histopathologic lesions.
We analyzed 58 cagA-positive H. pylori clinical isolates taken
from patients with gastroduodenal ulcer (n = 39) and nonulcer
dyspepsia (n = 19). EPIYA motifs were determined by polymerase
chain reaction (PCR) amplification and sequencing of the resulting
products. cagA status was determined by PCR cagA amplification
and serum CagA ELISA. H. pylori colonization and the associated
gastritis was evaluated by the modified Sydney system and
statistical analysis performed by Fischer’s exact test. EPIYApositive H. pylori clinical isolates in the antrum were correlated
significantly with the presence of gastroduodenal ulcer ( p = .002).
The association was strong with the presence of duodenal ( p = .016)
but not gastric ulcer ( p = .091). There was significant positive
association with the severity of chronic inflammatory infiltration
( p = .037) and the activity of chronic gastritis ( p = .033), but not
with higher levels of H. pylori colonization ( p = .108). No statistical
significance was observed in the fundus.
In conclusion, the severity of chronic inflammatory infiltration
and the activity of chronic gastritis developed in the antrum of
H. pylori-positive patients seem to be associated with the presence
of EPIYA TPMs in CagA protein, irrespective of the levels of
H. pylori colonization in the gastric mucosa. This association is
significant in patients with duodenal but not gastric ulcer.
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Abstract no.: 03.14
UreA2B2: A Second Urease System in the
Gastric Pathogen Helicobacter felis
R. G. J. Pot,* E. J. Kuipers,* P. J. M. Nuijten,†
L. A. M. de Haan,† P. Loeffen,† A. H. M. van Vliet* and
J. G. Kusters*
*Erasmus MC–University Medical Center, Rotterdam, the
Netherlands, †Intervet International BV, Boxmeer, the Netherlands

Objective. Urease enzyme is a major virulence factor of
Helicobacter species. Murine infection with the animal pathogen

Virulence Factors and Pathogenesis
Helicobacter felis is a model for human H. pylori infection and has
been used frequently to test the efficacy of urease-based vaccines
against Helicobacter infection. The aim of this study was to
investigate the urease system of H. felis.
Results. Immunoblot analysis of H. felis strains with ureasespecific antibodies revealed two immunoreactive bands of 67 and
70 kDa. The 67 kDa protein was identified as the urease large
subunit UreB, whereas the N-terminal amino acid sequence of the
70 kDa protein displayed 45% identity with the H. felis UreB
protein and was tentatively named UreB2. The gene encoding the
UreB2 protein was subsequently shown to be organized in a gene
cluster named ureA2B2. This gene cluster was present in the
chromosome of all tested H. felis strains, even in those strains
where UreB2 expression was absent. Insertional inactivation of the
ureB gene led to complete absence of urease activity, whereas
inactivation of the ureB2 gene did only result in lowered urease
activity ( p = .043).
Discussion. The gastric pathogen H. felis expresses two sets of
urease subunits, a unique feature among bacterial pathogens. The
exact function of the UreA2B2 system is currently unknown, as the
UreA2B2 proteins do not seem to constitute an active urease
enzyme. We hypothesize that UreA2B2 may contribute to the
pathogenesis of H. felis infection by either antigenic variation or by
allowing a switch in urease expression in unfavorable conditions.
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Abstract no.: 03.15
New Pathogenicity Markers for Peptic Ulcer
Disease Found in Helicobacter pylori Strains
Isolated from Portuguese Children
M. Oleastro,* A. Carvalho,* B. Nunes,† A. Ménard,‡
D. Queiroz,§ L. Monteiro* and F. Mégraud‡
*Instituto

Nacional de Saúde, Lisbon, Portugal, †Observatório
Nacional de Saúde, Lisbon, Portugal, ‡Laboratoire de Bactériologie,
Université Victor Ségalen, Bordeaux, France, §Laboratorio de Pesquisa
Bacteriologia, Faculdade de Medicina, Universidade Federal de Minas
Gerais, Belo Horizonte, Brazil

Comparison of two Helicobacter pylori strains isolated from a
peptic ulcer (PUD) and a gastritis from two young children, by
polymerase chain reaction (PCR)-based subtractive hybridization,
showed the presence of two genes ulcer-associated and J99-specific
( jhp562 and jhp870). We investigated by PCR and sequencing the
presence of these genes on H. pylori strains isolated from 77
Portuguese children (21 DU, 3 GU, and 53 with gastritis). We also
evaluated the association to previously described virulenceassociated genes. Both jhp562 and jhp870 were significantly
associated with PUD ( p < .01, OR = 8.44 and 6.60, respectively).
The presence of jhp562-positive genotype was strongly associated
with vacAs1, cagA+, babA2+ genotypes, and oipA “on” status,
whereas jhp870 was associated with vacAs1, cagA+, babA2+
genotypes, hopQ I allele, and oipA “on” status. The risk for PUD
increased slightly when jhp562-positive genotype was combined
with (1) cagA+ alone (OR = 9.17 versus OR = 9.56) (2) vacAs1
alone (OR = 13.76 versus OR = 15.36), or (3) both cagA+/vacAs1
(OR = 8.13 versus OR = 11.07). Association of jhp870 with cagA
or vacA did not improve the discrimination between disease
outcome.
To support these results, we studied a group of H. pylori strains
isolated from Brazilian children with DU and gastritis, from which
data concerning cagA and vacA were available. Association of
jhp562 and jhp870 with cagA+ and vacAs1 was also observed.
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556
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Although individually neither jhp562 nor jhp870 were statistically
associated with DU, the combination cagA+/vacAs1/jhp562+
presented the higher risk for this disease.
These results suggest that jhp562 and jhp870 genes are candidates
as virulence markers of H. pylori.
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Abstract no.: 03.16
The Effects of Helicobacter pylori Virulence
Factors on the Immune Response in Human
Gastric Mucosa
S. Wen,* C. Felley,† H. Bouzourene,† L. Hammarström,*
P. Michetti† and Q. Pan-Hammarström*
*Division

of Clinical Immunology, F79, Karolinska University Hospital
Huddinge, Stockholm, Sweden, †Division of Gastroenterology,
University Hospital, Lausanne, Switzerland

Helicobacter pylori infects more than half of the world’s population
and constitutes a major risk factor for peptic ulcer and gastric
cancer development. H. pylori virulence factors are considered to
play important roles in determining the clinical outcome of the
infection. Intimate contact with host cells, mediated by outer
membrane proteins such as BabA, is thought to be involved in the
pathogenesis of the histologic changes. However, the underlying
mechanism is still largely unknown. We therefore studied the gene
expression profiles in human gastric mucosa infected by different
strains of H. pylori, using cDNA microarrays. The genotype of
H. pylori in infected human gastric biopsies was determined by
reverse transcriptase-polymerase chain reaction (RT-PCR). Five
triple-positive (CagA+, VacAS1+, BabA2+) and five doublepositive (CagA+, VacAS1+, BabA2−) samples were identified, and
the corresponding biopsies subsequently analyzed by cDNA
inflammatory microarrays. The data show that a number of genes
are up-regulated in the triple-positive as compared to the doublepositive samples, including interleukin 1 receptor accessory protein
(IL1RAP) and teratocarcinoma-derived growth factor 1 (TDGF1),
which are both involved in cancer development. In addition,
ENA78, a CXC chemokine that potentially attracts and activates
neutrophils in the inflammatory process, is down-regulated.
Further analysis of these genes and related factors/pathways may
help us to better understand the role of BabA in the pathogenesis
of H. pylori infection.
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Abstract no.: 03.17
Lesser Potency of Helicobacter pylori than
Escherichia coli Lipopolysaccharide, but Positive
Interaction with Ibuprofen, in Apoptosis
Induction
A. P. Moran,* E. Durkin† and P. J. Hanson†
*Department

of Microbiology, National University of Ireland, Galway,
Galway, Ireland, †School of Life and Health Sciences, Aston University,
Birmingham, UK
Helicobacter pylori lipopolysaccharide (LPS) causes apoptosis in
the stomach and in cultured gastric mucosal cells, but its reported
high potency (10−9 g/ml) contrasts with the low immunologic
activity of this LPS. NSAIDs, which have been suggested to
interact with H. pylori to promote gastric damage, also induce

apoptosis in the stomach and in primary cell cultures. The present
study was undertaken to further investigate the apoptosis-inducing
action of H. pylori LPS and explore potential interactions between
the NSAID, ibuprofen, and LPS on apoptosis in gastric mucous
cells. Apoptotic effects of LPSs from H. pylori NCTC 11637 and
Escherichia coli O111:B4 on primary cultures of guinea-pig gastric
mucous cells were investigated in the presence and absence of
ibuprofen. Cell loss was estimated by a crystal violet assay, and
apoptosis determined from caspase activity and from condensation
and fragmentation of nuclei. Exposure to E. coli LPS for 24 hours
caused cell loss and enhanced apoptotic activity at = 10−9 g/ml, but
similar effects were only obtained with H. pylori LPS at higher
concentrations (= 10−6 g/ml). Caspase 3-, 8-, 9-like activities were
all significantly increased ( p < .05) after 6 hours exposure to
H. pylori LPS (10−5 g/ml). The onset of apoptosis in response to
ibuprofen was slower than with LPS (24 hours versus 6 hours).
Whereas ibuprofen (250 µmol/l) caused cell loss and apoptosis,
addition of E. coli or H. pylori LPSs enhanced these effects. Hence,
although of lower potency, H. pylori LPS could contribute to
apoptosis-related chronic gastric damage that is enhanced by the
use of NSAIDs.

Abstract no.: 03.18
Helicobacter pylori Stimulates Cancer Cell
Invasion: Molecular Mechanisms Involved
Abstracts
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M. J. Oliveira,* A. C. Costa,* L. Henriques,*
R. J. Thomas,† J. Atherton,† J. C. Machado,*‡
M. Mareel,§ A. Leroy§ and C. Figueiredo*‡
*IPATIMUP

– Institute of Molecular Pathology and Immunology of the
University of Porto, Porto, Portugal, †Institute of Infection, Immunity
and Inflammation, University of Nottingham, Nottingham, UK,
‡Faculty of Medicine, University of Porto, Porto, Portugal,
§Laboratory of Experimental Cancerology, Ghent, Belgium
Helicobacter pylori, a bacterial pathogen that colonizes the human
gastrointestinal tract, is associated with the development of gastritis,
gastric and duodenal ulcers, and gastric cancer. In the last two decades,
several studies have been performed on the characterization of the
major bacterial virulence factors and on the molecular interactions
established between the bacterium and the host cells. However,
how these molecular interactions contribute to gastric cancer
development remains to be determined.
Invasion is the hallmark of malignancy either through local
spread or through metastasis to distant organs. At the primary site
of cancer, invasion occurs when cancer cells are stimulated by
extrinsic factors. Bacteria, abundant at the primary site, are putative
sources of such factors. We have recently demonstrated that enteric
bacteria stimulate colon cancer cell invasion and motility through
the production of a soluble motility factor.
Using a similar approach, we investigated the effect of H. pylori
on gastric cancer invasion and clarified the molecular mechanisms
involved. AGS gastric cancer cells were cocultured with distinct
H. pylori strains on top of collagen type I gels or of Matrigel-coated
filters. Our results indicate that H. pylori stimulates cancer cell
invasion and that direct contact between the bacterium and the
cells and a functional bacterial type IV secretion system are
required. Stimulation of invasion and motility occurred in a PI3Kindependent manner but involved the activation/phosphorylation
of specific tyrosine kinase receptors and an increased production of
matrix metalloproteases.
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Abstract no.: 03.19
Relationship Between the Diversity of cagA Gene
of Helicobacter pylori and Gastric Cancer in Japan
S. Satomi,* S. Yamazaki,* A. Yamakawa,* R. Masaki,*
T. Okuda,* A. Muramatsu,* S. Lee,* H. Suto,† Y. Ito,*
Y. Yamazaki† and T. Azuma‡
*Second

Department of Internal Medicine and †Department of
Endoscopic Medicine, Faculty of Medical Sciences, University of Fukui,
Fukui, Japan, ‡Frontier Medical Science in Gastroenterology,
International Center for Medical Research and Treatment, University
of Kobe, Kobe, Japan
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between any functional status of sabA and hopZ with other genes
in the adult population. Finally, we compared some genotype
combinations. In strains isolated from children, the risk for PUD
increased when sabA off was associated with: cagA+ (OR = 11.733
versus OR = 9.17), vacAs1 (OR = 15.600 versus OR = 13.76), and
cagA+/vacAs1 (OR = 13.475 versus OR = 8.125).
We concluded that neither sabA nor hopZ is pathogenicity
markers for the PUD in a Portuguese population, however, sabA
off genotype can contribute to the distinction between PUD and
gastritis when associated with other virulence genes.

Abstract no.: 03.21
The Mongolian Gerbil Model is Useful to Study
Helicobacter pylori-Associated Gastroduodenal
Diseases
Abstracts
8Virulence Factors and Pathogenesis

Background and Aims. CagA is one of the most studied
virulence factors of Helicobacter pylori. We recently showed that
there are two different CagA sequence motifs between East Asian
strains and Western strains. East Asian CagA has a distinct sequence
at the SHP-2-binding site and confers stronger SHP-2-binding and
-transforming activities than those of Western-type CagA. We
investigated the diversity of CagA in strains from two different
areas in Japan (Fukui and Okinawa), where gastric cancer risk is
different, and examined the relationship between CagA sequence
diversity and clinical outcome. The death rate of gastric cancer is
more than 2.4 times higher in Fukui than in Okinawa.
Methods. A total of 176 strains (97 in Fukui and 79 in Okinawa)
was subjected to sequence analysis of the cagA gene.
Results. Prevalence of East Asian CagA was significantly higher
in cancer strains than in gastritis strains in Okinawa. Most cancer
strains in Okinawa (19/21) carried East Asian CagA as well in Fukui.
Two Okinawan cancer strains carried Western-type CagA with two
or three repeats of WSS (Western CagA-specific, SHP-2-binding
sequence), whereas most Western-type CagA strains from patients
with gastritis or peptic ulcer carried only one repeat of WSS.
Conclusion. These findings suggest that East Asian CagA motif
and the number of repeats of WSS correlate with the pathogenesis
of gastric cancer.
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Abstract no.: 03.20
sabA and hopZ are not Pathogenicity Markers for
the PUD in a Portuguese Population
A. Carvalho,* M. Oleastro,* B. Nunes† and
L. Monteiro*
*Instituto

Nacional de Saúde, Lisbon, Portugal, †Observatório
Nacional de Saúde, Lisbon, Portugal

The aim of this work was to study the potential of sabA and hopZ
genes as virulence markers for peptic ulcer disease (PUD) in
Helicobacter pylori strains isolated from Portuguese patients,
106 isolated from adults (50 with PUD, 56 with gastritis) and 72
from children (19 with PUD, 53 with gastritis). Genotyping was
performed by polymerase chain reaction (PCR) and sequencing of
the 5′ region of the genes.
In the majority of strains, both genes were on (57.3% for sabA,
59.0% for hopZ). We also observed that sabA on was more associated
with gastritis only in strains isolated from children ( p = .019,
OR = 0256). hopZ on was more prevalent in strains from PUD,
however, the difference was not significant. Supporting these
results, we found that sabA on was significantly associated with the
less-virulent genotypes (cagA−, vacAs2, and oipA off) in the strains
isolated from children. On the other hand, there was no association

G. Rieder,* J. L. Merchant† and R. Haas*
*Max

von Pettenkofer-Institute, Ludwig-Maximilians University,
Munich, Germany, †Internal Medicine, University of Michigan,
Ann Arbor, MI, USA
The effects of Helicobacter pylori cag-PAI were investigated on the
development of chronic atrophic gastritis, peptic ulcer, and chronic
pancreatitis in a gerbil model.
Methods. Mongolian gerbils were infected with H. pylori type I
strain or an isogenic cagY mutant for 7 months. Paraffin sections
of antrum and corpus were stained for metaplastic changes of the
gastric mucosa and fibrous changes in the pancreas. Stomach pH,
blood glucose and plasma gastrin, lipase, and amylase were
measured. Frozen biopsies were used for reverse transcriptasepolymerase chain reaction (RT-PCR) quantifying the expression of
H+/K+-ATPase and of cytokines IL-1β, IFN-γ, and KC.
Results. Wild-type infected gerbils showed a severe transmucosal
inflammation in the antrum and corpus with an increased IL-1β,
IFN-γ, and KC mRNA expression. Atrophy, hyperproliferation,
hypergastrinemia, and hypochlorhydria were observed. About 90%
of the WT-infected gerbils developed peptic ulcer and metaplastic
changes. Transmural inflammation and pancreatitis were developed
in 56% and 33% of WT-infected and mutant-infected gerbils,
respectively. Typical parameters of a chronic pancreatitis were
present.
Conclusion. The cag-PAI of H. pylori is responsible for a severe
inflammation that results in corpus-dominant atrophic gastritis,
metaplastic changes, and peptic ulceration. Independent of the cagPAI, we observed the development of pancreatitis, especially in
animals that revealed a transmural antral inflammation and peptic
ulceration. The chronic pancreatitis revealed fibrous changes as
shown in trichrom stained sections. This novel observation
demonstrates that Mongolian gerbils are an adequate model to
investigate the H. pylori-induced chronic pancreatitis. A deeper
understanding of the pathomechanism of a H. pylori-associated
pancreatitis might reveal clinical relevance.
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Abstract no.: 03.22
The Relationship of Helicobacter pylori CagA
Status with Preneoplastic Conditions of Gastric
Mucosa
K. Wolle,* A. Leodolter,* T. Wex,* M. Vieth,† J. Reetz,*
U. Peitz* and P. Malfertheiner*
*Department

of Gastroenterology, Hepatology and Infectious
Diseases, Magdeburg, Germany, †Department of Pathology,
Magdeburg, Germany

Background. Patients with Helicobacter pylori infection and abnormalities in the gastric mucosa, such as intestinal metaplasia (IM), severe
atrophy, and with the topographic characteristics of pangastritis or
corpus-predominant gastritis are at a higher risk to develop gastric
cancer. Bacterial and host factors contribute to the development of
gastritis pattern at increased risk for gastric cancer development.
Aim. Assess the relationship of bacterial CagA status with
preneoplastic conditions of gastric mucosa in our population.
Methods. One hundred thirty-seven patients with preneoplastic
conditions of gastric mucosa of whom 31 suffered from a corpuspredominant gastritis, 82 from a pangastritis, 24 with at least
moderate atrophy as well as 49 with IM were included. The control
group consists of 68 subjects without dyspepsia or history of peptic
ulcer disease but known H. pylori infection. Furthermore, 40
patients with gastric cancer and evidence of an H. pylori infection
were included. CagA status was assessed by an immunoblot
(H. pylori ViraBlot, ViraMed Biotech AG, Germany).
Results. In patients with IM or atrophy, the prevalence of CagA
was significantly higher as compared to controls (see table).
CagA prevalence (%) OR
Gastric cancer
Intestinal metaplasia
Atrophy
Corpus-predominant gastritis
Pangastritis
Controls

95.0
91.8
82.5
80.6
72.0
61.8

11.8
6.96
4.33
2.58
1.59
1

95% CI
2.6–52.9
2.24–21.6
1.18–16.0
0.93–7.13
0.80–3.16
Reference

Conclusion. The presence of CagA is tightly related with preneoplastic conditions of the gastric mucosa. Corpus-predominant or
pangastritis, unlike in other reports (Uemura et al. 2001), are not
tightly linked to the phenotypic expression of chronic gastritis.
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Abstract no.: 03.23
Effect of Helicobacter pylori and Recombinated
Protein CagA on the Expression of Heat Shock
Protein (HSP)70 in MKN-7 Cells
A. Targosz, P. Pierzchalski, A. Krawiec, U. Szczyrk,
T. Brzozowski, S. J. Konturek and W. W. Pawlik
Department of Physiology, Jagiellonian University Medical College,
Cracow, Poland
Heat shock proteins (HSP) are crucial for the cell integrity under
normal growth and during pathophysiologic conditions such as
colonization of human stomach by Helicobacter pylori. The effect
of H. pylori on mRNA expression for HSP70 in the gastric
epithelial cells has been little studied and remains unconclusive. We
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556

determined the gene expression for HSP70 in the epithelial MKN7
cells stimulated by two live strains of H. pylori: 1, cagA+ and vacA+
and 2, cagA– and vacA– with or without the coincubation with the
recombinated protein cagA (OraVax Inc., Cambridge). Culture of
MKN7 cells were incubated with H. pylori (1 × 109 of per dish)
with or without cagA (10 µg/ml of medium). After 3, 24, and
48 hours of incubation, the cells were harvested and total cellular
RNA was isolated; the expression for HSP70 mRNA being
determined by reverse transcriptase-polymerase chain reaction
(RT-PCR). The strain H. pylori (cagA+ vacA+) inhibited in a timedependent manner the expression of mRNA for HSP70. When the
MKN-7 cells were coincubated with H. pylori (cagA+; vacA+) and
cagA, the disappearance of the signal for HSP70 mRNA after
48 hours was observed. H. pylori (cagA–; vacA–) incubated with
MKN-7 cells also attenuated the expression of mRNA for HSP70 but
the addition of the recombinated cagA to H. pylori (cagA–; vacA–)
failed to affect the signal intensity for HSP70 mRNA as compared
to that obtained with H. pylori alone. We conclude that H. pylori
suppresses gene expression of HSP70 in MKN-7 human gastric
epithelial cells possible because of the presence of bacterial
secretory system responsible for the translocation of cagA into the
eukaryotic cells.

Abstract no.: 03.24
Lewis Expression by Helicobacter pylori Isolates
of Indigenous Nahuatl Patients from Mexico
Abstracts
8Virulence Factors and Pathogenesis

H. Annuk,* J. Torres,† G. Gonzalez-Valencia† and
A. P. Moran*
*Department

of Microbiology, National University of Ireland, Galway,
Ireland, †Unidad de Investigacion en Enfermedades Infecciosas,
Instituto Mexicano del Seguro Social, Mexico City, Mexico
Mimicry of Lewis (Le) antigens, expressed on the O-sidechain of
lipopolysaccharide (LPS), have been implicated in Helicobacter
pylori pathogenesis. Previous studies have demonstrated a
tendency for isolates from particular geographic regions to express
certain Le antigens. Previous work has shown that although Lea
and Leb occurs, Lex and Ley expression is high in European isolates
but lower in Chinese and Japanese isolates, where high expression
of Lea or Leb was found. In the present study, we analyzed 42
isolates from 29 individuals of Nahuatl origin from Mexico. In nine
cases, isolates from multiple gastric sites of individual patients
(antrum, corpus, and gastric juice) were taken. The strains were
analyzed by dot blotting, but predominantly using a whole-cell
ELISA with anti-Lex, anti-Ley, anti-Lea, and anti-Leb monoclonal
antibodies. Based on Le differential expression, nine expression
permutations were detected serologically. Combined Lex and Ley
expression accounted for the majority of isolates (15); Lex (1), Ley
(10), and Leb (1) alone occurred; Lea (2) was only expressed in
combination with other Le antigens; and only three strains were
untypeable. Lex expression by Mexican isolates (55%) was similar
to that of European isolates; Ley expression (83%) was lower but
more comparable to that of the European than Japanese population.
Isolates from the antrum (67%) and gastric juice (58%) had similar
Lex expression, whereas corpus isolates had lower Lex expression
(33%). Ley expression was identical (89%) in corpus and antrum
isolates. Thus, European and Mexican isolates show certain
homogeneity in Le expression despite geographically isolated
backgrounds.
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Genotyping and Phenotyping Helicobacter pylori
Virulence Markers in Iranian Gastric Cancer and
Nongastric Cancer Patients
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M. Mohammadi,* M. Zohari,* M. Ghaffarpour,*
Y. Talebkhan,* L. Zamaninia,* M. A. Mohagheghi,†
H. R. Vaziri,‡ N. Mohajerani* and R. Sarrami*
*Biotechnology

Department, Pasteur Institute of Iran,
Institute, Tehran Medical University, ‡Endoscopy Unit,
Mofarrah Hospital, Tehran, Islamic Republic of Iran
†Cancer

The epidemiology of Helicobacter pylori infection in Iran creates a
public health implication because of its high prevalence and its
association with gastric cancer and peptic ulcer disease. Recent
studies suggest that genotypes and phenotypes of H. pylori with
regard to its virulence markers such as VacA and CagA potentially
correlate with the severity of the associated gastroduodenal
diseases. vacA s1m1 strains are identified as highly toxic and are
associated with increased gastric epithelial damages, enhanced gastric
inflammation, and duodenal ulceration. However, in developing
countries, type I H. pylori strains (cagA+/vacA tox+) are highly
prevalent regardless of the clinical manifestations. To evaluate the
most prevalent genotype among our highly infected population,
H. pylori strains were isolated from 25 gastric cancer (GC) and 61
non-GC patients. polymerase chain reaction (PCR) analysis of
vacA and cagA genes, and serum Western blotting were performed.
s1/m2 was found to be the most prevalent vacA genotype in both
studied groups. There was no association between cagA gene status
and disease outcome as nearly all of the isolated strains were cagA
positive. According to serological studies, host responses toward
H. pylori virulence markers (mainly CagA and VacA) were similar
in GC and non-GC patients. Furthermore, host antibody responses
to 35 kDa and 37 kDa antigens were more frequent in non-GC
subjects and were inversely associated with GC. This study thereby
questions the role of cagA gene status or antibody response thereto
as a suitable marker in screening H. pylori-infected population in
risk of gastric cancer development and proposes further studies.
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Abstract no.: 03.26
Proliferating Activity of Gastric and Duodenal
Epithelium in Helicobacter pylori-Associated
Duodenal Ulcer Disease
R. A. Abdulkhakov, S. R. Abdulkhakov and A. P. Kiyasov
Kazan State Medical University, Kazan, Russian Federation
Introduction. Helicobacter pylori influences both proliferation
and apoptosis of gastric epithelial cells.
Aims and Metods. The aim of our work was to evaluate gastric
and duodenal epithelial cell proliferation in patients with H. pyloriassociated duodenal ulcer disease before and after the course of
eradication therapy. Twenty patients were examined. Triple
therapy consisting of proton pump inhibitor, amoxicillin, and
clarythromycin was used for eradication. H. pylori diagnosing and
eradication were proved by biochemical and cytology methods.
Eight biopsies were examined in each case: from the margin of
ulcer, 0.5 sm near the ulcer, from antral part and body of the
stomach before treatment and 6 weeks after the end of eradication
therapy. Paraffin sections were stained immunohistochemically
with antibodies to proliferative cell nuclear antigen (PCNA).
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Results. In all cases we observed increased proliferative activity of
epithelial cells. The number of PCNA-positive cells was the largest
in biopsies from the margin of ulcer, lesser – near the ulcer and in
antral part, least of all – in biopsies from the body of stomach.
The number of positive cells correlated with the activity of
inflammation. After the eradication of H. pylori, the number of
proliferating cells decreased in all cases although it was still higher
in zones of inflammation.
Conclusion. So increased proliferation of epithelial cells is the
result of both influence of H. pylori and tissue injury (ulceration).
Increased proliferation in zones with inflammation confirms the
important role of inflammation in epithelium regeneration.

Abstract no.: 03.27
Virulent Helicobacter pylori Associated with
Gastric Intestinal Metaplasia Assessed in
Archived Gastric Tissue
Abstracts
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A. Nami,* P. Dowling,* M. O’Sullivan,* N. Swan,†
P. Crotty,† N. Breslin,* B. Ryan,* H. O’Connor* and
C. O’Morain*
*Trinity

college Dublin, Dublin, Ireland, †Department of Pathology,
Adelaide & Meath Hospital, Dublin, Ireland

Background. Helicobacter pylori has been recognized as a major
gastric pathogen the most severe being gastric cancer. Distal cancer
evolves from the sequence of events from normal tissue to gastritis
to atrophy to intestinal metaplasia, and finally, dysplasia. The
accurate detection of the organism could be essential for proper
patient management, and particularly for the eradication of the
bacteria following treatment. Both the host and bacterial virulence
factors are involved in the clinical outcome.
Aims. To detect and evaluate the association of the H. pylori
virulence factors (cagA, vacA, and iceA) in patients with intestinal
metaplasia (IM) and gastritis (G).
Methods. Eighty-six patients were confirmed with IM and G by
histology finding; DNA was extracted from 10 µm sections of
paraffin wax embedded tissues. To purify DNA, Gene Clean III
Kit was used. Two µl of DNA was subjected to the nested
polymerase chain reaction (PCR) for the analysis of cagA, vacA
subtype (s & m), and iceA genes (iceA1, iceA2).
Results. The overall prevalence of cagA in H. pylori strains was
43% (37/86). The prevalence of cagA, vacAs1m1, and iceA1 was
significantly associated with IM ( p = .001, p = .002, p = .001,
respectively).
Conclusion. Our results suggest that the nested PCR is a highly
valuable method in the detection and genotyping of H. pylori in
paraffin wax embedded tissue. Virulent H. pylori is associated with IM.
Table Distribution of cagA, vacA, and iceA according to clinical
disease (*p < .05)
vacA
Diagnosis

cagA

IM (n = 44)
G (n = 42)

s1m1

s1m2

iceA
s2m2

iceA1

iceA2

36%
59%
5%
61%
30%
68%
(30/44)* (16/44)* (26/44) (2/44) (27/44)* (13/44)
17%
7%
7%
86%
14%
10%
(7/42)
(3/42) (3/42) (36/42) (6/42) (4/42)
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Study of hpaA Patterns in Helicobacter pylori
Clinical Isolates from Children or Adults and
from Patients with Gastritis and Peptic Ulcer
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J. A. García-Campos,* T. Alarcón,* A. Pérez de Ayala,*
E. García-Peñuela,* D. Domingo,* M. J. Martínez† and
M. López-Brea*
*Hospital de La Princesa, Madrid, Spain, †Hospital del Niño Jesús,
Madrid, Spain

Aim. To know the prevalence of the different patterns of hpaA
gene in Helicobacter pylori clinical isolates obtained from children
or adults.
Materials and Methods. One hundred nine H. pylori clinical
isolates were studied: 50 from children and 59 from adults. Isolation
of H. pylori was carried out from gastric biopsy specimens by
standard culture methods. The hpaA gene was detected by
polymerase chain reaction (PCR) (375 bp fragment) and after
digestion with HinfI fragments were separated on agarose gel
(3.5%). Pattern 1 showed two fragments of 115 and 260 bp, pattern
2 showed three fragments of 46, 69, and 260 bp, and pattern 3 had
the undigested 375 bp fragment.
Results. Sixty-four percent of the strains showed hpaA pattern 1,
17% pattern 2, and 3% pattern 3, whereas 16% were negative for
this gene. Only 66% of strains from children were hpaA positive,
whereas 98% of strains from adults give a positive signal for this
gene ( p < .05).
Pattern 1

Pattern 2

Pattern 3

hpaA-negative

hpaA pattern in strains from children
48%
14%

4%

34%

hpaA pattern in strains from adults
77%
19%

20%

20%

Conclusion. A high prevalence of strains showing no
amplification of the hpaA gene was found in our Spanish H. pylori
clinical isolates. The percentage was higher in strains from children
than from adults. Pattern 1 was the most prevalent in both groups
of patients studied.
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Abstract no.: 03.29
Local Immune Response and Virulence Factors
of Helicobacter pylori Infection in Chile
J. C. Araya, J. C. Roa, M. Cuba, L. Anabalón,
A. Sierralta, E. Ríos and I. Roa
Universidad de La Frontera, Temuco, Chile
Clinical outcomes of Helicobacter pylori infection are multifactor
and most likely depend on either bacterial pathogenic abilities or
host and environmental factors. The study investigated in a Chilean
high-risk gastric cancer population the linkage between local
immunity response and H. pylori virulence factors (vacA, cagA,
and iceA). Gastric samples were obtained from 87 adult patients,
with (n = 72) and without (n = 15) H. pylori infection. Four
samples were taken for histology (n = 2); semi-quantitative reverse
transcriptase-polymerase chain reaction (RT-PCR) for IL-4, IL-10,

© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556

and IFN-gamma (n = 1); and H. pylori genotyping (n = 1). Results
show that in 86% of patients infected with H. pylori; it was possible
to determine Th1-Th2 immune response, with Th1 in 37/62
patients (60%) and Th2 in 25/62 patients (40%). There was no
relationship between cagA, vacAs1, and iceA1 genotype and the
type of immune response (Th1 or Th2). Finally, the presence of
iceA2 allele type was statistically significantly correlated with
Th1/Th2 immune response and had been more frequently
presented in patients with Th2 than Th1 response (84% and 49%,
respectively, × 2, p = .002).
Discussion. The most frequent immune response in H. pylorirelated gastritis was a cell-mediated one, as previously described in
the literature. However, the frequency of Th2 immune response
was higher than the usually reported in Western countries. On the
other hand, a clear correlation was found between iceA2 allele type
with Th2 immune response, a genetic marker that would be useful
to identify H. pylori species that stimulates a more efficient immune
response to H. pylori removal.

Abstract no.: 03.30
Prevalence of Infection with Multiple
Helicobacter pylori Strains in Slovenian Pediatric
Population
Abstracts
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M. Homan,* B. J. Kocjan,† M. Poljak,† G. Panter† and
K. Seme†
*University Children’s Hospital, Ljubljana, Slovenia, †Institute of
Microbiology and Immunology, Ljubljana, Slovenia

Background. Helicobacter pylori genome contains only a single
copy of vacA (s-region, m-region) and iceA (iceA1, iceA2) gene.
Therefore, detection of multiple H. pylori genotypes in a clinical
sample indicates the presence of multiple H. pylori strains.
Aims. To determine the prevalence and genetic diversity of vacA
and iceA genes, and the frequency of multiple H. pylori strain gastric
infections in Slovenian pediatric population; and to analyze the
relationship between multiple H. pylori strain infections and the
severity of antral inflammation.
Methods. DNA was isolated from 53 H. pylori-positive gastric
biopsies. They were also obtained for histologic evaluation
according to the Updated Sydney Classification. H. pylori vacA
and iceA status was determined.
Results. Among 53 children infected with H. pylori, vacA
genotypes s1a/m1, s1a/m2, and s2/m2 were found in 32.1%, 28.3%,
and 28.3% of the cases, respectively. Multiple vacA genotypes were
observed in 11.3% of the cases. Allelic genotypes iceA1 and iceA2
were identified in 31 (58.5%) and 18 (34%) patients. Furthermore,
while two biopsy specimens (3.8%) contained both iceA allelic
genotypes, they were also undetectable in two cases. Based on the
presence of vacA and iceA genotypes in the same tissue sample,
13.2% of the gastric samples contained multiple H. pylori
genotypes. No statistically significant differences existed between
the severity of antral inflammation and single or multiple strain
H. pylori infections ( p = .22).
Conclusion. Coinfection with multiple H. pylori strains is rare in
Slovenian children. Multiple strain H. pylori infections might not
be associated with more severe antral inflammation, as suggested
recently in some studies.
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Abstract no.: 03.31
Lewis Antigen Expression in Helicobacter pylori
Isolates from Spanish Patients: Strains from
Children Versus Strains from Adults
J. A. García-Campos,* T. Alarcón,* J. Díaz-Regañón,*
E. Aznar,* J. M. Azcona,* M. J. Martínez† and
M. López-Brea*
*Hospital de La Princesa, Madrid, Spain, †Hospital del Niño Jesús,
Madrid, Spain

Purposes. To determine the presence of Lewis antigen in
Helicobacter pylori strains by using different methods; to compare
the Lewis antigen expression in strains isolated from children and
adults.
Methods. Ninety-one H. pylori strains were studied: 53 were
from children and 38 from adults. Upper endoscopy was
performed and biopsy cultured following standard methodology.
Strains were conserved at −70 °C until used. Lipopolysaccharide
(LPS) was extracted from a 48-hour culture by miniphenol water,
and detection of Lewis antigen was determined by different
methods: a standard serodot (DB) method using monoclonal
anti-LewisX and anti-LewisY and peroxidase-labeled secondary
antibodies, Enzimo inmmuno assay (EIA) using LPS (EIA-LPS),
whole cells 48-hour culture or whole cells frozen culture using the
same monoclonal antibodies and alkaline phosphatase-labeled
secondary antibodies.
Results. EIA performed with whole cells (fresh or frozen cultures)
showed the highest positivity for both LewisX and LewisY. Of the
87 strains tested, 33% expressed LewisX and LewisY simultaneously,
7% only LewisX, 31% only LewisY, and 29% no Lewis antigen.
Sixty-seven percent of strains from pediatric patients showed one
or more Lewis antigen compared with 76% of strains from adult
patients.
Conclusions. Whole cells EIA showed the highest detection of
LewisX and LewisY. Although Lewis expression were more
frequent in strains obtained from adults, no statistical differences
were observed compared with strains from children.

Abstract no.: 03.32
In Vitro Investigation of Proinflammatory
Properties of Helicobacter pylori Strains Involved
in Low-Grade Gastric Mucosa-Associated Tissue
(MALT) Lymphoma
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P. Lehours,* G. Lasne,* A. Gallois,* A. Ménard,*
A. Ruskone-Fourmestraux,† J. Delchier‡ and
F. Mégraud*
*Université Victor Segalen Bordeaux 2, Laboratoire de Bactériologie,
Bordeaux, France, †CHU St Antoine, Paris, France, ‡CHU Henri
Mondor, Creteil, France

In a previous study, we showed that the main Helicobacter pylori
virulence factors including CagA are not associated with strains
isolated from patients with MALT lymphoma, suggesting that
MALT pathogenesis was not linked to the occurrence of more
proinflammatory H. pylori strains. Our aim was to test, in vitro,
the proinflammatory properties of H. pylori strains isolated from
MALT.
We investigated the ability of 36 H. pylori MALT strains to
induce interleukin-8 (IL-8) secretion by AGS cells. Briefly,
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H. pylori strains were harvested from 2 days plate cultures then
resuspended in brucella broth medium. The broth was adjusted to
an optical density of 0.6 at 600 nM. The bacterial suspensions
(35 µl) were inoculated in each well in triplicate on AGS cells
cultured to 60–70% of confluence. After 18 hours of coculture, the
supernatants were recovered in order to quantify the proinflammatory cytokine IL-8 (R & D Systems).
Because IL-8 production is mostly dependent on a functional cag
secretion system, we studied 16 cagA-positive and 20 cagAnegative MALT strains. High IL-8 production was observed in
cagA-positive strains (1379 pg/ml ± 659). All the cagA-negative
strains induced low rates of IL-8 (84 pg/ml ± 52), indicating that
they do not have proinflammatory potential and probably no other
important proinflammatory factor. The results are being currently
analyzed according to the presence of other virulence factors.
In conclusion, if the involvement of H. pylori strains in MALT
lymphoma is well established, its pathomechanism still remains to
be elucidated.
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Abstract no.: 03.33
CagA,VacA Helicobacter pylori Strains and
Epitheliocyte Apoptosis in Stomach Mucus in
Ulcer Disease in Khakassia
V. V. Tsukanov,* S. V. Barkalov,* A. V. Kononov† and
O. V. Shtygasheva‡
*State

Scientific Medical Research Institute for Northern Problems,
Krasnoyarsk, Russian Federation, †Omsk State Medical Academy,
Omsk, Russian Federation, ‡Khakassian Republican Hospital, Abakhan,
Russian Federation
Aim. To study Helicobacter pylori, genotypes, the relationship
between proliferation and epitheliocyte apoptosis in ulcer disease
of duodenum in the Europoid and Mongoloid of Khakassia.
Methods. We examined 27 Europoid and 24 Khakass duodenum
ulcer disease patients. Immune gistochemical test was carried out
in bioptats from three parts of stomach, using streptavidin-biotin
method. As initial antibodies we used mice monoclonal antibodies:
proliferation antigen Ki-67, representative of caspase effector
CPP-32, which regulates apoptosis irreversible stage. We
determined proliferation index as percentage share of positively
colored epitheliocytes. In all the patients, H. pylori infection
was found by morphological and urease methods. Besides, we
determined VacA, CagA, IceA, BabA types and subtypes of
H. pylori by microbiological and polymerase chain reaction (PCR)
methods.
Results. CagA and S1S2 subtypes of H. pylori VacA strains were
registered in 93.3% and 70.0% Europoid and in 57.1% ( p < .01)
and 42.9% ( p < .05) Mongoloid. Proliferation index (PI) in the
Khakass was evidently higher than in the Europoid. Apoptosis
index (AI) in ulcer diseases was 32.0% in the Khakass and 32.9%
in the Europoid and was higher ( p < .01) than in patients without
ulcer disease. PI/AI coefficient in both target populations in ulcer
disease was lower than 1 (0.71 in the Khakass; 0.62 in the
Europoid), which is caused by apoptosis hyperfunction.
Conclusion. There are definite differences in proportions between
proliferation and apoptosis processes in the examined target
population, which can be connected with differences between
H. pylori genotypes.
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Abstract no.: 03.34
In Perforated Peptic Ulcer Patients Helicobacter
pylori Infection Tends to Persist

Abstract no.: 03.35
Virulence of CagA and VacA in Helicobacter
pylori Adult Infection in our Country

H. Andreson,* T. Sillakivi,† M. Peetsalu,† A. Peetsalu†
and M. Mikelsaar*

F. Kias, F. Mouffok, F. Taleb, B. Touchene, Z. Guechi,
A. Bouhadef and H. Berrah

*Department

of Microbiology and †Surgery, University of Tartu, Tartu,

Laboratoire Algerien de recherche sur Helicobacter, Algiers, Algeria

Estonia
In perforated peptic ulcer patients (PPU), Helicobacter pylori
infection tends to expose clinically as recurrent ulcer. We have
investigated PPU patients for the persistent infection or reinfection
with H. pylori, emerging after surgical intervention and eradicative
therapy.
Materials and Methods. Peptic ulcer patients patients (33) were
operated on and H. pylori eradicative therapy applied. The
colonization of antral mucosa by H. pylori was graded by
histologic evaluation, and DNA of H. pylori was isolated initially,
2–5 months and 1 year after treatment. Polymerase chain reaction
(PCR) amplification was applied for examination of vacA allelic
types, cagA and ureA genes of H. pylori. Ten patients were selected
for PCR-RFLP analyses of glmM gene products, digested by
HhaI.
Results. After 1 year, the vacA alleles of H. pylori showed the
complete eradication in 10/33 (30%) of the PPU patients and the
same strain persisted in 19/33 (58%) of noneradicated patients,
whereas in 4/33 (12%) the new strain emerged. Persistent infection
by the same strain was proven by PCR-RFLP in 8/9 of tested
patients. Regardless of the results of eradication, the significant
decrease ( p < .05) in density of H. pylori colonization 2–5 months
after therapy was detected.
Conclusion. In the majority of PPU patients 1-year after therapy,
no eradication of H. pylori was obtained because of the persistent
infection. After therapy, the short-term decrease of the density of
bacteria hints that the reason for eradication failure is not associated
with the antibiotic resistance of H. pylori strains.

CagA and VacA are two important factors implicated in Helicobacter
pylori virulence.
The prevalence of these factors is variable according to the
geographical location.
The aim is to seek for these factors in subjects infected by
H. pylori and to evaluate the importance according to the clinical
statute.
Two hundred ten H. pylori-positive sera (58 ulcers and 152
gastritis) collected between 2000 and 2004 were tested by
HelicoBlot 2.1 (Genelabs)
A high diversity of H. pylori strains was found with a
predominance of CagA+ VacA− Carracter: 32% of 210 were tested
CagA+ VacA+, 40% CagA+ VacA−, 8.5% CagA− VacA+, and
19.5% were CagA− VacA− (19.52%).
According to the clinical statute: in 152 sera of gastritis, 28%
were CagA+ VacA+, 38% were CagA+ VacA−, 8.5% were CagA−
VacA+, 32.5% were CagA− VacA−; about the ulcers, 41% of
58 sera were tested CagA+ VacA+, 44.8% were CagA+ VacA−,
8.6% were CagA- VacA+, and 5% were CagA− VacA−.
So CagA is more implicated in ulcer (86% of cases) than in
gastritis (66% of cases).
The H. pylori virulence (CagA+ 72%, VacA+ 40.4%) is in
correlation with Mediterranian results, but it is less important
than in the Asiatic one: Turkey (Absyanik et al.) CagA+ 83%,
VacA+ 65%; Japan (Maeda et al.) CagA+ 90%, VacA+ 59%.
Determination of H. pylori virulence is very important for
diagnostic purposes and also to evaluate H. pylori infection gravity.
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Abstract no.: 04.01*
Specific African Genotype among Helicobacter
pylori Strains
G. I. Perez Perez,* A. Z. Olivares,* K. N. Horstman,*
R. M. Peek,† C. N. Bernstein,‡ E. Garza Gonzalez,§
J. Torres¶ and M. J. Blaser*
*New York

University, New York, NY, USA, †Vanderbilt University
School of Medicine, Nashville, TN, USA, ‡University of Manitoba,
Winipeg, MB, Canada, §Universidad Autonoma de Nuevo Leon,
Monterrey, Nuevo Leon, Mexico, ¶Instituto Mexicano del Seguro
Social, Mexico City, Mexico
Helicobacter pylori spread within families is the primary mode of
transmission in humans. Colonization persists throughout the
lifetime of a host. H. pylori strains possess specific gene sequences
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556

that can identify the geographic origin of its cognate human host,
and thus may represent useful biomarkers for human migrations
and ancestry. To determine whether H. pylori strains isolated from
African American patients contain a particular genotype that is
shared with strains from African patients but is not present in
strains isolated from other ethnic groups, we studied 235 H. pylori
isolates [African American (14.9%), Caucasian (20.0%), Asian
(14.9%), Hispanic (34.0%), and Amerindian (16.2%)] from
patients undergoing GI endoscopy. Sequence analysis of polymerase
chain reaction (PCR) products amplified from three housekeeping
genes ureI (585 bp), atpA (627 bp), and ahpC (528 bp) was
performed as described (Microbiology 2004; 150) in 26 strains.
We also studied 233 H. pylori strains to determine the presence of
a 180-bp insert that was specifically found in strains of African
origin (McNulty, JCM, 2004:42). All three housekeeping genes
distinguished strains of African origin from those of other ethnic
origins, but ureI showed the best discrimination; the presence of
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the 180-bp insert correlated with the sequence analysis in 73% of
the 26 strains. As expected, the 180-bp insert was rarely found in
strains from Asian [1/35 (2.9%)]. Using this as the reference group,
the 180-bp insert was found significantly more often in Hispanics,
Amerindians, and African-Americans. We can now identify
H. pylori strains of African origin from among patients of other
geographic origins using a simple method.
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Abstract no.: 04.02
Helicobacter pylori: Epidemiological
Investigations by a Noninvasive Protocol Using
Stool Specimens
S. Puz, A. M. Hirschl, C. Schabereiter-Gurtner,
Z. Kovách, M. Rotter and A. Makristathis
Department of Clinical Microbiology and Hygiene, Medical University
Vienna, Austria, Vienna, Austria
Twenty years after the first successful cultivation of Helicobacter
pylori, the source(s) of infection and the route(s) of transmission are
not yet clarified. Nearly all protocols, so far, require cultured
isolates. Thus, studies including relatives of index patients are
extremely restricted.
Therefore, we developed a noninvasive and easy-to-perform
protocol, which enables for H. pylori typing using not only cultured
isolates but also biopsies and, most importantly, stool specimens.
The method is based on two H. pylori-specific biprobe real-time
polymerase chain reaction (PCR) assays using fragments of the
glmM and the recA genes as target sequences. Discrimination between
strains results from differences in melting curves after successful
amplification. In case of identical melting curves, sequencing of the
amplification products is necessary to confirm strain identity.
In comparison to the gold standard of H. pylori diagnosis (by
rapid urease test, histology, and culture), the sensitivity of the
glmM assay in stool specimens was 98% and that of the recA assay
was 92%. The specificity of both assays was 100%. Using unrelated
H. pylori isolates and stool samples from unrelated patients, the
discriminatory capacity of the typing protocol was nearly 100%.
Furthermore, this protocol allows for single-strain identification in
mixed infections.
In an ongoing study, the investigation of eight African and 15
Austrian households with an infected index child may contribute to
a more precise characterization of intrafamilial transmission patterns.
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Abstract no.: 04.03
The Association of Helicobacter pylori CagA
Strains Prevalence with Ulcer Diseases in Siberia
Mongoloids
V. V. Tsukanov, O. V. Shtygasheva, S. V. Barkalov,
J. L. Tonkikh, O. L. Garkun, A. E. Barmakov and
E. P. Bronnikova
State Scientific Medical Research Institute for Northern Problems of
Siberian Division of Russian Academy of Medical Sciences,
Krasnoyarsk, Russian Federation
Aim. To study the interconnection of Helicobacter pylori CagA
strains and ulcer diseases in the Mongoloids and the Europoids in
different regions of Siberia.
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Methods. We carried out large-scale epidemiologic research in
Tyva, Khakassia, Evenkia, Yakutia, and Eastern Siberia middle
latitudes. H. pylori was determined by serologic, morphologic
(Gimza coloring), and urease techniques, by polymerase chain
reaction (PCR) method in 3494 patients (1365 Mongoloid, 2129
Europoid). IgG CagA was diagnosed by immune-ferment-analysis
(IFA) technique in blood serum in 562 subjects in Khakassia and
493 in Evenkia. Esophagofibregastroduodenoscopy was carried out
for 5215 subjects (2701 Europoid and 2514 Mongoloid).
Results. Total prevalence of ulcer disease in the Europoid made
8.4%, in the Mongoloid 3.5%. H. pylori prevalence made in the
Mongoloid 91.3%, in the Europoid 89.6%. H. pylori CagA
prevalence in the Mongoloid made 39.4%, in the Europoid 60.3%
( p < .001). In all the regions, H. pylori dissemination density in
mucous layer of the stomach’s antral part was higher in the
Europoid than in the Mongoloid by 1.5–3 times. H. pylori strains
were associated with ulcer disease in the Mongoloid, but not in the
Europoid of Siberia.
Conclusion. H. pylori CagA association with ulcer diseases is
opposite to CagA prevalence index in target population.

Abstract no.: 04.04
Prevalence and Spread of Enterohepatic
Helicobacter Species in Mice Reared under
Specific Pathogen-Free Conditions
8Abstract
Abstracts

M. Selgrad,* U. Bohr,* C. Ochmann,† A. Fenske,†
T. Wex* and P. Malfertheiner*
*Department

of Gastroenterology, Hepatology and Infectious
Diseases, Magdeburg, Germany, †Central Animal Laboratory,
Magdeburg, Germany
Aim. The aim of this study was to detect prevalence and spread of
enterohepatic Helicobacter species (EHS) in mice reared under
specific pathogen-free conditions.
Methods. Feces samples of 41 mouse strains were analyzed for
Helicobacteraceae using a group-specific polymerase chain reaction
(PCR). Species identification in positive samples was performed by
DNA-sequencing and restriction fragment length polymorphism
(RFLP). Several additional experiments were carried out to evaluate
the spread of EHS when mice are harbored in different caging systems.
Results. Helicobacter species were detected in 35/41 (85%) of the
tested mouse strains. Altogether five different Helicobacter strains
were identified: H. ganmani, H. hepaticus, H. typhlonicus, Helicobacter
sp. “hamster B,” and H. sp. “ulmiensis.” In 26 mouse strains, a
single Helicobacter species was detected and nine mouse strains
were shown to have coinfections with two or more Helicobacter
species. Transmission of EHS occurred in 100% (35/35) when pairs
of Helicobacter negative and infected mice shared the same cage. If
Helicobacter-free mice were reared in open cages next to cages with
EHS-positive animals, de novo infection of mice was observed in
32% (8/26) within 8 weeks. In contrast, when the same experiment
was repeated with polycarbonate-filter top equipped cages, all 26
mice remained uninfected in the observation period. Helicobacter
infection could also be completely prevented during a 12-month
follow-up in mice harbored in individually ventilated cages.
Conclusion. Infection with EHS occurs in mice reared under SPF
conditions and can easily spread in animal facilities. This can be
prevented if polycarbonate-filter tops or individually ventilated
cages are used.

Abstracts
8Abstract

© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556

483

Epidemiology and Transmission
Abstract no.: 04.05
Helicobacter pylori Reinfection in InsulinDependent Diabetes Mellitus Patients:
A 5-Year Follow-Up
Epidemiology and Transmission

V. Ojetti,* D. Pitocco,† A. Migneco,*
N. Gentiloni Silveri,* G. Gasbarrini,* G. Ghirlanda†
and A. Gasbarrini*
*Department
†Department

of Internal Medicine, Catholic University, Rome, Italy,
of Diabetology, Catholic University, Rome, Italy

Objective. Previous data showed that diabetic patients had low
Helicobacter pylori eradication and high reinfection rate.
Aim. To evaluate H. pylori reinfection in insulin-dependent
diabetes mellitus (IDDM) patients and in dyspeptic controls 5
years after successful eradication.
Methods. Forty patients affected by IDDM and 50 dyspeptic
controls, previously treated for H. pylori infection and eradicated,
were submitted to urea breath test (UBT) after 5 years of followup. Daily insulin requirement, glycosilated hemoglobin (HbA1c),
and development of organ damage were evaluated.
Results. We found a significantly higher incidence of H. pylori
reinfection in IDDM patients versus controls. In particular, 27%
IDDM patients versus 4% controls resulted reinfected after 5 years
( p < .001). In 5-year follow-up in reinfected diabetic patients, an
increase in the levels of HbA1c compared to values at enrolment
(8.26 versus 7.48, p < .01) was observed, whereas no significant
increase was found in the negative group. Furthermore, the
H. pylori-positive group showed increased insulin requirement
compared to H. pylori-negative patients (0.69/kg versus 0.61/kg).
These data reached not statistical significance. Finally, we found
statistically significant higher prevalence of diabetic organ damages
in the reinfected group compared to negative patients: neuropathies,
42% versus 10% ( p < .01); nephropathies, 42% versus 15% ( p < .01);
retinopathies, 28.6% versus 5% ( p < .05), respectively.
Conclusions. IDDM patients show higher H. pylori reinfection
rates compared to dyspeptic controls. H. pylori reinfection is
associated with poorer glycemic control and higher incidence of
organ damage. UBT as follow-up screening in eradicated IDDM
patients seems a useful tool to detect reinfected patients and
optimize glycemic control.
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Abstract no.: 04.06*
The Mother as Intrafamilial Source of
Helicobacter pylori Infection:
A Prospective Birth Cohort
M. Weyermann,* G. Adler,† H. Brenner* and
D. Rothenbacher*
*Department

of Epidemiology, The German Centre for Research on
Ageing, D-69115 Heidelberg, Germany, †Department of Internal
Medicine I, University of Ulm, D-89081 Ulm, Germany
Objective. We investigated the Helicobacter pylori prevalence in a
large group of parents and their offspring during a 3-year followup to elucidate the intrafamilial source of infection.
Methods. Between November 2000 and November 2001, all
mothers and their partners were recruited after delivery of their
offspring at the University of Ulm. Infection status of women
was determined by 13C-urea breath test. Infection status of the
fathers at baseline and of the infants at the age of 1, 2, and 3 years
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was determined by a monoclonal H. pylori antigen proof in
stool.
Results. Of the included 1066 children at baseline, stool samples
were available for 890 (84%), 870 (82%), and 834 (78%) at the age
of 1, 2, and 3, respectively. Incidence of infection was 1.3%, 1.4%,
and 0.6% in the first, second, and third years of life, respectively.
The prevalence among children at age 3 was 2.4%. After adjustment
for infection status of the spouse and nationality, the odds ratio for
H. pylori infection of the child at age 3 was 12.9 (95% CI 3.2–52.5)
if the mother was infected and 1.4 (95% CI 0.4–4.6) if the father
was infected. The number of older siblings was no risk factor for
H. pylori infection of the child.
Conclusions. This study suggests that infected mothers are the
main source of H. pylori infection of their children in the
population studied and that prevalence of H. pylori infection is
decreasing rapidly in recent birth cohorts in Western countries.

Abstract no.: 04.07
Recurrence of Helicobacter pylori Infection
After Eradication: Long-Term Follow-Up of
1000 Patients
Abstracts
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J. P. Gisbert,* M. Luna,* D. Olivares,* M. Herrerias,†
B. Gomez,† J. Mones,‡ M. Castro-Fernandez,§
P. Sanchez-Pobre,¶ A. Cosme** and J. M. Pajares*
*La

Princesa University Hospital, Madrid, Spain, †Hospital Virgen
Macarena, Sevilla, Spain, ‡Hospital Santa Creu i Sant Pau, Barcelona,
Spain, §Hospital de Valme, Sevilla, Spain, ¶Hospital 12 de Octubre,
Madrid, Spain, **Hospital de Donostia, San Sebastian, Spain
Aim. To study the incidence of Helicobacter pylori recurrence and
its chronological aspects (the exact moment when it appears), and
to evaluate whether it would be recommendable to perform
periodic controls (e.g., with 13C-urea breath test [13C-UBT ]) to
detect H. pylori recurrence after eradication success.
Methods. One thousand patients in whom H. pylori had been
eradicated were prospectively studied. Several therapies were used,
mainly proton pump inhibitor-based regimens for 7–10 days. Four
to eight weeks after completion of therapy, 13C-UBT was performed,
and it was repeated each from 12 months to 5 years to study
H. pylori recurrences.
Results. Up to now, 1000 patients have been followed up (407 for
1 year, 189 for 2 years, 23 for 3 years, 215 for 4 years, and 166 for
5 years), giving 2.544 patient-years of follow-up. A total of
73 H. pylori recurrences were observed, giving a yearly recurrence
of 2.9% per patient-year of follow-up. Respective risk of H. pylori
recurrence for each period was 13% at 1 year, 5.3% at 2 years, 4.3%
at 3 years, 1.4% at 4 years, and 2.4% at 5 years.
Conclusion. Risk of posteradication H. pylori recurrence is higher
during the first year, which suggests that most recurrences during
this period are recrudescences and not true reinfections. However,
long-term recurrence of H. pylori infection is infrequent in our
area. Therefore, after the first year, it seems not necessary to
perform periodic controls (e.g., with 13C-UBT) to detect H. pylori
recurrence after eradication success.
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Abstract no.: 04.08
Natural History of Helicobacter pylori in
Childhood and Factors Determining the
Epidemiology of Infection
A. O. Özen, D. Ertem and E. Pehlivanoglu
Marmara University School of Medicine, Division of Pediatric
Gastroenterology, Hepatology and Nutrition, Istanbul, Turkey
High seroprevalence rates for Helicobacter pylori have been
reported in developing countries, yet few studies exist determining
the pattern of change in the epidemiology of H. pylori infection in
children. Our aim was to conduct a prospective study to elucidate
the outcome, rate of acquisition, and loss of H. pylori infection in a
population of healthy children in order to identify the best time to
institute strategies that might protect children from infection.
Methods. This study is based on follow-up of 327 healthy Turkish
children aged 3–12 years. The follow-up was conducted 6 years
after the baseline examination. H. pylori status was determined by
13C-urea breath test (UBT). Children were investigated for
sociodemographic variables and several symptoms.
Results. Data from 136 of 327 (41%) children were available. The
prevalence of infection increased from 52.9% to 56.6%, which was
mainly confined to children younger than 10 years of age. The
annual acquisition and loss rates of H. pylori were 2.3% and 0.9%,
respectively. Socioeconomic status, household density, and antibiotic
use during 6 months were inversely related to H. pylori prevalence.
The frequency of headache but not abdominal pain or dyspepsia
was higher in H. pylori-infected children.
Conclusions. In this study, the acquisition rate of H. pylori
infection was 2.5-fold higher than the loss of infection, and the
acquisition mostly occurred before 10 years of age. Data regarding
acquisition and loss of H. pylori infection are critical for
understanding the epidemiology of infection and development of
preventive and treatment strategies.
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Abstract no.: 04.09
Helicobacter pylori Infection is No Longer the
Major Cause of Peptic Ulcer in Copenhagen
County
B. Søndergaard and P. Bytzer
Department of Medical Gastroenterology, Glostrup University
Hospital, Glostrup, Denmark
Introduction. Peptic ulcer disease is almost always caused by
infection with Helicobacter pylori or by ulcerogenic drugs or by a
combination of these.
Aims and Methods. We aimed to examine the prevalence of
H. pylori infection and the intake of NSAIDs and aspirin (ASA) in
patients diagnosed with peptic ulcer at an endoscopy center. Case
forms for patients with an endoscopic diagnosis of uncomplicated
peptic ulcer during the years 2002 and 2003 were reviewed.
Results. One hundred thirty-four patients (66 males) were
investigated. Mean age was 70 years, range 12–94 years. Thirtyeight percent were smokers. Eighty-three patients had gastric ulcer,
42 patients had duodenal ulcer, and nine patients had combined
ulcer. In six patients, H. pylori status could not be determined. A total
of 66/134 (49%) peptic ulcer patients were infected with H. pylori.
H. pylori was more common in patients with gastric ulcer compared
to patients with duodenal ulcer (61% versus 42%, p = .0024). A
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total of 48/83 gastric ulcer patients used either NSAIDs (11), ASA
(30), or both (7). Six of these 83 patients were classified as having
idiopathic ulcer disease. A total of 28/48 duodenal ulcer patients
had used either NSAIDs (7), ASA (13), or both (8). Six of these 42
patients were classified as having idiopathic ulcer disease.
Conclusion. The frequency of H. pylori infection in patients with
peptic ulcer disease is rapidly decreasing. Use of NSAIDs and aspirin
is now the major causative factor for duodenal ulcer in Copenhagen
County.

Abstract no.: 04.10
Quality of Life of Peptic Ulcer Patients After
Eradication Treatment of Helicobacter pylori
8Abstract
Abstracts

H. Maaroos, R. Keevallik, H. Kolk, I. Kull, K. Labotkin
and R. Tammur
University of Tartu, Tartu, Estonia
Objectives. The aim of this study was to assess the effectiveness of
Helicobacter pylori eradication treatment for the life quality of the
patients.
Methods and Patients. Upper gastrointestinal endoscopy, the
SF-36 scale, and the gastrointestinal symptoms rating scale
(GSRS) were used. Altogether, 91 peptic ulcer patients (mean age
46.7 years, 45 male and 46 female) were included in the study
5 years after H. pylori eradication treatment. Peptic ulcer was
healed in 59 cases and relapsed in 32 cases. The control group was
formed of 598 (mean age 49.4 years, 39% male, 61% female)
randomly selected persons. Summary statistics were obtained for
each of the dimensions of SF-36 and GSRS scales for all performed
measurements. Differences between the two peptic ulcer groups
and the population group were calculated.
Results. Overall evaluation of health ( p = .039) and physical
functioning ( p = .02) was lower and physical pain disturbed patients
more ( p = .005) in the cases of recurrent ulcer than in cases of healed
ulcer. The peptic ulcer patients irrespectively of recurrences evaluated
their emotional functioning ( p = .04) lower and it disturbed more
their everyday life ( p < .0001) and social functioning ( p = .02)
compared with the population group.
Conclusion. Physical health after peptic ulcer treatment was more
disturbed in recurrent ulcer cases. The disturbances in mental
component of health occurred even in cases of healed ulcer. It
shows that early effective treatment is needed to predict the chronic
course of peptic ulcer and to ensure improvement of the patients’
quality of life after treatment.
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Abstract no.: 04.11
Time Trend on the Prevalence of Helicobacter
pylori Infection and Gastric Mucosal Atrophy in
an Urban Area of Japan
K. Yagyu, S. Kikuchi and Y. Obata
Aichi Medica University, Nagoya, Japan
Subjects and Methods. Subjects were healthy workers aged 48 –
83 years in 1989 (1182 [940 men; 252 women]) and 1998 (2950
[2439 men; 521 women]) who had participated in an annual health
check-up program of a company in an urban area of Japan. We
measured Helicobacter pylori IgG antibody and pepsinogen I and
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556
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II in their sera using J-HM-CAP™ and RIAbeads Pepsinogen I
and II ™. Subjects were classified by H. pylori status (positive/
negative) and pepsinogen values (normal /mild /severe). We observed
the changes in the prevalence of H. pylori infection and serologic
atrophy of gastric mucosa in each 9-year age group (48 –56, 57–65,
and 66–83) between 1989 and 1998.
Results. The prevalence of H. pylori infection in each group was
64% (48–56), 69% (57– 65), and 64% (66 – 83) in 1989, 52% (48–
56), 60% (57–65), and 65% (66 – 83) in 1998, respectively. The
prevalence of mild atrophy in each group was 20% (48–56), 18%
(57–65), and 16% (66 – 83) in 1989, 15% (48–56), 19% (57–65), and
21% (66–83) in 1998, respectively. The prevalence of severe
atrophy in each group was 14% (48 –56), 20% (57– 65), and 27%
(66–83) in 1989, 12% (48 –56), 18% (57– 65), and 27% (66–83) in
1998, respectively.
Conclusion. The prevalence of H. pylori infection and gastric
mucosal atrophy was decreased in 48 –56 and 57– 65 age groups
during the 9-year period. The decline of the prevalence of gastric
mucosal atrophy during the 9-year period was smaller than that of
H. pylori infection.

Abstract no.: 04.12
Detection of Helicobacter pylori Urease Gene in
the Oral Yeast
8Abstract
Abstracts

F. Siavoshi,* A. H. Salmanian† and F. A. kbari*
*Microbiology

Department, Faculty Science, Tehran University, Tehran,
Islamic Republic of Iran, †National Research Center for Genetic
Engineering & Biotechnology, Tehran, Islamic Republic of Iran

Understanding the mode(s) of transmission of Helicobacter pylori
comprises one of the headings that are emphasized regarding
treatment and control of H. pylori infection. In order to reveal the
important role of oral yeast in the transmission of H. pylori,
polymerase chain reaction (PCR) was recruited to target H. pylori
urease gene in total DNAs extracted from oral yeasts.
PCR was performed on DNAs from five oral yeasts in which
H. pylori-specific genes, 16SrDNA, cagA, and vacA were detected
in the previous studies. Primers (two forward and one reverse)
were designed for amplification of the segments of ureA and ureB
genes. PCR conditions were optimized as 2.5 mmol/l MgCl2,
100 ng of template and annealing temperature of 53 °C. H. pylori
and Escherichia coli were used as positive and negative controls,
respectively. PCR products were analyzed using 100 bp ladder.
The size of amplified products of five oral yeasts and control
H. pylori, obtained from seminested PCR, was 406 bp, which
corresponded to H. pylori urease gene. No band was detected from
control Escherichia coli.
Several lines of evidence propose fecal–oral and oral–oral routes
for transmission of H. pylori. Although isolation of the bacterium
from environmental or human oral cavity has not been successful.
In this study, H. pylori urease gene has been detected in the oral
yeast in which 16SrDNA, vacA, and cagA genes have been detected
in the previous studies. It is proposed that ubiquitous yeast plays a
crucial role in accomodating H. pylori outside the human stomach
and its delivery to GI tract.
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Abstract no.: 04.13
Factors Affecting the Adhesion of WaterStressed Helicobacter pylori to Plumbing
Materials
N. F. Azevedo,*† A. P. Pacheco,* A. R. Pinto,*
C. W. Keevil† and M. J. Vieira†
*Center

for Biological Engineering, Braga, Portugal,
Healthcare Unit, School of Biological Sciences,
University of Southampton, Southampton, UK

†Environmental

The most important route(s) of transmission for Helicobacter
pylori among the human population has yet to be identified, but
water and associated biofilms have been considered as potential
environmental reservoirs in several studies. Although molecular
techniques have identified H. pylori in water-associated biofilms,
there is a lack of studies reporting what factors affect the attachment
of the bacterium to plumbing materials. Therefore, the influence of
shear stress, temperature, inoculation concentration, and different
abiotic substrata on the total counts of attached H. pylori was
evaluated using epifluorescence and scanning electron microscopy.
Results were statistically significant for adhesion of the bacterium
at different shear stress ( p < .001), with higher numbers of attached
H. pylori being obtained at the lowest flow velocities of the water.
By contrast, temperature, inoculation concentration, and different
substrata appeared to have no effect on attached bacteria ( p > .05).
The importance of shear stress in the attachment of the microorganism indicates water storage reservoirs or wells, where low
shear forces are usually present, as more probable locations for the
subsistence of H. pylori attached to the surfaces and consequently
embedded in biofilms. This conclusion supports the findings
observed by others where the ingestion of well water was correlated
with an increased chance of developing an H. pylori infection.
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Abstract no.: 04.14
Time Trend on the Prevalence of Helicobacter
pylori Infection and Gastric Mucosal Atrophy in
a Rural Area of Japan
Y. Obata, S. Kikuchi and K. Yagyu
Aichi Medical University, Aichi, Japan
Subjects and Methods. Subjects were healthy individuals aged
40–69 years in 1997 (560 [195 men; 365 women]) and 2003 (499
[164 men; 335 women]) who had participated in a health check-up
program in a rural area of Japan. We measured Helicobacter pylori IgG
antibody and pepsinogen I and II in their sera using J-HM-CAP™
and RIAbeads Pepsinogen I and II™. Subjects were classified by
H. pylori status (positive/negative) and pepsinogen values (normal/
mild/severe). We observed the changes in the prevalence of H. pylori
infection and serologic atrophy of gastric mucosa in each 10-year
age group (40–49, 50–59, and 60–69) between 1997 and 2003.
Results. The prevalence of H. pylori infection in each group was
52% (40–49), 66% (50–59), and 74% (60–69) in 1997, 34% (40 –
49), 59% (50–59), and 63% (60–69) in 2003, respectively. The
prevalence of mild atrophy in each group was 16% (40–49), 19%
(50–59), and 22% (60–69) in 1997, 4% (40–49), 7% (50–59), and
12% (60–69) in 2003, respectively. The prevalence of severe
atrophy in each group was 3% (40–49), 13% (50–59), and 18%
(60–69) in 1997, 1% (40–49), 7% (50–59), and 13% (60– 69) in
2003, respectively.
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Conclusion. The prevalence of serologic atrophy of gastric
mucosa was decreased in all age groups during the 6-year period,
and especially the great decline was observed in younger age
groups. The decline of the prevalence of H. pylori infection during
the 6-year period was smaller than that of gastric mucosal atrophy.
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Abstract no.: 04.15
Seroprevalence of Helicobacter pylori Infection in
Tehran University Students from 2001 to 2003
E. Hoodeh,* A. Azammi,† A. Sarafnejad,* F. Siavoshi,‡
S. Masserrat,§ M. Safar,† N. Dostkhah,† P. Shariati,†
S. Astaraki† and T. Shahrestani*
*Tehran University of Medical Sciences, School of Public Health,
Tehran, Islamic Republic of Iran, †Tehran University Students Health
Center, Tehran, Islamic Republic of Iran, ‡ Faculty of Sciences,Tehran
University, Tehran, Islamic Republic of Iran, §Tehran University of
Medical Sciences, Shariati Hospital, Tehran, Islamic Republic of Iran
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Garcia Hospital in Havana, Cuba. Biopsies were maintained at −70
°C before being cultured on three different media (two selective
and one nonselective) and incubated for 7 days at 37 °C under a
microaerobic atmosphere. The presence of H. pylori was identified
by oxidase, catalase, and urease activities. DNA was extracted, and
polymerase chain reaction (PCR) was performed with primers
H2761676, which amplify a 397 bp fragment of the cagA gene.
Clarithromycin susceptibility was measured by the gel diffusion
method. The diagnoses of patients were: 1 gastric carcinoma; 19
duodenal ulcers; 8 gastric ulcers; and 89 non-ulcer dyspepsia,
including (62) gastritis, (9) hiatal hernia, (2) biliary reflux, (1) gastric
polyps, and (15) no abnormality. Among the 117 biopsies tested, 83
were H. pylori-positive (70.9%). The cagA status determined for 35
cases gave a positive result in 31 cases (88.5%). Only 3% of the
strains were resistant to clarithromycin. Most strains were cagApositive and likely harbor the cag pathogenicity island. The low
resistance to clarithromycin in the strains studied probably reflects
the low degree of use of the antibiotic in this population.
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Objectives. Helicobacter pylori infection is a birth-cohort-related
phenomenon, i.e., different cohorts show different rate and prevalence
of infection. A seroepidemiologycal study was conducted in a
young population of Tehran University students to investigate the
seroprevalence of H. pylori and to detect the relationship with
birth-cohort phenomenon.
Subjects and Methods. During the 3 years (from 2001 to 2003), a
total of 2000 serum samples collected from Tehran University
students, between 18 and 24 years old. These students admitted for
a routine check-up in Tehran University Students Health Center.
All sera were tested for the presence of IgG antibodies against
H. pylori by using an in-house ELISA technique. A whole cell
sonicated antigen was used for coating the ELISA plates.
Results. In this study, 1434 subjects were seropositive, 566 subjects
were seronegative, and the seroprevalence of H. pylori infection
was 71.7%.
Conclusions. According to the results of prior studies, the
seroprevalence of H. pylori infection in Iran was about 90% but
this study indicated the seroprevalence of H. pylori infection
decreased to about 71.7%. Decreasing the seroprevalence of H.
pylori infection may be related to improvement of socioeconomic
status, public hygiene, and traditional living conditions in Iran.
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Abstract no.: 04.16
Helicobacter pylori Infection in Havana, Cuba.
Prevalence and cagA Status of the Strains
B. Gutiérrez Carrillo, T. Vidal, C. Valmaña, C. Camou,
A. Santos, F. Mégraud, N. González, L. Leonard,
R. Martínez and O. Díaz-Canel
Instituto Finlay, Cuidad de La Habana, Cuba
Almost no studies have been performed to determine the prevalence,
antibiotic resistance, or virulence factors of the bacterium. To measure
the prevalence of Helicobacter pylori infection among patients
attending endoscopy in three clinics in Havana, Cuba, to evaluate
clarithromycin resistance, and to determine the cagA status of the
strains obtained. Endoscopy was performed and biopsies were
obtained from 117 successive patients attending the Institute of
Oncology, the Institute of Gastroenterology, and the Calixto

Abstract no.: 04.17
Helicobacter pylori-Negative Gastric Ulcers
N. Rossolimos,* M. Theofilopoulou,* S. Balas,*
P. Aggeli,* C. Vassiliou,* V. Xiromeritou,* G. Karatzikos,*
G. Kafiri† and K. Papadimitriou†
*Departments

of Gastroenterology and †Histopathology, Ippokration
General Hospital, Athens, Greece

Objective. The prevalence of Helicobacter pylori-negative ulcers
is highly variable geographically. In pooled series from the United
States, 26% of 315 patients with uncomplicated gastric ulcers
(GUs) were H. pylori-negative. In contrast, the reported prevalence
of H. pylori-negative ulcers from Europe is much lower.
The aim of this study is the determination of the prevalence of
H. pylori-negative GU among the southern Greek population.
Methods. One hundred ten patients of a median age of 51 years
(21–88) who were not taking NSAIDs and underwent upper GI tract
endoscopy because of epigastric discomfort were diagnosed with
GUs. The methods of diagnosis used for H. pylori infection were
firstly by histologic examination and secondly by rapid urease test.
Results. Seventy-two patients (65.5%) were H. pylori-positive
and 38 (34.5%) H. pylori-negative. The percentage of H. pylorinegative GU is higher than that reported internationally.
The majority of these ulcers (after histologic examination) were
diagnosed as “idiopathic” except for a small number, that were
related to lymphoma, carcinoma, Crohn’s disease, or other uncommon
causes of GU.
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Abstract no.: 04.18
Risk Factors of Intratrafamilial Transmission of
Helicobacter pylori in Thailand
V. Mahachai* and R. Vilaichone†
*Department

of Medicine, Chulalongkorn University Hospital,
Bangkok, Thailand, †Department of Medicine, Thammasat University
Hospital, Pathumthani, Thailand
Background and Aims. Intrafamilial tramission is considered as a
major route of Helicobacter pylori infection. This cross-sectional
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556
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study was design to evaluate the factors associated with intrafamilial
H. pylori transmission and seroprevalence of H. pylori infection
among Thai families.
Patients and Methods. Clinical information, structured questionnaires, and blood samples were obtained between June 2002 and
May 2003. The structured questionnaire was completed for all
family members by the same researcher. H. pylori status assessed
by anti-H. pylori serology (HM-CAP; Enteric Product Inc.,
Westbury, NY and HB 2.1; Genelabs Diagnostics, Singapore).
Results. Total of 140 family members including 71 H. pyloripositive family members and 69 H. pylori-negative family members
were evaluated in this study. The seroprevalence of H. pylori infection
in H. pylori-positive family members was significantly higher than
family members of H. pylori-negative (74.7% versus 39.1%;
p < .001). The multiple logistic analysis demonstrated that age
(OR = 6.3; 95%CI = 2.1–19.2, p < .01), share drinking cup behavior
(OR = 10.5; 95%CI = 2.7–40.5, p < .001), and belong to family
member of H. pylori-positive patents (OR = 10.8; 95%CI = 4.1–28.5,
p < .001) are the independent risk factors of H. pylori infection.
Conclusion. This study supported the role of intrafamilial
transmission of H. pylori infection among Thai families. Improvement of personal and family hygiene should be emphasized for
prevention of H. pylori infection.
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Abstract no.: 04.19
The Influence of Helicobacter pylori Infection and
Surgical Procedures on the Development of
Gastric Ulcers in Symptomatic Patients after
Bariatric Surgery
M. Wu,* C. Yang,† W. Lee,‡ H. Wang§ and J. Lin*
*College

of Medicine, National Taiwan University, Taipei,
Taiwan China, †Departments of Internal Medicine,
‡Surgery, and §Internal Medicine, En Chu Kong Hospital, Taipei,
Taiwan China
Background. There are few data relating to the role of Helicobacter
pylori infection and surgical procedures in gastric ulcer following
bariatric surgery.
Methods. Subjects with upper gastrointestinal symptoms
postbariatric surgery and receiving gastroscopic examinations were
prospectively enrolled. All clinical data including age, sex, body
mass index (BMI) before surgery, and surgical method were
recorded. IgG antibodies against H. pylori were measured in
preoperative serum by enzyme-linked immunosorbent assay.
Results. A cohort of 636 patients undergoing laparoscopic vertical
banded gastroplasty (LVBG) or gastric bypass (LGBP) was recruited.
The seropositivity of H. pylori in symptomatic and asymptomatic
patients after surgery was 39% (32/82) and 39.7% (220/554),
respectively. Endoscopic examinations revealed 22 (26.8%) of 82
symptomatic patients had gastric ulcer. Comparison of demographic
characteristics between patients with ulcer (n = 22) and patients
without ulcer (n = 60) showed no difference in distribution of
gender, age, BMI, and seroprevalence of H. pylori (27.3%, 6/22
versus 43.3%, 26/60, p = .212). Patients undergoing LGBP showed
a higher rate of gastric ulcer (45.5%, 10/22) when compared with
patients undergoing LVNG (20%, 12/60; p = .027).
Conclusion. Gastric ulcers in symptomatic patients following
laparoscopic bariatric surgery are related to surgical procedures
rather than exposure to H. pylori infection.
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The Association Between Helicobacter pylori,
Betel Chewing, and Oral Cancer
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G. Jayakumar,* N. Perera,† N. Fernando,*
I. Amarasingha‡ and J. Holton§
*Department

of Microbiology Faculty of Medical Sciences, University
of Sri Jayewardenepura, Nugegoda, Sri Lanka, †General Hospital,
Badulla, Sri Lanka, ‡Cancer Institute, Maharagama, Sri Lanka, §Centre
for Infectious Disease and International Health, University College,
London, UK
Introduction. Betel chewing predisposes to periodontal disease
and oral cancer. Studies show that people with gum disease are
more likely to test positive for Helicobacter pylori. It is not
known if the lesions produced by betel predispose to colonization
by H. pylori. Further the role of this organism in oral cancer is
not known. We determined the presence of antibodies to H. pylori
in oral cancer patients, betel chewers, and nonbetel chewers
to determine the association H. pylori, betel chewing, and oral
cancer.
Method. Ninety subjects (66 men) of which 30 were patients with
oral cancer presenting to Cancer Institute Maharagama, 30 betel
chewer, and 30 nonbetel chewers from Religious and Welfare
Service Center Maharagama were tested for H. pylori by commercial
ELISA (Novum Diagnostica, Dietzenbach, Germany). Oral biopsies
from patients were cultured for H. pylori.
Results. Three (10%) of oral cancer patients tested positive for
H. pylori by serology, two cultures were also positive. Sixty-seven
percent of the oral cancer patients were betel chewers using tobacco
and areca nut. Three (10%) of betel chewers also tested positive for
H. pylori. However, none of the nonbetel chewers tested positive
for H. pylori. There is a significant difference in the presence of
H. pylori between betel chewers and nonbetel chewers at presence
of α equal to 0.2 ( [ p = .118, which is < 0.2]; Fisher exact test ). Same
association was found between oral cancer and nonbetel chewers
( p = .118). No significant difference was seen between presence of
H. pylori in betel chewers and oral cancer patients.
Conclusion. Betel chewing predisposes to colonization with
H. pylori.
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Abstract no.: 04.21
Epidemy of Consumption of Proton Pump
Inhibitors?
K. Seppälä,* L. Veijola,† P. Sipponen,* P. E. T. Arkkila*
and T. U. Kosunen*
*University

of Helsinki, Helsinki, Finland, †Herttoniemi Municipal
Hospital, Helsinki, Finland
Background. After eradication of Helicobacter pylori infection
gastric mucosa and ulcers are healed and PPI are rarely indicated.
Aim. To study the use of PPI (A) nationally and (B) in patients
with peptic ulcers after healed H. pylori infection.
Material and Methods. 1, National consumption of PPIs as daily
doses per 1000 inhabitants (DDD) in 1998–2004 and DDD of
combinations of drugs for eradication of H. pylori in 2000–04 was
obtained from the National Agency for Medicines. 2, We selected
in alphabetic order 1000 of 4465 patients receiving a mailed
questionary. All had gastroscopy at our hospital within 1989 –95.
271/1000 paptients had peptic ulcer with successful eradition
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therapy; consumption of PPI could be analyzed in 220/271 patients
who returned the questionary.
Results. 1, The national DDD of PPIs increased gradually from
5.95 in 1998 to 21.87 in 2004. The DDD of packages for eradication
decreased from 0.09 in 2000 to 0.07 in 2004. 2, One hundred seven
of the 220 patients reported no further endoscopies and 113
reported at least one additional endoscopy after the initial study.
No ulcer recidives were reported.
Number of subjects according to
used PPI and later endoscopies
Additional endoscopies

PPI
Yes

No

Total

No
Yes
Total

17
92
109

90
21
111

107
113
220

p = .0001.

Conclusions. The national consumption of PPIs associated with
eradication of H. pylori infection decreased but increased strongly
with other indications. Many patients with healed peptic ulcer
disease seemed to receive PPIs for symptoms that could have been
treated with cheaper antacids.

Abstract no.: 04.22
Prevalence of Helicobacter pylori Infection in
Santo Domingo
Abstracts
8Abstract

B. Gutiérrez Carrillo
Academia de Ciencias de República Dominicana, Santo Domingo,
Dominican Republic
Santo Domingo is one of the few areas where the prevalence of
Helicobacter pylori has not been studied despite the frequent
occurrence of associated diseases. Our aim was to determine the
prevalence of the infection in a group of 100 consecutive patients
submitted to upper digestive tract endoscopy in a capital city
hospital.
Information concerning the age, gender, and main symptoms
were collected and a serum sample obtained. H. pylori serology
(IgG) was performed using Pyloriset EIA-IIIG from Orion
Diagnostic (Finland).
The reason for endoscopy was epigastralgia in more that 90% of
the cases, the mean age was 43 years, with 54 men and 46 women.
Peptic ulcer disease was diagnostic in 20 cases, normal mucosa in
12 cases, and endoscoped gastritis was found in the other cases.
Among the 100 serums tested, 84 were positive (84%). The
prevalence of H. pylori infection in Santo Domingo is high and is
typical of that reported in other developing countries. Further
studies are needed to get further insight on H. pylori infection in
the Caribbean.
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Abstract no.: 04.23
Seroprevalence of Helicobacter pylori Infection
Among Patients Attending Lagos University
Teaching Hospital Dental Clinic, Lagos, Nigeria
K. S. Oyedeji,* S. I. Smith,* O. A. Odeniyi,†
A. O. Coker,‡ A. O. Arigbabu,§ S. Iwuanyanwu¶ and
K. O. Savage‡
*Nigerian Institute of Medical Research,Yaba, Lagos, Nigeria, †School
of Medical Laboratory Sciences, Lagos University Teaching Hospital,
Lagos, Nigeria, ‡University of Lagos, College of Medicine, Idi-Araba,
Lagos, Nigeria, §Obafemi Awolowo University Teaching Hospital
Complex, Ile-Ife, Nigeria, ¶School of Medical Laboratory Sciences,
Lagos University Teaching Hospital, Lagos, Nigeria

Background and Aim. One of the modes of transmission of
Helicobacter pylori is oral–oral route, and the organism has been
isolated from plaque of dental caries patients in Western, Nigeria.
The level of dental hygiene and dental education is still very low
in Nigeria making this route more predisposed to H. pylori infection.
This study attempts to determine the seropositivity to H. pylori
among patients who ordinarily come for dental check-ups.
Material and Methods. One hundred twenty serum samples were
collected from 120 patients that visited the Lagos University
Teaching Hospital dental Clinic within the study period ( January
to July 2004). The sera were screened for H. pylori antibody using
the enzyme-linked immunosorbent assay method.
Results. All the samples were positive for H. pylori antibody after
the ELISA serologic screening comprising of 19 (15.8%) men and
101 (84.2%) women. The average age of males and females screened
was 44.5 years and 41.2 years, respectively. Most of the patients
belong to the low-income educated class.
Conclusion. This result indicates that the rate of H. pylori infection
is very high in this environment and that most people are asymptomatic carriers, therefore signifying the need for general screening
of the populace for possible H. pylori infection to reduce the rate of
transmission. As some of the patients were diagnosed as having dental
infection, it buttresses the fact that H. pylori could be transmitted
through oral route and also the act of premastication of food for
infants be discouraged to further limit the spread of the infection.
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Abstract no.: 04.24
Possible Predisposing Factors to Helicobacter
pylori Infections among Dyspeptic Nigerians
K. S. Oyedeji,* S. I. Smith,* A. O. Coker,†
A. O. Arigbabu,‡ E. T. Idowu* and A. J. Adedoyin*
*Nigerian

Institute of Medical Research,Yaba, Lagos, Nigeria,
of Lagos, College of Medicine, Idi-Araba, Lagos, Lagos,
Nigeria, ‡Obafemi Awolowo University Teaching Hospital Complex,
Ile-Ife, Ile-ife, Nigeria
†University

Background and Aim. Most epidemiologist believe the primary
route of Helicobacter pylori infection in developing countries is
through fecal–oral route. However, no work has been carried out
to determine the route of H. pylori transmission in our environment
despite its high prevalence (77.1%). This is the first study to document
the possible predisposing factors to H. pylori infection among
dyspeptic Nigerians by the use of questionnaires on respondents.
Materials and Methods. One hundred thirty-eight respondents
who had complaints of dyspepsia and were positive to the diagnostic
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556
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methods for H. pylori positivity in this environment were involved
in the study. Structured questionnaires were administered on the
subjects. All questionnaire data were entered and analyzed using
epiinfo software (version 6.04: Center for Disease Control and
Prevention, Atlanta, GA, USA).
Results. Majority of the respondents were traders and had postsecondary education. The commonest sign experienced by the
respondents during ulcer episode was acute pepperish pain (31.9%),
whereas 5.1% experienced dizziness.
Majority of the respondents (31.9%) attributed the cause of the
H. pylori infection to the source of drinking water. Twenty-two

point five percent (22.5%) attributed it to inadequate sanitation or
hygiene, whereas 18.1% responded that it may be because of their
poor living condition.
Conclusion. The possible predisposing factors to H. pylori
infection can be attributed to the source of drinking water,
inadequate sanitation and hygiene, poor living condition, and
overcrowding. However, habit or type of food does not have much
influence on the acquisition of the organism in this environment.
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Abstract no.: 05.01*
Complement-Mediated Phagocytosis of
Helicobacter pylori-infected Gastric Epithelial
Cells: A Novel Mechanism for Sensing Luminal
Bacterial Infection
K. A. Ryan,* A. T. Hawley,† K. Ravichandran† and
P. B. Ernst†
*University

College Cork, Cork, Ireland, †University of Virginia,
Charlottesville,VA, USA

Helicobacter pylori resides in the mucous layer of the gastric
lumen, yet elicits a robust immune response in the lamina propria.
It is known that gastric epithelial cells undergo apoptosis in
response to H. pylori infection, and that phagocytes engulf
apoptotic cells. As the phagocytosis of infected epithelial cells
could provide a mechanism for luminal antigen detection, we
assessed the ability of macrophages to bind and engulf H. pyloriinfected gastric epithelial cells in vitro.
Control or H. pylori-infected AGS gastric epithelial cells were
cocultured with peripheral blood-derived macrophages or PMAdifferentiated THP-1 cells and fluorescent microscopy was used to
assess binding of infected cells to phagocytes. Macrophages
preferentially bound and engulfed AGS cells undergoing apoptosis
after exposure to H. pylori or camptothecin and phagocytosis of
apoptotic cells were confirmed by confocal microscopy.
Pretreatment of H. pylori-infected AGS cells with Annexin V
diminished binding by 90%, indicating that apoptosis was
necessary for recognition by the macrophage. Engulfment of
gastric epithelial cells by macrophages was abolished by removal or
heat-inactivation of media serum, whereas reconstitution with C1q
complement protein restored binding of the macrophage to the
apoptotic epithelial cells. Macrophages and THP-1 cells, but not
the epithelium, expressed the receptors for PS, C1q, and C3bi as
assessed by flow cytometry and reverse transcriptase-polymerase
chain reaction (RT-PCR). Internalization of H. pylori following
engulfment of apoptotic, infected epithelial cells in a complementmediated process may be a novel mechanism whereby phagocytes
contribute to the inflammatory response to H. pylori infection.

Abstract no.: 05.02*
Influence of Endotoxic Activity of Helicobacter
pylori Lipopolysaccharide on Physicochemical
Parameters
A. P. Moran,* A. B. Schromm,† J. Andrä,†
M. H. J. Koch,‡ U. Seydel† and K. Brandenburg†
*Department

of Microbiology, National University of Ireland, Galway,
Galway, Ireland, †Laborgruppe Biophysik, Forschungszentrum Borstel,
D-23845 Borstel, Germany, ‡European Molecular Biology Laboratory,
c/o DESY, D-22603 Hamburg, Germany
Lipopolysaccharide (LPS) is an important component of the outer
membrane of Helicobacter pylori and induces significantly lower
endotoxic and immunologic responses than enterobacterial
LPS. This property may contribute to the ability of H. pylori to
produce persistent infection compared to more aggressive
pathogens. To understand the physical basis within LPS for these
lower bioactivities, we performed a physico-chemical analysis
of rough- and smooth-form H. pylori LPSs, their lipid A
components, and the dephosphorylated forms of these LPSs and
lipids A. Biophysical analysis included determination of 1, the acyl
chain-melting behavior of the different samples; 2, the inclination
angle of the lipid A backbone plane against the membrane plane; 3,
the aggregate structure of samples; and 4, the LPS binding protein
(LBP)-induced intercalation of the samples into a phospholipid
membrane (corresponding to the composition of the macrophage
membrane). Results were correlated with those obtained in a
bioassay of endotoxin-induced production of cytokines in human
mononuclear cells and in a CHO cell system for testing receptor
(i.e., TLR-2 and -4) reactivity. H. pylori preparations showed
similar behavior to those of enterobacterial endotoxins, such as
LBP-induced intercalation and tendency to produce an inverted
cubic aggregate structure, but also deviations, such as phase
transition behavior and lower TLR-reactivity. Furthermore, a low
inclination angle of the lipid A diglucosamine backbone with
respect to the membrane plane was found, which has been
correlated previously with low bioactivity. Hence, these
investigations give a biophysical basis for understanding the
reduced bioactivities of H. pylori LPS.

Abstracts
8Abstract

Abstracts
8Abstract

© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556

490
Abstract no.: 05.03*
The Secreted Peptidylprolyl cis-, trans-Isomerase
HP0175 of Helicobacter pylori Induces Vascular
Endothelial Growth Factor (VEGF) Expression in
Gastric Epithelial Cells
M. Kundu, P. Saha and S. K. Pathak
Bose Institute, Calcutta, India
Helicobacter pylori causes gastric damage and is involved in gastric
carcinogenesis. Vascular endothelial growth factor (VEGF) is an
angiogenic factor that plays a major role in the reconstruction of
normal mucosa architecture by stimulating angiogenesis. It is
overexpressed in human gastric carcinomas. H. pylori up-regulates
VEGF expression in gastric epithelial cells. We have previously
reported that the secreted peptidylprolyl cis-, trans-isomerase,
HP0175 of H. pylori signals through Toll-like receptor 4 and
induces apoptosis of gastric epithelial cells. In this study, we have
evaluated the role of HP0175 in VEGF expression, another
contributor to remodeling of the gastric mucosa.
We addressed this question by analyzing whether HP0175
modulates VEGF expression in the gastric epithelial cell line AGS.
AGS cells treated with HP0175 showed increased levels of VEGF
mRNA as assessed by reverse transcriptase-polymerase chain
reaction (RT-PCR) as well as VEGF protein as assessed by ELISA.
Activation of the MAP kinase pathway is known to regulated
VEGF expression. Transfections with dominant-negative constructs,
as well as use of pharmacologic inhibitors suggested that HP0175mediated VEGF expression was dependent on the MEK /ERK
pathway and on phosphatidylinositol 3-kinase. In addition, HP0175
activated the transcription factor Sp1, which regulates VEGF
expression and is widely associated with carcinoma. In conclusion,
HP0175 emerges as one of the newly identified secreted antigens
of H. pylori involved in VEGF expression and remodeling of
the gastric epithelium. The role of epidermal growth factor
receptor- and cyclooxygenase-2-dependent pathways, both of which
stimulate VEGF expression, in the HP0175-stimulated process, are
being investigated.
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Abstract no.: 05.04*
Function and Recruitment of Mucosal
Regulatory T Cells in Human Chronic
Helicobacter pylori Infection and Gastric
Adenocarcinoma
K. Enarsson,* A. Lundgren,* M. Hermansson,†
A. Svennerholm,* S. Lundin* and M. Quiding-Järbrink*
*Department of Medical Microbiology and Immunology, Gothenburg,
Sweden, †Department of Surgery, Sahlgrenska University Hospital,
Gothenburg, Sweden

The presence of CD4+CD25high natural regulatory T cells (Treg)
may limit the magnitude of effector responses, which may result in
failure to sufficiently control infections and tumors. However, the
suppressive function and antigen specificity of CD4+CD25high Treg
in Helicobacter pylori-infected gastric mucosa is largely unknown.
Therefore, we characterized the CD4+CD25high cells in the gastric
mucosa of H. pylori-infected patients suffering from gastric
adenocarcinoma with regard to function and homing phenotype.
This was performed in both nontumor and tumor mucosa to also
identify potential differences in Treg phenotype between the two
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tissues. CD4+CD25high cells from both tissue types were shown to have
an increased expression of CTLA-4 compared to CD4+CD25low/–
cells, and to exclusively express mRNA for the Treg-specific
gene FOXP3. CD4+CD25high Treg from nontumor mucosa were
shown to suppress H. pylori-induced proliferation and IFN-γ
production. Furthermore, preliminary results indicated that Treg
with comparable activity can be found also in the tumor mucosa.
CD4+CD25high Treg expressed significantly higher levels of lselectin and CCR4 in both tissues, compared to CD4+CD25low/–
cells, and the CCR4-ligand CCL22 was produced in the nontumor
and tumor mucosa. In conclusion, we now show that CD4+CD25high
Treg from both nontumor and tumor mucosa express CTLA-4
and FOXP3 and can suppress CD4+CD25low/– cells in an antigenspecific manner. Increased expression of l-selectin and CCR4 on
mucosal Treg suggests that these molecules are important for Treg
recruitment to both nontumor and tumor gastric mucosa.

Abstract no.: 05.05*
Helicobacter pylori-Induced Gastritis and
Carditis, but not Reflux-Induced Carditis, is
Associated with an Infiltration of CD4+CD25+
Regulatory T Cells into the Inflamed Mucosa
Abstracts
8Abstract

A. Kandulski,* T. Wex,* U. Peitz,* A. Roessner,†
D. Küster† and P. Malfertheiner*
*Clinic

of Gastroenterology, Hepatology and Infectious Diseases,
Otto-von-Guericke University Magdeburg, Magdeburg, Germany,
†Institute of Pathology, Otto-von-Guericke University Magdeburg,
Magdeburg, Germany
Background. Helicobacter pylori infection and abnormal gastroesophageal reflux are the two main etiologic factors of chronic inflammation at the cardia. CD4+CD25+ regulatory T cells (Treg cells) are
characterized by the expression of the transcription factor FOXP3.
Aim. To study the role of Treg cells in carditis with respect to H.
pylori and gastroesophageal reflux disease (GERD).
Methods. The study included 73 patients, 32 patients were H.
pylori-positive, and 17 had GERD. From the 41 H. pylori-negative
patients, 19 had GERD. Biopsies were taken from the antrum
and cardia. Histologic assessment was performed according or in
analogy to the updated Sydney classification. FOXP3, TGF-β1,
and IL-10 were analyzed by quantitative reverse transcriptasepolymerase chain reaction (RT-PCR) and statistically evaluated by
nonparametric Mann–Whitney U-test.
Results. FOXP3 transcript levels were induced 15- and 14-fold in
antrum and cardia mucosa of H. pylori-positive compared to H.
pylori-negative patients ( p < .003). Furthermore, the gene expression
of Treg cell-derived cytokines TGF-β1 and IL-10 were similarly
up-regulated in antrum (TGF-β1: 3-fold, p = .014; IL-10: 2.8-fold,
p = .019) and cardia (TGF-β1: 2.7-fold, p = .05; IL-10: 1.5-fold,
p = .28). The expression levels of all three genes positively correlated
with the degree of gastritis. Furthermore, positive correlations
were identified between FOXP3 and TGF-β1 (r = 0.361, p < .0001)
and IL-10 (r = 0.307, p < .0001) demonstrating the functional
activity of the infiltrating regulatory T cells. The presence of
GERD did neither affect the gene expression of FOXP3, TGF-β1
nor IL-10 in cardia mucosa.
Conclusion. The H. pylori-induced gastritis in antrum and cardia,
but not the chemically induced carditis is associated with an
activation of Treg cells.
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Abstract no.: 05.06
Helicobacter pylori-Induced FOXP3 + Regulatory
T cells in the Mouse and Human Gastric Mucosa
Favor Chronic Bacterial Persistence
R. Rad, L. Brenner, M. Friedrich, A. Dossumbekova,
S. Bauer, M. Gerhard and C. K. Prinz
II. Medical Department, Munich, Germany
Background/Aims. Helicobacter pylori chronically infects more
than half of the world’s population, thereby causing peptic ulcers,
lymphoma, and carcinoma. The reasons for its lifelong persistence
in the human host are poorly understood.
Methods/Results. We found that H. pylori induces the gastric
influx of regulatory T (Treg) cells, which are potent suppressors of
antimicrobial immune responses. After infection of C57Bl/6 mice
with H. pylori SS1, large numbers of CD4+/CD25+ Treg cells
infiltrated the gastric mucosa. In parallel, expression of the Treg cell
marker FOXP3 increased in the infected mouse stomach. To analyze
the functional relevance of this Treg cell response, CD25+ T cells
were depleted systemically in vivo before infection (using antiCD25 antibodies). Six weeks later, these mice developed
dramatically increased gastric inflammatory responses compared
to nontreated mice. This resulted in markedly reduced bacterial
colonization. Analyzing gastric biopsies from 108 patients, FOXP3
expression was absent or very low in non-infected, but high in
infected persons. Of note, patients with a pronounced gastric Treg
cell response were colonized more densely, suggesting that Treg
cells favor bacterial survival. Virulent H. pylori strains bearing a
CagPAI induced stronger Treg cell responses, which may explain
their high prevalence.
Conclusion. Treg cells contribute to the inability of the immune
system to eradicate the bacterium, resulting in chronic persistence
of the microbe. Immune evasion by induction of a Treg cell
response, with a strain type-dependent modulation of the extent of
this response, reflects the excellent adaptation of H. pylori to
humans over thousands of years of coevolution.

Abstract no.: 05.07
Lactobacillus johnsonii La1 Attenuates
Helicobacter pylori-Associated Gastritis and
Reduces the Levels of Proinflammatory
Cytokines in the Gastric Epithelium of C57BL/6
Mice
8Abstract
Abstracts

D. N. Sgouras,* E. Panayotopoulou,* B. MartinezGonzalez,* K. Petraki,* S. Michopoulos† and A. Mentis*
*Laboratory

of Medical Microbiology, Institut Pasteur Hellenique,
Athens, Greece, †Gastroenterology Clinic, Alexandras General
Hospital, Athens, Greece
The effect of Lactobacillus johnsonii La1 administration to
experimental Helicobacter pylori infection was studied. We
administered continuously over a period of 3 months, through the
water supply, live La1 to H. pylori-infected C57BL/6 mice and
followed colonization, and development of H. pylori-associated
gastritis in the lamina propria. We also determined the levels of proinflammatory chemokines macrophage inflammatory protein-2
(MIP-2) and keratinocyte-derived cytokine (KC) in the serum and
gastric tissue. We documented a significant attenuation both in
lymphocytic ( p = .038) and neutrophilic inflammatory infiltration
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556

( p = .003) in the lamina propria as well as in the circulating levels of
anti-H. pylori IgG antibodies ( p = .003), although we did not
observe a suppressive effect of La1 on H. pylori colonizing
numbers. Other phylogenetic-related lactobacilli did not attenuate
H. pylori-associated gastritis to the same extent. MIP-2 serum
levels were distinctly reduced during the early stages of H. pylori
infection in the La1-treated animals and gastric mucosal levels of
MIP-2 and KC were also found depressed. Accordingly, H. pyloriinduced IL-8 secretion by human adenocarcinoma AGS cells in
vitro was also significantly reduced ( p = .046) in the presence of La1
spent culture supernatants, when neutralized to pH 6.8 without
concomitant loss of H. pylori viability. These observations point
out that during the early infection stages, administration of La1 can
attenuate H. pylori-induced gastritis in vivo possibly, by reducing
proinflammatory chemotactic signals responsible for the
recruitment of lymphocytes and neutrophils in the lamina propria.

Abstract no.: 05.08
Helicobacter pylori Activates Human MonocyteDerived Dendritic Cells (MoDC) Followed by
NK-Cell Activation In Vitro and In Vivo
Abstracts
8Abstract

P. Voland,* R. Rad,* N. Hafsi† and C. K. Prinz†
*II. Medical

Department Technical University Munich, Munich,
Germany, †Department of Human Biology, Technical University
Munich, Freising, Germany.

Helicobacter pylori infection leads to chronic gastritic inflammation.
We investigated the response of human monocyte-derived dendritic
cells (MoDCs) and their ability to activate NK cells in vitro. MoDCs
were generated from isolated monocytes by culture in the presence
of IL-4/G-CSF. MoDCs were incubated with H. pylori and
expression of MHC-class II, CD80, and CD83 as well as cytokine
release was measured by FACS and ELISA. CD56+ NK cells were
isolated from allogenic donors and cocultured with H. pylori
pulsed MoDCs. Cytokine release from cocultures was determined
by ELISA and cytotoxicity of NK cells was assessed by cytotoxicity
assays. CD56+ NK cells were stained in sections from gastric
biopsies of infected and non-infected individuals.
Results. H. pylori strongly stimulated the expression of MHCclass II, CD80, CD86, and CD83 molecules in MoDCs and
induced a 50-fold increase in IL-12 secretion. Immature MoDCs
were further incubated with different proteasome inhibitors
(CytochalasinA, PSI, MG132) before pulse with H. pylori leading
to complete inhibition of IL-12 secretion but not IL-8 secretion.
Coculture of mature MoDCs with NK cells strongly potentiated
IFN-γ and TNF-α release from NK cells and expression of CD69,
indicating their activation. We found no induction of cytotoxic NK
cells in the cytotoxicity assay. Large numbers of CD56+ cells were
found in the H. pylori-infected mucosa but not in non-infected
controls.
Conclusion. H. pylori stimulates human MoDCs and induces
their maturation. MoDCs in turn activate NK cells of the secretory
but not the cytotoxic type. Thus, H. pylori-induced NK cells may
function as NK- “helper”cells that potentiate the innate and
adaptive immune responses toward H. pylori.
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Abstract no.: 05.09
Innate Immune Response of Human Neutrophils
to Helicobacter pylori isToll-Like Receptors 2- and
4-dependent
L. Alvarez, M. Camorlinga, J. Torres and C. Maldonado
Istituto Mexicano del Seguro Social, Mexico City, Mexico
Introduction. Helicobacter pylori is a Gram-negative bacterium
that colonizes the human gastric mucosa. Infection is associated
with a marked infiltration of gastric epithelium and lamina propia
by neutrophils. It is well established that neutrophil density
correlates with H. pylori-induced tissue damage. Initiation of the
innate immune response to H. pylori is just beginning to be
unraveled and recent works support the role of Toll-like receptors
(TLRs). We investigated the role of TLR2 and TLR4 in the
response to H. pylori.
Methods. Peripheral blood neutrophils were isolated from
healthy H. pylori-negative volunteers and were cocultured with
H. pylori strain 26,695. After 0.5, 1, 3, 6, 24, and 48 hours the release
of IL-8, TNF-α, and IL-10 into the culture supernatants was
measured by ELISA. Total RNA was extracted from cells and
TLR2 and TLR4 mRNA were quantified by real-time reverse
transcriptase-polymerase chain reaction (RT-PCR). The role of
TLR2 and TLR4 were investigated by blocking assay with specific
monoclonal Abs anti-TLRs.
Results. At 3 hours after stimulation, the neutrophils produced a
significant increase in IL-8 production. TNF-α and IL-10 secretion
was significantly increased since 6 and 24 hours, respectively. The
mRNA expression levels of TLR2 and TLR4 was down-regulated
by H. pylori at 6 hours after stimulation, and blocking experiments
revealed that TLR2 and TLR4 participate in IL-8 and IL-10
secretion in response to H. pylori.
Conclusion. In this study, we have demonstrated for the first time
the role of TLR2 and TLR4 in the inflammatory response of
human neutrophils to H. pylori.
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Abstract no.: 05.10
Interferon Gamma (IFNg) and Interleukin-10
(IL-10) Haplotypes Differently Influence
Helicobacter pylori Infection Outcome
C. F. Zambon,* D. Basso,† A. Falda,† A. Stranges,†
S. Schiavon,† C. Belluco,‡ F. Di Mario,§ F. Navaglia,†
P. Fogar,* E. Greco,† M. Rugge¶ and M. Plebani†
*Departments

of Medical and Surgical Sciences, †Laboratory Medicine,
and ‡Oncological and Surgical Sciences, University of Padova, Padova,
Italy, §Department of Gastroenterology, University of Parma, Parma,
Italy, ¶Department of Pathology University of Padova, Padova, Italy
Interferon gamma (IFNg) is associated with the development of
Th-1-like, cell-mediated immune responses and plays a pivotal
role in H. pylori-infected mucosa, as does the anti-inflammatory
cytokine IL-10. Our aims were to ascertain whether the haplotypes
made of 1, intron 1 IFNg +874TA SNP and CA repeat polymorphism or 2, IL-10–1082AG, −819CT and −592AC SNPs,
influence H. pylori infection outcome and mucosal inflammation.
H. pylori-infected patients were studied: 100 noncardia gastric
cancer (NCGC), 28 duodenal ulcer (DU), and 71 chronic gastritis
(CG). The haplotypes were estimated using the arlequin software
version 2.000. Nine possible IFNg haplotypes were found, the
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most frequent being A-13 and T-12. DU was less frequent in
T-12 haplotype with respect to NCGC (χ2 = 23.6, p < .01) or CG
(χ2 = 17.0, p < .01). Three possible IL-10 haplotypes (−1082, −819,
−592) were identified, ACC, ATA, GCC, none being correlated with
disease diagnosis. None IFNg or IL-10 haplotypes were correlated
with gastritis grade or intestinal metaplasia. Six possible IL-10
genotypes were inferred: ACC/ACC, ACC/ATA, ATA/ATA,
ACC/GCC, ATA/GCC, GCC/GCC. The ATA/ATA was more
frequent in NCGC with respect to CG (χ2 = 4.04, p < .05). The
ATA/ATA was more frequent, whereas GCC/GCC was less
frequent in CG patients than in those without intestinal metaplasia
(χ2 = 11.04, p < .05). In conclusion, the IFNg high producer
haplotype T-12 was protective for DU, probably because of the
inhibitory effect on acid secretion of this cytokine. The attenuated
IL-10 response of ATA/ATA low producers is probably implicated
in the development of precancerous (intestinal metaplasia) and
cancerous H. pylori-associated lesions.

Abstract no.: 05.11
Heligmosomoides polygyrus Parasitism
Attenuates the Progression of Typhlocolitis,
Epithelial Hyperplasia, and Dysplasia in the
IL-10–/– Mouse Model of Helicobacter hepaticusAssociated Inflammatory Bowel Disease
Abstracts
8Abstract

M. T. Whary,* N. Sundina,* C. Nagler-Anderson,†
P. R. Nambiar* and J. G. Fox*
*Massachusetts
†Massachusetts

Institute of Technology, Cambridge, MA, USA,
General Hospital, Boston, MA, USA

Prior studies demonstrated that Th1-promoted gastric atrophy
secondary to Helicobacter felis infection in C57BL/6 mice was
ameliorated by concurrent Th2 responses to Heligmosomoides
polygyrus, a murine intestinal nematode. To determine if H. polygyrus
infection would reduce Th1-mediated typhlocolitis, we examined
the effect of coinfection with H. polygyrus and Helicobacter
hepaticus on progression of disease in the IL-10 –/– mouse model
of inflammatory bowel disease. IL-10–/– mice on the C57BL/6
background were infected with H. polygyrus, H. hepaticus, or
sequentially with H. polygyrus followed by H. hepaticus and
evaluated at 4, 8, and 16 weeks post-infection. H. hepaticus
infection caused significant typhlocolitis by 4 weeks that was
characterized by mononuclear infiltration of the lamina propria,
epithelial hyperplasia, and epithelial dysplasia. H. polygyrus alone
did not cause pathology but coinfection with H. hepaticus
significantly reduced the severity of inflammation ( p < .01),
hyperplasia ( p < .03), and dysplasia ( p < .05) associated with H.
hepaticus infection of the lower bowel. The parasitic infection was
also associated with elevated systemic levels of eosinophils, Th2associated IgG1 and total IgE levels, and the Th1-associated IgG2c
response to H. hepaticus antigens was reduced early in the course
of infection. The ameliorating effect of parasitism on the mucosal
damage associated with H. hepaticus in the IL-10–/– mouse IBD
model supports prior findings that parasitism can reduce
Helicobacter-associated gastrointestinal tissue damage.
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Abstract no.: 05.12
Helicobacter pylori Vacuolating Cytotoxin
Activates Expression of Eotaxin in Gastric
Epithelial Cells via STAT6 Pathway
J. M. Kim,* J. S. Kim†, H. C. Jung† and I. S. Song†
*Hanyang
†Seoul

University College of Medicine, Seoul, Republic of Korea,
National University College of Medicine, Seoul, Republic of

Korea
Background and Aims. Helicobacter pylori-infected gastric mucosa
from patients with active chronic inflammation is characterized by
infiltration of various inflammatory cells such as neutrophils and
eosinophils. Although many papers have demonstrated several
mechanisms for neutrophil infiltration, there has been no report
regarding eotaxin, which is known to be a potent chemoattractant
to recruit eosinophils. The present study was to investigate the
mechanisms of eotaxin expression in H. pylori vacuolating cytotoxin
(Vac)-stimulated gastric epithelial cells.
Methods and Results. The combined stimulation with Vac purified
from H. pylori and IL-4 increased the expression of eotaxin in
MKN-45 gastric epithelial cell lines and primary human gastric
epithelial cells, as assessed by quantitative reverse transcriptasepolymerase chain reaction (RT-PCR) and ELISA. In the gastric
epithelial cells transfected with an eotaxin promoter-luciferase
reporter plasmid, costimulation with purified Vac and IL-4 induced
more luciferase activity than either purified Vac alone or IL-4 alone
did. However, such up-regulation was significantly decreased in
MKN-45 cells transfected with luciferase reporter plasmid bearing
an eotaxin promoter that has a mutation at binding site for STAT6. In
MKN-45 cells transfected with STAT6 antisense oligonucleotide
(ODN), eotaxin promoter activity was also suppressed compared
with cells transfected with sense ODN. Furthermore, tyrosine
phosphorylation of STAT6 was increased in both MKN-45 and
primary gastric epithelial cells stimulated with purified Vac and
IL-4, as assessed by immunoblot assays.
Conclusions. These results suggest that Vac-mediated upregulation of eotaxin expression in human gastric epithelial cells
may be facilitated by IL-4 via a STAT6-dependent mechanism.
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Abstract no.: 05.13
The Neutrophil Activating Protein (HP-NAP) of
Helicobacter pylori Plays a Role in Adherence to
Gastric Epithelial Cells
M. M. Gerrits,* F. Namavar,† M. Sparrius,†
A. H. M. van Vliet,* E. J. Kuipers,*
C. M. J. E. Vandenbroucke-Grauls† and J. G. Kusters*
*Erasmus
†Vrije

MC-University Medical Center, Rotterdam, the Netherlands,
Universiteit Medical Center, Amsterdam, the Netherlands

Objectives. Adherence of Helicobacter pylori to the gastric
epithelium is believed to be an important step in the induction of
active inflammation of the mucosal layer. Several specific adhesins,
like SabA, BabA2, AlpA, and AlpB, have already been identified,
but other factors may well be involved.
Aim. To assess the role of the neutrophil activating protein (HPNAP) in adherence of H. pylori to epithelial cells.
Methods. The napA gene of H. pylori strain ATCC43504 was
disrupted by insertion of a kanamycin cassette. Strain ATCC43504
and napA mutant were tested for their ability to adhere to Hela cells
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556

and gastric tissue sections. In addition, the binding of HP-NAP to
mucin and sulfated oligosaccharides was studied by ELISA.
Results. Wild-type H. pylori ATCC43504 displayed strong
binding to Hela cells, but mutation of the napA gene resulted in
a 10-fold reduction of this binding. The difference in adherence
between the wild-type strain and napA mutant was also observed
when using gastric tissue sections. Adhesion of the wild-type strain
was primarily towards the mucus layer covering the epithelial cells.
When compared to the wild-type strain, the napA mutant
displayed strongly reduced binding to purified mucin and sulfated
oligosaccharides, suggesting that HP-NAP is indeed involved in
binding to sulfated mucins.
Conclusion. HP-NAP is a multifunctional protein that plays an
important role in the chronicity of H. pylori infection through
binding to the gastric epithelium. The cell surface receptor involved
in the interaction with HP-NAP is still unknown, but probably
contains sulfated oligosaccharides.

Abstract no.: 05.14
Modulation of the Oxidative Stress and
Mitochondrial Dysfunction by Antioxidants in
AGS Cell Line Infected by Helicobacter pylori
Abstracts
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M. Calvino Fernández, J. Pérez de Hornedo,
G. de Arriba de la Fuente and T. Parra Cid
Unidad de Investigación, Hospital Universitario de Guadalajara,
Guadalajara, Spain
Introduction. Variations of intracellular redox status may either
trigger or block apoptotic death program, depending on oxidative
stress’ severity through mitochondrial transmembrane potential
(∆Ψm)’s alteration.
Therefore, ROS and apoptosis have been implicated in
Helicobacter pylori-mediated gastric disorders whereas diets high
in antioxidants are thought to be protective.
Objectives. Analysis of ROS content and ∆Ψm in AGS cells
infected by H. pylori using membrane-permeable lipophilic cationic
fluorochromes and the role of supplementation with antioxidants
(vitamin E).
Materials and Methods.
• AGS human gastric epithelial cells (ATCC-CRL1739) were
cocultured with H. pylori (ATCC-49503, cagA+/vacAs1a) for
24 hours (107−108 cfu/ml), without or with vitamin E (10− 4 M).
• (a) ROS production was assessed by oxidation of 2′,7′dichlorodihydrofluorescein diacetate (H2-DCF-DA) and MitoSOX
Red reagent.
• (b) Mitochondrial function was indirectly assessed by ∆Ψm measured
by 5,5′,6,6′-tetrachloro-1,1,3,3′-tetraethylbenzimidazolcarbocyanine
( JC-1) and Mitotrackers® Orange/Green.
Assays were performed by flow cytometry (FC) (FACScan) and
confocal microscopy (CM) (Olympus IX81).
Results. H2-DCF-DA (FC): approximately 2.3-fold increased
was observed following incubation of AGS with H. pylori. The
addition of vitamin E avoided this effect. These data were confirmed
by CM using MitoSOX. JC-1 red/green mean of fluorescence
(CM) decreased in cocultures with regard to control (1.3–0.9), and
showed intemediate values with the antioxidant (1.1). Mitotrackers
assays by CM indicated that green/red fluorescence increased with
the coinfection (0.71–1.31) and with vitamin E reverted to initial
data (0.69).
Conclusions. Treatment with radical scavengers corfirm that a
link exists between both processes (oxidative stress and apoptosis)
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and ROS could mediate the mitochondrial-dependent apoptosis
induced by H. pylori.

Abstract no.: 05.15
Response to LPS and Helicobacter pylori Disease
Diversity
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Abstract no.: 05.16
Modulation of Gastric Epithelial Human
β-Defensins (HBD)-2 and -3 during
Helicobacter pylori Infection
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M. Chmiela,* A. Grebowska,* T. Rechcinski,†
E. Czkwianianc,‡ L. Bak-Romaniszyn,‡ A. Moran,§
M. Druszczynska,* M. Kowalewicz-Kulbat,* M. Dziuba,†
A. Owczarek,* M. Krzeminska-Pakula,†
I. Planeta-Malecka‡ and W. Rudnicka*
*Department of Immunology and Infectious Biology, University of
Lodz, Lodz, Poland, †Medical University, Lodz, Poland, ‡Mother and
Child Health Center Institute, Lodz, Poland, §National University of
Ireland, Galway, Ireland

Lipopolysaccharide (LPS) and innate pattern-recognition receptors
are important for the outcome of infections diseases. LPS-binding
protein (LBP) and soluble CD14 (sCD14) facilitate transfer of LPS
to a cell surface protein CD14 (mCD14) and Toll-like receptor 4,
triggering proinflammatory response.
In this study, the CD14-159C/T polymorphism of the gene
encoding the CD14 receptor has been estimated together with
plasma concentration of sCD14 and LBP.
The Helicobacter pylori infection was detected by serology (antiH. pylori IgG/IgA). sCD14 and LBP were measured by ELISA,
and CD14 genotyping was performed with polymerase chain
reaction (PCR). The H. pylori-infected (Hp+) or -uninfected
(Hp–) dyspeptic patients and patients with coronary heart disease
(CHD): unstable angina pectoris (UAP) or myocardial infarction
(MI) as well as healthy subjects were included in the study.
In the patients with H. pylori-related or -unrelated dyspepsia,
there was no difference in the LBP and sCD14 concentration.
However, there was a correlation between the level of antiH. pylori IgG and sCD14. In Hp+ group, the CC genotype was
linked with active gastritis whereas CT genotype with non-active
gastritis. However, there was no correlation between the genotype
and sCD14 concentration. In the CHD group the LBP and sCD14
levels were significantly higher as compared with healthy donors.
These proteins were at a higher concentration in H. pyloriseropositive than in H. pylori-seronegative patients. There was a
correlation between CT genotype and sCD14 concentration in MI
patients.
The results show that an individual susceptibility to H. pylori
LPS may influence the course of infection.

P. K. Boughan,* R. H. Argent,† A. G. Bowie,‡ S. J. Ong,*
S. J. Cook,§ O. Sorensen,¶ N. J. Klein,* J. C. Atherton**
and M. Bajaj-Elliott*
*Institute of Child Health, London, UK, †Institute of Infection,
Immunity, and Inflammation, and the Wolfson Digestive Diseases
Centre, Queen’s Medical Centre, Nottingham, UK, ‡Department of
Biochemistry, Trinity College, Dublin, UK, §Laboratory of Molecular
Signalling, The Babraham Institute, Babraham Hall, Cambridge, UK,
¶Lund University, Section for Clinical and Infectious Medicine,
Department of Clinical Sciences, Biomedical Center B14, Lund,
Sweden, **Institute of Infection, Immunity, and Inflammation, and the
Wolfson Digestive Diseases Centre, Queen’s Medical Centre,
University of Nottingham, Nottingham, UK

Background. Human β-defensins are potent bactericidal agents
against Helicobacter pylori. In the present study, we have investigated
the contribution of MAPK and NFêB pathways in regulating
defensin gene expression.
Methods. AGS gastric epithelial cells were pretreated with MAPK
inhibitors prior to infection with a cytotoxic H. pylori strain (60,
190), and hBD-2 and hBD-3 gene expression was quantified by
reverse transcriptase-polymerase chain reaction (RT-PCR). Transient
transfection studies were conducted utilizing HBD-2 and -3
promoter luciferase constructs followed by bacterial stimulation.
Activation of stably transfected conditional MAP kinase mutants
in HEK-293 cells allowed further delineation of the role of
individual MAPK pathways in defensin gene regulation. The
potential role of bacterial virulence factors in host innate defense
was established by the use of isogenic mutant strains.
Results. Wild-type H. pylori-induced hBD-2 and -3 gene expression
in AGS cells in a time and dose-dependent manner. Two to fourfold
increase of hBD-2 and hBD-3 was observed by promoter-luciferase
assays. Marked induction of β-defensin (hBD-3 > hBD-2) genes
was observed during specific activation of the JNK and p38
pathways. A conditional kinase mutant stimulating only the Raf
MEK1/2 ERK1/2 pathway was able to induce hBD-3. Among the
isogenic mutants tested CagPAI-negative strain was unable to upregulate defensin expression.
Conclusions. An intact CagPAI is required for full activation of
hBD-2 and hBD-3. Selective activation of p38 and JNK MAPK
pathways increased both hBD-2 and hBD-3 gene expression in
contrast, the ERK pathway alone was sufficient for hBD-3
expression.

Abstracts
8Abstract

8Abstract
Abstracts

© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556

495

Inflammation and Host Response
Abstract no.: 05.17
The Down-Regulation of Secretory Leukocyte
Protease Inhibitor (SLPI) Expression in Antral
Mucosa is a General Phenomenon in
Helicobacter pylori-Related Gastroduodenal
Diseases
T. Wex,* A. D. Sokic-Milutinovic,† V. Todorovic,‡
M. Bjelovic,§ T. Milosavljevic¶ and P. Malfertheiner*
*Clinic

of Gastroenterology, Hepatology and Infectious Diseases,
Otto-von-Guericke University Magdeburg, Magdeburg, Germany,
†Clinic for Gastroenterology and Hepatology, Institute for Digestive
Diseases, Clinical Center of Serbia, Belgrade, Serbia and Montenegro,
‡Department of Immunohistochemistry and Electron Microscopy,
Institute for Medical Research, Belgrade, Serbia and Montenegro,
§Department of Esophageal and Gastric Surgery, The First University
Surgical Hospital, Institute for Digestive Diseases, Clinical Center of
Serbia, Belgrade, Serbia and Montenegro, ¶Clinic for Gastroenterology
and Hepatology, Institute for Digestive Diseases, Clinical Center of
Serbia, Belgrade, Serbia and Montenegro
Background. The secretory leukocyte protease inhibitor (SLPI)
represents a multifunctional protein of the gastric mucosa exerting
antimicrobial and anti-inflammatory effects. Recently, a downregulation of antral SLPI expression in Helicobacter pylori-infected
healthy volunteers was demonstrated.
Aim. To analyze mucosal SLPI expression in patients with
different gastroduodenal disorders.
Methods. The prospective study included 90 patients with the
following diseases: gastric cancer (GC, n = 22), duodenal ulcer
(DU, n = 17), H. pylori-positive dyspeptic patients (NUD, n = 31),
and H. pylori-negative dyspeptic patients (n = 20). During
gastroduodenoscopy, biopsies were taken each from antrum, corpus,
and tumor tissue if suspected. SLPI expression was analyzed by
quantitative reverse transcriptase-polymerase chain reaction
(RT-PCR) and ELISA.
Results. Antral SLPI levels were reduced by 75% in H. pyloriinfected patients (1494–1826 pg/50 µg protein) regardless the
underlying disease (NUD, DU, GC) compared to H. pylori-negative
dyspeptic patients (6563 pg/50 µg protein, p < .001, anova).
Tumor tissue had twofold higher SLPI levels than the surrounding
normal gastric mucosa (3900 pg/50 µg protein versus 1826 pg/
50 µg protein, p = .013, anova). SLPI levels of the tumor tissue
were significantly reduced compared to SLPI levels of antral
mucosa in H. pylori-negative dyspeptic patients ( p < .001, anova).
This reduction was slightly stronger in the intestinal type than
diffuse gastric cancer, but without reaching statistical significance.
The SLPI levels of the corpus mucosa were unchanged among all
groups. SLPI protein levels did not correlate with SLPI-mRNA
amounts suggesting that the SLPI down-regulation is not primarily
regulated at the transcriptional level.
Conclusion. The down-regulation of SLPI in antral mucosa is a
general phenomenon of H. pylori infection and is therefore
unlikely to be involved in the disease outcome.
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Abstract no.: 05.18
The Sialic Acid-Binding SabA Adhesin of
Helicobacter pylori is Essential for Non-Opsonic
Activation of Human Neutrophils
S. Teneberg,* M. Unemo,† M. Aspholm-Hurtig,‡
T. Borén‡ and D. Danielsson†
*Institute of Medical Biochemistry, Göteborg, Sweden, †Department of

Clinical Microbiology, Örebro University Hospital, Sweden,
of Medical Biochemistry and Biophysics, Umeå
University, Sweden

‡Department

Infiltration of neutrophils and monocytes into the gastric mucosa
is a hallmark of chronic gastritis caused by Helicobacter pylori.
Certain H. pylori strains non-opsonized stimulate neutrophils to
production of reactive oxygen species causing oxidative damage of
the gastric epithelium. Here, the contribution of some H. pylori
virulence factors, the blood group antigen-binding adhesin BabA,
the sialic acid-binding adhesin SabA, the neutrophil-activating
protein HP-NAP, and the vacuolating cytotoxin VacA, to the
activation of human neutrophils in terms of adherence, phagocytosis,
and oxidative burst, was investigated. Neutrophils were challenged
with wild-type bacteria and isogenic mutants lacking BabA, SabA,
HP-NAP, or VacA. Mutant and wild-type strains lacking SabA had
no neutrophil-activating capacity, demonstrating that binding of
H. pylori to sialylated neutrophil receptors plays a pivotal initial
role in the adherence and phagocytosis of the bacteria and the
induction of the oxidative burst. The link between receptor binding
and oxidative burst involves a G-protein-linked signaling pathway
and downstream activation of PI3-kinase as shown by experiments
using signal transduction inhibitors. Collectively our data
suggest that the sialic acid-binding SabA adhesin is a prerequisite
for the non-opsonic activation of human neutrophils, and thus is
a virulence factor important for the pathogenesis of H. pylori
infection.
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Abstract no.: 05.19
Helicobacter pylori Infection Induced
Cardiovascular Changes in Rats
O. Kulaputana, D. Thong-Ngam, R. Prabjone and
S. Pathumraj
Chulalongkorn University, Bangkok, Thailand
Background. Helicobacter pylori infection has been known to
affect local gastrointestinal tract and systemic functions.
Objective. To investigate the effect of H. pylori infection on
cardiovascular system.
Methods. Twelve male Sprague–Dawley rats pretreated with
streptomycin were inoculated with 1 ml of H. pylori suspension
(108−1010 cfu/ml) by gavage for three consecutive days. Another 12
rats serving as controls received sterile normal saline. Two weeks
after inoculation, six rats in each group were sacrificed, whereas the
rest of the animals were sacrificed at week 3. Intra-arterial blood
pressure, heart rate (HR), and serum TNF-alpha were measured.
H. pylori infection in gastric tissues was identified by positive rapid
urease test and histopathology.
Results. At 2 weeks, there were no differences between the two
groups on systolic blood pressure (SBP), diastolic blood pressure
(DBP), and HR. At week 3, H. pylori-infected rats showed a
significantly higher SBP (123.8 ± 4.4 versus 108.2 ± 4.2 mmHg,
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p < .05) and mean pressure (108.4 ± 2.1 versus 98.2 ± 2.9 mmHg,
p < .05), and slower HR (339 ± 19 versus 403 ± 6 bpm, p < .05).
TNF-alpha was significantly increased in H. pylori group at both
week 2 (62.0 ± 18.7 versus 8.7 ± 1.8 pg/ml, p < .05) and 3 (76.8 ± 23.2
versus 9.9 ± 2.6 pg/ml, p < .05).
Conclusion. Alterations in circulatory dynamics occur in
subacute H. pylori infection. TNF-alpha could be one of the
inflammatory mediators responsible for the early cardiovascular
changes in H. pylori infection.

Abstract no.: 05.20
Sugar Turns Benefit of Cholesterol into Immune
Evasion in Microbial Infection
8Abstract
Abstracts

Inflammation and Host Response
were performed intravital fluorescent microscopy to examine
leukocyte adhesion on post-capillary venules by using acridine
orange to label leukocyte. Serum TNF-alpha and IL-10 levels were
analyzed using ELISA technique.
Results. In H. pylori infection groups, the leukocyte adhesion
were significantly increased when compared with the control
groups (13.40 ± 1.00 cells/field versus 2.47 ± 0.62 cells/field).
TNF-alpha levels were higher in H. pylori infection groups
(76.76 ± 23.18 pg/ml versus 9.91 ± 2.62 pg/ml). IL-10 levels were
also higher in H. pylori infection groups (663.60 ± 105.33 pg/ml
versus 383.99 ± 62.58 pg/ml, respectively) (p < .05).
Conclusion. Chronic H. pylori infection could induce infiltration
of inflammatory cells and enhance the release of proinflammatory
cytokine such as TNF-alpha, IL-10. By means of these mediators,
they induced the expression of leukocyte–endothelium interaction.

C. Wunder,* Y. Churin,* F. Winau† and T. F. Meyer*
*Department of Molecular Biology, Max Planck Institute for Infection
Biology, Berlin, Germany, †Department of Immunology, Max Planck
Institute for Infection Biology, Berlin, Germany

Helicobacter pylori represents a most successful bacterial parasite
that colonizes the stomach since early human evolution. Following
the initial demonstration of H. pylori’s pathogenic potential,
evidence has been accumulated that H. pylori is the leading cause
of gastric ulcers, carcinoma, and lymphoma. Cholesterol is a
physiologic constituent of membranes critical for their biologic
function, but is stigmatized as mediating detrimental effects in
obesity and cardiovascular disease. Since H. pylori is auxotrophic
for cholesterol, we explored the assimilation of cholesterol by
H. pylori upon infection. Here we show that H. pylori follows a
cholesterol gradient and extracts the lipid from plasma membranes
of epithelial cells for subsequent glycosylation. Cholesterol
promotes phagocytosis of H. pylori by antigen-presenting cells
and enhances an antigen-specific T-cell response. Consistently,
cholesterol-rich diet during bacterial challenge leads to a reduction
of the H. pylori burden in the stomach. Intrinsic α-glycosylation of
cholesterol, however, abrogates phagocytosis of H. pylori and
subsequent T-cell activation. Hence, we propose a novel mechanism
regulating host–pathogen interaction which describes glycosylation
of a lipid tipping the scales towards immune evasion or response.
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Abstract no.: 05.21
Effects of Chronic Helicobacter pylori Infection on
Changes of Gastric Microcirculation,TNF-alpha,
and IL-10 Levels in Rats
D. Thong-Ngam, R. Prabjone, S. Pathumraj,
N. Visedopas, T. Chatsuwan and
Chulalongkorn Helicobacter Study Group
Chulalongkorn University Hospital, Bangkok, Thailand
Background. Helicobacter pylori infection causes gastric
inflammation and the release of cytokines.
Aims. To investigate the effects of chronic H. pylori infection on
leukocyte adhesion, serum TNF-alpha, and IL-10 levels.
Methods and Materials. The 12 male Sprague–Dawley rats were
inoculated with H. pylori suspension (about 108−1010 cfu/ml;
1 ml/rat) by gavaging twice daily, with an interval of 4 hours, for
three consecutive days. Three weeks after H. pylori inoculation, defined
infection by positive urease test and histopathology, the animals

Abstract no.: 05.22
Host Innate Immune Response to Helicobacter
pylori Infection
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E. I. Kazakos,* A. Harris,† S. J. Ong,* P. K. Boughan,*
M. Curtis† and M. Bajaj-Elliott*
*Infectious

Diseases and Microbiology Unit, The Institute of Child
Health, London, UK, †MRC Molecular Pathogenesis, Centre for
Infectious Diseases, Institute of Cell and Molecular Sciences, Bart’s and
The London School of Medicine and Dentistry, London, UK
Introduction. At present the role of Helicobacter pylori-derived
proteases in disease pathogenesis is unknown. To gain greater
insight into the potential contribution of protease function to
bacterial virulence, we studied the effect of isogenic mutant strains
representing serine, aspartic and cysteine family of proteases on
host innate immunity.
Methodology. Gastric epithelial cells (AGS) were cocultured with
wild-type and isogenic H. pylori strains at an MOI of 100 and
time-dependent IL-8 and β-defensin gene expression was evaluated
by reverse transcriptase-polymerase chain reaction (RT-PCR).
Characteristics of the isogenic mutant strains are available on
request (courtesy A.G. Harris).
Results. Low IL-8 gene expression was observed in control,
unstimulated AGS cells, which markedly increased upon infection
with wild-type H. pylori. Among the panel of serine mutants tested
sppA had minimal effect, whereas prc and htrA showed a modest
reduction in IL-8 expression which did not reach significance. The
single threonine-protease mutant (hsIV ) utilized showed a greater,
almost two-fold, reduction in IL-8 levels. Metalloprotease (pepF,
pqqE) inhibitors also exhibited a tendency for reduced IL-8 levels.
Human β-defensin 1 (hBD-1) was also found to be constitutively
expressed and the expression was not modulated in the presence
of the various strains employed; however, a twofold increase in
hBD-1 expression was observed in the presence of the prc strain. In
contrast, all mutants were able to increase human β-defensin 3
(hBD-3) mRNA expression 8 hours post-infection.
Conclusions. Bacterial-derived proteolytic activities modulate
host innate immune responses in a dynamic fashion. How these
individual proteases affect host–pathogen interactions at the
mucosal surface requires further investigation.
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Abstract no.: 05.23
Cox-2-Dependent Water Influx Through
Aquaporin 5 in Gastric Inflammation
M. Weber, A. K. Walduck and T. F. Meyer

contribute to the fall in serum levels of ghrelin and the rise in levels
of gastrin being responsible for the decrease in appetite and
dyspeptic symptoms observed in H. pylori-infected mountain
children, the effects that could be ameliorated by H. pylori
eradication.

Department of Molecular Biology, Max Planck Institute for Infection
Biology, Berlin, Germany

Abstract no.: 05.25
Helicobacter pylori IgA and IgG Antibodies as
Indicators of the Risk of Gastric Cancer and
Peptic Ulcer Disease in Comparison to Gastritis
Abstracts
8Abstract

Helicobacter pylori infection causes chronic gastric inflammation
leading to a variety of gastroduodenal disorders ranging from
peptic ulcer disease to gastric carcinoma. H. pylori infection also
causes increased expression of the prostaglandin synthase
cyclooxygenase-2, which has been implicated in tumorogenesis.
We investigated the mechanisms underlying the observation that
H. pylori infection leads to Cox-2-dependent swelling of gastric
epithelial cells in vitro. We show that H. pylori-induced swelling is
facilitated by the translocation of aquaporin 5 (Aqp5) to the plasma
membrane and is initiated by the influx of chloride. Chloride
channels become activated due to Ca2+ influx triggered by
inflammatory mediators such as prostaglandin E2 (PGE2).
Furthermore translocation of Aqp5 to the cell membrane is mediated
by the tight junction adaptor protein zona occludens-1 (Zo-1).
This process may represent a general mechanism underlying the
development of edema formation during acute inflammatory
events.
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Abstract no.: 05.24
Relationship Between Ghrelin and Helicobacter
pylori Infection in Polish Adult Shepherds and
Their Children
S. J. Konturek,* W. Bielanski,* M. Plonka,*
P. C. Konturek,† T. Pawlik‡ and T. Brzozowski*
*Department

of Physiology, Jagiellonian University Medical College,
Cracow, Poland, †Department of Medicine I, University of ErlangenNuremberg, Erlangen, Germany, ‡Department of Internal Medicine,
Jagiellonian University Medical College, Cracow, Poland

Ghrelin is a natural endogenous ligand for the growth hormone
secretagogue receptor, known to stimulate food intake and body
weight gain, but the relationship between ghrelin release and
Helicobacter pylori infection is controversial. We assessed plasma
and gastric contents of ghrelin and leptin by RIA in 150 H. pyloripositive and H. pylori-negative adult shepherds and their children
before and after H. pylori eradication. Shepherds with full contact
with sheep showed the highest (100%) H. pylori prevalence
compared to other mountain residents without contact with sheep
(80%) or urban age-matched controls (64%). Shepherd children
with full sheep contact were H. pylori-infected at about three times
higher rate than those from the same area, but without contact with
sheep or those from the urban area. The gastric ghrelin content in
corpus mucosa was several folds higher than in antral mucosa and
it was significantly higher in the H. pylori-eradicated than that in
H. pylori-infected mucosa. Serum levels of ghrelin were greatly
increased, while levels of gastrin significantly decreased in
H. pylori-negative as compared to H. pylori-positive subjects. In
mountain children, serum levels of ghrelin and leptin were about
twice higher in H. pylori-negative than in H. pylori-positive
children, whereas gastrin levels were significantly reduced in
H. pylori-negative children. We conclude that H. pylori infection is
extremely high in shepherds and their children and this may
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556

T. U. Kosunen,* K. Seppälä,* S. Sarna,* A. Aromaa,†
P. Knekt,† J. Virtamo† and H. Rautelin*
*University

of Helsinki, Helsinki, Finland, †National Public Health
Institute, Helsinki, Finland

Background. Helicobacter pylori infection is the most important
risk factor for peptic ulcer disease and distal gastric cancer.
Aim. To analyze H. pylori IgG and IgA antibodies as indicators of
the risk of gastric ulcer (GU), duodenal ulcer (DU), and subsequent
gastric cancer (CA) in comparison to chronic gastritis (CHR-G).
Materials and Methods. The risk analysis was based on the data
of H. pylori antibodies of IgG and IgA classes reported in part
earlier (Gut 2002; 51, Suppl.11:A22). The original data, obtained
using enzyme immunoassay, showed high prevalence of IgA and
IgG antibodies in all 20-year-age cohorts in all four groups. The
risk analysis was carried out in a one year study involving cohorts
aged 15 to 94 years in a logistic regression model.
Results. The prevalences of IgG antibodies were similar (89–97%)
in all age cohorts in all groups. The prevalence of IgA antibodies
showed only minor variation by age. It was higher in the CA (84–
91%) and GU groups (78–91%) than among DU (68–77%) and
CG patients (55–75%); OR 2.49, 95% CI 1.86–3.34 between the
GU and DU groups, OR 2.57, 95% CI 1.95–3.39 between the GU
and CG groups.
Association of H. pylori IgA and IgG antibodies with the risk of
CA, GU, or DU in comparison to CHR-G.
IgA

IgG

Subjects with

n

OR

95% CI

OR

95% CI

CHR-G
CA
GU
DU

1525
363
482
882

1
2.41
2.57
1.13

1.79–3.53
1.95–3.39
0.95–1.35

1
1.28
0.69
0.72

0.81–2.02
0.46–1.03
0.55–0.99

Conclusions. The IgA-response was, but not the IgG-response,
associated with an increased risk of CA and GU in comparison
with CHR-G-patients.
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Abstract no.: 05.26
T- and B-cell Responses in Helicobacter pyloriInfected Duodenal Ulcer Patients and
Asymptomatic Subjects in Bangladesh
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Abstract no.: 05.27
Helicobacter pylori Infection of the Patients with
Ischemic Heart Disease
8Abstract
Abstracts

L. G. Bajenov,*† L. S. Tairova* and A. N. Aripov‡
T. R. Bhuiyan,* A. Lundgren,† P. K. Bardhan,* F. Qadri*
and A. Svennerholm†
*International Centre for Diarrhoeal Disease Research, Bangladesh
(ICDDR,B), Dhaka, Bangladesh, †Department of Medical Microbiology
and Immunology, Göteborg University, Göteborg, Sweden

Available evidence indicates that the prevalence of Helicobacter
pylori infection in the Bangladeshi population is over 80%,
although the majority of infected individuals remain asymptomatic
with only about 15% developing peptic ulcers and a smaller
proportion with gastric malignancies. Although H. pylori induces
a vigorous immune response, it is not protective and the host fails
to clear the infection.
In order to better understand factors that predispose to
symptomatic illness, we analyzed the B- and T-cell responses in
blood and gastric and duodenal mucosa of duodenal ulcer (DU)
patients (n = 10) and asymptomatic carriers of H. pylori infection
(AS) (n = 10) using flow cytometry.
Lower frequencies of CD19+ B cells were found in the blood of
DU patients than in the AS individuals. The numbers of
CD4+CD25high regulatory T cells were decreased in the antrum as
well as the duodenum in DU patients compared to AS individuals,
although the differences were not significant. CD4+ and CD8+
lamina propria T cells from the antrum and the duodenum of DU
patients expressed decreased levels of the chemokine receptors
CXCR3 and CCR4 compared to cells from AS individuals. Antral
T cells from DU patients also expressed the homing receptor lselectin to a lower extent than T cells from AS individuals.
These preliminary results suggest that different T- and B-cell
populations may be recruited to and accumulate in the gastrointestinal
mucosa of DU patients compared to in AS individuals and that this
may be of importance for development of duodenal ulcer disease.

*Republican

Specialized Centre of Surgery, Tashkent, Uzbekistan,
Helicobacter Study Group, Tashkent, Uzbekistan, ‡Institute of
Raising the Level of Physicians’ Skill, Tashkent, Uzbekistan
†Uzbek

The purpose of the given work was examination of the patients
with atherosclerotic lesions of vessels for Helicobacter pylori
infection comparing with Chlamydia pneumoniae.
Thirty-four male patients with ischemic heart disease (IHD) of
ages ranging from 45 to 65 years (a basic group) were investigated.
Twenty-three practically healthy men formed a control group. We
determined IgG and IgM antibodies to H. pylori and C. pneumoniae
in their blood serum by immune-enzyme method (“Human,”
Germany) before treatment by traditional methods and by
specialized liposomes (SL) with antimicrobial and antioxidant
components.
In the basic group, the index of seropositive results made
53%, whereas in the control group, it made only 17.3% ( p < .01).
Influence of conservative and surgical treatments on amount of
antibodies to H. pylori was not found, but in the group of the
patients using at treatment SL, the authentic reduction of titer of
antibodies ( p < .05) was revealed.
Seropositivity to C. pneumoniae at determination of IgG
antibodies was more expressed in the basic group and made 33.3%,
whereas it was 12.6% ( p < .05) in the control group. IgM antibodies
to C. pneumoniae in both groups were not revealed that speaks for
availability of the chronic infectious process at the patients. The
realization of treatment by SL promoted authentic reduction of
titer of antibodies to C. pneumoniae.
These data confirm an essential role of the infectious factor,
particularly H. pylori, in atherosclerosis etiology and its
complications, requiring changes of the approaches to their
diagnostics, treatment, and prevention.
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Abstract no.: 06.01*
Increased Expression of Survivin in Gastrin
Enhancement of Helicobacter pylori-Induced
Precancerosis in Mongolian Gerbils
T. Brzozowski,* P. C. Konturek,† S. Kwiecien,*
W. Bielanski,* S. J. Konturek,* R. Pajdo,* W. Pawlik,*
G. Burnat† and E. G. Hahn†
*Department of Physiology, Jagiellonian University Medical College,
Cracow, Poland, †Department of Medicine I, University of ErlangenNuremberg, Erlangen, Germany

Survivin is a member of the inhibitors of apoptosis protein (IAP)
family and a suppressor of cell death, but the role of apoptosis and
survivin in the Helicobacter pylori infection in Mongolian gerbils
has not been extensively investigated. Mongolian gerbils were

inoculated with H. pylori strain (cagA+ vacA+, 5 × 106 cfu/ml
i.g.) with or without the daily treatment for 3 weeks with 1, vehicle
(saline); 2, gastrin-17 (10 nmol/kg i.p.); and 3, omeprazole
(30 mg/kg s.c.). At 4, 12, 30, and 60 weeks upon gastric H. pylori
inoculation, the morphologic changes in glandular mucosa
(histology), density of H. pylori colonization (number colonies
per plate), gastric blood flow (GBF) (H2-gas clearance), plasma
gastrin (RIA), and expression of survivin, proapoptotic Bax, and
antiapoptotic Bcl-2 (Western blot) were evaluated. The gastric
H. pylori infection was detected in all animals by histology and
H. pylori culture. By the end of the study, typical hyperplasia with
cellular atypia was observed together with atrophic gastritis, intestinal
metaplasia, dysplasia, and intraepithelial neoplasia, particularly in
gerbils treated with gastrin or omeprazole. Treatment with gastrin
and omeprazole was accompanied by four- to fivefold increase in
plasma gastrin levels, dramatic overexpression of survivin and Bcl-2
proteins, and down-regulation of Bax in the H. pylori-infected
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556
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gastric mucosa. The GBF in H. pylori-infected gerbils treated with
gastrin-17 or omeprazole was significantly lower than that in
H. pylori-infected treated with vehicle, and this fall in GBF remained
constant until the end of the observation period. We conclude that
gastrin shows antiapoptotic activity and promotes H. pyloriinduced precancerosis due to increased expression of Bcl-2 and
survivin.

Abstract no.: 06.02*
NH4+ Inhibition of SLC26A9: A Possible
Mechanism Behind Helicobacter pylori-Induced
Reduction in Gastric Juxtamucosal pH
Abstracts
8Abstract

J. Henriksnäs,* M. Storm,† M. Phillipson,* L. Engstrand,†
M. Soleimani‡ and L. Holm*
*Department

of Medical Cell Biology, Uppsala University, Uppsala,
Sweden, †Department of Bacteriology, Swedish Institute for Infectious
Disease Control, Solna, Sweden, ‡Department of Medicine, University
of Cincinnati, Cincinnati, OH, USA
Background. The gastric mucosa is covered by a mucus layer
wherein a pH gradient can be formed. This mucus-bicarbonate
barrier is the first line of defense against acid, and it can maintain
the epithelial surface neutral when challenged with luminal acid.
SLC26A9, an apical Cl−/ HCO3− exchanger expressed in gastric
surface epithelial cells, is unlike other anion exchangers or
transport proteins reported to date, in that it is inhibited by NH+4 .
The gastric pathogen Helicobacter pylori produces NH+4 through
its urease activity, and could thus inhibit SLC26A9 and the
bicarbonate transport. We have previously shown that both NH+4
and a chronic infection with H. pylori reduce the ability to maintain
the epithelial surface pH neutral. In this study, we investigated if a
chronic infection with H. pylori alters the expression of SLC26A9.
Methods. FVB/N mice expressing human α-1,3/4-fucosyl
transferase (producing Leb epitopes) were inoculated with H. pylori.
mRNA levels were measured in total stomach preparation using
Northern blot analysis and real-time polymerase chain reaction
(PCR) in surface epithelial cells obtained by gentle scraping of the
mucosa.
Results. The expression of SLC26A9 increased by 45% in total
stomach (n = 3) and by 80% in surface cells (n = 3) in infected mice.
Conclusions. The reduction in gastric juxtamucosal pH by H.
pylori most probably reflects a reduced bicarbonate transport
across the epithelium, e.g., through inhibition of the Cl–/ HCO3−
exchanger SLC26A9. The up-regulation of SLC26A9 in H. pyloriinfected mice might be an attempt to overcome the effect of NH+4
inhibition.

Abstract no.: 06.03*
Apoptosis in Helicobacter pylori Gastritis is
Related to cagA Status
M. M. D. A. Cabral, C. C. Mendes, D. M. M. Queiroz,
G. A. Rocha, A. M. C. Rocha and A. M. M. F. Nogueira
Federal University of Minas Gerais/F. of Medicine, Belo Horizonte, MG,
Brazil
Background. Apoptosis has been reported in Helicobacter pyloriassociated gastritis and it has been related to atrophy development.
Infection by cagA+ strains is associated with atrophy.
Aims. To investigate if cagA status is related to apoptosis in
H. pylori-associated gastritis.
Patients and Methods. Fifty patients (22 men, 28 women, median
age 40 ± 13.8 years, range 17–75 years) presenting with H. pylori
gastritis were studied. Immunoexpression (sABC) for
antiapoptotic (bcl2 and bclx) and proapoptotic proteins (bax and
bak) was scored (0–4) in gastric biopsies from the antrum (lesser
and greater curvatures), incisura, and corpus (greater curvature).
H. pylori and cagA status were determined by polymerase chain
reaction (PCR).
Results. All proteins were expressed in the cytoplasm of foveolar
cells, frequently in a granular pattern; bcl2 expression was weak in
most of the cases; bax and bak expression was higher than bcl2 and
bclx in most cases. In intestinal metaplasia (IM), bax and bak were
strongly expressed at the bottom of the lesion; bax and bak
expression was significantly higher in patients infected by cagA+
strains than by negative ones ( p = 10−3). Anti-apoptotic proteins
were significantly more expressed in the antral lesser curvature
than in the other regions of the stomach, irrespective of IM (bcl2:
p = .02; bclx: p < .001); bak expression was higher in the lesser
curvature (antrum and incisura), than in the other regions
( p = .002).
Conclusions. Infection by cagA+ strains is significantly associated
with apoptosis, mainly in the lesser curvature, which may have a
role on atrophy development.
Financial Support. CNPq and Fapemig.
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Abstract no.: 06.04*
Effect of Helicobacter pylori Infection on
Hepatitis C Virus Infection
H. El-Zimaity, B. Yoffe, S. Tavakoli-Tabassi, B. Hollinger,
S. Abudayyeh, Z. Nurgalieva and B. Anand
Baylor College of Medicine, Houston, TX, USA
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Background. Hepatitis C virus (HCV) is a major cause of chronic
liver disease, cirrhosis, and hepatocellular carcinoma. A possible
explanation for differences observed in patient’s response to
antiviral treatment is the confounding effect of concurrent
infections such as Helicobacter pylori.
Aim. To compare response to antiviral treatment in H. pyloripositive versus H. pylori-negative patients.
Methods. HCV viral load was determined at baseline, after 24 and
48 weeks of treatment, and at 6 months after stopping antiviral
therapy. Sustained virology response (SVR) was defined as negative
hepatitis C virus-polymerase chain reaction (HCV-PCR) 6 months
post-therapy. H. pylori status was assessed by serology.
Results. One hundred seven patients with HCV infection were
included. Forty-two (39%) were H. pylori antibody-positive. The
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556
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SVR rate was lower among H. pylori-positive patients compared to
H. pylori-negative patients (19% versus 43%) ( p = .01). By ordered
logistic regression analysis, other factors associated with a lower
SVR rate were genotype 1 and being African American. The
baseline viral load was also lower in H. pylori-negative patients
compared to H. pylori-positive patients ( p < .001). After treatment,
the mean viral load in the nonresponder patients (27 H. pylorinegative and 32 H. pylori-positive) was higher in H. pylori-positive
patients (2.32 × 106 ± 3.2 versus 1.51 × 106 ± 4.8 copies) ( p = .056).
Conclusion. H. pylori infection is associated with significantly
lower sustained virologic response rate and a higher HCV viral
load compared to patients without H. pylori infection. Eradication
of H. pylori infection might result in a significant improvement in
the outcome of HCV treatment.

Abstract no.: 06.05
Helicobacter pylori Infection Under 2 Years of
Age Causes Significant Alterations in
Gastrointestinal Mucosa
Abstracts
8Abstract

E. Tutar,* D. Ertem,* S. Cam,* E. K. Karaa,† M. Ugras*
and E. Pehlivanoglu*
*Marmara University School of Medicine, Division Pediatric
Gastroenterology and Nutrition, Istanbul, Turkey, †Marmara University
School of Medicine, Department of Pathology, Istanbul, Turkey

Introduction. It has been suggested that early acquisition of
Helicobacter pylori infection was related to severe chronic H.
pylori-related gastrointestinal diseases, which might result in
several health issues in their later life including gastric carcinoma
and mucosa-associated lymphoid tissue (MALT) lymphoma.
Aim. The aim of this study was to investigate the frequency of
H. pylori-related endoscopic and histopathologic findings in infants
and young children.
Method. One hundred fifty-two children younger than 24 months
of age who underwent endoscopy for gastrointestinal problems
such as failure to thrive, chronic diarrhea, vomiting, wheezing, and
persistent iron deficiency anemia were included in the study.
H. pylori infection was diagnosed on the basis of histopathologic
examination. Endoscopic and histopathologic findings were analyzed
and compared between H. pylori-positive and -negative groups.
Results. Overall, 40 of 152 children (26.3%) were infected with
H. pylori. The frequency of gastritis was 19.1% (29/152) in the study
group and 83% (24/29) of the infants with gastritis were H. pyloripositive. The endoscopic findings regarding esophageal and gastric
hyperemia, antral nodularity, gastric and duodenal ulcer were
not different in both H. pylori-positive and -negative groups.
Esophagitis and gastritis were more common in H. pylori-positive
group ( p < .01, p < .0001, respectively). No correlation was found
between the density of H. pylori and mucosal changes in gastric
mucosa.
Discussion. As the histologic spectrum of H. pylori-related
gastrointestinal findings varied from normal gastric histology to
severe chronic active gastritis even in children under 2 years of age,
H. pylori infection and related long-term complications should be
assessed cautiously in infected individuals.
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Abstract no.: 06.06
Improved Diagnoses of Corpus Gastric Atrophy
H. El-Zimaity, D. Y. Graham, A. Campos, L. Guerrero,
A. Chavez and V. Cardenas
Baylor College of Medicine, Houston, TX, USA
Background. The current hypothesis is that gastric adenocarcinoma
develops through a cascade of events that involves multifocal
atrophic gastritis. We recently confirmed corpus atrophy is a
continuous process that progresses proximally and towards the
greater curve.
Aim. To compare a sampling and histopathologic approach for the
evaluation of corpus atrophy with the Sydney System.
Methods. Patients had eight gastric biopsy specimens obtained
from defined locations (four corpus, four antral). Sites were
designed to capture the atrophic border as it expands proximally;
two corpus sites correspond to Sydney System recommendations.
Atrophy was defined as loss of normal glandular components with
or without its replacement with intestinal metaplasia and/or
pseudo-pyloric metaplasia. The overall grade of atrophy was then
scored on a scale of 0–3 based on number and location of corpus
biopsies with atrophy.
Results. One hundred eighty patients were examined (139
Helicobacter pylori-positive). Corpus atrophy was present in 73
patients. Atrophy in patients with grade 1 and grade 2 was present
in distal corpus biopsies located proximal to the normal antrum–
corpus junction (lesser curve > greater curve), which are not
included in the Sydney System recommendations. More severe
atrophy was present in more proximal biopsies, which corresponds
to those recommended by the Sydney System. Atrophy was never
present in the proximal biopsies with sparing of distal corpus
biopsies. Corpus atrophy was significantly under diagnosed using
the Sydney System ( p < .001).
Conclusion. The system used is more suitable for clinical
evaluation and research related to identifying the presence and
extent of precancerous progressive atrophic gastritis.

Abstract no.: 06.07
Different Mechanisms are Involved in the
Control of Gastrin Synthesis and Secretion in
Helicobacter pylori-Infected Patients with
Duodenal Ulcer and Functional Dyspepsia
8Abstract
Abstracts

A. D. Sokic-Milutinovic,* V. Todorovic,† T. Wex,‡
O. Mitrovic,† T. Milosavljevic* and P. Malfertheiner‡
*Clinical

Center of Serbia, Belgrade, Serbia and Montenegro,
for Medical Research, Belgrade, Serbia and Montenegro,
‡Clinic for Gastroenterology, Hepatology and Infectious Diseases,
Otto-von-Guericke University, Magdeburg, Germany
†Institute

Background. Gastric Helicobacter pylori infection leads to
chronic gastritis which is characterized by the presence of
inflammatory cells as well as changes in the cytokine and hormone
pattern. The aim of our study was to analyze gastrin expression in
relation to other cytokines in H. pylori-positive patients with
duodenal ulcer (DU) and functional dyspepsia (FD).
Methods. The study included 47 H. pylori-infected patients
(17 DU, 30 FD). During endoscopy, antral mucosa biopsies were
taken for histologic examination, protein, and transcript analyses as
well as for organ culture. Expression levels of IL-1β, IL-8, TNF-α
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556
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and gastrin were determined by quantitative reverse transcriptasepolymerase chain reaction (RT-PCR) and in part by ELISA. Serum
gastrin concentration was determined using ELISA, whereas antral
G cells were identified using immunohistochemistry and expressed
as number of cells/mm2 mucosa.
Results. Antral gastric mucosa of H. pylori-positive patients
revealed similar levels of gastrin in both DU and FD that were not
significantly increased in comparison with H. pylori-negative
group. Groups did not differ in antral G cells number, nor in
respect of gastrin mRNA contents. Gastrin serum levels were
significantly lower in DU (45 ± 9 pg/ml) versus FD (91 ± 12 pg/ml)
patients. Gastrin mRNA levels in FD patients ( p < .05) and antral
gastrin protein concentration in DU patients correlated with antral
IL-8 protein concentration ( p < .05). Correlation of serum gastrin
levels and antral TNF-α concentration was observed only in FD
patients.
Conclusions. It appears that different mechanisms are involved in
the control of gastrin synthesis and secretion in H. pylori-infected
individuals with and without duodenal ulcer.

Abstract no.: 06.08
Study of the Prevalence of Helicobacter pylori in
Accordance with Biopsy Sites in Asian
Populations
8Abstract
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T. Matsuhisa,* N. Matsukura,† N. Yamada‡ and
N. Uemura§
*Gastrointestinal

Endoscopy, Nippon Medical School, Tokyo, Japan,
Medical School, Tokyo, Japan, ‡Pathology, Nippon
Medical School, Tokyo, Japan, §Endoscopy, International Medical
Center of Japan, Tokyo, Japan
†Surgery, Nippon

Background. Japanese gastric mucosa is atrophic compared with
other Asian populations (Matsuhisa T., Helicobacter 8:29–35,
2003). Although the type of gastritis in Japanese changes from
antrum-predominant to corpus-predominant in older people, other
Asian populations is antrum-predominant in every age (Matsuhisa
T., J Gastroenterol 39:324–328, 2004). Histologic prevalence of
Helicobacter pylori was studied in accordance with biopsy sites
among Asian populations.
Materials and Methods. In all, 1950 Japanese, 561 Chinese, 473
Vietnamese, 434 Thai, and 243 Nepalese were included in this
study. Histologic diagnosis of H. pylori infection was performed
according to triple-site gastric biopsy method. The first site is
taken from the greater curvature of the lower antrum, the second is
taken from the greater curvature of the upper body, and the third
is taken from the lesser curvature of the lower body.
Results. Histologic diagnosis of Japanese showed significantly
high in the second compared with in the first and the third (first:
64.4%; second: 72.5%; and third: 65.5%). Chinese, Vietnamese,
Thai, and Nepalese prevalence showed similar value in each
specimen (50.1–51.3%, 45.9–49.4%, 64.2–70.9%, and 48.1–49.8%,
respectively). There were no differences in prevalence among
biopsy sites.
Conclusion. There was a difference in histologic diagnosis of
H. pylori among biopsy sites in Japanese and no difference in other
Asian populations. These results depend on the difference of gastric
mucosa and the type of gastritis.
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Abstract no.: 06.09
Helicobacter pylori Infection Induces a Shift in the
Proliferation–Apoptosis Distribution Pattern of
the Gastric Epithelium
S. Holck,* I. Holm,† P. P. Holck,‡ M. Pedersen,§
L. P. Andersen,¶ A. Nørgaard,** H. Permin†† and
S. Norn‡‡
*Department

of Pathology, Hvidovre Hospital, Hvidovre, Denmark,
of Biomedical Science, Copenhagen, Denmark,
‡Institute of Molecular Pathology, University of Copenhagen,
Copenhagen, Denmark, §Department of Pathology, Hillerød Hospital,
Hillerød, Denmark, ¶Department of Microbiology, Rigshospitalet,
Copenhagen, Denmark, **Department of Medicine, Hillerød Hospital,
Hillerød, Denmark, ††Department of Infectious Disease, Bispebjerg
Hospital, Copenhagen, Denmark, ‡‡Institute of Pharmacology,
University of Copenhagen, Copenhagen, Denmark
†Faculty

Background. In the normal gastric mucosa, the proliferative zone
is localized to istmus whereas apoptotic shedding dominates in
superficial epithelium. An altered architecture in Helicobacter
pylori-positive gastritis may result from a changed balance in
apoptosis/proliferation kinetics. Therefore, kinetics and its
association to H. pylori status were examined.
Design. Antral biopsies from 55 dyspeptic patients were
previously evaluated for H. pylori status (FEMS 36:175, 2003).
Additional sections were immunostained for the proliferation
marker Ki-67 and for apoptosis using the TUNEL method.
Immunopositive epithelial cells were graded (0-+++) regardless of
the microanatomic distribution, and in the following
compartments: surface (f1), upper half (f2), and lower half of
foveolae (f3). Cases with reverse pattern were recorded, i.e.,
TUNEL-positive cells in f3 exceeding that of f2 and f1 and Ki-67positive cells in f1 exceeding that of f2 and f3.
Results. Reversed apoptotic pattern was correlated to H. pylori
density ( p = .048) and to the extent of apoptosis regardless of
compartments ( p = .006). Reversed proliferative pattern was not
recorded; however, 20% of the study population showed Ki-67positive cells in f1 and the density was correlated positively to the
extent of apoptosis ( p = .003) and marginally to H. pylori positivity.
Conclusion. This disruption of normal apoptosis/proliferation
distribution pattern deserves attention, considering comparable
dynamic alterations characterizing dysplasia in other parts of the
GI-tract (Am J Clin Pathol 119:723, 2003). This switch, particularly
in apoptosis, to a lesser degree in proliferation, may signify an early
event in the H. pylori-gastritis–dysplasia sequence.
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Abstract no.: 06.10
Local Infection by Helicobacter pylori has no
Effect on the Number of Serotonin-Producing
Endocrine Cells of the Cardiac Mucosa
A. J. A. Barbosa,*† F. A. Nunes,* F. M. Soares,*
N. S. Champs,* E. C. D. Moraes* and W. Albuquerque*
*Faculdade

de Medicina UFMG, Belo Horizonte, Brazil, †Instituto Alfa
de Gastroenterologia, Belo Horizonte, Brazil
It has been proposed that Helicobacter pylori-associated gastritis
may have an effect on the endocrine cell density in gastric mucosa.
Serotonin is produced by the enterochromaffin (EC) cells found
along the gastrointestinal mucosa. The aim of the present study was
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to examine the effect of H. pylori-associated carditis on the local
number of EC cells. Forty-eight dyspeptic patients (24 men, 24
women, mean age 42 years, range 7–79 years) underwent an upper
gastroduodenal endoscopy with gastric biopsies from the cardiac
mucosa. Sections of the biopsies were stained for H&E and Giemsa
and used for histology and H. pylori detection, respectively.
Staining of argyrophil cells and EC cells was performed by the
Grimelius and immunoperoxidase methods, respectively. The
quantitative evaluation of EC cells in cardiac mucosa was classified
according to the number of these endocrine cells in the mucussecreting or mixed glands, which are typical of the cardiac mucosa,
as: 1, absent; 2, scattered; and 3, numerous. Among the 48 patients
studied, 35 were H. pylori-negative, and 13 were H. pylori-positive,
i.e., presenting active carditis with local H. pylori infection. Most of
the argyrophil cell population was composed by EC cells. The
Table shows that the number of EC cells of the cardiac mucosa does
not seem to be affected by H. pylori infection ( p > .05).
Distribution of 48 patients according to the number of EC cells in the
cardiac mucosa

Patients
H. pylori-positive (n = 13)
H. pylori-negative (n = 35)

Numerous
EC cells
n (%)

Scattered
EC cells
n (%)

Absent
EC cells
n (%)

09 (69)
16 (46)

04 (31)
15 (43)

0 (0)
04 (11)
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Abstract no.: 06.11
Bacterial Load after Helicobacter pylori
Eradication Predicts the Changes of Gastric
Antral Mucosa, Serum Gastrin-17, Pepsinogen-I,
and Pepsinogen-II Levels
S. I. Pimanov and A. V. Makarenka
State Medical University, Vitebsk, Belarus
Aim. To investigate the changes of gastric mucosa morphology,
levels of serum gastrin-17, and pepsinogen I, and II after eradication
of Helicobacter pylori.
Patients and Methods. Eighty patients with H. pylori-associated
duodenal ulcer before 2 months and 1 year after eradication were
studied. Among patients with unsuccessful eradication, two groups
were distinguished: the group with negative rapid urease test,
positive results of polymerase chain reaction (PCR), and decreased
bacterial density according to morphologic score (partial
eradication group, 21 patients); the group with positive RUT (rapid
urease test) and high bacterial density (failed eradication group,
37 patients).
Results. Before eradication and 1 year after its serum, levels of
gastrin-17 (pmol/l) were 2.91 ± 1.83 and 1.55 ± 1.14 ( p = .005) in
the group with successful eradication; 2.56 ± 1.61 and 1.48 ± 1.15
( p = .021) in the group with partial eradication; 2.69 ± 2.16 and
2.21 ± 2.68 ( p = .10) in the group with failed eradication. Serum
levels of pepsinogen-I (mkg/l) constituted 110.19 ± 34.85 and
76.53 ± 28.02 ( p = .001); 116.08 ± 29.64 and 85.45 ± 38.50 ( p = .001);
108.20 ± 32.84 and 100.17 ± 47.58 ( p = .070), respectively. Serum
levels of pepsinogen-II ( pmol/l) were 12.17 ± 8.77 and 7.68 ± 5.35
( p = .006); 16.66 ± 11.92 and 7.17 ± 4.56 ( p = .001); 13.55 ± 9.37,
and 11.27 ± 9.28 ( p = .110), respectively. In the group with successful
eradication inflammation, activity, atrophy, and lymphoid follicles

in the antral mucosa fell. In the group with partial eradication, antral
mucosa activity changed from 1.86 ± 0.85 to 0.98 ± 0.33 ( p = .003)
and H. pylori score reduced from 2.26 ± 1.04 to 0.75 ± 0.60
( p = .0004). Other morphologic changes in antrum and body
mucosa in different groups were statistically not significant.
Conclusion. Patients with duodenal ulcer after successful and
partial eradication have positive morphologic and functional
changes of gastric mucosa.

Abstract no.: 06.12
Non-invasive Testing for Gastric Atrophy in
North America
8Abstract
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Z. Z. Nurgalieva,* D. Y. Graham,*† H. El-Zimaity,*
A. Campos,‡ L. Guerrero,§ A. Chavez,‡ A. R. Opekun*
and V. Cardenas‡
*Baylor

College of Medicine, Houston, TX, USA, †Michael E. DeBakey
VAMC, Houston, TX, USA, ‡UT School of Public Health, El Paso, TX,
USA, §UT School of Public Heath, El Paso, TX, USA

Background. Gastric cancer risk is directly correlated with the
severity and extent of mucosal atrophy.
Aim. To evaluate non-invasive testing for antral and/or corpus
atrophy in North America.
Methods. Gastric biopsies were obtained from four defined
locations in the antrum and four in the corpus. Sections were
scored for the presence of Helicobacter pylori and gastric atrophy
on a visual analog scale (0–5). Atrophy was defined as loss of
normal glandular components with and without its replacement
with intestinal metaplasia and/or pseudo-pyloric metaplasia. Corpus
atrophy was then scored as 0–3 based the number of biopsies with
atrophy. Patients sera were also examined for pepsinogen 1,
pepsinogen 2, gastrin 17 (fasting and stimulated) (Biohit Diagnostics,
Finland).
Results. Forty-three of 179 patients were H. pylori-negative.
Corpus atrophy was present in 9.6% of study subjects (n = 135)
(grade 1 = 8, grade 2 = 4, and grade 3 = 1) and antral atrophy was
present in 30.8%. There was a significant inverse relationship
between the grade of corpus atrophy and the PGI/II ratio (r =
–0.31, p < .01). The PGI/II means were 9.3, 8, and 3.9 for superficial
gastritis, mild atrophy, and moderate to severe corpus atrophy,
respectively. Stage 2 or 3 was significantly different from those
without atrophy. There was also a significant negative correlation
between fasting serum gastrin and PGI/II ratio (r = –0.331)
( p = .01).
Conclusion. Non-invasive testing in North American patients is
both possible and practical using G17 and pepsinogen assays for
the diagnosis of the precancerous condition of moderate to severe
corpus atrophy.
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Abstract no.: 06.13
Accuracy of “Serologic Gastric Biopsy” in
a Cohort of Dyspeptic Patients
L. G. Cavallaro,* R. Merli,* S. Liatopoulou,* I. Franzè,*
M. Maino,* V. Iori,* G. Cavestro,* A. Gnocchi,†
P. Caruana,‡ A. Franzè† and F. Di Mario*
*University

of Parma/Department of Clinical Sciences, Section of
Gastroenterology, Parma, Italy, †Gastroenterology and Endoscopic
Unit, Az. Ospedaliera, Parma, Italy, ‡University of Parma/Pathologic
Institute, Parma, Italy

Background. Serum pepsinogens (sPGI and sPGII), gastrin-17
(G-17), and antibodies anti-Helicobacter pylori have been proposed
as a “serologic gastric biopsy.” These markers could be important
in a pre-endoscopic management of dyspeptic patients.
Aim. To assess the accuracy of sPGI, sPGII, G-17, and anti-H.
pylori to discriminate normality, inflammation, and atrophy of
gastric mucosa in dyspeptic patients.
Methods. One hundred seventy-six consecutive patients (49
years ± 17 SD, 107 women, 69 men) with dyspeptic symptoms and
not in therapy with antisecretory gastric drugs were studied. All the
patients underwent gastroscopy with biopsies and blood test for
sPGI, sPGII, G-17, and anti-H. pylori. Patients were classified in N
(with normal gastric mucosa), NACG (with non-atrophic chronic
gastritis), and ACG (with atrophic chronic gastritis moderate/
severe) according to histologic findings and separately by means of
serologic tests, in a masked way.
Results. According to the histologic findings, patients resulted:
76 N, 79 NACG, and 21 ACG (7 predominantly in antrum, 8 in
corpus, and 6 diffused). By means of serologic analysis, the same
patients were classified in: 77 N, 82 NACG, and 17 ACG (4
predominant in antrum, 10 in corpus, and 3 diffused). Accuracy,
sensitivity, specificity, positive and negative predictive values of
serologic diagnosis in comparison to histology were, respectively,
81, 79, 83, 78, 81% to detect normality; 80, 80, 80, 77, 83% to detect
inflammation; 96, 78, 98, 82, 98% to detect atrophy.
Conclusion. Serum pepsinogens, gastrin-17, and anti-H. pylori
are useful markers to screen normal gastric mucosa from nonatrophic and atrophic chronic gastritis.

8Abstract
Abstracts

Abstract no.: 06.14
Atrophy with Helicobacter pylori Gastritis in
Adults
K. Kalem, H. Guedouar, N. Djennas, Z. Lamari,
F. Souilah, A. Bouhadef, A. Berrah, F. Mouffok and
Z. Guechi

Results. Two-hundred fifty-four (sex ratio = 0.85). The mean age
was of 8.25 years (11 months–16 years). H. pylori was histologically
diagnosed in 242 (95% antral and in 66% fundal) and the load is,
respectively, minimal, moderate, or important in 32%, 61%, and
17%. The GC was observed in 248 (97%).
In antrum, mucosa was not modified in 6 (2%) and presenting
gastritis without atrophy in 18 (7%). The atrophy was noted in 230
(90%) with 121 (52%) mild, 109 (47%) moderate.
In fundus, mucosa was not modified in 80 (31%) and presenting
gastritis without atrophy in 31 (13%). The atrophy was observed
in 143 (56%) with 129 (90%) mild, 14 (9%) moderate.
There was no severe atrophy or intestinal metaplasia or epithelial
dysplasia in children in this study.
Conclusion. Chronic gastritis with H. pylori was frequent in
Algerian children.
In antrum, the atrophy was high, important, and associated to
mild atrophy of fundus in half of the cases.

Abstract no.: 06.15
Prevalence and Age-Related Distribution of
Intestinal Metaplasia of the Gastric Mucosa
Abstracts
8Abstract

N. Rossolimos,* C. Vassiliou,* P. Aggeli,* S. Balas,*
M. Theofilopoulou,* V. Xiromeritou,* G. Karatzikos,*
A. Bousiotou,† G. Kafiri† and K. Papadimitriou†
*Ippokration

General Hospital, Department of Gastroenterology,
Athens, Greece, †Ippokration General Hospital, Department of
Histopathology, Athens, Greece
Objective. The excessive consumption of antibiotics and
antisecretory drugs during recent years principally by older ages
and the systematic eradication of Helicobacter pylori worldwide
(according to the criteria of Maastricht) may have caused remarkable
changes in the H. pylori population, which is implicated in the
provocation of gastric intestinal metaplasia (IM). The aim of this
study is the determination of the prevalence and of the age related
distribution, of gastric IM as it has developed recently.
Methods. A total of 751 patients of a median age of 54 years (22–
90) who underwent gastroscopy were included in the study. None
of them had history of upper GI tract surgical procedure. Biopsies
were taken from the antrum, the angularis, and the body of the
stomach for the diagnosis of IM according to the Houston
modification of Sydney’s classification.
Results. Of all the patients, 238 (31.7%) were diagnosed with IM
of all types. The higher and the lower percentages of prevalence of
IM were 36.0% and 13.0% in the eighth and third decades of age,
respectively. The analytical results are cited below.

[20,29] [30,39] [40,49] [50,59] [60,69] [70,79] [80,89]

Pathology UHC Parnet, L.A.R.H., Algiers, Algeria
Background. The atrophy of chronic gastritis (GC) with
Helicobacter pylori in Algerian children has not been studied yet.
The score atrophy determines the groups of the young patients
presenting a risk for neoplasia.
Aim. To determine the prevalence of H. pylori and to evaluate
atrophy according to the Sydney System.
Methods. The study was prospective, led in coobservation by five
pathologists using gastroscopic biopsy from children presenting
recurrent abdominal pains or an intolerance to gluten. The patients
were submitted to other tests (test fast to the urease, serology,
culture, HpSA).

n = 751
n = 238
Percentage
(%)

58
15
25.9

74
20
27.0

125
180
32
64
25.6 35.6

222
80
36.0

69
24
34.8

χ2 = 10,97, p < .10, Pr = 0.0892.

Conclusions. Instead of wide eradication of H. pylori in the
general population, gastric IM is prevalent in a high percentage of
them.
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Aim. To develop a simple rat model of chronic H. pylori infection
for research study in the future.
Materials and Methods. Eighty-five Sprague–Dawley rats were
divided into three groups. The first group of 63 rats was pretreated
with streptomycin and then was inoculated with H. pylori. The
second group of 10 rats was pretreated with omeprazole and then
was inoculated with H. pylori. The third group of 12 salineinoculated rats served as control. Two weeks after inoculation, rats
were sacrificed and the stomachs were removed. Antral biopsies
were performed for urease test and the stomachs were taken for
histopathology. The success of H. pylori inoculation is defined as
positive both in the urease test and histopathology.
Results. There were 44/63 (69.84%) in group 1 and 6/10 (60.00%) in
group 2 success of H. pylori inoculation, respectively. Histopathology
detected organism along mucus lining the surface epithelium and
crypt lumen and demonstrated mild to moderate gastric inflammation
in the successfully inoculated rats. There were normal histopathology
and no organism in the control group and the group that
represented failure of H. pylori inoculation. The results of the
urease test and pathology are all in concordance with one another.
Conclusion. In this study, we purposed the simple model of
chronic H. pylori infection in rats. There was a favorable successful
rate and was accompanied by a mild to moderate mucosal
inflammation. This animal model could be used for research
studies in the future.

Abstract no.: 06.16
Atrophy with Helicobacter pylori Chronic
Gastritis in Adults
K. Kalem, H. Guedouar, N. Djennas, Z. Lamari,
F. Souilah, A. Bouhadef, B. Touchene, F. Mouffok
and Z. Guechi
Pathology UHC Parnet, L.A.R.H., Algiers, Algeria
Background. Chronic gastritis (GC) with Helicobacter pylori
involves gastric atrophy. Now, atrophy is defined better but
remains variably appreciated according to gastric regions, examined
specimens, and used histologic techniques.
Aim. To determine the prevalence of H. pylori gastritis and to
evaluate atrophy according to the Sydney system.
Methods. Study was prospective, led in coobservation by five
pathologists using gastroscopic biopsy from adults with epigastralgic
pain. Patients were submitted to other tests: urease test, serology,
culture, HpSA, Cag, and VacA.
Results. Five hundred twenty-four patients (sex ratio = 0.6), 98
presenting duodenal ulcer.The mean age was 36.5 years (18–75).
The serology, urease test, culture, HpSA, Cag, VacA were
positive, respectively, in 92%, 87%, 64%, 54%, 72%, and 40%. The
histology showed H. pylori in 497 (94.8%) and GC in 524 (100%).
In antrum, chronic gastritis was diagnosed in all patients and
without atrophy in 30 (6%). Atrophy was detected in 494 (94%) with
196 (39%) mild, 287 (58%) moderate, 11 (2%) severe. Intestinal antral
métaplasia was observed in 30 (6%) with 7 (1%) severe dysplasia.
In fundus, mucosa was not modified in 57 (10%) and presenting
gastritis without atrophy in 121 (23%). The atrophy was observed in
347 (66%) with 268 (77%) mild, 77 (22%) moderate, and 2 severe.
Intestinal fundal metaplasia was noted in six (1%) with one severe
dysplasia.
Conclusion. In adults presenting epigastritic pain, chronic
gastritis with H. pylori was quasi-constant. Atrophy was frequent,
predominant in antrum with 60% moderate and rarely severe.
Intestinal metaplasia and severe epithelial dysplasia were rare and
always associated to severe atrophy.

Abstract no.: 06.18
Evaluation of Elementary Histologic Lesions of
Chronic Gastritis After Eradication of
Helicobacter pylori
8Abstract
Abstracts

F. Souilah
Pathology UHC Parnet, L.A.R.H., Algiers, Algeria
Aims. In Algeria, gastric pathology related to Helicobacter pylori
is very frequent and begins in early childhood and rare studies
about it are published. The purpose of this study is to appreciate in
short term the evolution of the histologic elementary lesions and to
evaluate their scores after eradication.
Materials and Methods. This is a prospective study of gastric biopsies
of 58 adult patients (17–77 years old) suffering from gastritis caused
be H. pylori, of which the positive diagnosis had been established
by the cultivation and/or histology and another test. The biopsies
had been taken before treatement and after H. pylori’s eradication,
and were controled after a period of at least 6 months (6–
24 months). The usual histochemical and immunohistochemical
techniques (hematoxylin–eosine, giemsa, PAS, antibody anti-H.
pylori) had been used. The classification according to the Sydney
System had been adopted, the parameters had been scored from
0 to 3 before and after eradication, and the fibrosis had also been
evaluated.

Abstract no.: 06.17
A Simple Rat Model of Chronic Helicobacter
pylori Infection for Research Study
8Abstract
Abstracts

D. Thong-Ngam, R. Prabjone, N. Visedopas,
T. Chatsuwan and Chulalongkorn Helicobacter Study
Group
Chulalongkorn University Hospital, Bangkok, Thailand.
Background. Helicobacter pylori is accepted as a human pathogen
for the development of gastritis and gastroduodenal ulcer diseases.
Antrum
Before treatment
Scores%
Chronic
Inflammation
Activity
Atrophy
Lymphoid follicles

0
0
5.17
3.44
36.20

1

2

Body
After eradication

3

65.51

31

3.44

65.5
22.4
58.62

24.13
70.68
3.44

5.17
3.44
1.72

0
0
87.93
5.17
55.17

1

2

93.10

6.89

12.06
46.55
36.20

0
46.55
8.62

Before treatment
3
0
0
1.72
0

0
0
20.68
24.13
67.24

After eradication

1

2

3

0

1

2

3

93.10

6.89

0

44.82

51.72

3.44

0

77.58
60.34
29.31

1.72
15.52
0

0
0
0

93.10
46.55
67.24

6.89
50
29.31

0
1.72
0

0
0
0
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Results. Four cases of intestinal metaplasia had been observed
before treatment and just two after eradication. The fibrosis
increased and surrounded some lymphoid follicles.

Conclusion. We can say that 6 months after the eradication of
H. pylori, we observed a persistence of the elementary lesions, but
there is a regression of the intensity of the scores.

Preneoplastic and Neoplastic Diseases
Abstract no.: 07.01*
Oxidative DNA Damage in Patients with
Gastritis and Gastric Cancer Infected by
Helicobacter pylori
M. L. Ribeiro,* M. S. P. Ladeira,† M. A. M. Rodrigues,†
W. Bartchewsky Jr,* C. L. S. Pinto,† R. G. Mattos,*
R. P. Prado,† S. Mendonça,* J. Guerra,‡ D. M. M.
Queiroz,‡ J. Pedrazzoli Jr* and D. M. F. Salvadori†
*Clinical

Pharmacology and Gastroenterology Unit, Sao Francisco
University Medical School, Braganca Paulista, Brazil, †Departamento
de Patologia, Faculdade de Medicina, UNESP, Botucatu, SP, Brazil,
‡Laboratório de Pesquisa em Bacteriologia, Faculdade de Medicina,
UFMG, Belo Horizonte – MG, Brazil
Helicobacter pylori infection has been considered to be greatly
responsible for the pathogenesis of gastric cancer. Bacterial
products and ROS released at the site of inflammation can induce
oxidative DNA damage and/or accumulation by inhibition of
DNA repair enzymes. The aim of the present study was to evaluate
the relationship among oxidative DNA damage, efficiency of
DNA repair, density of H. pylori, and the relevance of cagA, vacA,
and iceA genotypes and host polymorphisms of GSTM1, GSTT1,
GSTP1, CYP2E1, and IL-1β in 24 non-infected patients, 41
infected patients with gastritis, and 61 with gastric cancer. Oxidative
DNA damage and the efficiency of DNA repair were analyzed by
the Comet assay, bacterial density was measured by quantitative
real-time polymerase chain reaction (PCR), and allelic variants
from H. pylori and host were evaluated by PCR. Oxidative DNA
damage was significantly higher among infected patients with
gastritis and cancer than in non-infected patients. There was no
correlation between oxidative DNA damage and H. pylori density.
Patients infected by virulent strains (cagA+, vacAs1m1, and iceA1)
showed higher levels of oxidative DNA damage. H. pylori-infected
patients with severe gastritis and carriers of GSTT1+/GSTP1ile/ile
showed larger oxidative DNA damage level. Additionally, the
efficiency of DNA repair of gastric epithelial cells from infected
patients with moderate or severe gastritis was lower than noninfected patients. Our results indicate that the infection by more
virulent H. pylori strains and host GSTT1+/GSTP1ile/ile genotype
are associated with oxidative DNA damage. Thus, the intensity of
inflammation could lead to impairment of DNA repair system.
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Abstract no.: 07.02
Long-Term Helicobacter pylori Infection of
Outbred North American Mongolian Gerbils in
Conjunction with High Salt Diet Does not Result
in Gastric Cancer – Revisiting the Model
I. T. Padol,* M. Sagar,* R. H. Riddell† and R. H. Hunt*
*McMaster University, Hamilton, ON, Canada, †Mount Sinai Hospital,
Toronto, ON, Canada

Background. The model of gastric adenocarcinoma induced by
longstanding Helicobacter pylori infection in Mongolian gerbils
was documented in Japan in the late 1990s. High consumption of
salt has also been shown to be an independent carcinogenic factor
for gastric cancer. We postulated that augmenting H. pylori
infection with a high salt diet would exaggerate gastric cancer in
this animal model.
Methods. Outbred Mongolian gerbils (Crl:MON [Tum] Charles
River Laboratories, Wilmington, MA) were infected with H. pylori
Sydney strain (SS1) and maintained on either normal or high salt
(8%) diet and water ad libitum for up to 2 years (49 in the normal
diet and 31 in the high salt diet group, 21 and 22 in non-infected
controls, respectively) and sacrificed in equal groups at 12, 62, and
104 weeks postinfection. The entire stomach was sectioned and
stained with hematoxylin and eosin (H&E) and Warthin–Starry
stain and then examined.
Results. H. pylori colonization of gastric mucosa did not result in
gastric cancer or in dysplasia at any time point during the study, up
to 2 years post-infection in either normal or high salt groups.
Conclusion. High salt consumption in conjunction with H. pylori
infection is not enough to trigger malignant changes in the gastric
mucosa of this animal model over 104 weeks. Our findings also
question the suitability of the Mongolian gerbil model in studies of
H. pylori-associated gastric cancer.
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Abstract no.: 07.03*
C/EBP-Beta is Expressed in Gastric Carcinoma
and Leads to Overexpression of
Cyclooxygenase-2
G. Regalo,*† P. Canedo,*† M. L. Campos,* M. B. Loncar,‡
C. Figueiredo,*† F. Carneiro*† and J. C. Machado*†
*IPATIMUP – Institute of Molecular Pathology and Immunology of the
University of Porto, Porto, Portugal, †Faculty of Medicine, University
of Porto, Porto, Portugal, ‡Division of Molecular Genetics, Institute of
Anthropology and Human Genetics, University of Tübingen, Tübingen,
Germany

Chronic inflammation plays a key role in progression towards
Helicobacter pylori-related gastric carcinoma (GC). Interleukin-6
receptor (IL-6R) signal transduction pathway was shown to be
potentially involved in gastric carcinogenesis. One of the key molecular
effectors of this pathway is the C/EBP-beta transcription factor.
Additionally, the putative tumorigenic cyclooxygenase-2 (COX-2),
shown to be overexpressed in GC, is one of C/EBP-beta target genes.
Immunohistochemistry for C/EBP-beta and COX-2 proteins
was preformed in a series of 90 GC. Expression of C/EBP-beta and
COX-2 in GC cell lines was analyzed using immunofluorescence
and Western blotting. Regulation of COX-2 expression by C/EBPbeta was assessed by 1, analysis of endogenous COX-2 expression
in GC cell lines after transfection with inactivating (LIP) C/EBPbeta isoforms; 2, a luciferase reporter assay through cotransfection
of the LAP C/EBP-beta isoform; and 3, a COX-2 promoter/
luciferase construct.
In normal mucosa, C/EBP-beta expression was confined to the
proliferative neck zone. C/EBP-beta was overexpressed in
preneoplastic lesions and in 71% of the GC cases. There was a
significant difference ( p = .003) in C/EBP-beta overexpression
among intestinal-type (82.1%) and diffuse-type (39.1%) GC. In
the majority of tumors and preneoplastic lesions, C/EBP-beta
overlapped COX-2 expression. In GC cell lines, transfection with
LIP resulted in loss of endogenous COX-2 expression.
Concordant results were obtained in a luciferase reporter assay for
the COX-2 promoter, after cotransfection with the LAP isoform.
Our results suggest that overexpression of C/EBP-beta associates
with progression towards GC, and that this association relates to
the ability of C/EBP-beta to up-regulate COX-2 expression.
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Abstract no.: 07.04
Helicobacter pylori-Stimulated Epithelial ERK
Phosphorylation is Reduced by the Specific
EGFR Inhibitor EKB-569
K. Danjo, Y. Du, A. H. T. Jeremy, P. A. Robinson and
J. E. Crabtree
Molecular Medicine Unit, University of Leeds, Leeds, UK
Introduction. Helicobacter pylori activates multiple signaling
pathways in gastric epithelial cells, including transactivation of the
EGF receptor (EGFR) and activation of MAP kinases, extracellularsignal related kinases 1 (ERK1), and ERK2. H. pylori activation of
the EGFR signaling pathway may be relevant to the epithelial
hyperproliferation and increased risk of gastric carcinogenesis. The
aim of this study was to evaluate whether H. pylori-induced
phosphorylation of ERK (pERK) is via the EGF receptor.

Preneoplastic and Neoplastic Diseases
Methods. A431 epithelial cells preincubated with the EGFR
inhibitor EKB-569 (0.001–1 µmol/l) were cocultured with H. pylori
(G27 cagPAI + , H12–5 A cagM– isogenic mutant). Total ERK and
pERK status was simultaneously quantified in situ using two-color
“in-cell Western blot” analysis.
Results. Both G27 and H12–5 A significantly increased pERK in
A431 cells compared to unstimulated controls. Maximum pERK
was observed at 1.5 hours (G27, mean ± SEM units, 205.1 ± 10.9
versus 100.0 control, n = 12, p < .001; H12–5 A, 210.6 ± 13.6,
n = 12, p < .001). EKB-569 dose-dependently inhibited pERK
induced by both strains. Inhibition of H12–5 A induced pERK
was observed at 100 nm EKB-569 (139.4 ± 14.4 versus 225.9 ± 22.2
untreated control, n = 4 paired t-test, p < .02) and inhibition increased
at 1000 nm EKB-569 (133.2 ± 9.4, p < .01). EKB-569 similarly
inhibited H. pylori G27-stimulated ERK phosphorylation.
Conclusion. ERK activation was induced by H. pylori strains
could be partially blocked by the specific EGFR inhibitor EKB569. The two-color “in-cell Western blot” analysis represents a
useful tool to evaluate inhibitors of H. pylori cell signaling pathways.
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Abstract no.: 07.05*
Significant Differences in the Distribution of
Polymorphisms in IL-1β-511, IL-1β-1473, and
IL1RN Between Ethnic Groups Resident in
Malaysia
H. M. Mitchell,* M. Ha,* K. Goh,† K. Fock‡ and
D. Forman§
*School

of Microbiology & Immunology, University of New South
Wales, Sydney, Australia, †Department of Medicine, University of
Malaya, Kuala Lumpur, Malaysia, ‡Changi General Hospital, Singapore,
Singapore, §Cancer Registry, Leeds, UK
Background. Although early studies showed that specific
polymorphisms in the IL-1β promoter and IL-1RN were associated
with an increased risk of gastric cancer, this finding has not been
upheld in all populations. This may relate to the background
prevalence of specific polymorphisms in different populations.
Aims. To determine the prevalence of polymorphisms in IL-1β511, IL-1β-1473, and IL1RN in Chinese, Malay, and Indian subjects
diagnosed with functional dyspepsia (FD) and to compare this with
that previously reported in East Asian and Western populations.
Methods. DNA was extracted from whole blood and polymorphisms in IL-1β-511 and IL-1β-1473 determined by PCR–
RFLP (polymerase chain reaction–restriction fragment length
polymorphism) using AvaI and StyI, respectively. IL-1RN
polymorphisms were determined by PCR. Genotype and allele
frequencies of IL-1 polymorphisms in East Asian and Western
countries were determined using MEDLINE.
Results. One hundred eighty-four residents in Malaysia (75
Chinese, 63 Indians, 46 Malays) were examined. Significant
differences in genotype frequencies of IL-1β-511 ( p = .002), IL-1β1473 ( p = .006), IL-1RN ( p < .001) existed between ethnic groups
(χ2 test). In each ethnic group, genotype frequencies did not deviate
significantly from Hardy–Weinberg equilibrium, except in Malays
for polymorphism IL1β-1473C/G (χ2 = 4.98 > 3.84 = χ2, d.f. = 1
(0.05). For each ethnic group, strong linkage disequilibrium existed
between IL1β-511T and IL1β-1473C (D′ = 0.5→1). Comparison
of East Asian and Western populations showed the T allele
frequency of IL1β-511 and the IL1RN 2 allele frequency was
significantly different (T-test, p = .001, p < .0005).
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556
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Conclusion. Differences in the prevalence of IL-1 gene polymorphisms in different populations may explain the lack of
association between IL-1 polymorphisms and GC in some
populations.
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Abstract no.: 07.06*
Epigenetic Alterations in Patients with
Helicobacter pylori-Associated Advanced
Changes in Gastric Mucosa and Patients with
Gastric Cancer – Risk Assessment by
Determination of Global Hypomethylation of
CpG Sites
A. Leodolter,* S. Alonso,* M. Ebert,† C. Roecken,‡
T. Wex,† U. Peitz,† P. Malfertheiner† and M. Perucho*
*The Burnham Institute, La Jolla, CA, USA, †Department of
Gastroenterology, Magdeburg, Germany, ‡Institute of Pathology,
Magdeburg, Germany

Hypomethylation of genome-wide CpG-sites is observed in tumor
tissues from cancer patients. Global hypomethylation is associated
with hypo- and hypermethylation of promoter regions. It is well
known that those with atrophy, intestinal metaplasia (IM), and
corpus predominant pangastritis (CPG) are at a higher risk for
development of gastric cancer (GC). The aim of this study was to
evaluate the methylation status of CpG-sites in GC patients and
to compare these with Helicobacter pylori-positive patients with
advanced gastritis to identify if genome-wide hypomethylation
event occurs in precancerous lesions.
Methods. Gastric DNA was analyzed from patients with GC
(n = 95, tumor/nontumor tissues), CPG (n = 19, H. pylori-positive, 9
with additional IM, 2 with atrophy), and controls (n = 17) without
H. pylori infection. In all patients, an M.SssI-enzyme-assay for
methylation of genome-wide CpG-sites with s-adenosyl-L[methyl-3H]methionine was performed. For standardization of
DNA amount and to calculate the percentage of methylated CpG
sites, a dam-enzyme assay was performed.
Results. The median value of methylation of CpG-sites (82.7%)
differed significantly in patients with GC compared to all other
groups. The non-tumor tissue revealed a lower amount of
methylated CpG-sites (85.8%) compared to tissue of controls. No
differences were observed between risk gastritis (88.8%) and
controls (89.0%). More importantly, 6 out of 19 patients (32%)
with advanced gastritis have lower levels of global methylation
than gastric cancer patients.
Conclusions. A substantial part of patients with H. pylori
infection and advanced changes in gastric mucosa have highly
decreased levels of global methylation of CpG-sites indicating that
in those patients frequent epigenetic alterations have been already
accumulated.
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Abstract no.: 07.07
Cytokine-Mediated Regulation of Oncogene
Pim1 in Helicobacter hepaticus-Induced Colon
Carcinoma in Mice
P. R. Varada,* S. E. Erdman,* K. M. Haigis,†
T. Poutahidis,† P. R. Nambiar,* A. Davidson,‡
B. H. Horwitz,§ T. Jacks† and J. G. Fox*
*Division

of Comparative Medicine, Massachusetts Institute of
Technology, Cambridge, MAUSA, †Center for Cancer Research,
Massachusetts Institute of Technology, Cambridge, MAUSA, ‡Columbia
University, New York, NYUSA, §Brigham and Women’s Hospital,
Boston, MA, USA

Chronic gut inflammation predisposes to colon cancer in humans
and mice. Mouse models of colon cancer are invaluable to test novel
therapies and more importantly to elucidate underlying mechanisms
of carcinogenesis. Previous studies from our laboratory have
established that: 1, Helicobacter hepaticus-infected 129/SvEv Rag2–/–
mice develop severe colitis and cancer; 2, IL-10-competent CD4+
CD45RBlowCD25+ regulatory lymphocytes disrupt the progression
from colitis to cancer; and 3, treating mice with established cancer
with IL-10 was sufficient to abolish epithelial tumors and fully
restore gut homeostasis. However, the mechanisms underlying
regression of severe colitis and associated carcinoma are complex
and poorly understood. Here we identify a cytokine-mediated
signaling pathway that regulates homeostasis in the colonic
epithelium. In 129/SvEv Rag2–/– mice infected with H. hepaticus,
severe colitis and invasive adenocarcinoma develop by 16 weeks
postinfection. Analysis of colon tissue samples collected at
necropsy has consistently revealed up-regulation of IL6 and Pim1,
an oncogene previously implicated in the pathogenesis of human
prostate cancer. Colonic epithelium from mice treated with IL-10competent CD4+CD25+ regulatory lymphocytes, or with IL-10-Ig
fusion protein alone, has displayed normalized expression of IL6
and Pim1 and reversion to normal morphology. This study
implicates cytokine-mediated modulation of epithelial oncogenes
as an important mechanism during cancer progression and
suggests that identifying such mechanisms might provide valuable
targets in designing future strategies aimed at cancer treatment and
prevention.
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Abstract no.: 07.08
MDR1 P-Glycoprotein Expression in Human
Gastric Tissue: Not Only Multidrug Resistance
A. Rocco,* M. D’Armiento,† D. Compare,*
P. De Colibus,* G. Budillon* and G. Nardone*
*Departments

of Clinical and Experimental Medicine,
Gastroenterology, and †Biomorphological and Functional Science,
Pathology, University Federico II, Napoli, Italy
P-glycoprotein (P-gp), one of the main factors implicated in cancer
multidrug resistance, can act as a primary antiapoptotic agent.
P-gp, undetectable in normal gastric mucosa, is overexpressed in up
to 50% of gastric cancers. Tumorigenesis can be imagined to mirror
organogenesis. In both processes apoptosis plays a key role.
To evaluate P-gp expression in human gastric mucosa we studied
40 Helicobacter pylori– normal gastric mucosa samples, 134
H. pylori+ chronic gastritis with (36) and without (98) intestinal
metaplasia, 69 gastric cancers (45 intestinal type and 24 diffuse

508
type), and 10 abortive human fetuses between the 17th and 36th
week of gestational age. P-gp expression was investigated by
Western blot and immunohistochemisty (anti-MDR1-glycoprotein
p, dilution 1:150).
Results. Western blot found that P-gp level progressively increased
from normal mucosa to H. pylori+ cases, gastric cancer, and human
fetal mucosa. By immunohistochemistry, P-gp was undetectable in
all normal gastric mucosa samples, whereas it was detected in 41/
77 H. pylori+ chronic gastritis without metaplasia and in all (36/36)
H. pylori+ chronic gastritis with metaplasia. In gastric cancer, an
intense P-gp immunostaining was found in 40/45 of intestinal type
and in 4/24 of diffuse type. In the human fetal stomach, P-gp was
expressed in the glandular cells progressively stronger from earlier
stage (17th−19th week) to later stage (24th−36th week). Further, Pgp was found expressed in blood vessel wall but not in the stromal
cells.
Conclusion. Our data suggest that P-gp plays a key role during
organogenesis and in the early phase of gastric tumorigenesis.
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Abstract no.: 07.09
iNOS Expression in Gastric Carcinogenesis:
A Molecular and Immunohistochemical Study
in Tissue Microarrays (TMAs) – Correlation
with Helicobacter pylori Infection
A. Karameris,* E. Tsiambas,† S. Gazi,‡
K. Gerontopoulos,§ G. Vilaras,¶ D. Stefanou**
and T. Rokkas††
*Department

of Pathology, 417 VA Hospital, Athens, Greece,
of Pathology, Evangelismos Hospital, Athens, Greece,
‡EOF, Athens, Greece, §Coronary Medicine, 417 NIMTS Hospital,
Athens, Greece, ¶Department of Pathology, 417 NIMTS Hospital,
Athens, Greece, **Department of Pathology, University of Ioannina,
Ioannina, Greece, ††Gastroenterology Clinic, Henry Dunant Hospital,
Athens, Greece
†Department

Aim. To examine the role of iNOS and Helicobacter pylori
infection in gastric carcinogenesis.
Material and Methods. Forty-five (25 H. pylori-positive [Hp+]
and 20 H. pylori-negative [Hp–]) gastric carcinoma cases were
studied. Twelve Hp+ and 10 Hp– carcinomas were classified as diffuse
and 13 Hp+ and 10 Hp– as intestinal type. Intestinal metaplasia
(IM) type I were observed in 5 Hp+ cases, IM II in 8, and IM III in
12 cases. Controls included 5 Hp– IM I, 6 IM II, and 10 IM III
cases. The TMArrayer apparatus (Chemicon, USA) was used for
the construction of TMAs. iNOS expression was determined by
immunohistochemistry and differential polymerase chain reaction
(PCR) in microcore samples taken by TMArrayer and properly
analyzed with an Image Analysis System (DIS-200, Digital Image
Systems, Hellas).
Results. Twelve of 13 of intestinal and 10/12 of diffuse Hp+ gastric
carcinomas overexpressed iNOS. Two of 5 IM I, 8/12 IM II, and
7/8 IM III Hp+ cases also expressed increased iNOS levels as well
as 5 diffuse and 5 intestinal-type H. pylori carcinomas. In addition,
0/5 Hp– IM I, 1/6 Hp– IM II, and 2/10 Hp– IM III cases expressed
high iNOS levels. Statistically significant differences, concerning
the expression of iNOS, were observed between Hp+ Ca and
Hp– Ca (< .01), between IM II and III (< .05), as well as between
Hp+ and Hp– IM II and III (< .01).
Conclusions. High iNOS expression is significant for the
initiation and promotion of gastric carcinogenesis. High iNOS
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levels in IM type II and III correlated well with H. pylori infection
and this may be a strong evidence for long-term follow-up.

8Abstract
Abstracts

Abstract no.: 07.10
Helicobacter pylori – A Prognostic Indicator After
Curative Resection of Gastric Carcinoma
H. Winter, G. Meimarakis, D. Ruettinger, I. Assmann,
M. Stolte, C. Quaas, K. Jauch and R. Hatz
Chirurgische Klinik und Poliklinik, Klinikum Grosshadern, LMU Munic,
Munich, Germany
The influence of Helicobacter pylori on survival after curative
resection for gastric adenocarcinoma is unknown. We report followup of H. pylori-positive (Hp+) and H. pylori-negative (Hp–) gastric
cancer patients who underwent curative resection for gastric
adenocarcinoma between 1992 and 2004.
Preoperative H. pylori status of 166 curatively resected patients
with gastric adenocarcinoma was examined by means of bacterial
culture, histology (H&E and Warthin–Starry stain), and serology.
We investigated associations with various prognostic factors as well
as the effect of H. pylori status on relapse-free and overall survival.
At median follow-up of 53.0 (mean 73.9) months, disease-free
and overall 5-year survival were 56.7% and 61.9%, respectively, in
Hp+ patients, and 19.2% and 19.2%, respectively, in Hp– patients
( p = .002). For multivariate analysis of various clinicopathologic
features, the impact of H. pylori status on relapse-free (hazard ratio
1.94 CI [1.20–3.13]) and overall survival rates was found to be a
new independent beneficial prognostic factor (hazard ratio 1.83
CI [1.13–2.99]). Other established prognostic factors (depth of
invasion, lymph node metastases, and preoperatively elevated
levels of carcinoembryonic antigen) were also significantly linked
with survival in our study.
Interpretation. Hp+ patients’ status is a new independent
prognostic factor for better relapse-free and overall survival after
curative resection for gastric adenocarcinoma. Our findings should
lead to more careful follow-up of Hp– patients due to their dismal
prognosis. If the mechanisms that lead to the reported differences
in survival are elucidated, our findings could contribute to new
strategies in the treatment of gastric cancer.

Abstracts
8Abstract

Abstract no.: 07.11
Comparison of Biopsy Sampling Methods for
Detecting Stomach Mucosal Precancerous
Changes
V. D. Pasechnikov, S. Z. Chukov, S. M. Kotelevets and
T. A. Chabannaya
State Medical Academy, Stavropol, Russian Federation
Aim. To compare the results of different schemes of stomach
mucosal biopsy sampling by evaluation of serum pepsinogen-1
(PG-1) and gastrin-17 (G-17) levels in patients with Helicobacter
pylori-associated chronic atrophic gastritis, with reference to
endoscopical Kimura–Takemoto’s staging, chromoendoscopic and
histologic features.
Materials and Methods. Two hundred sixty-seven dyspeptic
H. pylori-infected patients were examined by chromoendoscopy
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556
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with random biopsy sampling according to the Sydney System and
according Kimura–Takemoto’s scale. Simultaneous assessment
of serum PG-1 and G-17 levels by enzyme immunoassay was
performed as a screening method for atrophic gastritis. The
serologic and morphologic results were compared with correlation
analysis.
Results. There was strong reverse correlation between the
histologically detected stomach mucosal atrophy (antral or corpus)
and the serum levels of the proper marker (respectively, G17 or
PG1) when gastric biopsies taken according to the Sydney
System were assessed. The use of Kimura–Takemoto’s scale
revealed the decreasing of serum PG-1 levels at O-2 and O-3 grades
of corpus atrophy, whereas serum G-17 levels were degreased in
parallel with the development of antral atrophy. There were not
any advantages in sampling biopsies for detecting intestinal
metaplasia (IM) by the Sydney System, or by Kimura–Takemoto’s
scheme. The obvious concordance was revealed between
histologically detected extent of IM and the number of foci of IM
detected by chromoendoscopy.
Conclusions. Biopsy sampling for detecting stomach mucosal
precancerous changes after non-invasive screening of atrophic
gastritis (e.g., by means of EIA) should be based preferably on the
visual signs acquired via chromoendoscopy than through routine
endoscopy, independently of the scheme of taking the biopsy.

Abstract no.: 07.12
Immunoproteome of Helicobacter pylori Strains
with Serum Samples from Patients with Gastric
Carcinoma (GC), Duodenal Ulcer (DU), and
Chronic Gastritis Only (CGO)
8Abstract
Abstracts

N. Figura,* A. Paffetti,† M. Valassina,‡ M. Valentini,‡
P. Lusini,† C. Gonnelli,* C. Lenzi,* N. Giordano,*
R. Nuti* and A. Santucci†
*Department

of Internal Medicine, Policlinico S. Maria alle Scotte,

†Mol. Biol. Department, Biochemistry, and ‡Mol. Biol. Department,

Microbiology, University of Siena, Italy
Background. Different Helicobacter pylori antigens may determine
the intensity of the inflammatory responses and the degrees of
gastric mucosa damage. To better define these antigens, we carried
out a comparative proteomic and immunoproteomic analysis of
different H. pylori strains, using different serum samples collected
from patients and controls.
Methods. We examined two H. pylori strains from two patients
with gastric carcinoma (GC), one strain from a DU (duodenal
ulcer) case, and one strain from a CGO (chronic gastritis only) case.
All strains were cagA and s1/m1 vacA subtype positive. Proteins
were submitted to 2D-PAGE, electrotransferred onto nitrocellulose
sheets, and were reacted with serum samples, diluted 1:600, from
patients with GC, DU, and CGO. Identification of protein spots
was performed by N-terminal microsequencing, gel matching, and
immunoblotting.
Results. The number of protein spots found ranged from 1500 to
1650. We observed a high variability in the expression of proteins
and sharing of virulence determinants, such as UreB, Cag26, CagA,
catalase, UreA, TagD, 26K antigen, HSPs, etc. We also detected
pathology-related potential markers: 1, CGO: tagD, 3R; 2, DU:
ppase, Ef-Tu; 3, GC: UreB accessory protein, HP0697, napA, and
12 unidentified proteins.
Discussion. The high degree of protein polymorphism and the
anti-H. pylori antibody distinct patters observed could possibly be
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556

related to the variable clinical outcome of the infection. Some
proteins, reacting exclusively with GC sera, might be considered
potential markers of GC.
Acknowledgements. This study was funded by the grant of the
Siena University PAR 2004, “Helicobacter pylori infection, host’s
aplotypes of inflammatory cytokines and risk of ischaemic heart
disease.”
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Abstract no.: 07.13
Relationships Between Gastric Cancer Among
Young Adults and Helicobacter pylori –
Comparison Over a Decade in the Tokyo Area,
Japan
S. Kikuchi, Y. Obata, R. Ushijima, K. Yagyu, Y. Lin,
T. Kobayashi and Tokyo Research Group on
Prevention of Gastric Cancer
Aichi Medical University, School of Medicine, Aichi, Japan
Background. Since 1986, incidence of gastric cancer among young
adults (less than 40 years old) (yGC) has been rapidly decreasing in
Japan.
Aim. To assess recent relationships between yGC and Helicobacter
pylori and to compare them with our previous study whose sera
were collected in 1988–1990.
Subjects and Methods. For a case–control study, plasma of
incident 54 yGC patients and 54 screenees (matched for age and
gender with patients) was collected in 1997–2002. H. pylori IgG
antibody using J-HM-CAP™ and pepsinogen I and II using
RIAbeads Pepsinogen I and II™ in the plasma were measured.
Subjects were classified by H. pylori status (positive/negative) and
pepsinogen values (normal/mild/severe). Cutoff for H. pylori
antibody was defined at 2.3. It was defined as severe serological
atrophy when pepsinogen I is less than 50 ng/ml and I to II ratio is
less than 2.0, as mild atrophy when less than 70 ng/ml and less than
3.0, respectively, and as normal in the other cases.
Results. Twenty (37%) controls and 44 (81%) patients were
H. pylori seropositive. In the H. pylori-seropositive, numbers of
subjects with normal, mild, and severe atrophy were 13, 5, and 2
among controls, and 28, 12, and 4 among patients, respectively. In
the seronegative, they were 33, 1, and 0 among controls and 9, 1,
and 0 among patients, respectively.
Conclusion. Compared with our previous study, H. pylori
seroprevalence was lower (81% versus 88%) and serologic atrophy
was less severe among patients, whereas no remarkable difference
was observed among controls.
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Abstract no.: 07.14
Helicobacter pylori as Inhibitor of Neoplastic
Processes

Abstract no.: 07.15
Helicobacter pylori Infection and Gastric Cancer
in Thailand

L. G. Bajenov,*† E. V. Rizaeva,* E. V. Artemova,*
T. L. Bajenova‡ and A. H. Kasimov*

R. Vilaichone,* S. Tumwasorn† and V. Mahachai‡

*Republican

Specialized Centre of Surgery, Tashkent, Uzbekistan,
†Uzbek Helicobacter Study Group, Tashkent, Uzbekistan, ‡Researchand-Production Medical Centre “BioHOPE”, Tashkent, Uzbekistan
For the last years, the researches of various microorganisms’ role in
malignant neoplasm regression have been sharply activated in the
world. The study of microbial substances, analogues to “Coley’s
vaccine” is one of the most prospective directions among them. We
have studied the ability of toxic substances of Helicobacter pylori
to induce regression of neoplastic processes.
We tested the preparation made of H. pylori clinic cultures
(HPP) and the preparation analogous to a classic “Coley’s vaccine”
(CV). We studied efficiency of these preparations on white mice
(line Balb/c) with carcinoma of small intestine. The mice (36 pieces)
were divided into three groups: 1, control (placebo); 2, injections of
CV into tumor; 3, injections of HPP into tumor. Injections were
made every second day for at least 2 weeks with increasing doses.
All animals of the first group perished within 3 weeks. For the second
and third groups of mice, 66.7% and 83.3% survived, respectively.
The morphologic researches confirmed absence of atypical cells at
the survived mice.
Thus, the preliminary results prove high efficiency of elaborated
anticancer drugs based on microbial toxic H. pylori substances.
These medicines are standard on the structure and are stable during
long storage. They do not contain living microorganisms, and they
are easily prepared and low in toxicity. Moreover, they can play a
certain role in organism immunization against H. pylori.

*Department

of Medicine,Thammasat University Hospital,
Pathumthani, Thailand, †Departments of Microbiology and
‡Medicine, Chulalongkorn University Hospital, Bangkok, Thailand
Background and Aims. Helicobacter pylori infection is considered
to be one of the major causes of gastric cancer. This cross-sectional
study was designed to evaluate the clinico-pathologic features and
prevalence of H. pylori infection in gastric cancer in Thailand.
Methods. Clinical information, endoscopic findings, histologic
features, and H. pylori status were collected from gastric cancer
patients between January 2000 and May 2002. H. pylori infection
assessed by the combination of rapid urease test, histology, culture,
and serology. Patients were regarded as H. pylori-positive if at least
one of the tests gave a positive result.
Results. A total of 59 gastric cancer patients were enrolled in this
study (31 men and 28 women, mean age 59.8 years [range 33 –
86 years]). The common presenting symptoms were dyspepsia
(71.2%), weight loss (69.5%), and anorexia (42.4%). Overall
prevalence of H. pylori infection was 83.1% and there was no
difference between male and female (87.1% versus 78.6%; p > .05).
The histologic staging had no significant difference between
H. pylori-positive and H. pylori-negative group. In addition, there
was no different between prevalence of H. pylori infection in
diffuse type and intestinal type gastric cancer (82% versus 85%;
p > .05). However, the prevalence of H. pylori infection was
significantly higher in nonproximal than proximal gastric cancer
(89% versus 6%; p < .01).
Conclusion. H. pylori infection was commonly found in
nonproximal gastric cancer. There was no difference of clinical
symptoms, histology type, and staging between H. pylori-positive
and H. pylori-negative gastric cancer in Thai patients.
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Abstract no.: 08.01*
Gastroesophageal Reflux and Helicobacter pylori:
A Population-Based Study
O. V. Reshetnikov,* S. A. Kurilovich,* E. D. Pylenkova,*
V. A. Krotova† and S. A. Krotov†
*Institute

of Internal Medicine, Novosibirsk, Russian Federation,
Federation

†Vector-Best, Novosibirsk, Russian

Introduction. Gastroesophageal reflux disease and its sequelae are
increasing in incidence in Western countries over the past few decades
as the prevalence of Helicobacter pylori is falling. Moreover, carriage
of CagA-producing strains of H. pylori may have a protective
effect against Barrett’s esophagus and esophageal adenocarcinoma.
Aims and Methods. The aim of the study was to estimate the
prevalence of symptoms of gastroesophageal reflux (GER) in the

general population of Novosibirsk, Russia, and to assess H. pylori
and CagA positivity.
A representative sample of 816 adults (368 males, 448 females
aged 45–70 years) completed a bowel disease questionnaire, and
GER symptoms (heartburn and acid regurgitation) were registered.
Sera were tested for antibodies against H. pylori and CagA protein
(HelicoBest, Vector-Best, Russia) using ELISA.
Results. Both symptoms were reported with the same frequency
by males and females. GER was reported at least once a month by
30.0% (29.1% in males and 30.8% in females, p = .59). Weekly
GER was found in 17.3% (17.1% in males and 17.3% in females,
p = .91). The prevalence of H. pylori infection was 84.4%, among
seropositive subjects antibodies against CagA protein were
detected in 55.4%. No significant difference was found in GER
symptoms according to H. pylori and CagA status.
Conclusion. The prevalence of GER symptoms in Russian adult
population appeared to be similar as compared to Western
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556
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countries, despite significantly higher (two- to threefold) prevalence
of H. pylori infection. Other factors than H. pylori and CagA status
are involved in the development of GER symptoms in our adult
population.

Abstract no.: 08.03
Influence of Helicobacter pylori on Symptoms of
Mild GERD During Long-Term Management
with Pantoprazole
K. Schütze* and T. Scholten†
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Abstract no.: 08.02*
Helicobacter pylori CagA-positive Strains Are
Associated with Microalbuminuria in Type 2
Diabetes
A. Pietroiusti,* M. Giuliano,† A. Magrini,‡
A. Bergamaschi§ and A. Galante*
*Tor Vergata

University/Department of Internal Medicine, Rome, Italy,
S. Eugenio/UO Diabetologia, Rome, Italy, ‡Tor Vergata
University/Cattedra Medicina del Lavoro, Rome, Italy, §Tor Vergata
University/Cattedra di Medicina del Lavoro, Rome, Italy
†Ospedale

Background. Microalbuminuria among patients with type 2
diabetes is associated with an increased risk of atherosclerosis. The
nature of this association is unclear. Infection with cytotoxinassociated geneA (CagA) strains of Helicobacter pylori may induce
atherosclerosis probably through cross-reaction between antiCagA antibodies and endothelial antigens, damaging endothelial
cells, and inducing local inflammation. In infected diabetic patients,
endothelial damage at the renal level may produce microalbuminuria.
To test this hypothesis, we evaluated the prevalence of CagApositive strains in 500 consecutive ambulatory patients with type II
diabetes (112 of whom with microalbuminuria) and in 500 healthy
controls.
Methods. The seroprevalence of infection by H. pylori and by
strains bearing CagA was assessed by ELISA. Microalbuminuria
was defined as a 24-hour urinary albumin excretion between 30 and
299 mg and was measured by nephelometry.
Results. H. pylori was found in 64% of patients with
microalbuminuria, 59% of patients without microalbuminuria,
and 58% of control group ( p = NS), whereas the prevalence of
CagA-positive strains was significantly higher in patients with
microalbuminuria than in patients without microalbuminuria
(55% versus 24%; OR 5.12, 95% CI 1.92–8.15) or in controls (55%
versus 21%, OR 6.33, 95% CI 2.74 –11.64), after adjusting for age,
sex, social status, history of peptic ulcer disease, diabetes duration,
glycosylated hemoglobin, hypertension, and renal function.
Conclusions. Patients with diabetes and microalbuminuria have
an increased prevalence of infection with H. pylori CagA-positive
strains. This finding might explain the association between
microalbuminuria and atherosclerosis in these patients.

*Hanusch Hospital,Vienna, Austria, †University of Witten-Herdeckke,
Hagen, Germany

Introduction. The results of the ORION TRIAL (published
elsewhere) showed that on-demand treatment with pantoprazole is
an effective treatment strategy in patients with mild GERD after
preceding healing from heartburn.
Objective. To point out the influence of Helicobacter pylori status
on symptoms of mild GERD during long-term on-demand
therapy with pantoprazole.
Methods. In this randomized, double-blind, placebo-controlled
study, patients with GERD 0/1 were treated with pantoprazole 20
mg for 4 weeks. At baseline endoscopy, four biopsies were taken
for the determination of H. pylori by CLOR Test. Following this,
patients were assigned to a long-term phase of 6 months with either
pantoprazole 20 mg or 40 mg or placebo on demand if they were
free of heartburn.
Results. Six hundred thirty-four patients were enrolled in this
study (ITT). Five hundred forty-three of them (ITT) were free of
heartburn after the acute phase and entered the long-term phase.
The H. pylori infection rates were 17%, 20.7%, and 22.2% in the
P40 group (n = 218), the P20 group (n = 217), and in the placebo
group, respectively. The influence of H. pylori status on the
weighted GERD symptom load in the three treatment groups of
evaluable patients is shown in the table:
P40 group
n Mean SD

P20 group
n

Mean SD

PLA group
n Mean SD

H. pylori-positive 37 2.86 1.68 45 3.18 2.74 24 3.93 2.57
H. pylori-negative 178 2.68 1.79 168 2.85 1.96 82 3.93 3.13
Conclusion. The results of this study indicate no influence of H.
pylori on symptoms of patients with mild GERD during long-term
management with pantoprazole on demand.
This trial was funded by an unrestricted grant of ALTANA
Pharma AG.
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Abstract no.: 08.04
Does Helicobacter pylori Infection Affect the
Occurrence of Reflux-Like Symptoms in General
Population? Multicenter Study*

8Abstract
Abstracts

W. Laszewicz
Department of Gastroenterology and Internal Medicine, Medical
University, Bialystok, Poland
Background. The role of Helicobacter pylori infection in
gastroesophageal reflux disease remain controversial.
Aim. To asses the incidence of reflux-like symptoms in H. pyloriinfected representative group of Polish population (multicenter
study).
Methods. The H. pylori infection incidence was assessed in 3307
adults subjects selected randomly from the population of big cities,
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556
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small towns, and villages in the proportion to age, basing on the
anti-H. pylori IgG antibody titers determined by ELISA. Every
subject was interviewed using questionnaire regarding reflux-like
complaints (pyrosis, belching, casting)
Results. The incidence of the infection in observed group was
2784/3307 (84.2%). It was more frequent in pyrosis (+) group
(86.5%) versus pyrosis (−) group (82.7%), p < .01. It also prevailed
in subjects with other reflux-like symptoms for 4 –6% ( p < .05–
p < .001; see table).
Conclusion. H. pylori infection seems to have small but significant
impact on the occurrence of reflux-like symptoms in the general
population.

Symptoms
Pyrosis (+)
Pyrosis (–)
Belching (+)
Belching (–)
Casting (+)
Casting (–)

n

H. pylori positive (%)

p

1119
1665
841
1943
411
2372

86.5
82.7
86.2
83.3
89.7
83.3

< .01
< .05
< .001

*Project

granted by Polish Ministry of Health # PCZ−08–19 and Polish
Committee for Research, #C 007/P05/2000.
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Abstract no.: 08.05
Development of De Novo Reflux Esophagitis in
Duodenal Ulcer Patients Associated with
Preexisting Reflux Symptoms, but not to
Helicobacter pylori Eradication: A 1-Year
Follow-up Study
L. Jonaitis, G. Kiudelis and L. Kupcinskas
Kaunas University of Medicine, Kaunas, Lithuania
Introduction. Unclear whether or not eradication of Helicobacter
pylori could provoke GERD.
Aim. To elucidate the role of H. pylori eradication and other
factors in the development of erosive esophagitis (EO) in duodenal
ulcer (DU) patients.
Methods. One hundred eighty-three H. pylori-positive DU
patients without EO were enrolled. In 142 patients, eradication
treatment was applied. Forty-one were in a control group treated
with omeprazole. Gastroscopy performed at baseline, 6 – 8 weeks,
and 12 months later or if DU relapses were suspected. Patients
with heartburn and/or regurgitation at least twice a week were
considered to be patients with concomitant GERD (Genval
consensus). H. pylori was diagnosed if one of the tests (urease test
and histology) was positive.
Results. One hundred fifty patients completed the study. Seventy
patients were successfully cured from H. pylori, in 49 patients
treatment of H. pylori was unsuccessful. Thirty-one control group
patients remained H. pylori-positive. EO developed in eight (11.4%)
of H. pylori-negative patients, in nine (18.4%) of unsuccessfully
treated patients, and in two (6.5%) of controls, p > .05 among
groups. Multivariate logistic regression analysis revealed three
factors significantly ( p < .05) predicting the occurrence of EO: age
more than 43 years with odds ratio (OR) −4.96 (95% CI: 1.47–
6.71), non-erosive GERD at baseline with OR −3.96 (1.34 –11.68)
and smoking at baseline with OR −3.17 (1.01–9.17). If all three risk
factors were present, the OR −18.5 (4.74 –71.42), p < .001.

Conclusion. H. pylori eradication did not influence incidence of
EO in DU patients during a 1-year follow-up period. Pre-existing
non-erosive GERD, smoking, and younger age are important for
the development of EO.
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Abstract no.: 08.06
Helicobacter pylori Infection Protects Against
Pollen Allergy
S. Imamura,* S. Mitsufuji,† S. Shiomi,† Y. Yamaoka,‡
S. Tachibana,† N. Kato,* K. Fukumoto,* Y. Sumida,*
K. Kanemasa,* H. Konishi† and T. Okanoue†
*Gastroenterology

& Hepatology, Nara City Hospital, Nara, Japan,
Gastroenterology & Hepatology, Graduate School of
Medical Sciences Kyoto Prefectural University of Medicine, Kyoto,
Japan, ‡Department of Medicine, Michael E. DeBakey Veterans Affairs
Medical Center and Baylor College of Medicine, Houston, TX, USA
†Molecular

Background and Aims. The prevalence of atopic diseases is
recently increasing especially in the developed countries, whereas
the prevalence of Helicobacter pylori infection is decreasing.
Infectious diseases during childhood are often thought to protect
atopic diseases and H. pylori infection acquired mostly in
childhood. Overall, we hypothesized that H. pylori infection might
protect atopic diseases such as pollinosis, defined as paroxysmal
ocular and nasal symptoms upon contact with pollens.
Materials and Methods. We collected urine samples from 94
volunteers (25–45 years old) and blood samples from 133
consecutive patients (17–99 years old) in the season of cedar pollen.
The presence of urine H. pylori IgG antibodies (URINELISA,
Otsuka Pharmaceutical, Tokyo, Japan) was compared with typical
pollinosis symptoms. The presence of serum H. pylori-IgG
antibody was compared with serum pollen (cedar)-specific IgE
antibodies.
Result. Among the urine samples, 26 (28%) were H. pyloripositive and 39 (42%) cases had typical pollinosis. Pollinosis was
present only in 4 of 26 (15%) cases with H. pylori infection
compared to 35 of 68 (51%) without infection ( p = .002). In the
serum samples, 57 (43%) samples were H. pylori-positive and 67
(50%) were pollen IgE positive. Pollen IgE was present in 16 of 57
(28%) with H. pylori infection compared to 51 of 76 (67%) without
infection ( p < .0001).
Conclusions. These data strongly suggest that H. pylori infection
reduces the risk of atopic disorders such as pollinosis.
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Abstract no.: 08.07
Role of Helicobacter pylori in Protection from
Intestinal Candidosis
L. B. Lazebnik,* S. G. Khomeriki* and N. M. Khomeriki†
*Central

Research Institute of Gastroenterology, Moscow, Russian
Federation, †Pushchino Medical Centre, Pushchino, Russian Federation

Objective. Candida spp. are classical representatives of
transitional flora. Acid environment and enzymes of stomach
represent barrier for their transit to intestine. The products of vital
activity of Helicobacter pylori compound another barrier. The
peptide HP (2–20), derived from ribosomal protein L1, displayed
strong fungicidal activity. The isolation of Candida from gastric
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556
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juice after course of standard triple therapy at H. pylori-positive
patients enlarged by 2.5 times and during antisecretory
monotherapy in H. pylori-negative patients by 3.5 times.
Aim. To study mutual relations of H. pylori and Candida in
gastric mucus in acid-related diseases and factors influencing
coexistence of these microorganisms.
Methods. Samples of antral mucosa obtained from 679 patients
with acid-related diseases before and after course of standard triple
therapy. We used histology and crush-cytology for revealing
H. pylori and Candida.
Results. Candida in gastric mucus at primary inspection revealed
at 112 patients mainly as single cells. In different groups of patients,
occurrence of Candida varied: it was maximal at chronic gastritis –
21% (4% coexistence with H. pylori), and minimal at oesophagitis
– 5%. In duodenal ulcer, Candida were found in 13% (10%
coexistence). At gastric ulcer, in 16% and 4%, respectively. After
treatment, Candida were found in the form of large colonies and
pseudomycelium in 33%.
Conclusion. The elevation of intragastric pH as a result of
antisecretory therapy and the elimination of H. pylori with its
fungicidal component from gastric mucus create optimal
conditions for development of Candida in the stomach and their
passage into an intestine with an early invasive growth.
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Abstract no.: 08.08
Helicobacter pylori Infection and Autoimmune
Diseases: Prevalence of Infection in Patients with
Hashimoto’s Thyroiditis and Alignment of
Thyroid Hormones with H. pylori Proteins
N. Figura,* G. Di Cairano,* A. Santucci,† C. Lenzi,*
C. Gonnelli,* S. Campagna,* B. Franci,* B. Lucani,*
S. Kristodhullu,* R. Nuti* and F. Pacini*
*Department

of Internal Medicine, Endocrino-Metabolic Sciences and
Biochemistry, University of Siena, Siena, Italy, †Dipartimento di Biologia
Molecolare, Università degli Studi di Siena, Siena, Italy
Helicobacter pylori infection may increase the risk of autoimmune
diseases (AD). We determined the prevalence of H. pylori infection
in patients with Hashimoto’s thyroiditis (HT) and the existence of
a cross-mimicry between TH and H. pylori antigens.
Patients and Methods. We defined the H. pylori infectious status
of 76 patients with HT and 66 age- and gender-matched controls
using a commercially available ELISA test. Then we aligned the Nacid sequence of thyroglobulin (TG) and thyroid peroxidase
(TPO) with H. pylori proteins to see whether there is a homology.
Sequences were taken from the site www.ncbi.nlm.nih.gov/
genome/guide/human/; alignments were made against the genomes
of H. pylori strains 26,695 using the blastp program available at the
site www.ncbi.nlm.nih.gov/sutils/genom_table.cgi.
Results. The prevalence of H. pylori infection was 64.4% in patients
and 39.3% in controls ( p = .004, OR = 2.79, 95% CI 1.3–5.8; χ2 test
with Yates’ correction). TG showed an identity of 32% and a
similarity of 58% with a dominion of 26 AA of an iron-regulated outer
membrane protein (frpB) of H. pylori 26,695. TPO showed an
identity of 39% and a similarity of 64% with a dominion of 27 AA of
pyridoxal phosphate biosynthetic protein J (pdxJ) of H. pylori 26,695.
Conclusions. H. pylori infection may raise the risk of AD,
including HT. The possible existence of circumscribed epitope
sequence homology of TH with H. pylori proteins may contribute
to the development of autoantibodies versus TG and TPO, which
are characteristics of such disease.
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556
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Abstract no.: 08.09
Virulent Strains of Helicobacter pylori in Patients
with Stable and Unstable Angina Pectoris
8Abstract
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F. Franceschi,* A. Gasbarrini,* G. Niccoli,† M. Candelli,†
M. Zocco,* M. Conte,† D. Roccarina,* G. Gasbarrini,*
F. Crea† and N. Gentiloni Silveri*
*Internal Medicine and †Institute of Cardiology, Catholic University,
Rome, Italy

Background. Previous studies have shown a potential role of
CagA-positive strains in the destabilization of atherosclerotic
plaques in patients with ischemic heart disease (IHD). In order to
verify this hypothesis, we have designed a study aimed at determining
either the prevalence of CagA-positive strains or the antibody titer
in patients with stable (SA) and unstable angina (UA).
Methods. Thirty-eight (30 males, mean age 64 ± 11 years) patients
with angiographically documented UA, 25 patients with
angiographically documented SA (21 males, mean age 62 ± 10 years),
and 50 healthy volunteers (38 males, mean age 62 ± 10 years) were
enrolled. The prevalence of Helicobacter pylori infection and
CagA-positive strains and the antibody titers were evaluated in all
subjects through ELISA.
Results. Prevalence of H. pylori infection was significantly higher
in patients with SA and UA compared to controls (60% in SA, 61%
in UA, and 38% in controls; p < .04). Prevalence of CagA-positive
strains was significantly higher in patients with SA and UA compared
to controls (44% in SA, 50% in UA, and 18% in controls; p < .001).
Prevalence of CagA-positive strains was higher in patients with
UA compared to those with SA, although was not statistically
significant. Interestingly, the titer of anti-CagA antibodies was
significantly higher in patients with UA compared to those with SA
(161 ± 120 RU/ml versus 78.7 ± 63.1 RU/ml; p < .04).
Conclusions. The anti-CagA antibody titer is significantly higher
in patients with UA compared to those with SA. This finding may
be consistent with antibodies anti-CagA playing a role in the
destabilization of atherosclerotic lesions.
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Abstract no.: 08.10
Does Helicobacter pylori Infection Influence
Simptomatologic Responsiveness to
Esomeprazole in Patients with
Gastroesophageal Reflux Disease?
M. Maino,* S. Bosi,* N. Stefani,* L. Fanigliulo,*
L. G. Cavallaro,* V. Iori,* G. M. Cavestro,* G. Nervi,†
A. Franzè† and F. Di Mario*
*Department

of Clinical Science, Chair of Gastroenterology, Parma,
Italy, †Gastroenterology and Endoscopic Unit, Az. Ospedaliera, Parma,
Italy
Background. Gastroesophageal reflux symptoms incidence can
rise 40% of people reporting symptoms at least monthly. PPI
therapy usually offers a good symptoms control. However, many
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factors can influence a good response to standard therapy. The role
of Helicobacter pylori on gastroesophageal reflux symptoms is still
a matter of debate.
Aim. To evaluate symptomatologic response to PPI-treatment
(esomeprazole) in GERD patients and its relationship to H. pylori.
Materials and Methods. One hundred fifteen consecutive
outpatients (43 males, 72 females; mean age 55 years, range),
referring to our Gastroenterology Unit with GERD symptoms,
underwent upper GI endoscopy with biopsies and were divided
into two groups accordingly to H. pylori status: 80 H. pylori
positive (group A) and 35 H. pylori negative (group B).
Patients were asked about typical GERD symptoms (i.e.,
heartburn and acid regurgitation) that were scored as follows:
0 = no symptoms; 1 = one symptom (heartburn or acid
regurgitation); and 2 = both symptoms (heartburn and acid
regurgitation). All patients started a therapy with esomeprazole
40 mg once daily for 2 months then reduced to 20 mg daily for the
following 2 months. Clinical evaluation and symptoms recording
were performed at baseline and at second and fourth months.
Results. At baseline, there were no differences in the two groups
regarding age, sex, and severity of GERD symptoms. Each group
showed a significative decrease in GERD-symptoms severity after
2 and 4 months with no statistically significant difference in
symptoms relief between the two groups.
Conclusion. H. pylori seems not to influence symptomatologic
response to esomeprazole in patients with GERD.
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Abstract no.: 08.11
Significance of Helicobacter pylori Eradication in
the Treatment of Gastroesophageal Reflux
Disease
M. Ticak, M. Katicic, B. Skurla, M. Prskalo, B. Sabaric,
V. Coli-Cvrlje, T. Filipec-Kanizaj, S. Naumovski-Mihalic
and B. Papa
Clinical Hospital Merkur, Zagreb, Croatia
Aim. To determine the effect of eradication of Helicobacter pylori
infection on subjective symptoms in patients with GERD.
Material and Methods. A total of 110 patients with diagnosed
GERD were included in the study. Of 65 patients with H. pylori
infection, eradication therapy was performed in 35 (the success rate
90%; 7-day therapy with pantoprazole, amoxicillin, clarithromycin)
and 45 patients tested negative for H. pylori. All patients received
pantoprazole for 4 weeks. Severity of subjective symptoms was
evaluated with the Nepean Dypepsia Index at baseline and after
1 month of treatment. Statistical analysis was performed using
analysis of variance.
Results. In all three groups of patients with GERD (H. pyloripositive eradicated, H. pylori-positive non-eradicated, and H. pylorinegative), a statistically significant decrease in dyspeptic symptoms
was reported ( p < .001). No statistically significant differences
were discovered in decrease in dyspeptic symptoms between the
groups ( p > .05).
Conclusions. 1, Eradication of H. pylori infection in patients with
GERD was not found to statistically significantly influence the
decrease of subjective symptoms, the patients with eradicated and
non-eradicated H. pylori infection experience a similar decrease; 2,
H. pylori infection does not have a statistically significant influence
on symptoms decrease in patients with GERD, the patients with
non-eradicated H. pylori infection and H. pylori-negative patients
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have decreased to an aproximately same extent; 3, statistically
significant decrease in symptoms in all three groups of patients is
the result of PPI therapy.
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Abstract no.: 08.12
An Evaluation of Immunological CrossReactivity Between VacA of Helicobacter pylori
and Myelin P0 Protein Using the Cerebrospinal
Fluid from Patients with Guillain–Barre
Syndrome
S. Chiba, K. Yonekura, S. Yokota, S. Tanaka,
T. Okabayashi, H. Huruyama, H. Matsumoto and
N. Fujii
School of Medicine, Sapporo Medical University, Sapporo, Japan
Objective. We have previously reported that antibodies against
recombinant vacuolating cytotoxin (VacA) of Helicobacter pylori
were detected in the cerebrospinal fluid (CSF) from patients with
Guillain–Barre syndrome (GBS). This study was carried out to
evaluate the immunologic cross-reactivity between VacA and
myelin P0 protein.
Materials and Methods. CSF samples positive for antibodies to
VacA were donated from 16 patients with GBS (13 male, 3 female;
mean age, 45.5 years). The recombinant fusion protein consisting
of P0 and GST protein (P0-GST) was harvested from cultured
recombinant Escherichia coli, which were transfected the P0-GST
expression plasmid. P0-GST was obtained as inclusion bodies due
to its hydrophobicity. Crude antigens including P0-GST were
separated by SDS-PAGE. Western blotting analyses were
performed according to the standard protocol; however, 0.05%
SDS had to be added to the transfer buffer due to hydrophobicity
of P0-GST.
Results. No specific IgG antibody against P0 protein was detected
in any of the CSF samples. The present study could not elucidate
the immunologic cross-reactivity between VacA and P0 protein.
Discussion. As regards the pathophysiologic role of CSF
antibodies to VacA in patients with GBS, our previous study
indicated a sequence homology between VacA and P0 protein
together with human (Na+ + K+)-ATPase α subunit, as the possible
target molecules of these antibodies. The present study failed to
find the molecular mimicry of VacA and myelin P0 protein.
Further study, including the evaluation of the molecular homology
between VacA and human (Na+ + K+)-ATPase α subunit, is
necessary because the exact mechanism of GBS remains
unresolved.
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Abstract no.: 08.13
Role of Helicobacter in Etiology and Pathogenesis
of Idiopathic Parkinsonism: Biologic Gradients of
Its Facets, Progression, and Global Severity
Based on Helicobacter pylori Antibody Profile
S. M. Dobbs,* R. Dobbs,* C. Weller,† N. L. Oxlade,†
A. Charlett‡ and I. T. Bjarnason§
*Clinical

Neuropharmacology, Institute of Psychiatry, and Department
of Gastroenterology, King’s College Hospital, London, UK, †Clinical
Neuropharmacology, Institute of Psychiatry, King’s College London,
London, UK, ‡Statistics Department, Health Protection Agency,
London, UK, §Department of Gastroenterology, King’s College
Hospital, London, UK
Background. A double-blind, placebo-controlled RCT of the
effects of Helicobacter pylori eradication on the time-course of
idiopathic parkinsonism (IP) indicates a direct, or surrogate, but
not necessarily unique, pathogenic role (Bjarnason et al.
Helicobacter 2005; in press).
A discriminant index for IP was based on the Western blot pattern
of serum H. pylori antibodies. The predicted probability of having
diagnosed IP was greatest when retaining an anti-CagA band, but
not anti-VacA, with age, and being antiurease B seronegative
irrespective of age. By age 80, this circumstance increases the odds
of IP fivefold (Dobbs et al. Gut 2002; 51 [Suppl 11]:A77). Antiurease ELISA antibody status did not complement the model.
A unifying explanation would be that the immune/inflammatory
pathogenic process continues, albeit more quietly, after Helicobacter
is undetectable by screening methods. Biologic gradients between
index and putative consequences would strengthen the hypothesis.
Methods. Association of index with neurologic disease load
and progression over 4 years was assessed and in 124 subjects with
196 without parkinsonism.
Results. Clinically relevant gradients were found between
index and disease burden, despite any confounding effect of
antiparkinsonian medication. The more archetypal the antibody
profile, the worse was posture, as gauged by forward displacement
of occiput ( p = .04); the shorter mean stride-length (= .003), longer
reaction time (= .002), and lesser cognitive efficiency (= .03), and
the greater their deterioration (= .006, .002 and .03); and the greater
overall disease severity (< .001).
Conclusion. The apparent importance of H. pylori in the
etiology/pathogenesis of IP is not confined to those with overt
evidence of infection.
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Abstract no.: 08.14
Portal Hypertensive Gastropathy: Participation
of Helicobacter pylori in Pathogenic Mechanisms
L. B. Lazebnik,* S. G. Khomeriki* and S. V. Melnikova†
*Central

Research Institute of Gastroenterology, Moscow, Russian
Federation, †Russian State Medical University, Moscow, Russian
Federation

Objective. Portal hypertensive gastropathy (PHG) was recently
discovered in 65% of patients with portal hypertension caused by
liver cirrhosis. Pathogenesis of this lesion is not cleared up, but
Helicobacter pylori could be important factor in its development.
Aim. To investigate morphologic changes in gastric mucosa at
patients with PHG and to establish the role of H. pylori.

Methods. Histologic investigation of gastric biopsies from 35
patients with liver cirrhosis was performed. H. pylori was revealed
in 19 patients. Four groups of the patients were discharged:
1, without PHG; 2, with PHG, but without varicose phlebectasia
of esophagus; 3, with varicose phlebectasia of esophagus-I; and
4, with varicose phlebectasia of esophagus-II. The evaluation of
inflammatory changes in gastric mucosa, colonization with
H. pylori, and gastric vascular ectasia was carried out.
Results. In all groups were submitted both H. pylori-positive and
H. pylori-negative patients. Correlation between antral and corpus
vascular ectasia (r = 0.665, p < .05) was found in all groups. Colonization of gastric mucosa by H. pylori at severe PHG was lower
than at initial stages. The colonization was significantly correlated
with inflammatory changes in II group (r = 0.902, p < .01), but less in I
(r = 0.25, p > .05), III (r = 0.467, p > .05) and IV(r = 0.559, p > .05)
groups. Colonization of corpus mucosa was positively correlated with
gastric vascular ectasia in I group (r = 0.926, p < .01), but statistically
nonsignificant negative correlation was observed at patients with PHG.
Conclusion. H. pylori at early stages of PHG via inflammatory
mechanisms promotes faster development of gastric atrophy.
Atrophic gastritis at severe PHG reduces colonization of gastric
mucosa by H. pylori.

Abstract no.: 08.15
The State of Gastroesophageal Mucosa and
Helicobacter pylori Infection in Chronic Renal
Insufficiency Patients After Kidney
Transplantation
Abstracts
8Abstract

E. Yakovenko, V. Anashkin, A. Ivanov, A. Yakovenko,
N. Agafonova and A. Prianishnikova
Russian State Medical University, Moscow, Russian Federation
Introduction. The states of gastroesophageal mucosa and prevalence
of Helicobacter pylori infection in chronic renal insufficiency
(CRI) patients after kidney transplantation are not well known.
Aims. To evaluate state of gastroesophageal mucosa, prevalence
and diagnostic methods for H. pylori infection in CRI patients after
kidney transplantation.
Materials and Methods. Thirty CRI patients after kidney
transplantation (26 male and 4 female, median age 32.4 years) were
included in clinical research, endoscoped, and tested for H. pylori.
The presence and severity of gastritis were graded according to a
modified updated Sydney classification. The grade of reflux
esophagitis (RE) was assessed according to Los Angeles classification, H. pylori status – by serology, histology, and CLO test.
Results. The presence of H. pylori infection defined serologically in
9 (30%), histologically in 26 (86.7%), and by CLO test in 25 (83.3%)
of the 30 researched patients. Of 25 H. pylori-positive patients, 21
(84%) had gastroesophageal reflux disease (GERD): non-erosive
GERD in 9 (36%), RE grade A in 8 (32%), and RE grade B in 3 (12%)
patients. Antrum and /or corpus gastritis revealed in 18 (72%)
H. pylori-positive patients. Gastric erosions and ulcers occurred in
10 (40%) and 1 (4%) H. pylori-positive patients, respectively.
Conclusions. The prevalence H. pylori infection was high in CRI
patients after kidney transplantation. The most reliable tests for
H. pylori infection in researched patients were the CLO test and
gastric histology. Whereas gastroesophageal lesions were defined
frequently in H. pylori-positive patients after kidney transplantation,
their severity was not high.
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Abstract no.: 09.01
Polymorphisms of TLR-4/TLR-2 and Risk of
Helicobacter pylori Infection and Duodenal Ulcer
Disease in Children
S. B. Moura, G. A. Rocha, A. M. C. Rocha, J. B. Guerra,
T. F. Soares, P. Bittencourt, L. M. G. Godoi,
L. R. Almeida and D. M. M. Queiroz
Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
Although host factors linked to the outcome of Helicobacter pylori
infection have been studied, no study has evaluated yet the role of
single nucleotide polymorphisms (SNP) in genes that encode
mediators of the innate immune response such as Toll-like receptor
(TLR)-4 and TLR-2 in the risk of H. pylori infection and H. pyloriassociated diseases in children. The SNPs of genes encoding TLR2 and TLR-4 are thought to impair the efficiency of bacterial ligant
signaling and the capacity to elicit the host’s defense against microorganisms. Considering that the infection is mainly acquired in
childhood, we evaluated 432 children (193 boys, mean age 9.4 ± 3.8 years,
range 1–18). Among them, 207 were H. pylori-positive (Hp+) (72 with
DU). cagA status was investigated by polymerase chain reaction
(PCR). TLR-4 (Asp299Gly) and TLR-2 (Arg753Gln, Arg677Trp)
polymorphisms were investigated by PCR–RFLP and confirmed
by sequencing. The allele Arg677Trp was not seen in this population.
The other alleles were in Hardy–Weinberg equilibrium. No
association was seen between the polymorphic alleles and DU
( p = .71, OR = 0.78, 95% CI = 0.33–1.94 for TLR-4 and p = .32,
OR = 1.68, 95% CI = 0.45 –5.65 for TLR-2). In addition, these
polymorphisms did not associate with H. pylori status ( p = .34,
OR = 0.63, 95% CI = 0.26–1.49 for TLR-4 and p = .69, OR = 0.75,
95% CI = 0.27–2.02 for TLR-2). However, the polymorphic G
allele of TLR-4 was significantly associated with infection
with cagA+ strains ( p = .02, OR = 9.08, 95% CI = 1.21–18.8).
Our results show that SNPs in TLR-2 and TLR-4 were neither
associated with the susceptibility to H. pylori infection nor
with the outcome of the infection in childhood. However, TLR-4
SNP was associated with susceptibility to more virulent H. pylori
strains.
Financial Support. CNPq/FAPEMIG.
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Abstract no.: 09.02
Lewis Expression in Helicobacter pylori Infection:
A Comparative Study Between Children and
Adults
T. Marques, C. T. Cartelle, D. M. M. Queiroz,
G. A. Rocha, A. M. C. Rocha and A. M. M. F. Nogueira
Federal University of Minas Gerais/F. of Medicine, Belo Horizonte, MG,
Brazil
Background. Lewis antigens (Le) act as Helicobacter pylori
adhesin receptors. Differences in LeA and LeB expression between
children and adults have been observed.
Aims. To compare Le expression in the gastric mucosa of children
and adults, with and without H. pylori infection.

Patients and Methods. Gastric immunoexpression (sABC) for
Lewis A (LeA), LeB, X (LeX), and Y (LeY) was studied in children
(n = 70, range 1–18 years; 46 H. pylori-positive (Hp+), 17 DU) and
adults (n = 46, range 23–81 years; 36 Hp+, 20 DU). H. pylori was
detected by urease, histology, and culture. Le expression was scored
as: negative, 5%, 5–25%, 25–50%, 50–75%, and > 75% of stained
epithelium.
Results. LeA was expressed in 45/70 children and in 28/46 adults
( p = .9). LeB expression was more frequent in adults (42/46; 91%)
than in children (31/70; 44%) ( p = .003), regardless of H. pylori
infection. Among children, LeB expression was higher in H. pylori
gastritis than in DU ( p = .04); in adults LeB expression was higher
in DU than in H. pylori gastritis ( p = .04). LeX foveolar expression
(LeXf ) was more frequent in Hp+ children (43%) than in adults
(17%) ( p = .02); LeXf expression was associated with DU in
Hp+ children ( p = .04), but not in adults ( p = .2). LeY foveolar
expression (LeYf ) was higher in adults with DU than those with
H. pylori gastritis ( p = .01); in children, no difference was found in
LeYf expression between these groups ( p = .8).
Conclusions. Le expression is different in the gastric mucosa of
children and adults. Comparative studies addressing Le expression
in these groups can contribute to understand the acquisition and
pathogenesis of H. pylori infection.
Financial Support. CNPq, Fapemig.
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Abstract no.: 09.03*
Gastric Epithelial Proliferation in
Helicobacter pylori-Infected Children
C. T. Cartelle, D. M. M. Queiroz, G. A. Rocha,
A. M. C. Rocha and A. M. M. F. Nogueira
Federal University of Minas Gerais/F. of Medicine, Belo Horizonte, MG,
Brazil
Background. Epithelial proliferation stimulated by Helicobacter
pylori may have a role on gastric carcinogenesis. Most studies on
gastric epithelial proliferation have been performed in adults.
Aims. To analyze gastric epithelial proliferation in children
infected by cagA+ strains.
Materials and Methods. We studied 54 children: 28 boys, 26 girls,
age 10 ± 3.7 years, 45 H. pylori-positive (Hp+) (34 cagA+), 15 with
duodenal ulcer (DU), and 30 with H. pylori gastritis. H. pylori and
cagA status were determined by polymerase chain reaction (PCR).
Epithelial proliferation was studied by immunohistochemistry
(sABC) by counting Ki67+ nuclei in the antral neck zone; the
percentage of Ki67+ nuclei was determined by case and by neck
zone in each diagnostic group and related to H. pylori infection and
cagA status.
Results. The percentage of Ki67+ nuclei was higher in Hp+ (40%)
than in H. pylori-negative (Hp–) (14.3%) patients ( p = 10−3), in DU
(41.7%) compared to Hp+ gastritis (40%; p = .075), and in cagA+
(42.1%) compared to cagA– patients (30.8%) (p = 10−3); among
H. pylori gastritis, epithelial proliferation was significantly higher
in cagA+ (42.9% Ki67+ nuclei) compared to cagA– patients (30.8%
Ki67+ nuclei) ( p = 10−3); among cagA+ patients, no difference was
observed in the percentage of Ki67+ nuclei in DU (41.7%) compared
to gastritis patients (42.9%) ( p = .45). However, the number of Ki67+
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556
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nuclei/neck zone was significantly higher in DU than in gastritis
( p = .001).
Conclusion. In children, infection by cagA-positive strains is
significantly associated with high epithelial proliferation. Differently
from adults, higher proliferative activity was observed in DU
compared to patients with non-ulcer gastritis.
Financial Support. CNPq, Capes, Fapemig.

Abstract no.: 09.04
Validation of Non-invasive Tests for
Helicobacter pylori Infection in Very Young
Children
Abstracts
8Abstract

G. Oderda, A. Rapa, E. Dondi, N. Castellino,
S. Zanetta and R. Boldorini
Clinica Pediatrica, Università del Piemonte Orientale, Novara, Italy
Non-invasive tests in very young children are particularly useful
for epidemiologic studies on risk factors and transmission of
Helicobacter pylori. Two multicenter studies (Megraud, Pediatrics
2005, Oderda, Gut 2001) showed low accuracy of both 13C-urea
breath test (UBT) and H. pylori stool antigen (HpSA) possibly for
inadequate specimen storage.
Aim. To evaluate accuracy of 13C-UBT and HpSA in children
< 6 years by performing the tests locally.
Patients and Methods. In 7 years, we enrolled 169 consecutive
young children (median 2.2 years, range 0.2–5.9) undergoing
endoscopy with gastric biopsy for histology (Giemsa) and urease
test (RUT). Children underwent 13C-UBT (100 ml orange juice
plus 50 mg 13C-Urea) breath analyzed at baseline and after 30
minutes. Same-day stools were collected, stored at −20 °C and
locally analyzed within a few days. Cutoff for 13C-UBT was 5‰,
for HpSA 0.160 OD. Children with two or more positive tests
were considered H. pylori-positive, with all tests negative taken as
H. pylori-negative.
Results. Thirty children were H. pylori-positive (17.5%), 124
were H. pylori-negative, 15 equivocal (only one test positive was
considered false positive). Sensitivity and specificity of histology
were 100% and 96%, of RUT 96% and 100%, of HpSA 100% and
98%, of UBT 93% and 94%. Twenty-two percent of positive UBT
were false positive.
Conclusion. Accuracy of non-invasive tests (13C-UBT and HpSA)
in very young children is quite satisfactory, provided samples are
locally analyzed, because storage and transportation may impair
results.

Abstract no.: 09.05
The Prevalence of Helicobacter pylori Infection in
Childhood, Demographic, and Socioeconomic
Factors: Results of a Population-Based Study by
Monoclonal Stool Antigen Test from the Czech
Republic
J. Sxkora,* P. Pazdiora,† J. Varvaøovská,*
K. K. Siala,* J. Schwarz,* F. StoΩickx,*
R. Pomahaèová* and K. Valeèková‡
*Charles

University Hospital Department of Paediatrics Divison of
Gastroenterology, Pilsen, Czech Republic, †Charles University
Hospital Department of Epidemiology, Pilsen, Czech Republic,
‡Charles University Hospital Department of Serology, Pilsen, Czech
Republic
Background. Prevalence of Helicobacter pylori varies between
developing and developed countries. Some evidence indicates
a more precipitous decline in H. pylori transmission in children
than in adults in industrialized nations. A better understanding of
the epidemiology of any particular region’s population is crucial.
H. pylori prevalence in asymptomatic children in the Czech Republic
currently remains inconclusive.
Design. A prospective cross-sectional epidemiologic survey
related to H. pylori infection in asymptomatic children aged 1–
15 years over a 2-year period (2003–2005) in a large population-based
sample.
Methods. H. pylori status was evaluated using non-invasive
monoclonal stool antigen test (HpSTAR DAKO Cytomation).
A structured questionnaire was completed and three-step statistical
analysis undertaken (pc alienware).
Results. Overall, 1600 of 1737 eligible healthy, mostly Czech
subjects, were randomly selected through stratified sampling
(response rate 92.1%). A total 0.3% of infection acquisition occurred
before 4 years of age. Overall, H. pylori prevalence was 6.1%
(98/1600), increasing significantly with age ( p < .001). Risk factors
included socioeconomic variables, overcrowding, and mother’s
education. Non-risk factors included sex, day-care center attendance
before 6 years of age, breastfeeding, antimicrobial agents, geographic
differences, Z scores for weight-for-age, weight-for-height, heightfor-age, dietary habits, water, pets, and any gastric complaints of
family members.
Conclusions. Taking cohort effect into account, current
prevalence of H. pylori from birth to 15 years of age appears to be
changing. The low infection prevalence (6.1%) reflects data from
other European countries demonstrating a decreasing trend in
H. pylori. However, socioeconomically disadvantaged children are
still at risk of this preventable infection.
Acknowledgement. Funded by the Ministry of Health Research
vote NI 7399–3/2003.
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Abstract no.: 09.06
Serum Ferritin, Hemoglobin, Soluble Transferrin
Receptor, and Helicobacter pylori Infection in
Peri-Urban Community Children in Bangladesh
S. A. Sarker,* S. Sultana,* S. Sattar,* L. Davidsson,†
T. Ahmed,* G. Fuchs,‡ C. Beglinger§ and N. Gyr§
*ICDDR, B: Centre for Health & Population Research, Dhaka,
Bangladesh, †International Atomic Energy Association,Vienna, Austria,
‡Arkansas State University, Little Rock, AR, USA, §University of Basel,
Basel, Switzerland

Background. Both iron-deficiency anemia (IDA) and Helicobacter
pylori infection are common in developing countries. Few studies
suggested a link between H. pylori infection and IDA in adults.
Objective. To investigate the association between H. pylori
infection and iron status in asymptomatic children of a peri-urban
community.
Methods. H. pylori infection was determined in 1086 children
aged 2–5 years by 13C-urea breath tests (UBT). The Hb level were
quantified by cyanmethemoglobin method; serum ferritin (SF)
and soluble transferrin receptor (sTfR) were asessed by ELISA
(Ramco, Houston, TX). Informed consents were obtained from
parents or legal guardian.
Results. Of the 1036 children, 74% were infected with H. pylori.
Compared to the children non-infected, SF and hemoglobn (Hb)
levels were significantly lower in H. pylori-infected children (mean
± SD, 10.6 ± 1.5 versus 10.3 ± 1.2%, p = .01 for Hb; 23.1 ± 20.2
versus 19.1 ± 16.1, µg/l for SF, p = .003). There was, however, no
difference in sTfR between infected and non-infected children
(mg/l; 8.8 ± 4.4 versus 8.6 ± 4.8, respectively, p = .28). The prevalence
of iron deficiency (ID) (SF < 30 µg/ l) and IDA (Hb < 11% plus
SF < 30 µg/ l or STfR > 8.5 mg/l) in H. pylori-infected children was
significantly higher than in noninfected children (52% versus
61%, p = .007, OR 1.45, 95% CI 1.90–1.93). The difference in
prevalence also existed when ID was defined by SF < 30 µg/l or
sTfR > 8.5 mg/ l.
Conclusion. A significantly lower serum ferritin and Hb levels
and higher prevalence of ID and IDA, indicate an association
between H. pylori infection and ID or IDA in this community.
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Abstract no.: 09.07
Comparison of Two Nitrofuran-Based SecondLine Quadruple Therapies in Childhood: Benefit
of Helicobacter pylori Eradication After Failure of
Initial Treatment
A. A. Nijevitch,* R. S. Khasanov* and M. M. Tuygunov†
*Children’s

Republican Hospital, Ufa-57, Russian Federation, †Research
Institute of Vaccine and Serum (Microgen), Ufa, Russian Federation

Background. Metronidazole-based triple therapy is the standard
first-line anti-Helicobacter pylori treatment regimen. Unfortunately,
the number of pediatric patients with treatment failure is increasing.
Aim. The aim of this study was to evaluate the efficacy of nifuratel
compared to furazolidone in non-metronidazole containing secondline combinations consisting of amoxycillin, bismuth subcitrate,
and omeprazole for H. pylori eradication in children with failure of
initial treatment.
Materials and Methods. Seventy-six H. pylori-positive pediatric
outpatients (male 40; mean age 13.7 ± 1.4 years; age range 12–
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16 years), suffering from chronic abdominal complaints, were
enrolled in this study. All had failed one initial attempt of
eradication of H. pylori metronidazole-based 1- to 2-week triple
therapy as defined by a positive histology.
Patients were randomized to receive a 2-week course of
omeprazole (0.5 mg/kg/once daily), bismuth subcitrate (8 mg/kg/
day/q.i.d.), amoxicillin (50 mg/kg/day/q.i.d.), with either nifuratel
(15 mg/kg/day/q.i.d.) (group A) or furazolidone (10 mg/kg/day/
q.i.d.) (group B). Intention-to-treat eradication rates were 89.2%
and 87.2% (CI 95%) and per protocol eradication rates were 89.2%
and 91.9% in groups A and B, respectively. The compliance was
excellent in the majority of the patients. Frequency of severe side
effects was higher with furazolidone (20.5%) than with nifuratel
(2.7%) ( p = .0289).
Conclusions. In the pediatric patients, who failed first-line
eradicating treatment, nitrofuran-based quadruple therapies
containing either nifuratel or furazolidone, PPI, amoxycillin, and
bismuth salt are successful second-line therapeutic approach for
H. pylori eradication. Nifuratel is preferred because of the lower
frequency of side effects.
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Abstract no.: 09.08
Paediatric Helicobacter pylori Infection:
Presentation and Outcome Over Two Decades in
a Single Center
M. Vitug-Sales,* H. M. Mitchell,† T. Bohane,‡ V. Tobias§
and A. Day‡
*Department

of Paediatric Gastroenterology, Sydney Children’s
Hospital, Sydney, NSW, Australia, †School of Biotechnology and
Biomolecular Sciences, University of NSW, Sydney, NSW, Australia,
‡School of Women’s and Children’s Health, University of NSW, Sydney,
NSW, Australia, §Department of Pathology, Sydney Children’s
Hospital, Sydney, NSW, Australia
Introduction. Although Helicobacter pylori remains a significant
health issue worldwide, in many developed countries rates of
infection are decreasing. This retrospective review aimed to
describe the experience of H. pylori disease in an Australian tertiary
pediatric center for over almost two decades.
Methods. Pathology and hospital records were used to identify all
children diagnosed with H. pylori infection at the Sydney
Children’s Hospital during the period 1987–2005. The details of
presenting symptoms, family history, endoscopic and histologic
findings, management, and outcomes were ascertained. Changes in
these variables over time were noted.
Results. Of 122 cases of H. pylori infection identified, the
pathology records and medical files from 94 patients (aged between
18 months and 19 years) were available for review. The annual
frequency of diagnosis fell over time, especially within the last
9 years. More than half of the group originated outside Australia.
The most common presenting symptom was epigastric pain (62%).
Family history of H. pylori or associated disease was present in
35%. Ulceration was noted in 20% of cases and just one quarter of
these presented with acute bleeding. Varied treatment options were
used and eradication was successful in 77% of children. Twenty-six
children had no symptom improvement despite successful
eradication.
Conclusion. The frequency of H. pylori infection at this tertiary
pediatric center has decreased substantially over the last 18 years.
Presentation patterns did not reflect infection-associated disease
or response to treatment. Although of reduced frequency in
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556
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Australian children, this gastric pathogen remains of particular
concern in immigrant populations.

Abstract no.: 09.09
Serum Pepsinogens in the Diagnosis of Acute
Helicobacter pylori Infection
8Abstract
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Z. Z. Nurgalieva,* A. R. Opekun,* M. C. Conner* and
D. Y. Graham*†
*Baylor

College of Medicine, Houston, TX, USA, †Michael E. DeBakey
VAMC, Houston, TX, USA

Background. Detection of acute Helicobacter pylori infection
remains problematic. The non-invasive definition includes a
positive UBT or stool antigen test and negative serology. However,
the possibility of false-positive tests is high and confirmation with
a second test would allow a definite diagnosis.
Aim. To determine whether serum PG levels can be used to
confirm acute H. pylori infection.
Methods. We tested serum collected from 18 volunteers who
became infected after oral H. pylori challenge. PGI and PGII were
measured by ELISA (Biohit, Helsinki, Finland). The cut-off values
to define PG-positive samples were defined as the mean + 2SD of
the baseline values: PG1 = 144 mg / l and 26 mg / l for PG2.
Results. At 1 week postinoculation, only 3 (17%) of H. pyloriinfected individuals had elevated PG1 levels; 28% had elevated
PG2 levels and 33% had either PG1 or PG2 elevations. Serum
samples were available for 14 subjects at 2 weeks, and 12 subjects
(86%) were PGI positive; 5 (35%) were PG2 positive. All PG2
positive were also PG1 positive. By 4 weeks, 17 of 18 (95%) were
PG1 positive.
Conclusions. Because of the relatively low posttest probability of
a single positive test (e.g., UBT or stool antigen) a confirmatory test
is needed to diagnose acute H. pylori infection. A positive PG1 or
PG2 would confirm the UBT or stool antigen results. Repeat
testing 2–4 weeks after onset of symptoms would increase the
likelihood of confirmation of which a recent H. pylori infection
was responsible for the symptoms.
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Abstract no.: 09.10
Antral Nodularity, Severe Gastritis, and Positive
Cytotoxin-Associated Protein (CagA) Serology
in Children Infected with Helicobacter pylori
T. Sabbi and M. Palumbo
Belcolle Hospital Viterbo, Rome, Italy
Helicobacter pylori infection is associated with gastritis and peptic
ulcer in children and adults. The endoscopic pattern of antral
nodularity is a peculiar finding in children.
To determine whether the antral nodularity and positive CagA
serology are associated to severe gastritis in children.
Twenty-five patients (15 male; age range 3–18 years; mean age
9 years) underwent esophagogastroduodenoscopy with antral
biopsy (histologic examination and urease rapid test) for a
suspicious upper gastrointestinal disease. In all of them, serum
sample were assayed for IgG antibodies to CagA.
Results show that nineteen children (76%) were H. pyloripositive by histopathology and urease rapid test. 15 of these 19
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556

(79%) H. pylori-positive patients were positive for CagA serology,
too. At endoscopic examination of the 19 infected children,
hyperemia and friability of the gastric antrum was observed in
seven (37%) patients and antral nodularity appearance in 12 (63%)
children. The histologic examination of all infected patients
showed an active microerosive gastritis and chronic gastritis
(lymphoplasmacytic infiltration). The CagA-positive children
presented an endoscopic finding of more intense hyperemia of
gastric antrum, associated to an important lymphoplasmacellular
infiltrate and degenerative and vacuolar lesions of gastric
epithelium. The six (24%) non-infected patients, also negative for
CagA serology, had a normal gastric finding but they presented
cardial hyperemia and distal esophageal erosions. In non-infected
children, there were no histologic signs of gastric inflammation.
Endoscopic finding of antral nodularity and positive CagA
serology in children suggest the presence of H. pylori infection and
are important markers of severe gastritis.

Abstract no.: 09.11
Helicobacter pylori and Recurrent Abdominal
Pain in Children
Abstracts
8Abstract

C. García-Rodríguez, C. García-Cendón,
P. Pernas-Gómez, Y. Pérez-Saldeño and
F. Martinón-Sánchez
SERGAS, Ourense, Spain
Introduction. Helicobacter pylori infection causes lesions in the
esophagus, stomach, and duodenum that produce recurrent
abdominal pain.
Material and Methods. We have studied 48 children that visited
our paediatric gastroenterology unit. Every child fulfiled Apley’s
criteria for recurrent abdominal pain. The children and their
parents were studied following a protocol and were required to
answer a questionnaire.
Results. Out of the 48 studied patients, 19 were boys (39.6%) and
29 were girls (60.4%). They were from 4 to 14 years old. Thirtyfour children underwent a 13C-urea breath test (70.8% out of the
total); it was negative in 24 children (70.6%), positive in 10 children
(29.4%), these 10 children were treated with omeprazole,
amoxycilin, and clarithromycin for 14 days. All this was shown
that they suffered from chronic gastritis and a positive culture of
gastric mucosa. Eighty percent of the children with H. pylori
infection progressed favorably from the disease.
Conclusions. The recurrent abdominal pain occurs in children
older than 4 years old, being more frequent in the group between 7
and 14 years old. We consider that 13C-urea breath test is a noninvasive method and useful in determining the etiology of the
recurrent abdominal pain and should take part of the initial
diagnosis. The upper endoscopy, when indicated, is fundamental
for the diagnosis. In this study, we confirm that there is a
relationship between H. pylori infection and gastritis. The
eradication of H. pylori reduces the symptoms of dyspepsia in
infants. This strategy turns out to be economical.
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Abstract no.: 10.01*
Candidate Biomarkers of Helicobacter pylori for
Discrimination of Clinical Isolates Associated
with Duodenal Ulcer or Gastric Cancer
G. Khoder,* J. D’Alayer,† A. Truong,‡ B. Janvier,*
A. Burette,§ C. Burucoa,* J. Fauchère* and
C. Atanassov*
*EA

3807, Poitiers, France, †Institut Pasteur, Paris, France,
Biosystems, Paris, France, §CHIREC/Sites de la Basilique &
E. Cavell, Bruxelles, Belgium
‡Ciphergen

Helicobacter pylori infection is closely associated with the
development of severe pathologies such as gastroduodenal ulcers
and gastric cancer. With regard to cancer, the predictive value of
most studied H. pylori virulent genotypes (e.g., cagA, vacA s1m1,
babA2) remains limited, which is mainly due to their wide
distribution among strains. In the search of other H. pylori markers
predictive for the evolution to gastric cancer, we compared the
protein profiles of H. pylori strains associated with either duodenal
ulcer (n = 12) or gastric cancer (n = 12). To that purpose, protein
extracts of the strains were analyzed by SELDI-TOF-MS through
using two types of ProteinChip array, CM10 and Q10. In this way,
13 statistically significant potential biomarkers ( p < .001) were
selected, which all have a mass/charge ratio below 20,000. Our
results imply that discrimination between strains associated with
different clinical outcome is therefore possible using protein profile
biomarkers. Structural identification of the most relevant
biomarkers is under way.

Abstract no.: 10.02*
Development of a Helicobacter Genus DNA
Probe for Fluorescent In Situ Hybridization in
Gastrointestinal Clinical Samples
8Abstract
Abstracts

I. A. M. Cooper,* G. L. Hold,* Z. Shen,† J. G. Fox† and
E. M. El-Omar*
*GI research group, Department of Medicine & Therapeutics,
University of Aberdeen, Aberdeen, UK, †Division of Comparative
Medicine, Massachusetts Institute of Technology, Cambridge, MA, USA

Background. Fluorescence in situ hybridization (FISH) can be
used for the rapid detection of bacteria, determining their location,
spatial distribution, and enumeration within a complex community,
such as the human gastrointestinal (GI) tract.
Aims. To develop a Helicobacter genus (FISH) probe to
investigate Helicobacter prevalence in clinical GI samples. To assess
published Helicobacter pylori probes for specificity and suitability
for use in a subtractive assay with the Helicobacter genus probe.
Materials and Methods. Published 16S rRNA sequences were
collected for Helicobacter species and FISH probes designed using
primrose computer software. Helicobacter genus probes were
selected, tested, and optimized against a panel of reference strains
(9 Helicobacter and 44 non-Helicobacter species) for specificity.
Four published H. pylori probes were also tested. Once optimized,
the FISH protocol was used to assess Helicobacter prevalence in a
variety of GI samples including gastric biopsies and fecal samples.

Results. One out of five Helicobacter genus probes was specific
for Helicobacter. Only one of the four published H. pylori probes
was found to be specific for H. pylori. Both probes gave a positive
signal with Campybacter-like organism (CLO)-positive biopsies
but not CLO-negative biopsies. Assessment of 100 infectious
diarrhea samples showed that non-pylori Helicobacter species were
not present, with H. pylori detected in one sample.
Conclusions. We have developed a FISH assay for the assessment
of Helicobacter species that has been successfully applied to a
variety of GI samples. We will continue to investigate patient
material where Helicobacter are implicated as etiological agents of
disease.
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Abstract no.: 10.03
Development of Highly Sensitive Method for
Detection of Clarithromycin-Resistant
Helicobacter pylori from Human Feces
E. Rimbara,* N. Noguchi,* T. Kawai† and M. Sasatsu†
*Department

of Microbiology, School of Pharmacy, Tokyo University
of Pharmacy and Life Science, Tokyo, Japan, †Endoscopy Center, Tokyo
Medical University Hospital, Tokyo, Japan
Backgrounds. Gastric infection of clarithromycin (CAM)-resistant
Helicobacter pylori is one of the major causes of failure to eradicate
this organism. A non-invasive and useful method for the detection
of CAM-resistant H. pylori from human feces was developed in
this study.
Methods. Feces taken from 33 patients were used in this study.
H. pylori DNA was extracted from feces by physical crushing using
the Fast-Prep System. The 23S rRNA gene of H. pylori containing
mutations that confer CAM resistance was amplified by nested
polymerase chain reaction (PCR). The mutations in the 23S rRNA
gene were detected by restriction fragment length polymorphism
(RFLP) method. H. pylori infection was tested by an enzymelinked immunosorbent assay of H. pylori in feces (HpSA ELISA)
from all patients and gastric biopsy specimens were taken for
H. pylori cultures from 18 patients.
Results. The 23S rRNA gene of H. pylori was amplified from feces
in 25 patients in whom both HpSA ELISA and culture results were
positive. Furthermore, the 23S rRNA gene of H. pylori was
detected in four patients in whom either HpSA ELISA (n = 1) or
culture (n = 3) results were negative. H. pylori DNA was not
detected by nested PCR in feces from patients who were H. pylorinegative in both HpSA ELISA and culture.The results of mutation
analysis of the H. pylori 23S rRNA gene amplified from feces
completely correlated with the susceptibilities of H. pylori isolates
to CAM. This nested-PCR/RFLP method can detect CAMresistant H. pylori within 8.5 hours.
Conclusion. This nested-PCR/RFLP method is useful for the
accurate diagnosis of CAM-resistant H. pylori infection from feces.
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Abstract no.: 10.04
Western Blotting for the Diagnosis of
Helicobacer pylori Infection in Patients with
Atrophic Body Gastritis
N. Figura,* A. Santucci,† E. Lahner,‡ R. Mini,†
G. Bernardini,† D. Vaira§ and B. Annibale‡
*DPT

of of Internal Medicine, University of Siena, Policlinico Santa
Maria alle Scotte, viale Bracci, Siena, Italy, †Dipartimento di Biologia
Molecolare, Università degli Studi di Siena, Siena, Italy, ‡Digestive and
Liver Disease Unit, University La Sapienza, Ospedale Sant’Andrea,
Rome, Italy, §Department of Internal Medicine and Gastroenterology,
University of Bologna, Bologna, Italy
Background. Helicobacter pylori may disappear from the stomach
of patients with atrophic body gastritis (ABG), decreasing the
reliability of histology and standard ELISA to diagnose an infection.
Patients and Methods. We examined by Western blotting (WB)
143 serum samples from patients with ABG: 31 with histology and
serology negative for H. pylori (H–/S–), 80 with H–/S+ and 32 with
H+/S+. CagA+, s1/m1, VacA subtype H. pylori strains 10K and 4Cb
were used as antigens, polyclonal rabbit sera anti-CagA, -58 kDa
VacA subunit, -UreB, -UreA, and -HspB as positive control and
sera from subjects with histology, serology, and culture negative for
H. pylori as negative control. Patients whose sera reacted with
CagA and/or VacA, and/or two or more other H. pylori antigens
were considered infected.
Results. One hundred thirty-eight serum samples (96.5%) were
positive for H. pylori infection independently of the antigen used.
One sample in the group H–/S– and four in the group H–/S+ were
negative at WB. VacA was the most frequently reacting antigen
(87.1% and 96.7% with strains 10K and 4Cb, respectively); CagA
reacted with c. 90% of sera. The mean number of antigens
recognized by the three groups of sera was similar with the two
strains and ranged from 3.0 ± 0.8 to 3.4 ± 0.9 (NS).
Conclusions. Western blotting may be superior to other
techniques to diagnose H. pylori infections in patients with ABG.
Utilization of two strains as an antigen may increase the sensitivity
of serologic tests.
Acknowledgements. Partly funded by the Siena University grant
“Helicobacter pylori infection, host’s aplotypes of inflammatory
cytokines and risk of ischemic heart disease.”
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Abstract no.: 10.05
Development of a Novel Real-Time Polymerase
Chain Reaction Assay for the Detection of
Helicobacter pylori in Wastewater Samples
P. Piqueres, Y. Moreno, J. L. Alonso, S. Botella,
J. Hernández and M. A. Ferrús
Universidad Politécnica de Valencia, Valencia, Spain
Introduction. Helicobacter pylori is the causative agent of gastritis
and duodenal ulcer and has been related to gastric cancer. The
transmission of H. pylori remains unclear but fecal–oral pathway has
been suggested. Epidemiologic studies suggest that environmental
factors are important. It has been hypothesized that water supplies
contaminated by sewage are potential routes of H. pylori transmission.
Objectives. We have developed a real-time polymerase chain
reaction (PCR) assay to detect H. pylori in environmental samples
and compared its effectiveness with traditional PCR method.
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556

Methods. Thirty wastewater samples were collected from several
secondary wastewater treatment plants located in Valencia, Spain,
and analyzed directly and after enrichment in nutrient broth
with dent-selective supplement. Samples were incubated under
microaerophilic conditions at 37 °C for 48 hours and submitted to
both real-time PCR and traditional PCR assay. Two specific
primers that amplify a 382-bp fragment from H. pylori 16S gene
were used.
Results. Without enrichment, we were not able to detect H. pylori
neither by traditional PCR nor by real-time PCR in any sample.
After enrichment, traditional PCR was not able to detect H. pylori
in any sample. However, H. pylori was detected in three
wastewater samples using real-time PCR assay.
Conclusions. We have developed an accurate, specific, and sensitive
method, capable of detecting H. pylori cells when traditional PCR
is not capable. Results demonstrate the presence of H. pylori in
wastewater samples and that real-time PCR is an excellent tool to
detect this bacteria in poorly contaminated environments.

Abstract no.: 10.06
Significantly Increased Helicobacter pylori
Concentration in Erosions, Ulcers as Compared
to Normal Antrum and Corpus, Determined by
UreaseA (ureA) Real-Time or Quantitative PCR
Abstracts
8Abstract

B. Molnár, Á. Ruzsovics, D. Szõke, B. Tóth and
Z. Tulassay
Second Department of Medicine, Semmelweis University, Budapest,
Hungary
Background and Aim. Rapid DNA-based quantitative and
qualitative assays for Helicobacter pylori determinations in gastric
or duodenal mucosa are missing. Our aim was to develop such
assays using real-time polymerase chain reaction (PCR).
Methods. Real-time PCR procedures were developed for
quantitative detection of H. pylori ureA generally by fluorescence
resonance energy transfer (FRET) and for cagA, vacA genotypes of
H. pylori by using SYBR Green I dye (SG). Calibration curve of
the H. pylori ureA was determined with serial dilutions of H. pylori
DNA (from 16 to 0.016 mg/µl). We compared the data with different
diagnostic methods: histology, 13C-urea breath test (UBT), and
Western blot in 45 patients. The bacterial density was determined
in the erosion, antrum, and corpus biopsies from 20 patients.
Results. All DNA preparations from H. pylori-infected patients
were amplified and detected, whereas none of the non-infected
patients’ DNA were found. Quantitative PCR detection of ureA
had the greatest sensitivity (98%) and specificity (100%). PCRdetected genotypes of H. pylori correlated with results of serology.
Results obtained with UBT (94% sensitivity, 90% specificity) were
equivalent to detection of H. pylori genes by Western blot (95%
sensitivity, 93% specificity). In erosions, the bacterial amount as
determined by the ureaseA concentration was 2835 + 536 bacteria
as compared to the 785 + 323 in the control antrum biopsies and
221 + 76 in the corpus.
Conclusion. Results of this work indicate that real-time PCR
FRET method of ureA is the most reliable for qualitative–
quantitative detection of H. pylori in gastric biopsy specimens. The
erosions show significantly increased H. pylori density.
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Abstract no.: 10.07
Immunoblot for Detection of Helicobacter
Infections in Laboratory Mice
I. Nilsson, W. Abu-Al-Soud, B. Barup and T. Wadström
Laboratory Medicine, Division Medical Microbiology, Lund University,
Lund, Sweden
Mouse models for various human diseases are widely used in
biomedical research. This is a first systematic attempt to develop
a specific serology to analyze the immune response in naturally
colonized and infected mouse colonies.
Aim. To evaluate the antibody responses to antigens of
Helicobacter bilis, Helicobacter hepaticus, and Helicobacter ganmani
in mice sera obtained from six animal houses.
Material and Methods. Sera from 106 mice (BalbC, C57BL/6,
C3H, IL-10-deficient, ICOS–/–, CD8–/–, IgA–/–xIL, IL-18–/–,
SPF) were analyzed by immunoblot (IB) using the cell surface proteins
of H. bilis (CCUG 38995) and H. hepaticus (CCUG 33637). For
the H. ganmani (CCUG 47872), a whole cell lysate was employed.
For interpretation, stained band patterns were compared to the sera
of experimentally infected mice of each species. From 62 of these
mice, genetic material were analyzed by PCR–DGGE (denaturing
gradient gel electrophoresis) for comparison with IB results.
Results. A specific antibody reactivity to H. bilis was found in
20%, to H. hepaticus in 18% and to H. ganmani in 16% of tested
mice sera and agreement between the IB and PCR–DGGE was
found in 84%, 95%, and 63%, respectively.
Conclusions. Infection with enteric Helicobacter seems to be
common in mice kept for animal experiments, independent of
mouse strain. Intestinal and hepatic naturally infected laboratory
mice may represent confounding factors in the interpretation of
animal bioassays. A serologic test with high specificity could be
of great value in health controls of laboratory mice and killing of
animals will not be necessary. Suggested antigens for future new
immuno-based tests are Helicobacter muridarum, Helicobacter
typhlonius, and Helicobacter rodentium.
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Abstract no.: 10.08
Diagnosis of Helicobacter pylori Infection in Stool:
23S rDNA Real-Time PCR Versus Antigen Test
S. Puz, C. Schabereiter-Gurtner, A. M. Hirschl,
Z. Kovách, M. Rotter and A. Makristathis
Department of Clinical Microbiology and Hygiene, Medical University
Vienna, Austria, Vienna, Austria
During recent years, non-invasive methods to detect Helicobacter
pylori infection gained importance especially for pediatric patients.
In a previous study, a 23S rDNA real-time polymerase chain
reaction (PCR) assay based on biprobe technology was developed,
allowing for the accurate detection of H. pylori and clarithromycinsusceptibility testing both in biopsy and stool specimens. In the
present study, the 23S rDNA real-time assay shall be compared to
the Amplified IDEIA H. pylori StAR stool antigen test.
Stool specimens of 46 European pediatric patients with
abdominal pain (0.5–19 years of age, average 9.8 years) and of 81
African individuals (0.5–70 years of age, average 12.4 years) were
tested by both assays.
Of the 46 stool specimens of the European pediatric patients, 10
were positive and 35 negative by both tests. One specimen (2.2%)
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was positive by PCR but negative by the antigen test. Of the
81 specimens of the African individuals, 62 were positive and 13
negative by both tests. The results of the assays were divergent in
six specimens (three positive by PCR and negative by antigen test
and three vice versa, 7.4%). Considering the long transportation
under suboptimal conditions of the African specimens, the overall
agreement between the two tests of 94.5% may be satisfactory.
In an ongoing study, the comparison of both tests to the gold
standard of H. pylori diagnosis (by rapid urease test, histology, and
culture) shall reveal whether the 23S rDNA real-time PCR, also
allowing for clarithromycin-susceptibility testing, might be the
better alternative to the antigen test.

Abstract no.: 10.09
Evaluation of Four Different Fecal Tests for
Determination of Cure After Helicobacter pylori
Treatment
Abstracts
8Abstract

X. Calvet,* M. Quesada,† I. Sanfeliu,‡ L. Ribera,§
V. Calvet,† V. Choat,¶ A. Montserrat,* V. Puig* and
F. Segura†
*Unitat

de Malalties Digestives, †Unitat de Malalties Infeccioses,
Hospital de Sabadell, Institut Universitari Parc Taulí, UAB, Sabadell,
Spain, ‡Laboratori de Microbiologia, UDIAT-CD, Institut Universitari
Parc Taulí, UAB, Sabadell, Spain, §Servei de Nefrologia, Hospital de
Sabadell, Institut Universitari Parc Taulí, UAB, Sabadell, Spain,
¶DakoCytomation, Glostrup, Denmark
Background. Usefulness of fecal tests to determine cure of
Helicobacter pylori infection after treatment remains controversial.
Differences in efficacy seem important between fecal antigen tests.
New monoclonal antigen-based tests seem to perform better than
previous polyclonal tests.
Objective. To evaluate the usefulness of four stool tests: two new rapid
monoclonal immunochromatographic tests – RAPIDHpStAR™
(DakoCytomation, Denmark) and Immunocard STAT! HpSA,
(Meridian Diagnostics, USA); a monoclonal EIA test – Amplified
IDEIA™ Hp STAR (DakoCytomation, Denmark) and a polyclonal EIA test – Premier Platinum HpSA (Meridian Diagnostics,
USA). These tools are for confirming the cure of H. pylori infection
after eradication treatment.
Methods. Cure of H. pylori infection was determined in 97
patients who underwent eradication treatment by concordance of
two consecutive tests. Fecal tests were performed according to the
specifications of the manufacturer. Sensitivity, specificity, and
positive and negative predictive values (PPV and NPV, respectively)
of a negative stool test for confirming H. pylori eradication were
calculated.
Results. A negative RAPIDHpStAR™ test had a sensitivity,
specificity, PPV, and NPV for confirming H. pylori eradication of
96–98, 73, 96, and 73– 80%, respectively. Corresponding values were
97, 91, 99, and 77% for Immunocard STAT! HpSA; 97, 73, 97, and
73% for Amplified IDEIA™ Hp StAR; and 79, 91, 98, and 35%
for Premier Platinum HpSA.
Conclusions. All tests showed a similar PPV, NPV, and sensitivity
values to confirm eradication after treatment except Premier
Platinum HpSA. With this polyclonal EIA, more than 20% of
cured patients tested positive. It had, consequently, a low
sensitivity and NPV to predict eradication.
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Abstract no.: 10.10
Development of a Real-Time or Quantitative
PCR Specific to Helicobacter pullorum
C. Pilon,* V. Prouzet-Mauléon,* A. Ménard,*
M. Desmonts† and F. Mégraud*
*Université

Victor Segalen Bordeaux 2, Bordeaux, France,

†Aérial, Illkirch, France

Helicobacter pullorum is now considered as an emerging human
pathogen. Indeed, it has been detected in several enteritis cases and
it has also been found in serious illnesses of the liver. However, the
real incidence of H. pullorum in human diseases as well as the
sources of possible food contamination are not known because
these bacteria are difficult to isolate and identify. The goal of this
study was to develop a real-time PCR allowing both a detection
and a quantification of this bacterium.
The gene coding for subunit A of the DNA gyrase was selected
as the PCR target because this gene is both present in all bacteria
and displays a great interspecies variability in nucleic sequences,
thus ensuring a good specificity. A 1300-bp fragment of this gene
whose sequence was hitherto unknown was amplified and
sequenced for five strains of H. pullorum and one strain of
Helicobacter canadensis, using degenerated primers. A couple of
primers and a TaqMan probe were designed, and a plasmid for
calibration and an internal PCR inhibition control plasmid were
constructed.
The sensitivity of the method is one equivalent genome by
reaction and the specificity is high as 10 different H. pullorum
strains lead to a positive PCR result, whereas H. canadensis strains
as well as diverse bacteria species were not detected. The method
was applied to 10 chicken cecal specimens that were all positive
suggesting a high prevalence in poultry. A large screening of human
clinical samples and of chicken samples is currently underway.

8Abstract
Abstracts

Abstract no.: 10.11
Point-of-Care Detection of Helicobacter pylori
Infection Using a Rapid Urine Antibody
Detection Device
A. Opekun, Z. Nurgalieva and D. Y. Graham
Baylor College of Medicine, Houston, TX, USA
Background. Point-of-care (POC) serology tests for Helicobacter
pylori IgG antibody generally have lower specificity and sensitivity
than send-out tests.
Aim. To evaluate POC test for detection of anti-H. pylori IgG
antibodies in urine. We compared the RAPIRUN® urine antibody
test, the HM-CAP® serum IgG antibody test and the 13C-urea
breath test (UBT) among outpatients in a primary care setting. To
exclude prior H. pylori infections, active H. pylori infection was
defined as both HM-CAP- and UBT-positive, H. pylori-negative
status was defined as both HM-CAP- and UBT-negative.
Methods. Each patient provided a blood sample, a urine sample,
and completed the UBT. The rapid urine test and UBT tests were
analyzed on site.
Results. One hundred eighty-nine adults (62 men, 127 women,
age range: 18–76 years; 83 White Hispanic, 71 Asian American, 20
Black people, 7 White people, and 8 other races). Seventy-eight
patients had active H. pylori infections (positive HM-CAP and
UBT) and 86 were H. pylori negative; 25 had discordant HM© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556

CAP/UBT results. Sixty-nine of the 78 with active H. pylori
infection had positive urine antibody tests and all 86 without
H. pylori infection had negative results (sensitivity = 88.5%,
specificity = 100%, PPV 100%, NPV 90.5%). The sensitivity was
85% and 100% when the rapid urine test was compared to the UBT
results.
Conclusion. The rapid urine antibody test is suitable for POC
detection of anti-H. pylori antibodies in urine and appears to have
better sensitivity and specificity than most POC serum tests and
appears suitable for use in Western populations.

Abstract no.: 10.12
Characteristics of Duodenal Ulcer in
Helicobacter pylori-Positive Patients in Algeria
Abstracts
8Abstract

N. Matougui,*† A. Tebaibia,† N. Oumnia,‡ M. Lahcene,*‡
F. Mouffok,* A. Bouhadef* and B. Touchene*‡
*Algerian

Laboratory Research of Helicobacter, Algiers University,
Algeria, †Internal Medecine Department, Kouba Hospital, Algeria,
‡Internal Medecine Department, Kouba Hospital, Algeria
Aim. To evaluate the prevalence of doudenal ulcer (DU) in the
Algiers area and to appreciate its features and the eradication rate
of Helicobacter pylori infection in this disease.
Patients and Methods. From 2000 to 2005, in 445 consecutive
endoscopies performed on adult patients suffering from dyspepsia
and not using NSAIDs, 95 (21%) cases (58 males; mean age:
36.5 years) of DU were found. Gastric biopsies were performed for
histology, rapid urease test (RUT), and culture with bacterial
susceptibility to antibiotics. Antibodies IgG anti-H. pylori, CagA
and VacA, and stool antigens (HpSA) were practiced. H. pylori
infection was defined if culture and/or histology and a third test
were positive. Patients have been treated by five different triple
therapies: H. pylori eradication has been assessed on the negativity
of all tests.
Results. H. pylori infection was established in 100% of the
patients. H. pylori diagnostic tests were positive for histology
(99%), serology (99%), RUT (93.5%), culture (70%), and HpSA
(60%). H. pylori resistance rates to antibiotics were: metronidazole
= 33%; clarithromycin = 7%; amoxicillin; and tetracycline = 0%.
CagA antibody was positive, 84%, and for VacA is 42%. Histology
has shown: chronic gastritis interesting antrum + fundus = 82%
and only antrum = 18%. Thirty-five patients have been treated and
controlled: H. pylori was eradicated in 27 (77%).
Conclusion. In the Algiers area, H. pylori infection is constant in
adult patients with DU not using NSAIDs. Most of H. pylori
strains are Cag(+). Resistance is high to metronidazole and
important to clarithromycin.
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Abst ract no.: 10.13
Usefulness of RAPID Hp StAR™, a New
Immunochomatographic, Monoclonal AntigenBased Fecal Test for Diagnosing Helicobacter
pylori Infection in Dyspeptic Patients
X. Calvet,* M. Quesada,† V. Calvet,† T. Choat,‡
I. Sanfeliu§ and F. Segura¶
*Unitat

de Malalties Digestives, †Unitat de Malalties Infeccioses,
Hospital de Sabadell, Institut Universitari Parc Taulí, UAB, Sabadel,
Spain, ‡DakoCytomation, Glostrup, Denmark, §Laboratori de
Microbiologia, UDIAT-CD, Institut Universitari Parc Taulí, UAB,
Sabadell, Spain, ¶Unitat de Malalties Digestives, Hospital de Sabadell,
Institut Universitari Parc Taulí, UAB, Sabadell, Spain

Background. Helicobacter pylori, a common human pathogen,
causes a chronic inflammatory process, which may ultimately lead
to the development of peptic ulcer disease or gastric carcinoma.
H. pylori antigens can be measured in human stools, which is
potentially a valuable non-invasive diagnostic tool.
Objective. To evaluate the usefulness of two new monoclonal tests
for detecting H. pylori antigens in dyspeptic patients’ feces
(Amplified IDEIA™ HpStAR, DakoCytomation, Denmark, and
a rapid immunochromatographic test RAPID Hp StAR™,
DakoCytomation, Denmark).
Methods. H. pylori infection was determined in 68 dyspeptic
patients who underwent endoscopy by concordance of urease test
and histology. Fecal tests were performed according to the
specifications of the manufacturer. Sensitivity, specificity, and
positive and negative predictive values (PPV and PNV, respectively)
were calculated for both Amplified IDEIA™ HpStAR and RAPID
HpStAR™. Concordance between different measurements was
estimated by Kappa statistics.
Results. The sensitivity of the RAPID HpStAR™ ranged from
96% to 98% and its specificity was 67%. PPV was 92% and PNV
80–90%. Corresponding Amplified IDEIA™ HpStAR values
were 98%, 83%, 94%, and 94%.
Conclusions. Both Amplified IDEIA™ HpStAR and RAPID
HpStAR™ were very sensitive, specific, and easy-to-perform
diagnostic tools for the diagnosis of H. pylori infection.
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Abstract no.: 10.14
Characteristics of Non-Ulcer Dyspepsia in
Algeria
N. Matougui,*† B. Touchene,*† M. Lahcene,*†
A. Tebaibia,† N. Oumnia,† M. L. Boudjella,*†
D. Boutarene,*† N. Hamiane,*† L. Himrane,†
F. Attou,*† F. Mouffok* and A. Bouhadef *
*Algerian Helicobacter Laboratory Research, Algiers University,
Algeria, †Internal Medecine Department, Kouba Hospital, Algeria

Aim. To evaluate the prevalence of non-ulcer dyspepsia (NUD) in
the Algiers area and to appreciate its features and the eradication
rate of Helicobacter pylori infection.
Patients and Methods. From 2000 to 2005, on 445 consecutive
endoscopies carried out on adult patients suffering from dyspepsia,
336 (75.5%) cases (88 males; mean age: 33 years) of NUD were
found. Gastric biopsies were performed for histology, rapid urease
test (RUT), and culture with bacterial susceptibility to antibiotics.
Antibodies IgG anti-H. pylori, CagA, VacA, and stool antigens

Diagnosis
(HpSA) were practiced. H. pylori infection was defined if culture
and/or histology and a third test were positive. Patients were
treated by five different triple therapies: H. pylori eradication were
assessed on the negativity of all tests.
Results. H. pylori infection was established in 292 patients (87%).
In these infected patients, H. pylori diagnostic tests were positive
for histology (93%), serology (97.6%), RUT (96%), culture (78%),
and HpSA (67%). H. pylori resistance rates to antibiotics were:
metronidazole = 47%, clarithromycin = 11.5%, amoxicillin, and
tetracycline = 0%. A double resistance was found in nine patients.
CagA antibody was positive, 61%, and for VacA is 32%. Histology
has shown: chronic gastritis interesting antrum + fundus = 79%,
only antrum = 20%, and only fundus = 1%. One hundred four
patients were treated and controlled: H. pylori was eradicated in 74
(71%).
Conclusion. In the Algiers area, H. pylori infection is almost
constant in adult patients with NUD. H. pylori strains mostly are
CagA(+). Resistance is high to metronidazole and important to
clarithromycin.

Abstract no.: 10.15
Applicability of a Helicobacter pylori Stool
Antigen Test to Determine the Results of
Eradication Therapy
Abstracts
8Abstract

S. Fukuda,* M. Tanaka,* T. Shimoyama,* M. Sato,†
R. Takahashi† and A. Munakata*
*Hirosaki University, Hirosaki, Japan, †Wakamoto Pharmaceutical Co.,
Ltd., Minami-Ashigara, Japan

Background and Aims. 13C-urea breath test (UBT) is usually
used to test the results of eradication therapy of Helicobacter pylori.
However, in most hospitals, results cannot be obtained immediately
because this test requires particular equipment. H. pylori stool
antigen tests are non-invasive and results are obtained within
10 minutes. The aim of this study was to examine whether stool
antigen test is applicable to determine the results of eradication
therapy.
Methods. Thirty-six patients infected with H. pylori (20 male
patients, 16 female patients, mean age 57.6) received eradication
therapy consisted of lansoprazole, amoxicillin, and either
clarithromycin or metronidazol. At least 5 weeks after finishing the
treatment, results were evaluated by 13C-UBT. On the same day,
Testmate rapid pylori antigen, which detects H. pylori-native
catalase in feces, was also performed and compared with 13C-UBT.
Results. In all the six patients with positive 13C-UBT, Testmate
rapid pylori antigen was also positive. In 29 13C-UBT-negative
patients 28 were also negative by Testmate rapid pylori antigen. A
patient, however, could not be tested because his stool was watery.
One patient who had gray zone result by 13C-UBT was negative
by Testmate rapid pylori antigen and was tested by 13C-UBT again
1 month later and the result was negative. Overall accuracy of
Testmate rapid pylori antigen to determine H. pylori eradication
was 97.2% when compared with 13C-UBT.
Conclusions. Testmate rapid pylori antigen is a useful diagnostic
test for immediate and accurate evaluation of H. pylori eradication
therapy.
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Abstract no.: 10.16
14C-Urea Breath Test: A Reliable and Practical
Test in Office-Based Diagnosis of Helicobacter
pylori Infection
S. Rasool, S. Abid, K. Mumtaz, H. A. Shah, S. Hamid,
M. Islam and W. Jafri
The Aga Khan University Hospital, Karachi, Pakistan
13C-urea breath test (UBT) is cumbersome and needs infrastructure,

whereas HpSA test is not acceptable to patients. 14C-UBT is
claimed to be reliable and easy to perform diagnostic test for
Helicobacter pylori.
Aims. To validate and compare cost of 14C-UBT with histopathology and rapid urease test (RUT) for diagnosis of H. pylori.
Methods. Sixty consecutive adult males and non-pregnant females
with dyspepsia were enrolled. During gastroscopy, two biopsies
were taken for histopathology and two for RUT. UBT was
performed after gastroscopy by 14C-urea-labeled capsules and
labeled CO2 was measured by a scintillation counter. Sensitivity
and specificity of UBT were calculated by comparing with results
of histopathology and RUT. Cost comparison of these three tests
was also performed.
Results. There were 35 (58%) males with a mean age
42.4 ± 13 years. H. pylori was diagnosed in 37 (61.6%) patients by
RUT. Histopathology has diagnosed H. pylori in 42 (71%) patients,
whereas UBT was positive in 36 (60%) patients. UBT has a
sensitivity of 83% and specificity of 94%; see Table 1. The cost of
gastroscopy and histopathology or RUT was $110 and $90,
respectively, whereas the cost of UBT was $15.

UBT
Rapid urea test

Sensitivity
(95% CI)

Specificity
(95% CI)

PPV
(95% CI)

NPV
(95% CI)

83%
(75 – 86)
87%
(80 – 88)

94%
(75 – 99)
97%
(80 –99)

97%
(87–99)
98%
(90–99)

71%
(56–75)
77%
(63–79)

Accuracy
87%
90%

Conclusions. 14C-UBT is a reliable and economical method for
the diagnosis of active H. pylori infection in office-based setting.

Abstract no.: 10.17
Diagnosis of Helicobacter pylori Infections in
Dyspeptic Nigerians: Comparison of Five
Detection Techniques
8Abstract
Abstracts

K. S. Oyedeji,* S. I. Smith,† A. O. Coker‡ and
A. O. Arigbabu§
*Nigerian

Institute of Medical Research, Yaba, Lagos, Nigeria,
Institute of Medical Research,Yaba, Lagos, Nigeria,
‡University of Lagos, College of Medicine, Idi-Araba, Lagos, Nigeria,
§Obafemi Awolowo University Teaching Hospital Complex, Ile-ife,
Nigeria
†Nigerian

Background and Aim. There is considerable interest in
diagnostic methods for Helicobacter pylori infection both before
and after treatment. The diagnosis of H. pylori infection is very
difficult in our region. Most of the available tests are costly and not
readily available. This study attempts to address these problems.
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556

Abstract no.: 10.18
Detection of Helicobacter pylori Infection in
Patients on Proton Pump Inhibitors
8Abstract
Abstracts

J. Yakoob, W. Jafri, S. Abid, N. Jafri, M. Islam and
Z. Abbas
Aga Khan University Hospital, Department of Medicine, Karachi,
Pakistan

Table 1 Sensitivity and specificity of UBT and RUT against
histopathology
Diagnostic
test

Material and Methods. Biopsies and blood samples were taken
from 532 patients presenting with varying degrees of gastroduodenal
pathology. The biopsies collected were screened for the presence of
H. pylori using culture technique, Campylobacter-like organism
test (CLO) (urease test), Gram reaction, serology, and polymerase
chain reactions (PCR).
Results. Of the 532 patients, 453 (85%) were seropositive for
H. pylori 1gG, 327 (62%) were positive by direct Gram’s stain, and
PCR detected 245 (46.1%) of the subjects. Urease (CLO) positivity
was found in 224 (42%), whereas H. pylori was isolated by culture
in 186 (35%) patients.The differences in the results was tested
statistically and found to be significant. In this study, 410 (77.1%)
patients were H. pylori-positive and 122 (22.9%) patients were
H. pylori-negative. Majority (25.0%) of the patients had Gram
reaction, serology, and were PCR positive. No test was positive in
79 (14.8%) patients.
Conclusion. From the study, the best detection methods were
Gram reaction, serology, and PCR. This means a patient can be
defined as positive for H. pylori in this environment even if the
culture was negative, but Gram reaction, serology, and PCR tests
were positive.

Aim. To determine the effect of proton pump inhibitor (PPI) on
rapid urease test (Pronto Dry) and compare it with polymerase chain
reaction (PCR) for the Helicobacter pylori urease C (ureC ) gene.
Methods. Forty-seven patients with dyspepsia attending the
endoscopy from January–May 2005 were enrolled. Four antrum
biopsy specimens were collected, two specimens each for Pronto
Dry and PCR. Pronto Dry results were read in 30 minutes and
1 hour after sampling. The color changed from yellow to pink
when positive. PCR amplified a homogeneous DNA fragment of
the expected size of 820 bp for ureC gene. The PCR products were
digested with restriction enzyme HhaI and analyzed by agarose
electrophoresis. PCR was used as the gold standard. Sensitivity and
specificity of Pronto Dry was compared against PCR.
Results. Fifty-seven percent (57%) (27/47) were males, mean age
44 ± 11.5 years; 83% (39/47) were using PPI at presentation. Eightyone percent (38/47) presented with abdominal pain and 19% (9/47)
with dyspepsia. Endoscopy showed gastritis 75% (35/47), gastritis
with gastroesophageal reflux disease (GERD) in 15% (7/47), and
GERD alone in 11% (5/47). Pronto Dry was positive in 28% (13/
47) and negative in 72% (34/47), whereas PCR was positive in 51%
(24/47) and negative in 49% (23/47). In the presence of PPI, Pronto
Dry had a sensitivity of 85% and specificity of 62%.
Conclusion. The sensitivity and specificity of Pronto Dry was
reduced on PPI. PCR may be considered in patients on recent acidreducing medications.
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Abstract no.: 10.19
Application of Quantitative or Real-Time PCR
Approach for Helicobacter pylori Detection

Abstract no.: 10.21
Diagnosis of Helicobacer pylori Infection Among
Dental Caries Patients by Stool Antigen Test

M. L. Ribeiro, R. G. Mattos, C. C. Ecclissato,
S. Mendonca and J. Pedrazzoli Jr.

S. I. Smith,* K. S. O. Oyedeji,* O. A. M. Odeniyi,†
A. O. Arigbabu‡ and A. O. Coker†

Clinical Pharmacology and Gastroenterology Unit, Sao Francisco
University Medical School, Bragança P, Braganca Paulista, Brazil

*Nigerian

Accurate diagnosis of Helicobacter pylori infection is very
important in both clinical practice and research purposes. The
sensitivity and specificity of the currently available tests for
H. pylori detection may be affected by several reasons. The aim of
the present study was to evaluate the sensitivity of real-time PCR
on H. pylori detection and quantification in 81 patients considered
to be negative by means of “gold standard” diagnostic methods
rapid urease test, culture, and histology. Our results showed that
the sensitivity of the real-time PCR assay is higher than those from
standard methods. Sixteen patients from the 81 considered to be
uninfected according to the references methods were H. pyloripositive, from which six were untreated patients, and 10 were
patients considered to be given eradication therapy. Thus, based on
these findings we recommend the real-time PCR should be used in
clinical studies to monitor treatment results in addition to the
regular methods.

Abstract no.: 10.20
Specific Antibodies to Helicobacter pylori and
Cytokine in Patients with Polyps of the Stomach
Abstracts
8Abstract

L. Lazebnik, T. Tsaregorotseva, M. Klishina, T. Serova,
E. Dubtsova and A. Gubina
The Central Research Institute of Gastroenterology, Moscow, Russian
Federation
Aim. Study of the specific antibodies to Helicobacter pylori (abHP) and cytokine levels in patients with polyps of the stomach (PS).
Material and Methods. ELISA was used to examine in the
peripheral blood of the ab-HP (IgG, IgA, IgM + IgG + IgA) and
cytokine levels in 52 patients with PS.
Results. Increase of concentration of serum antibodies
(IgM + IgG + IgA) to CagA-HP (1 : 40 –1 : 640, median = 1 : 180,
in control −1 : 10) were detected in 84% of patients with PS. In the
patients with polyps of antrum were found the maximal levels
of ab-HP (median = 1 : 240). Increase of concentration of serum
IgG-HP (median = 1 : 1060, in the control −1 : 110) were detected
in 80% of patients with PS. Increase of concentration of serum
IgA-HP (median = 1 : 660, in the control −1 : 140) were detected
in 46% of patients with PS. Increase of concentration of serum
ab-HP (IgG, IgA, IgM + IgG + IgA) is one of the indications of
the intensiveness of infiltration, atrophy, and proliferation in the
stomach in patients with PS.
In the patients with PS were found increase of cytokine levels
(IL-1β, IL-8, IL-12, IFNγ, TNF-α) – 190–510 pg/ml; in control
−1 : 40.
Conclusion. Increase of serum ab-HP levels may be useful as one
of the diagnostic criteria of polyps of stomach, associated with
H. pylori, indications for anti-Helicobacter therapy in the patients
with PS.
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Institute of Medical Research, Lagos, Nigeria, †College of
Medicine, University of Lagos, Lagos, Nigeria, ‡Department of Surgery,
Obafemi Awolowo Teaching Hospitals Complex, Ile-Ife, Nigeria
Background and Aims. The route of transmission of Helicobacter pylori especially in developing countries is probably
fecal–oral and oral–oral. As the oral cavity can be regarded as a
possible reservoir of the organism, it provides a possible tool for
the rapid and non-invasive diagnosis of infection especially in
Nigeria where power outages are constant and culture of H.
pylori is difficult. This study aims to detect H. pylori in dental
plaques and stomachs of patients who reported with dental
problems using stool antigen test.
Methods. Forty patients presenting with various dental problems
had their stool samples screened for H. pylori infection, using the
stool antigen test by DakoCytomation, and biopsies taken from
them after informed consent for culture. All patients had not been
on any prior medication.
Results. Fourteen patients (35%) had peptic ulcer disease, whereas
26 (65%) had marginal gingivitis and were either normal or had
mild gastritis. All the patients (100%), irrespective of their disease
status, were found to have H. pylori by stool antigen test, whereas
culture showed only 2.5% of the patients with H. pylori infection.
Conclusion. The results show the significance of the stool antigen
test as a diagnostic tool in the absence of culture of the organism
and its relative affordability. This is because in Nigeria, power
outages occur frequently and has made the culture of H. pylori in
Nigeria absolutely difficult apart from the costs associated with
endoscopy. From earlier studies, culture had always been found to
be of very low sensitivity.
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Abstract no.: 10.22
The Difference in the Incidence of
Helicobacter pylori Infection Between Old (more
than 65 years) and Young Patients with Upper
Gastrointestinal Bleeding due to Peptic Ulcer
C. Kim,* D. Lee,† N. Kim,† J. Kim,† J. Whang,† Y. Park,†
H. Chung,* D. H. Kim* and I. Song*
*Seoul

National University Hospital Department of Internal Medicine,
Seoul, Republic of Korea, †Seoul National University Bundang Hospital
Department of Internal Medicine, Sungnam, Republic of Korea
Recent reports show that Helicobacter pylori infection accompany
90% of duodenal ulcers and 75% of benign gastric ulcers. There is
no study of the relationship between H. pylori infection and upper
gastrointestinal bleeding that may be lethal to the old patients.
We examined the incidence of H. pylori infection for upper GI
bleeding due to peptic ulcer according to age.
The enrolled patients were diagnosed as duodenal ulcer (DU)
and/or benign gastric ulcer (BGU) by gastroscopy on first visit,
and Campylobacter-like organism (CLO) test was performed.
They were divided into two groups, those patients older than
65 years, and those younger than 65 years. We calculated the
incidence of H. pylori infection and the odds ratio.
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556
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In the group of less than 65 years of age, 68.6% were infected.
But in the older age group, 40% were infected. This result was
significant (odds ratio: 0.30). If we considered the location of the
ulcer in each group, the incidences of H. pylori infection in gastric
ulcer were 40.9% in the older group and 61.9% in the younger
group, and in duodenal ulcer, 50.0% and 72.7%, respectively, in
each group. The trend of lower infection incidence was shown in
the older group than in the younger group. On the other hand,
in the cases of combined ulcers the older group had no infected
patient, the younger group had 75.0% infection of enrolled cases.
In simultaneous ulcers, the younger group had higher incidence.
We think that this result in the combined ulcer case may be caused
by other reasons, for example, NSAIDS or the weakness of defense
mechanism.

Methods. Twenty-one patients with gastric ulcer and 83 patients
with duodenal ulcer were surveyed. Presence of H. pylori was
verified by histologic, bacterioscopic methods, rapid urease test,
and ELISA.
Results. In our researches, the low results of diagnosis were
determined for bacterioscopic test: 65.4–65.6%. The rapid urease
test revealed 82.6–97.6% of patients. The histologic test showed
78.3–97.6% positive results.
The optimum results were received with ELISA: 91.6% for H.
pylori gastric ulcer and 100% for H. pylori duodenal ulcer. We see
that the highest degree of H. pylori infection was found in duodenal
ulcer patients (100%).
Conclusions. The level of detection of H. pylori antibodies by
ELISA for patients with duodenal ulcer shows a big degree of
H. pylori contamination, and also the expressiveness of the immune
reaction.
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Abstract no.: 10.23
Specific Antibodies to Helicobacter pylori in
Diseases of Stomach
L. Lazebnik, T. Tsaregorotseva, M. Klishina, T. Serova
and A. Gubina
The Central Research Institute of Gastroenterology, Moscow, Russian
Federation
Aim. Comparative study of the specific antibodies to Helicobacter
pylori (ab-HP) levels in patients with diseases of stomach (DS).
Material and Methods. ELISA were examined in the peripheral
blood of the ab-HP (IgG, IgA, IgM + IgG + IgA) levels of 112 DS
patients with chronic gastritis (CG), gastroesophageal reflux disease
(GERD), stomach peptic ulcer (SPU), and gastric cancer (GC).
Results. Increase of concentration of serum IgG-HP (median =
1:604) were detected in 78% of patients with DS. In the patients
with CG, GERD were found in maximal levels of IgG-HP (1:420–
1:1060); in the patients with SPU, GC were in minimal levels
(1:220–1:340); in the control, 1:110. Increase of concentration of
serum IgA-HP (median = 1:442) were detected in 39% of patients
with DS. Serum IgA-HP were maximally increased (1:640–1:980)
in the patients with SPU, GC; minimal (1:180; in control, 1:140)
in the patients with GERD, CG. Concentrations of antibodies
(IgM + IgG + IgA) to CagA-HP were significantly increased
(1:40–1:640, median = 1:180; in control, 1:10) in the patients with
DS in 82%. Basic therapy in patients with SPU led to a statistically
significant decrease of concentration of serum ab-HP.
Conclusion. Increase of serum ab-HP levels is one of the tests of
gastric lesions, associated with H. pylori, indications for antiHelicobacter therapy in the patients with DS, as well as additional
criterion for the estimation of its efficiency and prognosis of diseases.
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Abstract no.: 10.24
Comparative Sensitivity of Various Methods of
Diagnosis of Helicobacter pylori Peptic Ulcer
T. V. Meka-Mechenko,* J. Kazakbaeva,* A. Zhangabylov†
and G. Esnazarova*
*Kazakh

Science Center for Quarantine and Zoonotic Diseases,
Almaty, Kazakhstan, †Kazakh Medical Institute, Almaty, Kazakhstan

Objects. To compare sensitivity methods of diagnosis of
Helicobacter pylori gastric and duodenal ulcer.
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556

Abstract no.: 10.25
Diagnosis of Helicobacter pylori Infection and
Determination of Clarithromycin Resistance in
Stool Specimens by Real-Time PCR
Abstracts
8Abstract

Ö. Yilmaz,* V. Prouzet-Mauléon,† N. Sen* and
F. Mégraud†
*Department

of Microbiology and Clinical Microbiology, Faculty of
Medicine, Dokuz Eylül University, Izmir, Turkey, †Laboratoire de
Bacteriologie, Université Victor Segalen Bordeaux 2, C.H.U. Pellegrin,
Bordeaux, France

Macrolide resistance in Helicobacter pylori infections is becoming
an increasing therapeutic problem. E-test and agar dilution tests
have been used as in vitro phenotypic methods for the detection of
macrolide resistance in H. pylori. When bacterial culture cannot be
used routinely, the patient should benefit from the determination
of macrolide resistance using noninvasive genotype-based methods.
In clinical H. pylori isolates, macrolide resistance is due to point
mutations in the 23S rRNA gene of H. pylori. In our study, a
real-time polymerase chain reaction (PCR) hybridization assay
was used to determine H. pylori infection and clarithromycin
resistance in stool specimens of 54 adult dyspeptic patients. Of 54
patients who had an upper endoscopy, 46 (85.2%) were found to
be H. pylori-positive by histopathology and/or rapid urease test.
Thirty-six patients (78.3%) were found positive by real-time PCR
in stools; 17 out of 36 (47.2%) were wild-type H. pylori, 13 (36.1%)
were mutant AG genotype, 4 (11.1%) were mutant AC
genotype, 1 (2.8%) showed an unknown mutant genotype, and
one (2.8%) patient carried two strains. The high number of
clarithromycin-resistant isolates could be explained by the
clarithromycin-based eradication therapy that the patients received
in the past. Real-time PCR in stool specimens is an easy and useful
noninvasive method to detect H. pylori infection that allows
clarithromycin-susceptibility testing.
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Abstract no.: 11.01*
Levofloxacin-Based Triple Therapy in First-Line
Treatment for Helicobacter pylori Eradication:
Update
A. Gasbarrini, E. C. Nista, M. Candelli, R. Finizio,
M. A. Zocco, V. Ojetti and G. Gasbarrini
Catholic University, Rome, Italy
Introduction. Therapies based on clarithromycin and amoxycillin
or metronidazole are the treatment of choice to eradicate
Helicobacter pylori. Levofloxacin seems to be a new option for
H. pylori eradication.
Aims and Methods. To compare two 7-day standard triple
therapies versus 7-day levofloxacin-based triple therapy in firstline treatment. Three-hundred consecutive H. pylori-positive
patients (132 male patients, 18–65 years of age) were randomized
to receive clarithromycin 500 mg b.i.d., amoxycillin 1 g b.i.d.,
esomeprazole 20 mg b.i.d. (group A: 100 patients); clarithromycin
500 mg b.i.d., metronidazole 500 mg b.i.d., esomeprazole 20 mg
b.i.d. (group B: 100 patients) and clarithromycin 500 mg b.i.d.,
levofloxacin 500 mg od, esomeprazole 20 mg b.i.d. (group C: 100
patients). H. pylori status was checked by 13C-urea breath test
6 weeks after the end of the treatment. A questionnaire on sideeffects was also administered.
Results. Two-hundred eighty-four patients completed the efficacy
analysis per protocol; eradication rate was 75% (75/100 patients)
and 79% (75/95) in group A, 72% (72/100 patients) and 77.4% (72/
93) in group B, 87% (87/100 patients) and 90.6% (87/96) in group
C in ITT and PP analysis, respectively. Eradication rate was
significantly higher using levofloxacin-based therapy than using
standard therapies in either ITT (87% versus 75%; p < .05; 87% versus
72%; p < .01;) or PP (90.6% versus 79%; p < .05; 90.6 versus 77.4;
p < .05) analysis. Prevalence of side-effects was similar among groups.
Conclusions. A 7-day levofloxacin-based therapy showed a higher
eradication rate than standard regimens in first-line scheme and could
be considered the best treatment, at least in the Italian population.
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Abstract no.: 11.02*
Long-Term Treatment Outcome of Primary
Gastric Low-Grade B-Cell Mucosa-Associated
Lymphoid Tissue Lymphoma
H. Y. Jung, G. H. Lee, K. D. Choi, S. S. Hong, J. Y. Jo,
H. C. Oh and J. H. Kim
Department of Gastroenterology, University of Ulsan, Asan Medical
Center, Seoul, Republic of Korea
Objectives. Primary gastric low-grade mucosa-associated
lymphoid tissue (MALT) lymphoma is known to be successfully
treated with anti-Helicobacter pylori therapy alone. Aims of this
study were to analyze duration to complete remission (CR),
recurrence rate, and to assess factors associated with recurrence.
Methods. Between 1996 and 2003, 97 H. pylori-infected patients
with MALT lymphoma were treated with anti-H. pylori therapy.
Endoscopy, endoscopic ultrasonography, abdominal CT scans,

bone marrow examination, and histologic examination of biopsy
samples were analyzed at initial diagnosis. Eradication of H. pylori
and tumoral response were assessed by follow-up endoscopy.
Mean follow-up period after CR was 29 months (range 3–97).
Results. Among 97 treated patients, 92 (94.8%) reached CR.
Median duration to CR was 3 months. Seventy (76.9%) patients
were in CR at 6 months, and 82 (90.1%) were in CR at 12 months.
Among 83 patients who were followed up after CR, MALT
lymphoma recurred in nine (10.8%). Kaplan–Meier survival
analysis showed 4.0% and 12.7% recurrence rate at 12 months and
24 months. H. pylori reinfection was only a significant risk factor
of recurrence, whereas endoscopic features, depth of invasion, and
BM involvement were not associated with recurrence.
Conclusions. Most of low-grade MALT lymphoma showed CR
with H. pylori treatment alone, and most patients were in CR at
12 months. However, survival analysis showed 12.7% of recurrence
rate at 24 months, and H. pylori reinfection was only risk factor of
recurrence. Hence, endoscopy with evaluation of H. pylori status
should be needed during follow-up of low-grade MALT lymphoma.
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Abstract no.: 11.03
Levofloxacin-Based Triple Therapy in
Second-Line Treatment for Helicobacter pylori
Eradication: Update
R. Finizio, E. C. Nista, M. Candelli, M. A. Zocco,
V. Ojetti, G. Cammarota, G. Gasbarrini and
A. Gasbarrini
Catholic University, Rome, Italy
Introduction. Compliance is the limit of the recommended
second-line treatment for Helicobacter pylori infection. Levofloxacin
is a new good option for Helicobacter eradication.
Aims and Methods. To compare a 10-day or 7-day levofloxacinbased therapy versus quadruple therapy in second-line treatment.
One hundred forty-six consecutive patients (67 male patients) who
had failed standard triple therapy were randomized to receive
levofloxacin 500 mg od, PPI b.i.d. and amoxycillin 1 g b.i.d. for
10 days (group A: 46 patients); or for 7 days (group B: 50 patients);
tetracycline 500 mg q.i.d., metronidazole 500 mg t.i.d., PPI b.i.d.
and bismuth salt 120 mg q.i.d. (group C: 50 patients) for 7 days.
H. pylori status was checked by 13C-urea breath test (UBT)
6 weeks after the treatment.
Results. Four dropouts occurred in group C due to side-effects.
Eradication rate in group A was 91.3% and in group B was 74% in
either ITT and PP analysis. In group C was 68% and 73.9% in ITT and
PP analysis, respectively. Eradication rate of 10 days of levofloxacinbased therapy was significantly higher than that observed using a
7-day levofloxacin-based therapy or quadruple therapy in either
ITT (91.3% versus 74%; p < .05; 91.3% versus 68%; p < .005;) or
PP (91.3% versus 73.9%; p < .05) analysis. Prevalence of side-effects
was significantly lower in groups A and B than in group C.
Conclusions. A 10-day levofloxacin-based triple therapy showed
a higher eradication rate and provides a better compliance than
quadruple regimen and seems the best second-line option for
Helicobacter infection.
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Abstract no.: 11.04*
Comparison of the Efficacy of Pre-Operative
Versus Post-Operative Proton Pump InhibitorBased Triple Therapy for Helicobacter pylori
Eradication in Patients Undergoing Subtotal
Gastrectomy
H. Song, I. Choi, C. Kim, S. Lee, S. Kim, E. Hong,
M. Kook, J. Lee, K. Ryu, Y. Kim and J. Bae
Research Institute and Hospital, National Cancer Center, Korea,
Goyang-si, Gyeonggi-do, Republic of Korea
Background. The efficacy of proton pump inhibitor (PPI)-based
triple therapy for Helicobacter pylori eradication is well established
in patients with intact stomach. However, it has not been
adequately evaluated in patients with subtotal gastrectomy that
might affect the outcome of eradication therapy due to altered
gastrointestinal motility or antibiotic activity.
Aim. This study is aimed to evaluate the efficacy of postoperative
PPI-based triple therapy in patients undergoing subtotal
gastrectomy.
Methods. One hundred fifteen patients with distal gastric cancer
were randomly assigned to either preop group (treatment before
surgery, 58 subjects) or postop group (treatment 2– 4 weeks after
surgery, 57 subjects). The regimen was a 7-day triple therapy based
on PPI (rabeprazole 10 mg b.i.d.), clarithromycin (500 mg b.i.d.),
and amoxicillin (1000 mg b.i.d.). H. pylori eradication was evaluated
by histology, rapid urease test, and urea breath test at 12 weeks after
surgery.
Results. By intention-to-treat (ITT) analysis, eradication was
successful in 82.8% (48/58) in the preop group and 75.4% (43/57)
in the postop group ( p = .33). By per protocol (PP) analysis,
H. pylori eradication rate was 84.2% (48/57) and 79.2% (42/53) in
each group ( p = .50). In the postop group, there was no difference
in eradication rates according to the Billroth I or II procedure by
ITT (72.5% versus 82.4%, respectively; p = .52) or PP analysis
(77.8% versus 82.4%, respectively; p = 1.00).
Conclusions. The postoperative PPI-based triple therapy was as
effective as the preoperative therapy in patients with distal gastric
cancer. In addition, the efficacy was not affected by gastrointestinal
reconstruction methods.
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Abstract no.: 11.05
HELYX Study Parts I and II:Treatment of LowGrade Gastric Non-Hodgkin’s Lymphoma of
Mucosa-Associated Lymphoid TissueType Stages
I and II1, an Interim Analysis
R. Schmelz,* C. Thiede,* S. Brückner,* B. Dragosics,†
A. Ruskoné-Formestraux,‡ T. Herrmann,§ M. Dawel,§
G. Ehninger,* S. Miehlke,* M. Stolte¶ and
A. Morgner-Miehlke*
*Medical

Department I, Technical University Dresden, Germany,
Süd,Vienna, Austria, ‡Service de
Gastroentérologie, Hôtel-Dieu, Paris, France, §Department for
Radiotherapy & Radiooncology, Technical University Dresden,
Germany, ¶Institute for Pathology, Klinikum, Bayreuth, Germany

†Gesundheitszentrum

Background. Eradication of Helicobacter pylori is an accepted
treatment for H. pylori-positive, low-grade gastric mucosa-associated
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556

lymphoid tissue (MALT) lymphoma. However, about 20% show
refractory disease or H. pylori-negative lymphoma.
Aim and Methods. A prospective, randomized study has been
designed to investigate occurrence of complete lymphoma remission
(CR) in H. pylori-positive gastric low-grade MALT lymphoma
stages I and II1 (part I) after eradication therapy. Refractory disease
or H. pylori-negative patients will receive radiotherapy (25.2 Gy
versus 36 Gy, part II). Correlation of clinical outcome with t(11;
18), and B-cell monoclonality is also performed.
Results. So far, 65 patients have been included. Sixty-two received
eradication therapy. Fifteen patients were randomized for radiation
(2 being H. pylori-negative, 13 patients with refractory disease).
Forty-four patients in HELYX part I already had three endoscopic
controls 30(68%) of those have shown CR. From 15 patients
having received radiation therapy (part II), 8 were radiated with 36
Gy, and 7 with 25.2 Gy. All patients with three or more endoscopic
controls (n = 5) achieved stable CR after radiation irrespective of
the dose applied. In part II t(11; 18) occurs in 22% compared to 4%
in part I. Seventy-eight percent of the irradiated patients show an
initial monoclonal lymphocyte population versus 50% of patients
with CR after eradication.
Conclusion. Most patients with H. pylori-positive low-grade
gastric MALT lymphoma stages I and II1 respond with stable CR
after eradication therapy. Nonresponders, t(11; 18) + or Hp–
patients may benefit from a radiation therapy. Low-dose radiation
with 25.2 Gy seems to be as effective as standard dose. However, a
larger patient number is needed.

Abstract no.: 11.06*
Systematic Review and Meta-Analysis: Proton
Pump Inhibitor Versus Ranitidine Bismuth
Citrate PlusTwo Antibiotics in Helicobacter pylori
Eradication
8Abstract
Abstracts

J. P. Gisbert,* L. Gonzalez,* X. Calvet† and J. M. Pajares*
*La

Princesa University Hospital, Madrid, Spain, †Hospital de Sabadell,
Barcelona, Spain

Objective. To systematically review the Helicobacter pylori
eradication efficacy with ranitidine bismuth citrate (RBC) and two
antibiotics, and to conduct a meta-analysis of randomized clinical
trials comparing the efficacy of proton pump inhibitor (PPI) versus
RBC with two antibiotics for 1 week.
Methods. Selection of studies: Studies evaluating RBC plus two
antibiotics were considered. For the meta-analysis, randomized
controlled trials comparing PPI versus RBC plus two antibiotics
for 1 week were included. Search strategy: Electronic and manual
bibliographical searches. Assessment of study quality and data
extraction: Independently performed by two reviewers. Data synthesis:
“intention-to-treat” eradication rate. Meta-analysis was performed
combining the odds ratios (OR) of the individual studies. Subanalysis:
Depending on the type of antibiotics and the quality of the studies.
Results. Mean H. pylori eradication with 7-day RBC–
clarithromycin–amoxicillin, RBC–clarithromycin–nitroimidazole,
and RBC–amoxicillin–nitroimidazole was 83%, 86%, and 71%,
respectively. The meta-analysis showed comparable efficacy with
RBC and PPI when they were combined with clarithromycin and
amoxicillin (OR = 1.11; 95% CI = 0.88–1.40), or with amoxicillin
and metronidazole (OR = 0.92; 95% CI = 0.60–1.41). However,
when comparing PPI versus RBC plus clarithromycin and a
nitroimidazole, higher cure rates with RBC than with PPI were
demonstrated (OR = 1.65; 95% CI = 1.15–2.37).
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Conclusion. The efficacy of RBC and PPI-based triple regimens
were comparable when using the clarithromycin–amoxicillin or the
amoxicillin–metronidazole combination. However, RBC seems
to have a higher efficacy than PPI when clarithromycin and a
nitroimidazole are the antibiotics prescribed. Therefore, if one
prefers to use the clarithromycin–nitroimidazole regimen, RBC
should be used instead of a PPI.

Abstract no.: 11.07
Esomeprazole-Based Therapy in
Helicobacter pylori Eradication: Any Effect by
Increasing the Dose of Esomeprazole or
Prolonging the Treatment?
8Abstract
Abstracts

J. P. Gisbert,* A. Dominguez-Munoz,†
A. Dominguez-Martin,† J. L. Gisbert,* S. Marcos*
and J. M. Pajares*
*La

Princesa University Hospital, Madrid, Spain, †Clinica Barroso,
Malaga, Spain

Aim. To study the efficacy of esomeprazole-based triple therapy
in Helicobacter pylori eradication and to evaluate, by a randomized
trial, the effect of increasing the dose of esomeprazole or
prolonging the treatment.
Methods. Four-hundred and fifty duodenal ulcer patients were
randomized to receive: 1, esomeprazole (20 mg b.i.d.), clarithromycin
(500 mg b.i.d.), and amoxicillin (1 g b.i.d.), for 7 days (E20–7d);
2, esomeprazole (40 mg b.i.d.) with the same antibiotics, also for
7 days (E40–7d); and 3, esomeprazole (40 mg b.i.d.) with the same
antibiotics, for 10 days (E40 –10d). Cure rates were evaluated by
13C-urea breath test.
Results. One hundred fifty patients received each treatment. Groups
were comparable in terms of demographic variables. Eight percent
of the patients did not return for follow-up. Compliance (98%) and
side-effects (only mild to moderate) in the two groups were comparable.
Per-protocol cure rates were 83.5% (E20–7d), 84.8% (E40–7d), and
88.2% (E40–10d). Intention-to-treat cure rates were, respectively,
74%, 78%, and 80% (nonstatistically significant differences).
Conclusions. Esomeprazole-based triple therapies offer comparable
efficacy to omeprazole-based therapies used in previous studies.
Increasing the dose of esomeprazole or prolonging the treatment does
not improve the results. Therefore, if esomeprazole-based triple
therapy is used in duodenal ulcer patients, a regimen with only 20 mg
twice daily of esomeprazole and for only 7 days may be sufficient.

8Abstract
Abstracts

Abstract no.: 11.08
Ranitidine Bismuth Citrate Rescue Therapy after
Helicobacter pylori Treatment Failure
J. P. Gisbert,* J. Fuentes,† D. Carpio,‡ L. Tito,§
J. Guardiola,¶ A. Tomas,** X. Calvet†† and J. M. Pajares‡‡
*La

Princesa University Hospital, Madrid, Spain, †Hospital Miguel
Servet, Zaragoza, Spain, ‡Complejo Hospitalario, Pontevedra, Spain,
§Hospital l’Esperit Sant, Barcelona, Spain, ¶Hospital Comarcal de l’Alt
Pènedes, Barcelona, Spain, **Hospital de Bellvitge, Barcelona, Spain,
††Hospital de Sabadell, Barcelona, Spain
Aim. Quadruple rescue therapy requires a complex scheme with
four drugs. Our aim was to evaluate the efficacy of ranitidine
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bismuth citrate (RBC)–tetracycline–metronidazole rescue regimen,
and to compare two different metronidazole dose schemes.
Methods. Prospective multicenter study including proton pump
inhibitor + clarithromycin + amoxicillin failures. Rescue regimen
included two 7-day treatments: 1, RBC (400 mg b.i.d.)–tetracycline
(500 mg q.i.d.)–metronidazole (500 mg t.i.d.) (RTM1); or 2, the
same regimen but with metronidazole 250 mg q.i.d. (RTM2).
Eradication was confimed with 13C-urea breath test.
Results. One hundred fifty patients were included (58 RTM1, 92
RTM2). All patients but two (one in each group) returned after
treatment. Eighty-six percent (86%) in group RTM1 and 95% in
RTM2 took correctly all the medications ( p = .076). Per-protocol
eradication with RTM1 and RTM2 was 74% (95% CI = 60–84%)
and 69% (59–78%). Intention-to-treat eradication rate was 64%
(51–75%) and 70% (59–78%) ( p > .05). Type of regimen was not
associated with eradication success in the multivariate analysis.
Adverse effects were more frequent with RTM1 (41%) than with
RTM2 (30%) ( p > .05).
Conclusion. Seven-day triple rescue therapy with RBC–
tetracycline–metronidazole is effective for H. pylori eradication,
and represents an encouraging alternative to quadruple therapy, with
the advantage of simplicity. The administration of metronidazole
every 6 hours (together with tetracycline), and at a low dose
(250 mg), achieves similar efficacy and is probably associated with
a better compliance and a lower incidence of adverse effects.

Abstract no.: 11.09
Higher Reinfection Rate in Celiac Disease
Patients After Successful Helicobacter
Eradication for Peptic Ulcer Disease
8Abstract
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K. D. Paraskeva,* N. Mathou,* N. Giannakou,†
A. Michalopoulou,† I. Ghiconti,† C. Spiliadi† and
J. A. Karagiannis*
*Gastroenterology
†Department

Unit, Agia Olga Hospital, Athens, Greece,
of Pathology, Agia Olga Hospital, Athens, Greece

Eradication regimes for Helicobacter pylori infection have
been proven particularly effective and with low reinfection (or
recrudescence) rate that is estimated ∼1–2% annually.
Aim of the study was to assess maintenance of the eradication in
patients with celiac disease. In 29 patients (16 male, 13 female, age
range 19–67 years) with celiac disease, all in clinical and histologic
remission on a gluten-free diet, benign peptic ulceration (20
duodenal, 9 gastric) was diagnosed endoscopically. None was on
long-term NSAIDs.
Of the 29 patients, 23 were Hp+ by histology and Campylobacterlike organism (CLO) test and received for both healing and
H. pylori eradication first-line triple schemes (PPI, clarithromycin,
amoxycillin) and those who failed (7/23) to become Hp– secondline quadruple schemes (PPI, bismuth compounds, amoxycillin,
metronidazole), both at the recommended dose and duration. All
had their ulcers healed, 20 of 23 became Hp– by histology/CLO
test and/or 13C-UBT, whereas three of 23 remained Hp+. Hp–
patients were reevaluated for their H. pylori status with 13C-UBT
after a mean observation period of 55 months (range 22–68 months).
Twelve of twenty (60%) remained Hp–, whereas 8/20 (40%)
became Hp+. Reinfection rate for matched nonceliac patients and
for similar observation period was ∼10%. Nine of twenty patients,
four Hp– and five Hp+, were re-endoscoped because of dyspeptic
symptoms and in three of nine, all Hp+, recurrence of duodenal
ulcer was diagnosed.
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556
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Even if the number of patients studied is small, it seems that
patients with celiac disease have higher than expected reinfection
rate. Genetic factors influencing susceptibility to H. pylori
infection by modulating the host immune response might be
implicated to explain this observation.

Abstract no.: 11.10
Presence of Duodenal Pseudodiverticulae Is
Predictive of Recurrence of Helicobacter pylori
and Recurrence of Ulcer Following Eradication
Therapy in Patients with Duodenal Ulcer
Abstracts
8Abstract

V. Ahuja, S. Singh and M. P. Sharma
All India Institute of Medical Sciences, New Delhi, New Delhi, India
A high rate of recurrence of Helicobacter pylori following
eradication therapy in patients with peptic ulcer disease is seen in
developing countries. Factors implicated are antibiotic resistance,
compliance, and treatment efficacy. Presence of pseudodiverticula
or duodenal deformity has not been evaluated as a risk factor for
recurrence.
Aim. To determine if presence of duodenal pseudodiverticula
or deformity is a factor predicting recurrence of ulcer and
H. pylori.
Methods. Two hundred fifty-seven patients who had presence of
active peptic ulcer and H. pylori were given standard triple regime
(lansoprazole, amoxycillin, clarithromycin/secnidazole) and
were followed up to determine the recurrence of peptic ulcer or
H. pylori. Urea breath test, rapid urease test, and histology were
performed. Presence of duodenal pseudodiverticula (PD) and/or
duodenal bulb (DD) deformity was noted on endoscopy.
Results. Two hundred fifty-seven patients (222 males) with a
mean age of 38.3 (± 13.1) years were included in the study. H. pylori
eradication attempts were: 1–169; 2–59; 3 –21; 4 – 6; 5 –1; 6–1 (no. of
attempts : no. of patients). In patients with presence of PD and/or
DD (n = 172) as compared to patients without PD/DD (n = 85),
primary failure of eradication (16.3% versus 18.9%), recurrence of
H. pylori (30.4% versus 31.6%), and recurrence of ulcer (36.4%
versus 18.8%, p = .06) was not significantly different. However, in
patients with presence of PD (n = 90) and without PD (n = 167),
there was a significantly increased rate of recurrence of H. pylori
(45.9% versus 31.6%, p = .05) and recurrence of ulcer (36.4%
versus 21.2%, p = .01).
Conclusion. Presence of duodenal pseudodiverticulae is an
important factor predicting recurrence of H. pylori and ulcer in
patients with peptic ulcer disease.
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Abstract no.: 11.11
Is 1-week Proton Pump Inhibitor-Based Triple
Therapy Sufficient to Heal Peptic Ulcer?
J. P. Gisbert and J. M. Pajares
La Princesa University Hospital, Madrid, Spain
Aims. To systematically review the efficacy on ulcer healing of
1-week combination of a proton pump inhibitor (PPI) plus two
antibiotics and to perform a meta-analysis of randomized clinical
trials to evaluate whether 7 days of PPI-based triple therapy is
sufficient to heal peptic ulcer.
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556

Methods. Studies where 1-week PPI-based triple therapy was
administered to heal peptic ulcer were included. Randomized
clinical trials comparing the efficacy on ulcer healing of 7-day PPIbased triple therapy versus this same regimen but prolonging the
PPI for several more weeks were included in the meta-analysis.
Electronic and manual bibliographical searches were conducted.
Meta-analysis was performed combining the odds ratios (OR) of
the individual studies.
Results. Twenty-four studies (2342 patients) assessed ulcer
healing with 1-week PPI-based triple therapy. Mean healing rate
was 86%, and 95% in Helicobacter pylori-eradicated patients. Six
studies (862 patients) were included in the meta-analysis. Mean
ulcer healing rate with a 7-day treatment was 91% versus 92%
when PPI was prolonged for 2–4 more weeks (OR = 1.11; 95%
CI = 0.71–1.74).
Conclusion. In patients with peptic ulcer and H. pylori infection,
prolonging therapy with PPI after triple therapy for 7 days with a
PPI and two antibiotics is not necessary to induce ulcer healing.
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Abstract no.: 11.12
Rescue Therapy with Levofloxacin after Multiple
Helicobacter pylori Treatment Failures
J. P. Gisbert,* A. Perez-Aisa,† M. Castro-Fernandez,‡
E. Lamas,‡ F. Bermejo,§ J. Ducons,¶ M. FernandezBermejo,** L. Benito,†† A. Cosme,‡‡ L. Lopez-Rivas,§§
J. L. Gisbert,* S. Marcos,* D. Olivares* and J. M. Pajares*
*La

Princesa University Hospital, Madrid, Spain, †Hospital Costa del
Sol, Malaga, Spain, ‡Hospital de Valme, Sevilla, Spain, §Hospital de
Fuenlabrada, Madrid, Spain, ¶Hospital San Jorge, Huesca, Spain,
**Hospital San Pedro de Alcantara, Caceres, Spain, ††Hospital Virgen del
Toro, Menorca, Spain, ‡‡Hospital de Donostia, San Sebastian, Spain,
§§Hospital San Agustin, Asturias, Spain
Aim. Eradication therapy with proton pump inhibitor,
clarithromycin, and amoxicillin is extensively used, although it fails
in a considerable number of cases. A rescue therapy still fails in
more that 20% of the cases. Our aim was to evaluate the efficacy
and tolerability of a levofloxacin-based regimen in patients with
two consecutive Helicobacter pylori eradication failures.
Patients and Methods. Design: Prospective multicenter study
including nine Spanish centers. Patients: In whom a first eradication
trial with omeprazole–clarithromycin–amoxicillin and a second
trial with omeprazole–bismuth–tetracycline–metronidazole (44
patients) or ranitidine bismuth citrate with these same antibiotics
(11 patients) had failed. Intervention: A third eradication regimen
with levofloxacin (500 mg b.i.d.), amoxicillin (1 g b.i.d.), and
omeprazole (20 mg b.i.d.) was prescribed for 10 days. Compliance
with therapy was determined from interrogatory and recovery of
empty envelopes of medications. Outcome: H. pylori eradication
was defined as a negative 13C-urea breath test 8 weeks after
completing therapy.
Results. Fifty-five patients, mean age 52 years, 45% males, 55%
peptic ulcer, 45% functional dyspepsia. All patients but four (93%)
took all the medications correctly. Per-protocol and intention-totreat eradication rates were both 67% (95% CI = 54 –78%). Adverse
effects were reported in five (9%) patients, including metallic taste,
abdominal pain, nausea/vomiting, diarrhea, vaginal candidiasis,
arthralgia/myalgia, and tendinitis, but none of them were severe.
One patient abandoned the treatment due to adverse effects
(tendinitis), which were resolved spontaneously after finalizing
treatment.
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Conclusion. Levofloxacin-based rescue therapy constitutes an
encouraging strategy after multiple previous eradication failures with
key antibiotics such as amoxicillin, clarithromycin, metronidazole,
and tetracycline.

Abstract no.: 11.13
Eradication of Helicobacter pylori for the
Prevention of Ulcer Bleeding Recurrence
8Abstract
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J. P. Gisbert,* R. Garcia-Gravalos,* F. Feu,† M. Pique,†
F. Bory,‡ N. Cañete,‡ A. Benages,§ P. Almela,§ F. Borda,¶
R. Aznarez,¶ X. Calvet,** S. Santolaria,†† M. Montoro,††
A. Cosme,‡‡ A. Perez-Aisa,§§ N. Fernandez,§§
M. Castro-Fernandez,¶¶ D. Olivares* and J. M. Pajares*
*La

Princesa University Hospital, Madrid, Spain, †Hospital Clinic,
Barcelona, Spain, ‡Hospital del Mar, Barcelona, Spain, §Hospital Clinico,
Valencia, Spain, ¶Hospital de Navarra, Pamplona, Spain, **Hospital de
Sabadell, Barcelona, Spain, ††Hospital San Jorge, Huesca, Spain,
‡‡Hospital de Donostia, San Sebastian, Spain, §§Hospital Costa del Sol,
Malaga, Spain, ¶¶Hospital de Valme, Sevilla, Spain
Aim. Eradication of Helicobacter pylori is associated with a very
low rate of ulcer recurrence. Our purpose was to verify the effect
of H. pylori eradication on ulcer bleeding recurrence secondary to
peptic ulcer disease.
Methods. Patients with acute hemorrhage secondary to
gastroduodenal ulcer were prospectively included. NSAID use
was not considered an exclusion criteria. H. pylori infection was
confirmed by rapid urease test, histology, or 13C-urea breath test.
Several therapies were used, mainly omeprazole or ranitidine
bismuth citrate-based regimens. Afterwards, an H2-antagonist
(ranitidine 150 mg o.d.) was administered until eradication was
confirmed by 13C-urea breath test 8 weeks after completing
eradication therapy. Patients with therapy failure received a second
or third course of therapy. Patients with eradication success did not
receive maintenance anti-ulcer therapy, and were controlled yearly
up to 5 years with a 13C-urea breath test. NSAID use was not
permitted during follow-up.
Results. Up to now, 163 patients have been followed up for at least
12 months, with a total of 245 patient-years of follow-up. Mean age
was 60 years, 71% were males, and 46% were previous NSAID
users. Sixy-eight percent (68%) had duodenal ulcer, 25% gastric
ulcer, and 7% pyloric ulcer. Recurrence of bleeding was
demonstrated in one patient at 1 year (incidence: 0.4% per patientyear of follow-up), which occurred after NSAID use.
Conclusion. Rebleeding does not occur in patients with
complicated ulcers after H. pylori eradication. Maintenance antiulcer
(antisecretory) therapy is not necessary if eradication is achieved.
However, NSAID intake may cause rebleeding in H. pylorieradicated patients.
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Abstract no.: 11.14
Reflux Esophagitis After Eradication of
Helicobacter pylori in Peptic Ulcer Patients:
Impact of Initial Corpus and Antral Gastritis
M. Katicic, M. Ticak, M. Prskalo, M. Dominis,
B. Sabaric, B. Skurla, T. Filipec-Kanizaj,
S. Naumovski-Mihalic, V. Colic-Cvrlje and B. Papa
University Hospital Merkur, Zagreb, Croatia
Helicobacter pylori infection usually causes antral gastritis with
increased acid secretion and risk of duodenal ulcer, or pangastritis
with risk of ventricular ulcer and suppression of acid secretion.
Eradication of the infection might therefore result in variable
effects on acid-related symptoms.
Aim. To investigate the prevalence of new GERD symptoms
(heartburn and regurgitation) in gastric and duodenal ulcer patients
after H. pylori eradication and consider its association with initial
antral and corpus gastritis.
Methods. Four hundred twenty-nine successfully eradicated
H. pylori-positive ulcers patients (GU 189; 90 women, 99 men; age
58.7 years; DU 240; 103 women, 137 men; age 51.0 years), were
followed up prospectively. After achieving eradication, all patients
underwent endoscopy for at least 1-year intervals (range, 1–
8 years). H. pylori status was checked by endoscopy with histology
(two from antrum and two from corpus), and GERD status using
questionnaire. The presence of gastritis was classified according to
the updated Sydney classification, modified for the purpose of this
study: Gastritis score (GS): activity (1–3) + chronic gastritis (1–3)
+ atrophy (1–3) for two specimens (corpus, antrum).
Results. Forty-seven (25%) of 189 GU patients and 72 (30%) of
240 DU patients worsened their GERD symptoms after H. pylori
eradication. Among these patients initial corpus, GS was significantly
higher than in patients without new GERD symptoms (GU 4.45
versus 3.52; DU 3.78 versus 2.78). Antrum GS did not show any
significant difference (GU 5.34 versus 5.21; DU 5.42 versus 5.29).
Conclusion. H. pylori eradication in peptic ulcer patients with
corpus gastritis, which is associated with an increase in gastric acid
secretion, may be an important factor determining the higher
prevalence of post-H. pylori eradication GERD.
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Abstract no.: 11.15
Rescue Therapy with Rifabutin after Multiple
Helicobacter pylori Treatment Failures
J. P. Gisbert,* L. Bujanda,† X. Calvet,‡ J. L. Gisbert,*
S. Marcos,* D. Olivares* and J. M. Pajares*
*La Princesa University Hospital, Madrid, Spain, †Hospital de Donostia,
San Sebastian, Spain, ‡Hospital de Sabadell, Barcelona, Spain

Aim. Eradication therapy with proton pump inhibitor,
clarithromycin and amoxicillin is extensively used, although it fails
in a considerable number of cases. A rescue therapy still fails in
more that 20% of the cases. Our aim was to evaluate the efficacy
and tolerability of a rifabutin-based regimen in patients with two
consecutive Helicobacter pylori eradication failures.
Patients and Methods. Design: Prospective multicenter study.
Patients: In whom a first eradication trial with omeprazole–
clarithromycin–amoxicillin and a second trial with omeprazole–
bismuth–tetracycline–metronidazole (17 patients) or ranitidine
bismuth citrate with these same antibiotics (43 patients) had failed.
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556
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Intervention: A third eradication regimen with rifabutin (150 mg
b.i.d.), amoxicillin (1 g b.i.d.) and omeprazole (20 mg b.i.d.) was
prescribed for 10 –14 days. Compliance with therapy was
determined from interrogatory and recovery of empty envelopes
of medications. Outcome: H. pylori eradication was defined as a
negative 13C-urea breath test 8 weeks after completing therapy.
Results. Fifty-eight patients, mean age is 55 years, 38% males,
38% peptic ulcer, 62% functional dyspepsia. All patients but one
took correctly all the medications. Per-protocol and intentionto-treat eradication rates were 65% (95% CI = 52–76%) and 64%
(51–75%). Adverse effects were reported in 23 (38%) patients,
including abdominal pain, nausea/vomiting, diarrhea, stomatitis,
fever/myalgia, and oral candidiasis. One patient abandoned the
treatment due to adverse effects (vomiting). Six patients (10%) had
neutropenia (< 1500) and/or thrombopenia (< 150,000), which resolved
spontaneously after finalizing treatment (although granulocyte
growth factor was prescribed in one case with < 500 neutrophils).
Conclusion. Rifabutin-based rescue therapy constitutes an encouraging strategy after multiple previous eradication failures with key
antibiotics such as amoxicillin, clarithromycin, metronidazole,
and tetracycline.

Abstract no.: 11.16
7-Day Ranitidine Bismuth Citrate- Versus
Levofloxacin-Based Triple-Rescue Therapy after
Helicobacter pylori Treatment Failure
8Abstract
Abstracts

J. P. Gisbert, J. L. Gisbert, S. Marcos, D. Olivares and
J. M. Pajares
La Princesa University Hospital, Madrid, Spain
Aim. Ranitidine bismuth citrate (RBC)-based rescue regimen has
been demonstrated to be an alternative to quadruple rescue therapy
after Helicobacter pylori eradication failure. On the other hand,
levofloxacin has, in vitro, remarkable activity against H. pylori.
Our aim was to compare, by a randomized trial, two different
7-day triple rescue regimens based on RBC or levofloxacin.
Methods. Patients in whom a first eradication trial with
omeprazole–clarithromycin–amoxicillin had failed were randomized,
in this single-center study, to receive 7-day treatment with: 1, RBC
(400 mg b.i.d.), tetracycline (500 mg q.i.d.), and metronidazole
(250 mg q.i.d.); or 2, levofloxacin (500 mg b.i.d.), amoxicillin
(1 g b.i.d.), and omeprazole (20 mg b.i.d.). Cure rates were
evaluated by 13C-urea breath test.
Results. At present, 67 patients have been included (22% peptic
ulcer, and 78% functional dyspepsia): 36 received the RBC
regimen, and 31 the levofloxacin one. Groups were comparable in
terms of demographic variables. Three percent of the patients (one
in each group) did not return for follow-up. Compliance was
slightly worse with the RBC regimen than with the levofloxacin
regimen (89% versus 97%; nonstatistically significant differences).
Side-effects (only mild/moderate) in the two groups were comparable
(about 40%). Tendinitis occurred in three (10%) patients treated
with levofloxacin. Per-protocol cure rates were 68% (95% CI, 50–
81%) in the RBC group and 69% (51– 83%) in the levofloxacin
group. Intention-to-treat cure rates were, respectively, 67% (50–
80%) and 68% (50–81%) (nonstatistically significant differences).
Conclusions. Both RBC- and levofloxacin-based rescue regimens
represent effective alternatives to quadruple therapy in patients
with omeprazole–clarithromycin–amoxicillin failure.
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Abstract no.: 11.17
Telithromycin-Based 7-DayTripleTherapy for the
Treatment of Helicobacter pylori Infection
D. Antos,* E. Bayerdörffer,† E. Bästlein,‡
W. Schneider-Brachert,§ J. Bubeck,‡ J. Alter,‡
M. Stolte¶ and N. Lehn§
*Dr

von Haunersches Kinderspital, Ludwig-Maximilians-University,
Munich, Germany, †Department of Hematology & Oncology,
University Hospital Marburg, Marburg, Germany, ‡Gastroenterologist
in private practice, Cologne, Germany, §Institute for Medical
Microbiology, University Hospital Regensburg, Regensburg, Germany,
¶Institute of Pathology, Klinikum Bayreuth, Bayreuth, Germany
Background. Failed primary anti-Helicobacter pylori therapy
results in a high rate of antimicrobial resistance. This necessitates a
search for new regimens to cure H. pylori infection. The aim of this
study was to evaluate the efficacy and tolerability of new
telithromycin containing 7-day triple therapy and to compare it
with standard French triple therapy in patients with known
H. pylori susceptibility to metronidazole and clarithromycin.
Methods. Fifty-five patients with documented antibiotic
sensitivity (E-test) and indication for anti-H. pylori treatment
based on 2/2000 Maastricht guidelines were randomized to receive
either esomeprazole 2 × 40 mg, telithromycin 2 × 400 mg, and
amoxycillin 2 × 1 g for 7 days (ETA, n = 28), or esomeprazole
2 × 20 mg, clarithromycin 2 × 500 mg, and amoxycillin 2 × 1 g for
7 days (ECA, n = 27). Cure check was performed 4–6 weeks after
conclusion of therapy.
Results. All 55 patients completed treatment and returned to the
examination after treatment. All 55 patients were available for perprotocol analysis. Twenty-seven of 28 patients of the ETA group
(96.4%, CI:86–99%) became H. pylori-negative compared with 24
of the 27 patients of the ECA group (88.9%, CI:76–93%, difference
between groups statistically not significant). Both regimens were
generally well tolerated with minor adverse events being seen in 8
patients (28.6%) of the ETA group and in 11 (40.7%) of the ECA
group. None of the patients discontinued treatment prematurely
due to adverse events.
Conclusion. The data of this pilot study suggest a better than 80%
efficacy of the new 7-day telithromycin triple therapy, which is
within the range of the French triple therapy in patients with METand CLA-susceptible strains.
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Abstract no.: 11.18
Eradication of Helicobacter pylori Infection in
a Large Population: 1-Day Quadruple Therapy
Compared with 7-Day Triple Therapy
L. Zhang, J. Ma, K. Pan, J. Li and W. You
Peking University School of Oncology, Beijing, China
Aims. To compare the efficacies of 1-day and 7-day therapies, we
conducted a large-scale trial of Helicobacter pylori eradication with
two therapies.
Methods. A total of 401 healthy residents aged 25–49 years from
Linqu, China were invited to participate in this study. The status of
H. pylori infection of each participant was determined by a 13Curea breath test. The participants were assigned into two aims: 158
participants received a 7-day triple treatment (four 250-mg capsule
of amoxicillin, b.i.d.; two 250-mg tablets of clarithromycin, b.i.d.,
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and one 30-mg capsule of lansoprazole, b.i.d.), and 243 participants
received a 1-day quadruple therapy (2 g amoxicillin, q.i.d.; 500 mg
metronidazole, q.i.d.; three 300-mg capsules of bismuth citrate,
q.i.d.; two 30-mg capsules of lansoprazole once daily). Six weeks
after the treatment, all the participants underwent a 13C-UBT to
assess the eradication of H. pylori infection.
Results. Of the participants, 229 completed the 1-day therapy
(94.3%) and 148 participants completed the 7-day therapy (93.7%).
Sixty-four of 229 participants (27.95%) had negative results of the
secondary 13C-UBT in the 1-day therapy. One hundred three of
148 participants (69.59%) had negative results in the 7-day therapy.
Conclusion. The 7-day triple therapy was efficient for H. pylori
eradication, and the 1-day therapy had a significantly lower cure
rate.

Abstract no.: 11.19
Helicobacter pylori Infection in HCV-Related
Chronic Liver Disease and Thrombocytopenia
Abstracts
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M. Candelli, E. C. Nista, G. Pignataro, M. Pompili,
M. A. Zocco, A. Grieco, G. Rapaccini, G. Gasbarrini
and A. Gasbarrini
Catholic University, Rome, Italy
Introduction. Helicobacter pylori and hepatitis C virus (HCV)
have been related to thrombocytopenia. Aim of this study was to
evaluate the effect of H. pylori eradication on platelet count in
patients with chronic liver disease affected by thrombocytopenia.
Methods. Fifty patients (10 women and 40 men; mean age,
65.8 ± 9.1) with liver disease (40 chronic hepatitis, 10 cirrhosis)
were enrolled by the Internal Medicine Department of Gemelli
Hospital in Rome. All patients with a platelet count < 100,000/
cmm performed a 13C-urea breath test and an evaluation of
antiplatelet associated antibodies. Patients with thrombocytopenia
and positive for H. pylori were eradicated with a standard therapy.
Eradication of H. pylori was evaluated 6 weeks after by UBT.
A platelet count was performed 1 and 3 months after H. pylori
eradication. A Mann–Whitney U-test was used to evaluate
differences between groups.
Results. Four patients with hepatitis and one with cirrhosis
presented low platelets count (mean values: 72,000 ± 17,000/cmm)
and were positive for H. pylori infection. Three patients with
hepatitis and one with cirrhosis were positive for antiplateletassociated antibodies. A significant improvement in platelet count
was observed in patients eradicated and with positive platelets
autoantibodies at one (70,000 ± 17,000/cmm versus 101,000 ± 12,000/
cmm; p < .001) and at 3 months (70,000 ± 17,000/cmm versus
99,000 ± 13,000/cmm). No improvement was observed after
eradication in the patient with negative platelet auto-antibodies.
Conclusions. Thrombocytopenia is common in HCV chronic
liver disease and related to H. pylori gastric infection by means of
autoimmune mechanisms. H. pylori eradication improves platelets
count. Further larger studies are needed to confirm these
observations.
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Abstract no.: 11.20
Clinical Trial Evaluating Amoxicillin and
Clarithromycin Hydrogels (Chitosan–Polyacrylic
Acid Polyionic Complex) for Helicobacter pylori
Eradication
J. P. Gisbert,* S. Torrado,† D. Olivares* and
J. M. Pajares*
*Gastroenterology

Unit, La Princesa University Hospital,Autonomous
University, Madrid, Spain, †Department of Pharmaceutical Technology,
School of Pharmacy, Complutense University, Madrid, Spain
Aim. It has been suggested that enhancement of amoxicillin or
clarithromycin concentration in the gastric tissue may improve
the anti-Helicobacter pylori effect of these drugs. This could be
achieved by allowing the drug to remain longer in the stomach
using freeze-dried hydrogels. Our aim was evaluate the efficacy of
an H. pylori-eradication regimen including amoxicillin and
clarithromycin hydrogels.
Patients and Methods. Design: Prospective clinical trial. Patients:
With functional dyspepsia (eight patients) or peptic ulcer (20
patients). Intervention: Seven-day regimen including rabeprazol
(20 mg b.i.d.), amoxicillin (1 g b.i.d.), and clarithromycin (500 mg
b.i.d.). In addition, amoxicillin and clarithromycin hydrogels were
administered twice daily during the 7 days. The hydrogel or
polyionic complex was prepared with Chitosan (Fluka Biochemika)
and Carbopol® 974P NF (BF Goodrich). Compliance with therapy
was determined from interrogatory and recovery of empty
envelopes of medications. Outcome: H. pylori eradication was
defined as a negative 13C-urea breath test 8 weeks after completing
therapy.
Results. At present, 28 patients have been included (mean age
45 years, 61% males). Eighty-nine percent of the patients took
correctly all the medications. Per-protocol and intention-to-treat
eradication rates were 72% (95% CI = 52–86%) and 71% (53–
85%). Adverse effects were reported in four (14%) patients,
including diarrhea in three patients, and nausea and heartburn in
one patient. No patient abandoned the treatment due to adverse
effects.
Conclusion. Although freeze-dried polyionic complexes could
serve as suitable candidates for amoxicillin/clarithromycin sitespecific delivery in the stomach, its addition does not increase the
eradication efficacy of the generally prescribed PPI–amoxicillin–
clarithromycin regimen.
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Abstract no.: 11.21
Difference in Helicobacter pylori Eradication
Rates in Patients with Peptic Ulcer and
Non-Ulcer Dyspepsia
S. Suh,* D. Lee,† Y. Park,† J. Hwang,† J. Kim,† N. Kim,†
H. Jung* and I. Song*
*Seoul

National University Hospital, Seoul, Republic of Korea, †Seoul
National University Bundang Hospital, Sungnam, Republic of Korea

Background. Physicians should try to achieve an optimal cure rate
with their initial Helicobacter pylori eradication therapy. Most
physicians use the same treatment in all their patients. There has
been several reports that H. pylori infection in patients with peptic
ulcer disease (PUD) is more likely to be cured than that in patients
with non-ulcer dyspepsia (NUD). But there is no report in Korea
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556
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about that issue. The aim of this study was to evaluate the
difference of eradication rates of H. pylori between patients with
PUD and patients with NUD in Korea.
Methods. Two hundred ninety-seven patients who underwent
upper endoscopy and treated with 7-day triple therapy (proton
pump inhibitor + amoxicillin + clarithromycin) and follow-up urea
breath test were reviewed retrospectively.
Results. Two hundred thirty-seven of 297 patients were PUD
(98 gastric ulcers, 167 duodenal ulcers, 28 both ulcers), and 60 of
297 patients were NUD. The eradication rates of each group were
85.7% (95% CI 80.6–89.6%) and 73.3% (95% CI 61.0–82.9%).
The eradication rate of the NUD group was lower than that of
PUD group ( p = .032).
Conclusion. The 7-day triple therapy with proton pump inhibitor
showed rather lower eradication rate in patients with NUD than
patients with PUD. Therefore, extension of treatment duration or
a more potent regimen may be needed for eradication of H. pylori
in patients with NUD.

Abstract no.: 11.22
Eradication Rate After RandomizedTreatment in
a Population with High Prevalence of
Helicobacter pylori Infection
Abstracts
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A. V. Makarenka and S. I. Pimanov
State Medical University,Vitebsk, Belarus
The aim of this study was to estimate the efficacy of eradication in
the region with high prevalence of the infection.
Patients and Methods. A total of 220 patients with Helicobacter
pylori-associated peptic ulcer were randomized to receive
omeprazole 20 mg, clarithromycin 500 mg, and amoxicillin 1000
b.i.d. for 7 days (OCA7, n = 34), for 14 days (OCA14, n = 33), the
same but also omeprazole 40 mg b.i.d. for 7 days (OOCA7,
n = 33), the same but also rabeprazole 20 mg b.i.d. (RCA7, n = 32),
colloidal bismuth subcitrate 240 mg b.i.d., amoxicillin 1000 b.i.d.,
and furazolidone 200 mg b.i.d. for 7 days (BAF7, n = 20; this
protocol was stopped prematurely); the same but also with
omeprazole 20 mg b.i.d. (OBAF7, n = 33); the same but also for
14 days (OBAF14, n = 35). The results of eradication were estimated
in accordance with RUT, data of polymerase chain reaction (PCR)
method, and/or histology examinations in 2 months after treatment.
Results. According to the results of RUT and RUT + histology/
PCR per protocol the eradication rates were 88.9 and 22.2% for
the OCA7; 96.2 and 38.4% for the OCA14; 92.9 and 39.3% for
the OOCA7; 83.3 and 30.0% for the RCA7; 12.5 and 6.2% for the
BAF7; 35.7 and 17.9% for the OBAF7; 81.3 and 34.4% for the
OBAF14 groups, respectively.
Conclusion. According to RUT data, the efficacy of triple
eradication therapy in the population with high prevalence of
H. pylori infection makes up about 83.3–96.2%, but if histology/
PCR methods are used additionally, these results are worse.
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Abstract no.: 11.23
Inhibition of Helicobacter pylori by Whole Cells
and Cellular Fractions of Lactobacillus
Plantarum
S. Rokka, V. Joutsjoki and H. Korhonen
MTT Agrifood Research Finland, Jokioinen, Finland
Background. Antibiotic resistance is a growing problem in the
treatment of Helicobacter infection. Further, it is not recommended
to treat all asymptomatic people with antibiotics. A number of
strains of lactic acid bacteria used in food fermentation have been
shown to inhibit the growth of Helicobacter pylori. The aim of this
study was to test the anti-Helicobacter activity of a Lactobacillus
plantarum MLBPL1 isolated from sauerkraut.
Methods. L. plantarum MLBPL1 was cultivated in MRS broth.
Cell-free culture supernatant was obtained by centrifugation.
Harvested cells were washed with HEPES. Washed cells were
mixed with glass beads and disrupted in a homogenizer. Cell wall
fragments and the intracellular fraction were separated from the
whole cell lysate by centrifugation. H. pylori NCTC 11637
suspension was distributed on brucella agar plates. Wells cut with
sterile straw were filled with sample of MLBPL1. Plates were
incubated under microaerophilic conditions for 3 days, and the
diameters of inhibitory zones were measured.
Results. The anti-Helicobacter activity was present in washed
MLBPL1 cells with an average diameter of inhibition zones 22 mm.
The inhibitory diameters of culture supernatant, whole-cell lysate
and cell wall fragments were 10, 15, and 12 mm, respectively. The
intracellular fraction did not inhibit the growth of Helicobacter.
Conclusion. In addition to the culture supernatant, the whole cells
as well as cell lysate of L. plantarum MLBPL1 contained antiHelicobacter activity. This suggests that the main activity is
primarily located in the cell wall from where it is probably
extracted into the culture supernatant.
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Abstract no.: 11.24
How Does Vitamin C Administration Decrease
the Risk of Gastric Cancer in the Helicobacter
pylori-Positive Patients with Atrophic Gastritis?
A. Tari,* Y. Kitadai,† M. Sumii,† H. Tani,* S. Tanaka† and
K. Chayama†
*Department

of Internal Medicine/Hiroshima Red Cross Hospital &
Atomic-Bomb Survivors Hospital, Hiroshima, Japan, †Hiroshima
University School of Medicine, Hiroshima, Japan
Introduction. A significant decrease in intestinal metaplasia of
gastric mucosa was achieved by coadministration of ascorbic acid
with Helicobacter pylori eradication in an Italian study.
Aims and Methods. This study investigates the usefulness of
vitamin C administration with or without H. pylori eradication to
prevent the development of gastric cancer in H. pylori carriers with
atrophic gastritis. Fifteen H. pylori-positive patients with moderate
to severe atrophic gastritis were divided into two groups, eight
patients successfully eradicated and seven patients nontreated. We
administrated ascorbic acid (1200 mg/day) orally for 4 months and
analyzed gastric juice pH, nitrite, and total vitamin C concentrations
in gastric juice and plasma, serum gastrin concentrations, and the
intensity of neutrophil infiltration in gastric mucosa before and
after ascorbic acid treatment.
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Results. In H. pylori-eradicated patients, acid output recovered
and the ratio of gastric juice to plasma vitamin C concentration
increased. Intragastric nitrite concentration decreased by
increment of intragastric vitamin C. Administration of vitamin C
to H. pylori carriers changed neither the concentrations of
intragastric vitamin C nor intragastric nitrite.
Conclusion. Administration of vitamin C with successful H. pylori
eradication can decrease the risk of gastric cancer in H. pylori-positive
patients before the development of stable mutation.
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Abstract no.: 11.26
Difference in Helicobacter pylori Eradication
Rates of the Second-Line Therapy in Patients
with Peptic Ulcer Disease and Non-Ulcer
Dyspepsia
S. Chung,* D. Lee,* N. Kim,* S. Jung,* J. Kim,* J. Hwang,*
Y. Park,* K. Lee,* H. Jung† and I. Song†
*Liver

Abstract no.: 11.25
Clinical Predictors Affecting the Eradication of
Helicobacter pylori
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Y. Byun, Y. Jo, J. Lee, S. Kim, S. Kim, H. Lee, Y. Park,
W. Shin and M. Song
Eulji Hospital, Seoul, Republic of Korea
Background and Aims. Antibiotic resistance and compliance are
regarded as the more important factors to affect the eradication.
However, it is not easy to applicate the antibiotic resistance test to
clinical field. We investigated other clinical predictors affecting the
eradication of Helicobacter pylori.
Methods. We retrospectively investigated the patients with
documented H. pylori infection between January 2004 and March
2005. All received a 1-week proton pump inhibitor (PPI)-based
triple therapy and examined the underlying chronic illnesses,
smoking, alcohol, therapeutic indication, and compliance scoring.
Eradication was assessed by 13C-urea breath test, rapid urease test,
or endoscopy at 4–6 weeks after therapy.
Results. Including 195 patients, the intention-to-treat (ITT)
eradication rates was 72.31%. The per protocol (PP) analysis on
the 169 patient gives an initial eradication rate of 83.43%. The
eradication rates according to the endoscopic indication were
81.96% (50/61) in GUs, 86.04% (37/43) in DUs, 81.28% (22/27) in
gastritis, 84.21% (16/19) in GU + DU, 85.71% (6/7) in polyps,
50% (1/2) in EGCa, and 100% (6/6) in the familial cancer history.
The rates according to the underlying chronic illnesses were
82.60% (19/23) in the diabetes, 70.37% (19/27) in the hypertension,
66.7% (2/3) in the renal disease, 100% (2/2) in the liver disease,
72.72% (8/11) in the cardiovascular disease, and 75% (9/12) in the
NSAIDs-related disease. There were no statistically significant
differences in the eradication rates according to the endoscopic
therapeutic indication, underlying diseases, sex, age, smoking,
alcohol, and PPI. The eradication rate was significantly higher in
compliant patients than in noncompliant patients ( p < .05).
Conclusions. Patient’s compliance for regimens should be the
most important factor that affects H. pylori eradication in the
clinical practice.
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Research Institute/Internal Medicine/Seoul National University
Bundang Hospital, Seongnam, Republic of Korea, †Liver Research
Institute/Internal Medicine/Seoul National University Collage of
Medicine, Seoul, Republic of Korea
Purpose. Proton pump inhibitor (PPI)-based triple therapy for
Helicobacter pylori eradication is widely used with considerable
failure rate (10–20%). Physicians should try to achieve an optimal
cure rate with their second-line therapy for H. pylori eradication.
There has been several reports that initial PPI-based triple therapy is
more effective in patients with peptic ulcer disease (PUD) than patients
with non-ulcer dyspepsia (NUD). But there is no report in secondline therapy for H. pylori eradication in that issue. Our aim was to
evaluate the difference in H. pylori eradication rates of the secondline therapy between patients with PUD and patients with NUD.
Methods. The subjects consisted of 65 patients infected with
H. pylori, who underwent endoscopy and failed eradication with
initial PPI-based triple therapy. They retreated with bismuth-based
quadruple therapy (PPI + bismuth + metronidazole + tetracycline)
and follow-up urea breath test were reviewed retrospectively.
Results. Forty-six of 65 patients were PUD (19 gastric ulcers, 26
duodenal ulcers, 1 both ulcers), and 19 of 65 patients were NUD.
The H. pylori eradication rates of the second-line therapy in PUD
group and NUD group were 93.1% (90% CI 85.4–100%) and
76.4% (90% CI 55.1–97.9%). The eradication rate of NUD group
was lower than that of PUD group ( p < .05).
Conclusions. Bismuth-based second-line therapy for H. pylori
eradication showed rather lower eradication rate in patients with
NUD than patients with PUD. Therefore, extension of treatment
duration or more potent regimen may be needed for second-line
therapy in patients with NUD.
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Abstract no.: 11.27
Therapeutic Effect of Lactobaccilus gasseri and
Plaunotol on Helicobacter pylori Infection
A. Takagi* and Y. Koga†
*General

Internal Medicine, Tokai University, Isehara, Japan,
Disease, Tokai University, Isehara, Japan

†Infectious

Proton pump inhibitor (PPI)-based triple therapy has been widely
applied to patients with Helicobacter pylori infection. However,
rate of treatment failure due to antibiotic resistance is increasing.
Probiotics are microorganisms with beneficial properties for the
host. We have demonstrated that Lactobaciilus gasseri has an
inhibitory effect on H. pylori. Furthermore, plaunotol, an acyclic
diterpene alcohol extracted from leaves of the plau-noi tree in
Thailand, has been used in Japan as a unique anti-ulcer agent for
patients with gastric ulcer. To determine the clinical usefulness of
Lactobacillus strains on H. pylori infection, we conducted a pilot
study in patients with chronic gastritis.
The 25 subjects were divided into two groups: a group receiving
of 120 g yogurt containing L. gasseri twice daily for 8 weeks and a
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556
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control group receiving yogurt without L. gasseri. Gastric biopsy
specimens were obtained from both the antrum and the body.
Gastric mucosal IL-8 levels were determined by ELISA. Histologic
findings were assessed using the updated Sydney classification.
IL-8 levels were significantly decreased after 8 weeks of ingesting
L. gasseri ( p = .0003). In contrast, IL-8 levels were not significantly
decreased in the control group. However, the histologic gastritis
scores did not differ between the two groups. After this study, 11
subjects continued to consume yogurts with L. gasseri twice a day
and were treated with gastroprotective agents, plaunotol 240 mg
for up to 6 months. Thereafter, we found that combination therapy
with plaunotol and L. gasseri improved hisitologic findings of
gastritis ( p = .0416). These findings suggest that plaunotol and
L.gasseri is effective for patients with H. pylori.

Abstract no.: 11.28
Seven-Day Triple Rabeprazole-Containing
Helicobacter pylori Eradication Therapy on the
Texas–Mexican Border
Abstracts
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V. Cardenas,* A. R. Opekun,† A. Campos,*
L. Guerrero,* H. M. T. El-Zimaity,† A. Chavez*
and D. Y. Graham†‡
*University

of Texas School of Public Health, El Paso, TX, USA,
College of Medicine, Houston, TX, USA, ‡Micheal E. DeBakey
VAMC, Houston, TX, USA
†Baylor

Background. Antibiotic resistance is the main reason of failure of
triple Helicobacter pylori eradication therapy with PPI-amoxicillinclarithromycin triple therapy.
Aims. To test a triple therapy in a population along the US–
Mexico border in relation to clarithromycin resistance.
Methods. A random sample of adults from Ciudad Juarez with
H. pylori infections received rabeprazole 20 mg, clarithromycin
0.5 g, and amoxicillin 1 g, each b.i.d. for 7 days. Efficacy was
assessed by 13C-urea breath test (UBT) carried out 4 or more weeks
after therapy.
Results. One hundred twenty-two patients were enrolled, and 111
were evaluated by UBT at 4 or more weeks after receiving therapy.
A total of 102 completed the protocol, 2 deviated from protocol,
and 5 stopped because of adverse events. The cure rate (ITT) was
93/111 (83.8% [95% CI = 76 – 89.8%]); the PP cure rate was 91/102
(89.2% [95% CI = 79.9–95.2%]). Side-effects were not serious and
only 6.6% (5/75) of those with AE stopped medication because of
side-effects. In the group of patients completing therapy, only 2.2%
of isolates had clarithromycin-resistant H. pylori (MIC = 0.5); none
of them had their infection cured. Resistance was not responsible
for most of the treatment failures in this population.
Discussion. In Ciudad Juarez, Mexico a 7-day rabeprazole
containing triple eradication therapy was both effective and welltolerated. Clarithromycin resistance was uncommon and the low
resistance rate may be responsible for the better outcome compared
to recent studies in US populations (Vakil et al., Aliment Pharm
Ther 2004;20:99–107).
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Abstract no.: 11.29
Antibacterial Effect of Crude Drugs on
Helicobacter pylori Infection
S. Shiomi,* M. Kita,* S. Tachibana,* S. Imamura,†
T. Yamamoto,* Y. Yamaoka,‡ M. Noda,* H. Konishi,*
S. Mitsufuji,* K. Kataoka,* T. Okanoue* and J. Imanishi*
*Kyoto Prepectural University of Medicine Graduate School of Medical
Science, Kyoto, Japan, †Nara City Hospital, Nara, Japan, ‡Baylor
College of Medicine, Houston, TX, USA

Aim. The eradication of Helicobacter pylori using antibiotics is
effective for the treatment of gastroduodenal diseases. However, it
has recently been reported that resistance to these antibiotics is
developing. In the present study, the antibacterial effect of crude
drugs against H. pylori was examined in vitro and in vivo.
Method. Crude drug: Rhei rhizoma, Coptidis rhizoma, Artemisiae
capillari flos, Caryophylli flos, Glycyrrhizae radix, etc., were used.
In vitro: 100 µl of water extract solution (1 mg/ml) of each crude
drug was added to 900 µl of suspension of H. pylori (1 × 107 cfu/ml),
and shaken in microaerobic round-bottomed tube under 37 °C and
then 10 µl of them was applied to blood agar, cultivated for 7 days
under microaerobic conditions, and the number of colonies was
counted.
In vivo: The water extract solution (1 mg/ml) of each crude drugs
was administered orally toC57BL/6 mice for 2 weeks after
inoculation with H. pylori, and then the numbers of H. pylori in the
stomach were measured 4 weeks later.
Result. R. rhizoma, A. capillari flos, and C. flos inhibited the
growth of H. pylori at a dose of 1 mg/ml and 1 × 10−1 mg/ml in
contact for 6 hours or more in vitro. H. pylori in the stomach was
significantly reduced in the R. rhizoma, A. capillari flos, C. flos, and
G. radix treatment groups compared with the control group in
vivo.
Consideration. These results suggest that C. rhizoma, A. capillari
flos, C. flos, and G. radix may be clinically useful for treatment of
H. pylori infection.
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Abstract no.: 11.30
14-day Quadruple Therapy with Ranitidine
Bismuth Citrate After Helicobacter pylori
Treatment Failure
D. Thong-Ngam, V. Mahachai and Chulalongkorn
Helicobacter Study Group
Chulalongkorn University Hospital, Bangkok, Thailand
Background. As a second-line therapy after Helicobacter pylori
treatment failure, a quadruple therapy with a proton pump inhibitor,
bismuth, metronidazole, and tetracycline is recommended.
Aims. To evaluate the efficacy of 14-day ranitidine bismuth citrate
(RBC)-based quadruple therapy.
Methods and Materials. Between June 2003 and May 2005, 34
patients who were H. pylori-positive after first-line (omeprazole,
amoxicillin, clarithromycin, or metronidazole) treatment failure
received 14-day quadruple therapy with RBC (400 mg b.i.d.),
rabeprazole (20 mg b.i.d.), metronidazole (500 mg t.i.d.), and
tetracycine (500 mg q.i.d.). Four weeks after completion of
treatment, eradication was confirmed with 14C-urea breath test.
Results. There are 18 men (52.9%) and 16 women (47.1%) with
mean age 47.34 ± 14.62 years. Per protocol eradication rate was
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86.7% and the intention-to-treat eradication rate was 76.5%.
Adverse effects were found 38.2% with bitter taste, nausea, and
dizziness. The mean age in the treatment failure group was
significantly younger than in the successful group (35.25 ± 13.91
versus 51.14 ± 13.88 years, p = .046). The abdominal symptoms
were improved after eradication (82.4%).
Conclusions. Fourteen-day quadruple therapy with ranitidine
bismuth citrate is effective and well tolerated for Helicobacter
pylori treatment failure. The younger age is a predictor of a
retreatment failure.

Abstract no.: 11.31
Antihelicobacterial Effect of Electrochemically
Activated Solutions and Prospects of Their
Application for Eradication of Helicobacter pylori
Abstracts
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L. G. Bajenov,*† E. V. Rizaeva* and S. S. Bajenova‡
*Republican

Specialized Centre of Surgery, Tashkent, Uzbekistan,
Helicobacter Study Group, Tashkent, Uzbekistan,
‡First Tashkent State Medical Institute, Tashkent, Uzbekistan
†Uzbek

Antihelicobacterial activity of the electrochemically activated
solutions (ECAS), in particular neutral anolyt (NA) and prospects
of its use for eradication of Helicobacter pylori were studied.
NA was produced with the help of the device “STEL.” The
preparation represents a colorless transparent liquid with a slight
chlorine odor, contains high-activity oxygenous combinations of
chlorine, free radicals, ozone – adding antimicrobial and washing
properties. NA is estimated on concentration of active chlorine, in
the initial solution it makes 350 ± 50 mg/l, pH 6.0 ± 1.0, redox
potential 700 ± 100 mV. NA antimicrobial effect was studied in
relation to the H. pylori clinical strains (7) and members of a normal
intestinal microflora (Escherichia coli, Lactobacillus plantarum,
Bifidobacterium bifidum, Bacteroides fragilis, etc.) by serial
dilution method in a fluid medium.
NA inhibited the growth of all examined microorganisms. At the
same time, the H. pylori cultures manifested the greatest sensitivity
to the researched agent. Even at dilution of the initial active chlorine
solution up to 6 mg/l, H. pylori practically instantaneously perished.
This sensitivity considerably exceeded that one of members of a
normal microflora, that allows to make a selective H. pyloridecontamination at sparing influence on normal microflora, thereby
reducing danger of development of disbacteriosis aggravating a
basic disease course.
The obtained results can become a basis for elaboration of
effective methods of treatment of helicobacteriosis applying ECAS.
Moreover, it is important that alongside expressed antihelicobacterial
activity and economic accessibility, these preparations also have
immunostimulating, anti-inflammatory, and regenerationaccelerating effects. Besides, microorganisms practically do not
acquire resistance to them.
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Abstract no.: 11.32
Gatifloxacin-Containing Sequential Therapy for
Helicobacter pylori Infection
D. Y. Graham,*† S. Abudayyeh,* H. M. T. El-Zimaity,*
J. Hoffman,† R. Reddy* and A. R. Opekun*
*Baylor

College of Medicine, Houston, TX, USA, †Michael E. DeBakey
VAMC, Houston, TX, USA

Background. The success rate of anti-Helicobacter pylori therapy
has continued to fall in part due to increasing resistance.
Aim. To test the sequential combination of high dose proton
pump inhibitor (PPI)-amoxicillin followed by the addition of
gatifloxacin for H. pylori infection.
Methods. This was a pilot study where patients with active
H. pylori infection received sequential therapy consisting of 40 mg
of esomeprazole and 1 g amoxicillin t.i.d., for 12 days. Both naive
and treatment failures were eligible. On days 6 through 12
gatifloxacin (400 mg in the morning) was added to produce a triple
therapy. Outcome was accessed by urea breath test (UBT) or
endoscopy with histology and culture performed 4–6 weeks after
ending antibiotic therapy.
Results. To date, the cure rate has been 100% among those who
received all three drugs. One patient stopped therapy after receiving
only the PPI plus amoxicillin, and therapy was unsuccessful. Side
effects include mild diarrhea/loose stools in 25%. Another patient
in whom gatifloxacin was contraindicated received 40 mg of
esomeprazole and 1 g amoxicillin t.i.d., for 12 days and then
metronidazole 500 mg t.i.d. on days 6 through 12 and the infection
was treated successfully.
Conclusion. Sequential therapy using the combination of highdose PPI and amoxicillin (the German therapy) followed by the
addition of gatifloxacin appears to be an excellent first- or secondline therapy for H. pylori infections.
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Abstract no.: 11.33
Sensitivity of the Clinical Strains of Helicobacter
pylori to Aspirinum
L. G. Bajenov*† and E. V. Rizaeva*
*Republican
†Uzbek

Specialized Centre of Surgery, Tashkent, Uzbekistan,
Helicobacter Study Group, Tashkent, Uzbekistan

The aspirinum antimicrobial activity in relation to Helicobacter pylori
comparing with other conditionally pathogenic microorganisms
was investigated in vitro.
The H. pylori clinical cultures (eight strains), gastric juice sample
inseminated with H. pylori (six samples), and Staphylococcus
aureus, Escherichia coli, and Candida albicans were tested.
Aspirinum antimicrobial activity was studied at its influence on
testing culture suspension in a saline. The aspirinum powder was
added to microbial suspensions and gastric juice samples from 10%
to 0.001% concentrations. Microbial suspensions and gastric juice
without aspirinum addition were used as a control. Inoculations
from these solutions were made on optimal mediums for each
microorganism after different expositions. Changes of pH of
solutions were insignificant and only at high aspirinum concentrations
(3% and above).
Aspirinum had a certain antimicrobial activity depending on
drug concentration, its influence duration, and examined microorganism species. The most sensitive one was H. pylori, for which
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556
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the minimum inhibiting aspirinum concentration made 10 µg/ml,
that was much lower than aspirinum concentration, created in a
stomach at an average therapeutic drug dosage.
Thus, alongside known adverse aspirinum effect on a stomach
mucous membrane, its positive effect also can take place that in
particular consists in H. pylori inhibition. This phenomenon can
be used in the creation of specialized drug forms and in the
elaboration of new effective schemes of eradication therapy and
prevention of helicobacteriosis with aspirinum application. Besides,
it would be expedient to study antihelicobacterial aspirinum
effect in cardiovascular patients, who are often prescribed with this
drug.

Abstract no.: 11.34
The Efficiency of Helicobacter pylori Eradication
in Eastern Siberia Inhabitants
Abstracts
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Methods. Patients with duodenal and gastric ulcer associated with
H. pylori, who were referred to endoscopy, were tested with antiH. pylori ELISA kit. H. pylori status for each patient was
determined by histology, rapid urease test (RUT), and culture.
Supervision over patients was conducted within 2 years. Treatment
was carried out with omeprazol 40 mg/day within 30 days;
amoxicillin, 2000 mg/day; and metronidazole, 1000 mg/day within
10 days in the beginning of treatment. Supporting therapy was
carried out using famotidine 20 mg/day within 1 month after the
termination of the basic course of treatment.
Results. The development frequency of duodenal and gastric ulcer
depends on the H. pylori eradication quality. At achievement of
eradication the number of recurrence within 2 years is only 5%. In
case of eradication absence, this parameter (38%) was practically
equal to the number of recurrence in that group which did not
receive anti-H. pylori treatments (40%).
Conclusions. The successful eradication of H. pylori in patients
with duodenal and gastric ulcer essentially reduces risk of
development of recurrence.

V. V. Tsukanov and E. A. Sugonyako
State Scientific Medical Research Institute for Northern Problems of
Siberian Division of Russian Academy of Medical Sciences,
Krasnoyarsk, Russian Federation
Aim. To study the influence of Helicobacter pylori eradication on
the frequency of ulcer disease relapse.
Methods. We examined 140 patients with duodenum ulcer disease
(93 men, 47 women). One hundred one subjects (group I, 57
subjects with noncomplicated cause; group II, 44 subjects with
ulcer hemorrhages) were provided with H. pylori eradication
by 7-day schedule: omeprasol (20 mg × 2 times) + clarithromycin
(500 mg × 2 times) + amoxycillin 1 g × 2 times). H. pylori was
diagnosed by morphological and urease techniques. Thirty-nine
subjects (group III, 24 subjects with ulcer hemorrhages; group IV,
15 subjects with noncomplicated cause) were made the control
group in which H. pylori eradication was not carried out.
Monitoring was made during 18 months.
Results. The efficiency of H. pylori eradication made 88.6% in
group I and 89.5% in group II. Acute ulcer disease during
18 months was marked in 27% subjects in group I and in 17.5%
subjects in group II, in 83.3% subjects in group III ( p < .01) in
73.3% subjects in group IV ( p < .01). During the reported period,
ulcer hemorrhages were not marked in group I and group II, their
frequency in group III and IV was 10.3% ( p < .05).
Conclusion. H. pylori eradication is an effective means of ulcer
disease prophylaxis, with its complications in Eastern Siberia
inhabitants.
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Abstract no.: 11.35
The Development Frequency of Duodenal and
Gastric Ulcer Recurrence Associated with
Helicobacter pylori after Eradication Therapy
J. Kazakbaeva,* T. V. Meka-Mechenko,* A. Zhangabylov†
and G. Esnazarova†

Abstract no.: 11.36
Anti-Helicobacter Activity of Novel Chalcones
8Abstract
Abstracts

M. Chen,* L. Zhai,* J. Blom,† L. P. Andersen* and
A. Kharazmi‡
*Department

of Clinical Microbiology, Rigshospitalet, Copenhagen,
Denmark, †Statens Seruminstitut, Copenhagen, Denmark,
‡Lica Pharmaceuticals A/S, Copenhagen, Denmark
Previously, we have shown that licochalcone A exhibits potent antiHelicobacter activity in vitro. In order to find new anti-Helicobacter
agents, a large number of chalcones has been synthesized and their
in vitro anti-Helicobacter activity has been tested.
Effect of more than 60 different novel chalcones on the in vitro
Helicobacter pylori has been tested against 6 different strains
including strains resistant to metronidazole (MIC > 32 µg/ml) in
an agar dilution assay. Some of the tested novel chalcones exhibit
potent inhibitory effect on the in vitro growth of H. pylori at
12.5 to 25 µmol/l and two of the novel chalcones at MIC of
9.4 µmol/l.
The mechanism of antibacterial activity of the novel chalcones
has also been investigated. Electron microscopic studies showed
that the bacteria swelled and its shape changed to round (coccoid)
from curved or spiral when they were incubated with licochalcone
A at 16 µg/ml. Licochalcone A and several chalcones inhibited the
activity of NADH-fumarate reductase, succinate-cytochrome c
reductase and succinate dehydrogenase of the bacterial electron
transport chain. The IC50 values of licochalcone A on the three
enzymes were 10 , 80 and 800 µmol/l, respectively.
These results reveal that some novel chalcones exhibit potent in
vitro anti-Helicobacter activity and might provide the basis for the
development of new class of antibacterial agents, and suggest that
their anti-Helicobacter effect might be due to the inhibition of the
electron transport chain and the activity of fumarate reductase of
the bacteria.

*Kazakh

Science Center for Quarantine and Zoonotic Diseases,
Almaty, Kazakhstan, †Kazakh Medical Institute, Almaty, Kazakhstan
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Objects. The development frequency of duodenal and gastric
ulcer recurrence in depending from Helicobacter pylori eradication
quality were studied.
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556
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NSAIDs, COXIBs, ASA and Helicobacter pylori Infection
Abstract no.: 12.01*
Serum Pepsinogen II and Gastrin-17 as Markers
of NSAIDs-Gastropathy Independently of
Helicobacter pylori Infection
L. Cavallaro,* N. Stefani,* R. Merli,* E. Morana,*
M. Maino,* V. Iori,* G. Cavestro,* A. Bertelè,†
A. Franzè† and F. Di Mario*
*Department of Clinical Sciences, Section of Gastroenterology, Parma,
Italy, †Gastroenterology and Endoscopic Unit, Az. Ospedaliera, Parma,
Italy

Background. Serum pepsinogen II (sPGII) is a reliable marker of
PMN cells infiltration of gastric mucosa during Helicobacter pylori
infection. Neutrophils within the gastric microcirculation and
cytokines release are critical events in NSAIDs-gastropathy.
Inflammation can deregulate somatostatin–gastrin axis in the
gastric antrum.

Aim. To evaluate gastric mucosa in patients with chronic NSAIDs
assumption by means of a panel of 4 tests: serum pepsinogens I (sPGI)
and II (sPGII), anti-H. pylori antibodies and gastrin-17 (G-17).
Materials and Methods. Two hundred seventeen dyspeptic patients
(105 women, mean age 50.3 ± 18 years) of whom 51 with chronic
assumption of ASA 100 mg/die (age: 63 years ± 15, group 1), and
166 without (age: 46 years ± 18, group 2) were enrolled.
A blood sample to evaluate sPGI, sPGII, G-17, and IgG-Hp
levels was performed.
Results. There was no significant difference as regards to IgG-Hp
between group 1 (45 ± 29 U/l) and group 2 (43 ± 34 U/l, p = .9).
SPGI levels were not different in group 1 (121 ± 77 µg/l) and group
2 (101 ± 57 µg/l, p = .13). SPGII and G-17 were significantly higher
in group 1 (sPGII = 13 ± 4 µg/l, G-17 = 15 ± 9 pg/l) than in group
2 (sPGII = 10 ± 8 µg/l, p = .02; G-17 = 14 ± 1 pg/l, p = .02).
Conclusion. Independently of H. pylori infection, sPGII and
G-17 select patients at major risk for NSAIDs gastric damage that
could benefit for proton pump inhibitor (PPI) protection.

Drug Resistance
Abstract no.: 13.01*
Mechanism of Resistance to Fluoroquinolones
among Helicobacter pylori Isolates from Belgian
Patients

associated with one or more mutations at position 87 and 91 in the
QRDR of gyrA. The high proportion (26%) of heterogeneous
susceptibility in H. pylori underlines the risk of missing
fluoroquinolone resistance by genotypic methods as well as the
importance of a careful inspection of the antibiogram.

P. Bogaerts, C. Berhin, H. Nizet and Y. Glupczynski
UCL Mont-Godinne, Mont-Godinne, Belgium
Abstracts
8Abstract

Background and Aim. We previously showed that 18% of
clinical Helicobacter pylori strains isolated in Belgium were
resistant to ciprofloxacin (EHSG 17th International Workshop,
2004). In this study, we aimed to analyze the mechanisms of resistance
of H. pylori to fluoroquinolones.
Methods. Four hundred eighty-eight H. pylori isolates originating
from different Belgian centers were tested for susceptibility to
ciprofloxacin (C) and levofloxacin (L) by E-test. MIC values
≥ 1 µg/ml were classified as resistant. Resistant strains were
evaluated for mutations in the quinolone-resistance determining
region (QRDR) of gyrA by DNA sequencing.
Results. Eighty-two (16.8%) of 488 strains were resistant to C and
L. Of these, 76 were further evaluated; 56 strains (74%) presented
a homogeneous resistant phenotype, and 20 (26%), a heterogeneous
susceptibility to fluoroquinolones. QRDR-sequencing revealed various
types of mutations at position 87 and /or 91 in all homogeneous resistant
isolates. In the 20 heterogeneous resistant isolates, a susceptible wildtype genotype was found in 17 and resistance mutations in only 3.
Colonies found in the inhibition zone were subcultured and showed
a mutated resistant genotype in all cases. Type and location of the
mutations did not match with the level of resistance to fluoroquinolone.
Conclusions. Primary resistance fluoroquinolones do frequently
occur in H. pylori isolates in Belgium. Resistance is always

Abstract no.: 13.02
ResiNet – A Nationwide Sentinel Study on
Helicobacter pylori Resistance – Why We do
Sensitivity Testing Already After the First
Treatment Failure
M. Kist,* E. Glocker,* B. Hobmaier* and H. P. Stüger†
*Institute

of Medical Microbiology and Hygiene, Department of
Microbiology and Hygiene, National Reference Centre for
Helicobacter pylori, University Hospital, Freiburg, Germany,
†Institute of Applied Statistics and Systems Analysis, Joanneum
Research, Graz, Austria
The treatment of Helicobacter pylori infections using antibiotic
triple regimens is significantly impaired if H. pylori is resistant
against metronidazole (MZ) and clarithromycin (CLA). The aim of
this ongoing study is to investigate risk factors for the development
of antimicrobial resistance in H. pylori.
For this purpose, the German National Reference Centre (NRZ)
for H. pylori in 2001 launched the nationwide sentinel study
ResiNet. The NRZ is intercalated with 16 microbiological centers
(MC) and about 50 gastroenterologists (GE) in clinical practice.
During “study weeks,” GE enrol consecutive patients into the
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556
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study, sending gastric biopsies for microbiological investigation
and completing a questionnaire. All MC use identical culture media
lots and standardized operation procedures.
At the end of March 2005, a total of 506 patients were
investigated. Overall, 34.5% and 15.5% of isolates were resistant to
MZ or CLA, respectively, and 10.9% showed double resistance
against both drugs. The frequencies of primary resistance (n = 365)
were 26.8% (MZ), 5.5% (CLA), and 2.5% (MZ and CLA),
compared to 53.1% (MZ), 50.0% (CLA), and 34.4% (MZ and
CLA) in patients pretreated once (n = 32). Repeated pretreatment
(n = 38) was associated with an increase of double resistances of up
to 73.7%. These results clearly indicate that a significant increase in
resistance to MZ and CLA already occurs after the first treatment
failure, reaching dramatically high resistances after repeated
empirical therapies.
In conclusion, the data clearly show that empirical treatment of
H. pylori infection is only justified in patients not pretreated
before, and culture and sensitivity testing are already mandatory
after the first treatment failure.

Results. Three hundred thirty-six of the 1000 participants were
H. pylori-positive by culture (49.7% women), 16.2% were
resistant to metronidazole (74% women), 1.5% to clarithromycin
(40% women), 0% to amoxicillin, and 0.3% to tetracycline. The
consumption of macrolides in the region was 0.8 DDD (1997).
Conclusion. The resistance to clarithromycin in this population
was low, probably caused by the low consumption of macrolides in
this region (Sweden in total 1.1 DDD) compared to other European
countries (Spain 5.8 DDD). The resistance rate to metronidazole
was 16.1% compared to 26.6% in a European multicenter study.
The results from Sweden show that resistance rates are low, which
may reflect the restricted use of antibiotics in Sweden.
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Abstract no.: 13.04*
Sentinel Surveillance of Primary Antibiotic
Resistance of Helicobacter pylori in England and
Wales over a 5-Year Period (2000–2004)
R. J. Owen and S. A. Chisholm

Abstract no.: 13.03
Antimicrobial Susceptibility of Helicobacter
pylori in a Swedish Random Adult Population
8Abstract
Abstracts

Centre for Infections-Health Protection Agency, London, UK
Antibiotic resistance is key in Helicobacter pylori eradication
failure, yet no sentinel scheme exists to monitor trends in resistance
in UK. We monitored H. pylori resistance in two centers over
5 years to the four antibiotics used in eradication. In total, 1021
isolates, 583 from Bangor in north Wales and 438 from Chelmsford
in south-east England, were collected from 2000 to 2004.
Susceptibilities to metronidazole (MTZ), clarithromycin (CLA),
amoxicillin (AMX), and tetracycline (TET), were determined by
disc diffusion and by E-test for MTZ and CLA. Patient gender was
recorded for 944 patients (48.7% male; 51.3% female).
Overall MTZ and CLA resistance rates were, respectively, 29.6%
and 8.6% in Bangor and 33.6% and 12.6% in Chelmsford. Three
isolates were TET resistant, whereas none was AMX resistant.
MTZ resistance rates in Bangor increased during 2000–2004
(16.6% to 31%), whereas CLA resistance fluctuated. Similar trends
were observed in Chelmsford isolates for MTZ, whereas CLA
resistance increased (6.3% to 14.8%). Statistically significantly higher
resistance rates were observed in females compared with males
(35.3% versus 27.0% for MTZ and 12.8% versus 7.0% for CLA).
In conclusion, CLA resistance rates were higher in H. pylori
recovered from urban (Chelmsford) compared with rural (Bangor)
areas of UK, with higher rates of resistance to both antibiotics
observed in females. In both areas, a temporal trend for increased
resistance in MTZ was observed. The findings highlight the
importance of H. pylori antibiotic resistance surveillance to inform
local testing and treatment strategies.

L. Engstrand,* T. Storskrubb,† J. Ronkainen,‡ P. Aro,§
K. Wreiber,* O. Cars,* N. Talley¶ and L. Agreus§
*Swedish

Insitute for Infectious Disease Control, Solna, Sweden,
hospital, Kalix, Sweden, ‡Center for Family Medicine, Karolinska
Institute, Stockholm, Sweden, §Centre for Family Medicine, Karolinska
Insitute, Stockholm, Sweden, ¶Department of Medicine, Univeristy of
Sydney, Sydney, Australia
†Kalix

Background. Antimicrobial resistance in Helicobacter pylori has
become an important factor leading to eradication failures.
Information on antimicrobial susceptibility is important for
selection of treatment regimens and such data are lacking for
nonpatients. In this study, we determined the resistance rates
for H. pylori against commonly used antibiotics in a random adult
Swedish population setting.
Methods. A random Swedish population sample (n = 3000, age
20–81 years) was surveyed using a validated questionnaire
assessing GI symptoms with a response rate of 74%; 1000 of the
responders were invited in random order and accepted a gastroscopy
with two biopsies from antrum and corpus, respectively, for
H. pylori culture. MIC for metronidazole, clarithromycin,
amoxicillin, and tetracycline was determined by E-test. Antibiotic
consumption in the same geographical area was studied and
reported as DDD (defined daily doseges/1000 inhabitants/day).
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No. of
strains

Codon
83 87

Modal MIC (mg/l)
Nalidixic acid

Ciprofloxacin-susceptible (Cip-S) strains (MIC ≤ 0.5 mg/l)
20
Thr Asp
64
93
Asn Asp
128
Ciprofloxacin-resistant (Cip-R) strains (MIC > 1 mg/l)
2
Ile Asp
256
6
Lys Asp
256
1
Tyr Asp
256
4
Asn Asn
256
2
Asn Tyr
256
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Pefloxacin
2
8
128
32
128
64
64

Ciprofloxacin
0.125
0.5
32
32
32
16
32

Moxifloxacin
0.5
0.5
32
16
16
8
32

Gatifloxacin
0.125
0.125
128
4
64
2
4
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Abstract no.: 13.05
Evidence of Polymorphism in Helicobacter
pylori GyrA at Codons 83 and 87 Leads to
Distinguishing Subpopulations with Regard to
the Susceptibility to Classic and New
Fluoroquinolones
V. Cattoir, J. Nectoux, C. Lascols, C. Soussy and
E. Cambau
Bacteriology, CHU Henri Mondor, APHP, University of Paris 12,
Creteil, France
Fluoroquinolones (FQ) are alternate drugs for the treatment of
Helicobacter pylori infection. Acquired resistance is known to
result from gyrA mutation at the 87 and the 83 codons (numbering
system in Escherichia coli) (85% and 15% of the strains described,
respectively). MICs of five quinolones were determined by agar
dilution for 128 clinical isolates of H. pylori and related to the
sequence of the quinolone-resistance determining region (QRDR)
in gyrA.
In the 113 (88%) Cip-S isolates, a polymorphism at 83 was
observed with 17.7% of strains harboring Thr83 and 82.3%
Asn83,the subpopulation harboring Thr83 being more susceptible
to quinolones. In the 15 Cip-R isolates (12%), a 32- to 256-fold
increase in MICs was associated to substitutions at 83 (60%) or 87
(40%). Determination of gyrA QRDR can predict for quinolone
susceptibility, and may help in the therapeutical decision.

Abstract no.: 13.06
Prevalence of Helicobacter pylori Antibiotic
Resistance in a Cohort of Italian Children with
RAP
Abstracts
8Abstract

G. L. de’Angelis,* L. G. Cavallaro,† B. Bizzarri,*
S. Liatopoulou,† N. de’Angelis,* V. Carappolo,*
A. Franzè‡ and F. Di Mario†
*Pediatrics Department, University of Parma, Parma, Italy, †Department
of Clinical Science, Section of Gastroenterology, Parma, Italy,
‡Gastroenterology and Endoscopic Unit, Az. Ospedaliera, Parma, Italy

Background. The primary Helicobacter pylori resistance to
standard antibiotic is higher in children than adults because of an
increased prescription of these drugs for respiratory tract
infections. This could affect the efficacy of the standard antibiotic
used in a proton pump inhibitor (PPI)-triple therapy.
Aim. To assess H. pylori antibiotic prevalence in H. pylori positive
children with recurrent abdominal pain (RAP).
Methods. Fifty-six H. pylori-positive consecutive children with
RAP were evaluated. All children were submitted to upper
gastrointestinal endoscopy with biopsies. H. pylori antibiotic
susceptibility testing on blood agar medium was performed.
Results. All the children (28 female, mean age: 9 ± 3 years, range
2–14) had the following endoscopical features: 44 patients with gastric
hyperemia, 4 with nodular gastropathy, 4 with erosive duodenitis,
and 3 with esophagitis. All the patients had H. pylori-related nonatrophic chronic gastritis, 10 of them had lymphoid hyperplasia.
Susceptibility testing showed the following prevalence resistance
rate: Ampicillin 6%, ciprofloxacin 6%, metronidazole 15%,
tetracycline 3%, and clarithromycin 30%. Three percent of the
patients had both resistance to metronidazole and to clarithromycin
and another 3% showed resistance to all the antibiotics.

Drug Resistance
Conclusions. H. pylori resistance to clarithromycin presented the
highest rate in these Italian children. A different management of
H. pylori infection in this cohort of patients may be necessary.

Abstract no.: 13.07
Evolution of Antimicrobial Resistance in
Helicobacter pylori Spanish Clinical Isolates
Obtained from Pediatric Patients (2000–2005)
8Abstract
Abstracts

T. Alarcón,* M. J. Martínez,† J. Díaz-Regañón,*
A. Pérez de Ayala,* J. A. García-Campos,* D. Domingo*
and M. López-Brea*
*Hospital

de La Princesa, Madrid, Spain, †Hospital del Niño Jesús,
Madrid, Spain

The aim of this study was to determine the resistance to
clarithromycin and metronidazole in Helicobacter pylori clinical
isolates obtained from pediatric patients (2000–2005).
Material and Methods. A total of 94 clinical isolates of H. pylori
were studied. Thirty-four strains were cultured in the period 2000–
2001, 35 during 2002, and 25 in 2003–2005.
The in vitro activity of clarithromycin and metronidazol was
determined by an agar dilution method using Mueller–Hinton agar
supplemented with 7% horse blood containing each antibiotic at
twofold dilutions from 128 to 0.008 mg/l. Plates were inoculated
with 106 cfu/drop and incubated at 37 °C during 2 days in a CO2increased atmosphere. MIC was determined as the lowest concentration
of the drug inhibiting visible growth. Strains were considered
resistant to clarithromycin when MIC > 0.5 mg/l, intermediate when
MIC = 0.5 mg/l, and susceptible when MIC < 0.5 mg/l. Metronidazol
MIC > 8 mg/l was considered resistant and ≤ 8 mg/l susceptible.
Results. Metronidazole resistance was 31.9% and clarithromycin
resistance was 50%. Data according to the different periods are
shown in the table.
Percentage of strains resistant (R) and susceptible (S) to metronidazole

MTZ-R
MTZ-S

2000–2001

2002

2003–2005

8.2%
91.2%

51.4%
48.6%

36%
64%

Percentage of strains resistant (R), intermediate (INT), and susceptible
(S) to clarithromycin
2000–2001
CLR-R
CLR-INT
CLR-S

38.2%
0%
61.8%

2002

2003–2005

51.4%
8.6%
40%

64%
0%
36%

Conclusions. Resistance to clarithromycin was very high in the
H. pylori strains obtained from Spanish pediatric patients. The
resistance was higher in the last period studied.
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Abstract no.: 13.08
Primary and Secondary Antibiotic Resistance
Rates of Helicobacter pylori Strains Isolated from
Korean Patients
H. C. Jung,* J. M. Kim,† N. Kim,* J. S. Kim* and
I. S. Song*
*Seoul

National University College of Medicine, Seoul, Republic of
Korea, †Department of Microbiology, Hanyang University College of
Medicine, Seoul, Republic of Korea

Since antibiotic resistance of Helicobacter pylori is the most
common reason for failure in its eradication, we tested the primary
and secondary antibiotic resistance rates of Helicobacter pylori
strains isolated from Korean patients. H. pylori strains were
isolated from antral biopsies in 65 patients with no antibiotic
therapy during the preceding 3 months, and in 67 patients who had
already undergone proton pump inhibitor (PPI)-based triple
therapy consisting of amoxicillin and clarithromycin for 1 week.
Antibiotic susceptibility test was performed using agar dilution
method recommended by the National Committee for Clinical
Laboratory Standards (NCCLS). Resistance breakpoints for
amoxicillin, clarithromycin, metronidazole, tetracycline were defined
as = 0.5, > 1.0, > 8, and 4 µg/ml, respectively. All breakpoints for
azithromycin, ciprofloxacin, levofloxacin, and moxifloxacin were
set at > 1.0 µg/ml.
Results. Overall primary resistance to amoxicillin, clarithromycin,
metronidazole, tetracycline, azithromycin, ciprofloxacin, levofloxacin,
and moxifloxacin was 18.5, 13.8, 66.2, 12.3, 32.3, 33.8, 21.5, and
21.5%, respectively. The rates of eradication were 96% for the
clarithromycin and amoxicillin-susceptible strains, but none of the
patients with clarithromycin-resistant strains could eradicate
the bacteria. Secondary resistance rates in triple PPI-based treatment
failure patients were: amoxicillin 26.9%, clarithromycin 85.1%,
metronidazole 70.1%, tetracycline 0%, azithromycin 89.6%,
ciprofloxacin 35.8%, levofloxacin 32.8%, and moxifloxacin 32.8%.
Among the clarithromycin-resistant strains studied, more than
95% showed cross-resistance to azithromycin.
Conclusions. These results suggest that the primary treatment
failure not only increased the resistance rates of amoxicillin,
clarithromycin, and azithromycin, but also a high prevalence of
clarithromycin-resistant strains may be associated with eradication
failure.
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Abstract no.: 13.09
Relevance of Clarithromycin Resistance in
Clinical Practice to Cure Helicobacter pylori

the rapid biopsy urease test. Eradication regimens consisted in proton
pump inhibitor (PPI)- or RBC-triple therapies for 7–12 days.
Post-TR assessment (OGD + B or 13C-urea breath test) was
performed 4–10 weeks after therapy. Susceptibility testing to M
and C was performed by disc diffusion method. In case of
treatment failure documented by a positive UBT, the patients were
offered to undergo another OGD to obtain biopsy specimens for
post-TX antimicrobial susceptibility testing in order to guide
rescue therapy.
Results. Results are reported in the next table. Post-TX antimicrobial
susceptibility testing was available for 58/71 (82%) post-TX
failures.

Treatment
regimen
OC14
OAC7-8
OAC12
LAC7-8
LAC10
OCT8

RCM7

Nb treated
and Pre-TX
AB-sensitivity
19 CS
0 CR
245 CS
17 CR
38 CS
2 CR
147 CS
16 CR
114 CS
15 CR
93 MS – CS
40 MR – CS
15 MS – CR
1 MR – CR
56 MS – CS
26 MR – CS
20 MS – CR
14 MR – CR

Hp cure
rate (%)

Nb of
Acquired
TX-failures C-resistance

11/19 (58%)

8

3/8 (37%)

225/245 (92%)
6/17 (35%)
37/38 (98%)
1/2 (50%)
135/147 (92%)
6/16 (37%)
111/114 (97%)
9/15 (60%)
86/93 (92%)
28/40 (70%)
8/15 (53%)
0/1 (–)
54/56 (96%)
20/26 (80%)
16/20 (80%)
2/14 (14%)

20
11
1
1
12
10
3
6
7
12
7
1
2
6
4
12

10/17 (59%)
0/1 (–)
1/11 (9%)
1/3 (33%)
0/4 (–)
3/8 (37%)
1/2 (50%)
1/4 (25%)

Conclusion. Primary resistance to clarithromycin affects negatively
the cure rate of PPI- and RBC-based triple therapies by, respectively,
35–60% and 15–40%. Acquired resistance to C was observed in
10–60% and 25–50% of treatment failures after PPI- or RBCtriple therapies.

Abstract no.: 13.10
Relationship Between Multidrug Resistance and
Outer Membrane Proteins in Helicobacter pylori
Strains Isolated from Children
Abstracts
8Abstract

T. Falsafi and M. Mahboubi
Azzahra University, Department of Biology,Tehran, Islamic Republic of
Iran

A. Burette,* C. VandenBorre† and Y. Miendje†
*CHIREC/site

de la Basilique and IME Cavell/Gastroenterology Unit,
Brussels, Belgium, †CHU Brugmann/Microbiology Department,
Brussels, Belgium
Aim of the study. To study the relevance of primary clarithromycin
(C) resistance on cure rates and the emergence of C-resistance in
case of treatment failure.
Method. During the last 10 years, nearly all consecutive patients
attending the out-patients endoscopy clinic were systematically
screened for H. pylori infection and tested for primary C and
metronidazole (M) resistance. Most naïve patients received their
eradication regimen after the endoscopy according to the result of
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556

Background. In Helicobacter pylori, the contribution of outer
membrane proteins (OMPs) to antibiotic resistance and or
multidrug resistance is not well established.
Objective. To evaluate the relationship between multidrug
resistance to amoxicillin, ampicillin, and tetracycline and OMPs
profile in pediatric H. pylori strains.
Materials and Methods. Sixteen H. pylori strains isolated from
children were characterized with respect to the antibiotic resistance
pattern to amoxicillin (AMX), ampicillin (AMP), and tetracycline
(TET), using disc diffusion and screening agar methods. Outer
membrane proteins were extracted from envelopes of sonicated
cells by a sarcosyl method and characterized using SDS-PAGE.
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Results. Analysis of antibiotic susceptibility results showed that
eight strains that were highly susceptible to AMX, and AMP, were
also susceptible to TET; two strains that were intermediately
resistant to AMX and/or AMP were either resistant or susceptible
to TET; and six strains that showed high-level resistance to AMX,
and AMP, were also resistant to TET. OMPs profiles comparison
of susceptibles, intermediates, and high-level β-lactam resistant
strains showed some differences in OMP profiles. One visible
difference corresponded to an approximately 31 kDa OMP, which
was present in the profile of high-level β-lactam resistant strains,
and absent in those of susceptible strains and intermediate ones.
Conclusion. A 31 kDa OMP can play a role in high-level β-lactam
resistance in clinical isolates of H. pylori, and may be associated
with acquired multidrug resistance to TET and other antibiotics.

Abstract no.: 13.11
In Vitro Activity of Fluorquinolones and
Rifampicin in Metronidazole and
Clarithromycin-Susceptible or -Resistant
Helicobacter pylori Spanish Clinical Isolates
Abstracts
8Abstract

A. Pérez de Ayala, T. Alarcón, D. Monclus,
M. Abanades and M. López-Brea
H.U. La Princesa, Madrid, Spain
Objective. The aim of our study was to determine the in vitro
activity of levofloxacin, ciprofloxacin, and rifampicin in
metronidazole- and clarithromycin-resistant and -susceptible
Helicobacter pylori strains.
Material and Methods. Thirty-eight isolates of H. pylori were
obtained following standard methodology from biopsies of
dyspeptic patients. In vitro activity was determined by E-test using
5% sheep blood agar and incubated at 37 °C during 3–5 days in a
CO2 atmosphere. MIC was determined as the point of complete
inhibition of growth. Breakpoint of the National Committee for
Clinical Laboratory Standards (NCCLS) for other microorganisms
were considered: susceptible if MIC < 1 mg/l for levofloxacin,
ciprofloxacin, and rifampicin; and resistant if MIC ≥ 4 mg/l for
rifampicin.
Results. Forty-three percent of the strains were resistant to
metronidazole and 51% to clarithromycin. MIC50, MIC90 and range
(mg/l) was: 0.064, 0.125, and 0.012–0.25 for levofloxacin; 0.064,
0.19, and 0.006–0.25 for ciprofloxacin; and 0.75, 1.5, and < 0.002–4
for rifampicin. All the strains were susceptible to fluorquinolones.
For rifampicin, 81.5% of strains were susceptible, 16% intermediate,
and 5.2% resistant.
Conclusions. The fluorquinolones tested showed an excellent in
vitro activity against H. pylori, despite the high resistance rate to
metronidazole and clarithromycin. A high percentage was sensible
to rifampicin but in vitro susceptibility test should be performed
before the use in clinical practice.

Drug Resistance
Abstract no.: 13.12
Detection of Virulence Factors in Helicobacter
pylori Clinical Isolates Susceptible or Resistant to
Clarithromycin
J. A. García-Campos,* T. Alarcón,* J. Díaz-Regañón,*
D. Domingo,* M. J. Martínez† and M. López-Brea*
*Hospital

de La Princesa, Madrid, Spain, †Hospital del Niño Jesús,
Madrid, Spain

The aim of this study was to determine the presence of several
virulence factors in Helicobacter pylori strains susceptible or
resistant to clarithromycin (CLR).
Material and Methods. A total of 104 strains of H. pylori were
obtained from gastric biopsies taken at routine endoscopy, cultured,
and identified by standard methodology. CLR susceptibility was
determined by an agar dilution technique using Mueller–Hinton
plus 7% lysed horse blood. Plates were inoculated with a Steer
replicator and incubated in 10% CO 2 atmosphere at 37 °C for
3–5 days. Resistance was considered when MIC ≥ 1 mg/l and
intermediate when MIC = 0.5 mg/l. DNA was extracted from a
48 hour culture and specific polymerase chain reaction (PCR)
performed to detect cagA gene, vacA s1- and s2-alleles, babA2
gene, and hopQ (alleles I and II). The presence of the appropriated
size fragments was detected by agarose gel electrophoresis.
Results. The overall clarithromycin resistance was 30%. The
prevalence of virulence factors in clarithromycin-susceptible and
-resistant strains were as follows:
cagA positive

vacA-s1

babA2 positive

hopQ positive

Percentage of virulence factors in CLR susceptible strains
70%
57%
35%

94%

Percentage of virulence factors in CLR-resistant strains
51%
54%
19%

86%

Conclusions. hopQ gene was more frequent among CLRsusceptible than -resistant H. pylori clinical isolates (94% versus 86%,
p < .05). cagA gene was more frequent among CLR-susceptible
strains although the differences were not statistically significant.
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Abstract no.: 14.01*
CD4+ Cells but not Mast Cells are Critical
Players in Immune Responses Leading to the
Eradication of Gastric Helicobacter Infection in
the IL-10–/– Mice
D. Velin, D. Bachmann and P. Michetti
CHUV, Lausanne, Switzerland
Compared to wild-type mice, IL-10 –/– mice clear has natural
H. felis infection. We previously showed that the H. felis infection
clearance in wild-type mice vaccinated intranasally with urease+
cholera toxin infection is dependent on the presence of both CD4+
cells and mast cells in vaccinated mice. In this study, we tested
whether the immune responses leading to the Helicobacter
clearance in IL-10–/– mice depend also on CD4+ cells and mast cells.
We depleted CD4+ cells from H. felis infected IL-10–/– mice. The
depletion of CD4+ cells prevented the H. felis eradication,
demonstrating that the CD4+ cells are critical players in the
bacterial eradication of IL-10–/– mice.
To look for a role of mast cells, we constructed mast celldeficient IL-10–/– mice: the IL-10–/– Wv/W double mutant mice.
Surprisingly, 2 weeks after H. felis infection, both IL-10–/– mice and
IL-10–/– Wv/W double mutant mice eradicated H. felis infection.
This result shows that the natural Helicobacter eradication of
IL-10–/– mice is not dependent on mast cells.
Altogether, we showed that the immune clearance of Helicobacter from the stomach in vaccinated wild-type and IL-10–/–
mice both depends on the CD4+ cell population. However, we
found that the mast cells are not critical players in immune
responses leading to Helicobacter eradication in IL-10–/– mice.
These results showed the complexity of the immune responses
leading to Helicobacter eradication from the stomach, and
highlighted the need to complete our understanding of the immune
mechanisms leading to Helicobacter clearance from the stomach.

Abstract no.: 14.02
Immunization of Mice with BabA Protects
Against Helicobacter pylori Infection
8Abstract
Abstracts

A. Hultberg,* S. Wen,* J. Bugaytsova,† H. Marcotte,*
T. Borén† and L. Hammarström*
*Laboratory Medicine, Huddinge, Sweden, †Department of Medical
Chemistry and Biophysics, Umeå University, Umeå, Sweden

Objectives. Investigation of the protection against Helicobacter
pylori infection in mice intranasally immunized with purified BabA
and CTA1-DD.
Methods. Both prophylactic and therapeutic studies were
performed with 10–12 male Leb transgenic mice in each group. In
the prophylactic study the mice were immunized intranasally once
a week for 4 weeks with 10 g purified BabA and 1 µg CTA1-DD.
Four weeks post-immunization they were challenged with 1.5 × 109
cfu/ml of a low passage streptomycin-resistant J99 H. pylori strain
( J99StrR) cultured for 24 hours, two times a week for 2 weeks. After
4 weeks, the mice were sacrificed, the stomachs were collected, and
the amount of H. pylori J99StrR was determined by culturing.
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556

In the therapeutic study, 10–12 male Leb transgenic mice in
each group were infected with J99StrR as in the prophylactic study.
After 4 weeks the mice were immunized intranasally as in the
prophylactic study and after 4 weeks, the study was terminated.
Stomachs were collected and the amount of H. pylori J99StrR was
determined by culturing.
Blood samples were taken before and during the studies to
follow the immune response and analyze the titers of antibodies
specific for BabA. Gastric secretions were collected from the
stomachs to investigate the sIgA titers.
Results. Both the prophylactic and therapeutic intranasal
immunizations with BabA and CTA1-DD gave a significant
protection against H. pylori J99StrR infection as compared to the
controls. The titers of sIgA in the gastric secretions were
significantly higher in the immunized groups as compared to the
control groups.
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Abstract no.: 14.03
Effect of Rebamipide on Colonic Epithelial
Barrier and Immune Response in IL-10-Deficient
Mice Infected with Helicobacter hepaticus
D. Laharie,* S. Ménard,† C. Asencio,* T. Vidal-Martinez,†
A. Rullier,‡ F. Zerbib,* C. Candalh,† F. Mégraud,*
M. Heyman§ and T. Matysiak-Budnik†
*Université Victor

Segalen Bordeaux 2, Laboratoire de Bactériologie,
Bordeaux, France, †INSERM EMI-0212, Faculté Necker, Paris, France,
‡Service d’Anatomo-pathologie, Hôpital Pellegrin, Bordeaux, France,
§INSERM EMI-0212, Faculté Necker, Paris, France
Background. The aim was to study the effect of rebamipide, a
mucosal protective agent, on the colonic epithelial barrier and the
immune responses in the experimental model of colitis in
interleukin-10 (IL-10)-deficient C57BL/6 mice infected with
Helicobacter hepaticus.
Methods. Four groups of mice were studied: control, infected
with H. hepaticus, infected with H. hepaticus and treated daily for
9 weeks with rebamipide enema (300 µg/day), and infected with
H. hepaticus and treated with placebo enema. At sacrifice, mesenteric
lymph node (MLN) cells reactivity (proliferation and cytokine
secretion) was studied in vitro in basal conditions and after
stimulation with Escherichia coli or H. hepaticus extract. Colonic
samples were used for histology and assessment of intestinal
permeability in Ussing chambers with evaluation of electrical
resistance (R), and of horseradish peroxidase (HRP) and mannitol
( Jman) fluxes.
Results. A very mild colitis (score < 2) was observed in all mice
without difference among the groups. Reinforcement of colonic
barrier (increase of R, decrease of Jman, and HRP transcytosis),
was observed in rebamipide-treated mice as compared to other
groups ( p < .05). Basal- and H. hepaticus-stimulated proliferation
of MLN cells, as well as basal- and E. coli- and H. hepaticusstimulated IFNγ and IL-12 secretion, were increased in rebamipidetreated group as compared to other groups.
Conclusions. In this slight inflammatory conditions, rectal
rebamipide reinforced integrity of the colonic barrier and revealed
a Th1 stimulatory effect on MLN cells. This beneficial local effect
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of rebamipide together with its Th1 immuno-stimulatory properties,
may be helpful in the management of Th2 inflammatory bowel
diseases like ulcerative colitis.

Abstract no.: 14.04
High Cholesterol/Cholic Acid/Dairy Fat
(Lithogenic) Diet Exacerbates Helicobacter pylori
Gastritis in the Glandular and Nonglandular
Stomach of C57L Mice
8Abstract
Abstracts

J. G. Fox,* K. J. Maurer,* A. B. Rogers* and
M. C. Carey†
*Massachusetts
†Harvard

Institute of Technology, Cambridge, MA, USA,
Medical School, Boston, MA, USA

To examine whether cholesterol plays a role in Helicobacter pyloriinduced gastritis, 4-week-old male C57L mice were infected with
H. pylori strain SS1 (n = 15) and another group was sham dosed
(n = 10). Mice (n = 10 infected and 10 uninfected) were either fed
a lithogenic diet (1% cholesterol, 0.5% cholic acid) for 8 weeks
beginning at 8 weeks or fed a standard mouse chow (n = 5).
Infected mice developed gastric disease more rapidly and severely
than is typical in other permissive strains. Glandular stomachs of
H. pylori-infected mice fed either diet demonstrated moderate
lymphocytic inflammation often extending into the submucosa
with marked glandular inflammation. Uninfected mice rarely had
inflammation and infected animals on chow or lithogenic diet had
significantly more inflammation than uninfected animals fed a
lithogenic diet ( p < .01, 2.1 ± 0.7, 2.1 ± 0.6 and 0.75 ± 0.8, respectively).
Glandular atrophy and mucous metaplasia was prominent in
infected mice; it was common to see complete loss of chief cells and
> 50% loss of parietal cells. Only mice that were both infected and
fed a lithogenic diet demonstrated a significantly higher metaplasia
score than uninfected mice fed a similar diet ( p < .01, 1.65 ± 0.8 and
0.5 ± 0.8, respectively). Animals that were fed the lithogenic diet
developed hyperkeratosis and inflammation of the squamous
stomach which lesions were exacerbated by H. pylori infection.
The squamous stomach of the mouse is histologically similar to the
esophagus of humans. Perhaps this model could be used to study
the ability of H. pylori to contribute to esophageal diseases.
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Abstract no.: 14.05
β-Estradiol and
Protective Effect of 17-β
Progesterone on G Cells in Helicobacter
pylori-Infected Female Mongolian Gerbils
M. Saqui-Salces,* I. Camacho-Arroyo,†
G. Ruiz-Palacios* and A. Gamboa-Dominguez*
*Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán,
México, D.F., Mexico, †Facultad de Química, Universidad Nacional
Autónoma de México, México, D.F., Mexico

Estradiol (E2) and progesterone (P4) have been suggested as
regulators of gastric mucosa.
Aim. To evaluate the effect of E2 and P4 on the number of antral
mucosa gastrin-producing cells (GC) during early and subacute
infection with Helicobacter pylori.
Methods. Thirty-four 15-week-old intact or ovariectomized
(OVH) female Mongolian gerbils were allocated to six groups:

CTL (intact + H. pylori), VEH (OVH + H. pylori + vehicle), E2L
(OVH + H. pylori + E2 50 µg/60 days), E2H (OVH + H. pylori
+ E2250 µg/60 days ), P4L (OVH + H. pylori + P4 15 mg/60 days)
and P4H (OVH + H. pylori + P4 50 mg/60 days). Intragastrical
H. pylori infection was performed with 1 × 106 UFC SS1 strain.
One week post-infection (WPI), E2 and P4 were supplemented with
subcutaneous 60-day release pellets. Gerbils were euthanized after 6
and 18 WPI. Gastric tissue was obtained and immunohistochemistry
for gastrin performed. GC were counted in 10 fields at 40× in antrum.
Results. At 6 WPI, GC were similar in groups. P4L showed
the highest (nonsignificant), whereas P4H showed the lowest
(significant versus VEH) GC. At 18 WPI, there was a significant
GC decrease in CTL and VEH, the latter presenting the lowest
value. E2H presented a significant increase of GC. P4L presented
the highest GC. E2H almost achieved the same GC number than
P4L. E2L, P4L, and P4H were not different in both study periods.
Comments. E2 administration prevents the decrease of GC and
P4 increases the GC only at low dose. These results suggest E2 and
P4 effects on G cells and H. pylori-induced gastritis (previously
evaluated) are related with dose and time of hormonal treatment.

Abstract no.: 14.06
Interaction of Helicobacter pylori Infection and
IL-4 Genetics in the Immunopathogenesis of
Atopy
Abstracts
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T. U. Kosunen,* T. Pessi,† M. Virta,† J. Karjalainen,†
H. Rautelin* and M. Hurme†
*University of Helsinki, Helsinki, Finland, †University of Tampere,
Tampere, Finland

Background. Both genetic and environmental factors, e.g., early
childhood infections, have a role in the pathogenesis of atopic
diseases.
Aim. To examine simultaneously the strength and possible
interactions of two known factors, Helicobacter pylori infection
and IL-4 genetics, on the risk of atopy and asthma.
Methods. H. pylori infection was verified by detecting antiH. pylori IgG antibodies (Pyloriset EIA-G III, Orion Diagnostica,
Espoo, Finland) in 245 adult asthmatics and 405 non-asthmatic
controls presenting a population-based case-control study. IL-4–
590 genotyping was performed by polymerase chain reaction
(PCR)-RFLP method. At least one positive skin prick tests (SPT)
was used as an indicator of atopy.
Results. A significant negative association was seen between the
presence of H. pylori antibodies and SPT positivity in both
asthmatics and controls ( p = .002 and p = .025, respectively) but the
effect of IL-4 polymorphism (SNP −590C/T) was nonsignificant in
both groups ( p = .071 and p = .072, respectively). However, IL-4
genetics had an effect on susceptibility to H. pylori; asthmatics
carrying the IL-4–590 allele T had a diminished risk to be H. pylori
infected (OR 0.485 95%CI 0.287–0.819). This effect was not seen
in controls. Logistic regression analysis indicated that H. pylori and
IL-4 effects on atopy risk are not interdependent.
Conclusions. The effect of H. pylori infection on atopy risk was
stronger than that of IL-4 genetics. There was no interaction
between these factors on the pathogenesis of atopy suggesting that
these factors have distinct immunopathogenetic mechanisms.
However, the genetic effect may modify the role of infective agents
via susceptibility to disease.
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Abstract no.: 14.07
Influence of Phosphorothioate
Oligodeoxynucleotides with Different ImmunoStimulatory Motives upon Helicobacter pylori
Infection in the Mongolian Gerbil (Meriones
unguiculatus)
W. Schneider-Brachert, S. Denk, J. Röhrl and N. Lehn
Institute for Medical Microbiology and Hygiene, Regenburg, Germany
CpG oligodeoxynucleotides (ODNs) are potent Th1-polarizing
adjuvants and activate the innate immune system to produce proinflammatory cytokines. In contrast GpG ODN (a C has been
replaced by G) can inhibit the activation of Th1 T cells in mice. We
examined the role of both ODNs in the Helicobacter pyloriinfection model Mongolian gerbil. The animals received four
weekly intraperitoneal injections with CpG or GpG ODNs,
starting 3 days before infection with H. pylori. After 4 weeks the
stomachs were removed and examined histologically. Cytokine
levels were evaluated with quantitative polymerase chain reaction
(PCR) (TaqMan). All infected gerbils showed inflammation in the
antrum, ranging from mild gastritis to the development of large
lymph follicles. Significantly elevated expression levels could be
observed in all infected gerbils compared to uninfected controls for
IFN-gamma, IL-1 beta, IL-6, and iNOS. There were no significant
differences between CpG and GpG ODN treated groups, all
expression levels were similarly elevated. TNF was only increased
in infected animals who received ODNs. No changes were
revealed for IL-10, IL-12p35, and IL-12p40 expression. In situ
hybridization showed elevated production of IFN-gamma and
IL-6 in all infected gerbils. In contrast to TaqMan analysis, the
expression of IL-10 was heavily increased in infected animals.
The production of IFN-gamma and IL-10 was slightly higher in
the group who received GpG instead of CpG ODN. Although
immunostimulatory CpG- and immunosuppressive GpG-effects
could be observed in several mice models, they had no impact on
the expression levels of pro-inflammatory cytokines in H. pylori
infection of Mongolian gerbils.

Abstract no.: 14.08
Protective Immunization Against “Candidatus
Helicobacter suis” with Heterologous Antigens
Stimulates Long-Term Immunity
8Abstract
Abstracts

A. Hellemans, A. Decostere, F. Haesebrouck and
R. Ducatelle
Faculty of Veterinary Medicine, University of Ghent, Merelbeke, Belgium
“Helicobacter heilmannii” type 1 colonizes the human stomach.
It has been shown to be identical to “Candidatus Helicobacter
suis,” a Helicobacter species colonizing the stomach of more than
60% of slaughter pigs. This bacterium is, until now, not isolated in
vitro. To study the effect of vaccination on “Candidatus H. suis”

infection, a mouse model was used. Mice were vaccinated intranasally
or subcutaneously with whole bacterial cell lysate of Helicobacter
felis or Helicobacter pylori and subsequently challenge infected with
“Candidatus H. suis.” Intranasal and subcutaneous immunizations
caused a decrease in fecal excretion of “Candidatus H. suis DNA”
from 1 week after immunization until the end of the experiment
(16 weeks after infection). At 16 weeks after infection, stomach
samples from immunized and non-immunized challenged infected
mice were all positive for “Candidatus H. suis.” OD values of
urease tests were decreased in immunized challenged animals
compared to non-immunized challenged animals. In conclusion,
sterilizing immunity was not achieved, but these heterologous
vaccinations against “Candidatus H. suis” reduced the gastric
colonization and shedding of the bacteria.

Abstract no.: 14.09
Development of a Vaccine Against
Helicobacter pylori
Abstracts
8Abstract

T. Aebischer,* D. Bumann,* H. J. Epple,† D. Y. Graham,‡§
W. Metzger,* T. Schneider,¶ M. Stolte,** M. Zeitz† and
T. F. Meyer*
*Max

Planck Institute for Infection Biology, Berlin, Germany, †Charite,
Campus Benjamin Franklin, Berlin, Germany, ‡Baylor College of
Medicine, Houston, TX, USA, §Michael E. DeBakey VAMC, Houston,
TX, USA, ¶Kinderklinik Heidberg – Klinikum Nord, Department of
Paediatrics, Hamburg, Germany, **Institute of Pathology, Klinikum
Bayreuth, Bayreuth, Germany
Immunization would be a welcome complementation to fight
Helicobacter pylori infection. Preclinical studies have demonstrated
the feasibility of vaccination. What may be learned from these
preclinical data for the development of a human vaccine will be
summarized. In addition, the global analysis of immunogenic
proteins, i.e., the immunoproteome, will be presented and how this
data set has been used to define criteria that not only confirmed all
experimentally tested vaccine antigens but led to the identification
of new vaccine antigens such as HP0231 and HP0410.
The translation of these results into clinical trials combining
vaccination with the recently developed human challenge model
will be presented. We expressed H. pylori urease or HP231 in the
common live typhoid vaccine Ty21a. This vaccine was promising
because three of nine vaccinees in an initial trial cleared H. pylori
after experimental infection. The effect on H. pylori infection
correlated with increased vaccine antigen-specific T-helper cell
responses, suggesting that, as shown before in mice, T-helper cells
may be required for protection. Transcriptional profiling of the
mucosa suggests that experimental infection recapitulates many
features of natural chronic infection and thus vaccination may
also be feasible against natural infection. Field studies would
greatly benefit from a tractable biomarker correlated with
protection and a strategy how such a marker may be identified will
be discussed.

8Abstract
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Abstract no.: 15.01*
Identification of Helicobacter spp. by Multiple
PCR-DGGE Analysis of the 16S rDNA
W. Abu Al-Soud, M. Al-Jammal, Å. Ljungh and
T. Wadström
Lund University, Lund, Sweden
Background. The number of species in the genus Helicobacter is
rapidly increasing, to include more than 26 species today that
colonize the gastrointestinal tract of humans and animals, which
are difficult to diagnose because of the close relatedness of these
species. The PCR–DGGE (polymerase chain reaction–denaturing
gradient gel electrophoresis) technique was developed by us to
identify of Helicobacter gut colonization; however, some closely
related Helicobacter spp. were difficult to separate. The aim of this
study was to increase the diagnostic efficiency of PCR–DGGE by
analyzing three variable regions of the 16S rDNA.
Methods. DNA was extracted from 40 Helicobacter strains.
Amplification of the 16S rDNA, was performed using Helicobacter
genus specific primers. The PCR product was used as a template to
amplify three fragments of the 16S rDNA that cover the V1-2, V3,
and V6-7 regions. Amplified PCR products were analyzed by
DGGE.
Results. DGGE analysis of the three regions showed mobility
patterns that were discriminatory for almost all Helicobacter spp.
including closely related species such as H. ganmani and H.
rodentium that were difficult to separate by other means.
Conclusions. The PCR–DGGE technique has proven to be an
easy, inexpensive, and efficient tool to identify Helicobacter spp.
and to detect gut and stomach colonization by more than one
Helicobacter spp., without the need for species-specific PCR
assays. In addition, the diagnostic efficiency of this technique was
increased by analysis of multiple regions of the 16S rDNA allowing
discrimination of almost all Helicobacter species.

8Abstract
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Abstract no.: 15.02*
PerR is a Regulator of Oxidative Stress Defense
in Helicobacter hepaticus
C. Belzer,* B. A. M. van Schendel,* E. J. Kuipers,*
T. Hoogenboezem,† P. W. M. Hermans,† J. G. Kusters*
and A. H. M. van Vliet*
*Erasmus MC-University Medical Center, Department of
Gastroenterology and Hepatology, Rotterdam, the Netherlands,
†Erasmus MC-University Medical Center, Department of Pediatrics,
Rotterdam, the Netherlands

Infection with Helicobacter hepaticus is associated with an active
cellular immune response accompanied by the production of
oxygen radicals. Iron also potentates the formation of reactive
oxygen species. Therefore, pathogens are forced to maintain
intracellular iron homeostasis and cope with oxidative stresses. The
H. hepaticus genome sequence contains genes encoding homologs
of bacterial oxidative stress defense proteins, and also a homolog
of the iron-responsive regulatory protein PerR, which mediates
regulation of peroxide stress defense in several other bacteria. In

this study we have investigated the expression and regulation of
oxidative stress defense systems of H. hepaticus.
Growth of H. hepaticus in iron-restricted conditions resulted
in altered expression levels of six proteins. Three of these
proteins displayed iron-repressed expression, whereas three
other proteins displayed iron-induced expression. Two of the
iron-repressed proteins were identified as AhpC (25 kDa) and
KatA (55 kDa). Both proteins are involved in the degradation
of peroxide compounds, and are known to contribute to the
bacterial oxidative stress defense. Mutation of the perR gene
resulted in high-level, iron-independent, expression of both AhpC
and KatA.
Conclusion. In H. hepaticus, iron metabolism and oxidative stress
defense are intimately connected via the PerR regulatory protein.
This regulatory pattern resembles that seen in the enteric pathogen
Campylobacter jejuni, but contrasts with the regulatory patterns
observed in the human gastric pathogen H. pylori. Therefore,
iron-dependent regulation of peroxide stress defense may be an
adaptation advantageous for enteric colonization.

Abstract no.: 15.03*
Detection of Enterohepatic Helicobacter Species
and Wolinella succinogenes in Biopsy Specimens
from Children with Inflammatory Bowel Disease
(IBD) and Irritable Bowel Syndrome (IBS)
Abstracts
8Abstract

H. M. Mitchell,* L. Zhang,* A. Day† and G. McKenzie‡
*School

of Microbiology and Immunology, University of New South
Wales, Sydney, Australia, †School of Women’s and Children’s Health,
The University of New South Wales, Sydney, Australia, ‡School of
Medical Sciences, University of New South Wales, Sydney, Australia
Introduction. Enterohepatic Helicobacter species can initiate
IBD in immunodeficient mice. Attempts to detect such organisms
in human IBD have resulted in divergent results.
Aim. To determine the presence and spatial distribution of
Helicobacteraceae (Helicobacter and Wolinella), in colonic biopsies
from children undergoing colonoscopy.
Methods. Three biopsies were collected from 18 children,
diagnosed with IBD [n = 12], IBS [n = 4] and 2 controls (without
symptoms or inflammation). DNA from one biopsy was used for
Helicobacteraceae-specific polymerase chain reaction (PCR) and
subsequent sequencing; the second to examine the spatial
distribution of Helicobacteraceae using specific rRNA fluorescent
in situ hybridization (FISH) and for PAS staining to assess the
depth of the mucus layer and the third for histology.
Results. Helicobacteraceae were detected in 12/12 children with
IBD (11 CD, 1 UC), 4/4 with IBS and 0/2 controls. Sequencing of
PCR products showed three to be closely related to H. hepaticus,
six to H. trogontum, five to W. succinogenes, and two to an
uncultured Helicobacter species previously detected in UC
patients. PAS staining showed children with IBD to have a
significantly thinner ( p < .001) mucus layer (0.84 ± 0.08 µm) than
children with IBS (3.30 ± 0.22 µm). Using FISH, a positive
Helicobacteraceae signal was detected in the mucus layer of 3/16
PCR-positive children.
Conclusions. This is the first report of the detection of Wollinella
species in the human gastrointestinal tract (GIT) and of the
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556
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detection of Helicobacter species or W. succinogenes colonizing the
colonic mucus layer of children with IBD or IBS. Further work is
required to clarify the roles of mucus-associated bacteria in IBD.

8Abstract
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Abstract no.: 15.04
Helicobacter hepaticus Infection in the TCR
alpha–/– and TCR beta–/– Mouse Models of IBD is
Associated with Increased Colonization of
Altered Schaedler Flora in the Inflamed Colon
M. T. Whary, N. Sundina, R. Sarma-Rupavtarm, M. Polz,
D. Schauer, Z. Ge, P. R. Nambiar and J. G. Fox
Massachusetts Institute of Technology, Cambridge, MA, USA
Altered Schaedler flora (ASF), consisting of eight anaerobes
recently speciated by our laboratory using 16S ribosomal RNA
analysis, have historically been used to colonize germ-free mice to
establish normal gut physiology. Little is known about potential
interaction between ASF colonization, bacterial pathogens such as
Helicobacter hepaticus, and intestinal disease in susceptible mice.
H. hepaticus-infected TCRα–/– and TCRβ–/– mice develop typhlocolitis
that emulates the dysregulated inflammatory response of human
inflammatory bowel disease (IBD) patients to their intestinal flora.
We used qPCR (quantitative polymerase chain reaction) based on
16S rRNA sequences to measure the levels of H. hepaticus,
ASF356, ASF502 (both Clostridium spp.), ASF360, ASF361 (both
Lactobacillus spp.), ASF500 (Gram-positive), ASF492 (Eubacterium),
ASF457 (Mucispirillum schaedleri), and ASF519 (Bacteroides sp.)
colonizing the colon of helicobacter-free and H. hepaticus-infected
TCRα–/– and TCRβ–/– mice (n = 20). After 6 months of natural
infection, H. hepaticus-infected TCRα–/– mice had more severe
typhlocolitis than infected TCRβ–/– mice ( p < .008) despite lower
H. hepaticus colonization levels ( p < .008). ASF360 was not
detectable and ASF502 and ASF519 were not impacted by H.
hepaticus infection. In contrast, the other five ASF species were all
present at significantly higher levels in the inflamed colon of
H. hepaticus-infected TCRα–/– mice compared to controls ( p < .04).
Colonization of ASF361, ASF492, and ASF500 were also higher in
H. hepaticus-infected TCRβ–/– mice ( p < .04). These results suggest
that H. hepaticus colonization and/or the associated typhlocolitis
favors increased colonization of select species of ASF in TCR
knockout mice and warrants further study given the interest in
probiotics for human IBD therapy.

Abstract no.: 15.05*
Detection of Helicobacter Species in Archival
Human UC Colorectal Tissue by Fluorescent
In Situ Hybridization (FISH)
8Abstract
Abstracts

I. A. M. Cooper,* G. L. Hold,* M. G. Smith,* B. Vijayan,†
N. Fyfe,‡ Z. Shen,§ J. G. Fox§ and E. M. El-Omar*
*GI

research group, Department of Medicine & Therapeutics,
University of Aberdeen, Aberdeen, UK, †GI unit, Aberdeen Royal
Infirmary, Aberdeen, UK, ‡Department of Pathology, University of
Aberdeen, Aberdeen, UK, §Division of Comparative Medicine,
Massachusetts Institute of Technology, Cambridge, MA, USA

Background. Data are conflicting regarding the role of Helicobacter
species in human IBD. This in part is due to the techniques used
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556

and to lack of definition of disease phenotypes. No studies have
investigated tissue obtained at de novo presentation before therapy
has been implemented.
Aim. To investigate archival paraffin-embedded tissue from
patients with confirmed ulcerative colitis (UC) for the presence of
Helicobacter species.
Subjects and Methods. Fifty-seven UC patients (38 relapsing, 19
de novo) and 12 healthy controls had archival biopsies investigated.
UC patient biopsies were taken from throughout the colon.
Healthy controls were asymptomatic subjects undergoing
colonoscopy and found to have macroscopically and histologically
normal tissue. FISH assays were designed to differentiate H. pylori
from non-pylori Helicobacter species. Sections were analyzed in
triplicate.
Results. Eleven of 57 UC patients (19%) were exclusively positive
for non-pylori Helicobacter, whereas only one was H. pyloripositive. None of the 12 controls had any Helicobacter ( p < .001
versus UC). Helicobacter were predominantly detected in the left
colon, especially in left-sided colitis cases. One of 19 de novo
patients had evidence of non-pylori Helicobacter. Positive relapsing
patients were almost always negative at first presentation,
subsequently becoming positive upon relapse. Helicobacter were
detected on the mucosa and in colonic crypts, in both inflamed and
non-inflamed tissues.
Conclusions. Non-pylori Helicobacter species are commonly
detected in UC patients, particularly in those with left-sided colitis.
These species do not appear to play a role at disease onset but may
be implicated in subsequent relapses.
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Abstract no.: 15.06
Detection of Helicobacter Species in Liver Tissue
of Polish Patients with Chronic Liver Diseases by
PCR–DGGE and Sequence Analysis
K. P. Bielawski,* P. Stalke,† W. Abu Al-Soud‡ and
T. Wadström‡
*Department

of Biotechnology, Intercollegiate Faculty of
Biotechnology, Gdansk, Poland, †Department of Infectious Diseases,
Medical University of Gdansk, Poland, ‡Section of Medical
Microbiology, Department of Laboratory Medicine, Lund University,
Lund, Sweden
Background. DNA of number of Helicobacter species that have
been isolated from the stomach, intestinal tract, and liver of a
variety of animals, have been detected in human bile and liver
samples. The aim of this study was to determine the possible
presence of Helicobacter species in the liver tissue samples of
patients with chronic liver diseases of different etiology.
Materials and Methods. Ninety-seven Polish patients (46 women,
51 men), aged 18–66 years (mean 41 ± 1) were admitted to the
Hospital for Infectious Diseases in Gdansk, Poland because of a
chronic liver disease. Liver biopsy specimens were examined
for the presence of Helicobacter species by a genus-specific
polymerase chain reaction (PCR) assay. PCR products of positive
samples were subsequently characterized by denaturing gradient
gel electrophoresis (DGGE) and DNA-sequencing.
Results. Using Helicobacter genus-specific PCR assay, Helicobacter
DNA was detected in 69/97 (68%) of liver tissue samples. Among
them, 45/70 (55%) positive samples were detected in patients
chronically infected with hepatotropic viruses (HBV or HCV), 9/
14 (64%) in patients with toxic liver damages and 9/13 (85%) in
patients with autoimmune liver diseases. No correlation was found
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between the frequency of Helicobacter PCR-positive results and
etiology of liver diseases and signs of chronic liver inflammation.
Conclusions. The presence of Helicobacter species DNA in liver
tissue may suggest a possible role of Helicobacter infection in
human chronic liver diseases.
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Abstract no.: 15.07
Prevalence of Novel Helicobacter in Feces of
Free-living Canada Geese in the Greater Boston
Area

part of the ureB gene of HLO135 revealed 99% and 96% similarity
with CHh, respectively, indicating that type HLO135 belongs to
the same species.
Of 123 human gastric biopsies harboring spiral organisms as seen
microscopically, nine were positive for HLO135 in the multiplex
PCR, suggesting infection with CHh.
The present study demonstrates the presence of CHh in cats,
dogs, and humans. Additionally, these results prove that the
previously developed multiplex PCR also enables us to identify
CHh.
(1) O’Rourke et al. (2004) IJSEM 54:2203–2211.
(2) Baele et al. (2004) JCM 42:1115–1122.
(3) Van den Bulck et al. (2005) JCM 43:2256–2260.

J. G. Fox, S. Howe, M. Tidd, S. Xu and N. S. Taylor
Massachusetts Institute of Technology, Cambridge, MA, USA

Abstract no.: 15.09
Spiral Organisms in the Stomach of Domestic
Animals:True Zoonosis?
Abstracts
8Abstract

Canada geese have increased substantially in the past decade and
have become a nuisance in some urban areas. Because of their close
contact with humans in parks and areas adjacent to surface
waterways, contact with their feces poses a zoonotic risk. A total
of 97 geese from 10 separate geographical locales in the greater
Boston area had their feces sampled for detection of Helicobacter
spp. Positive identification of Helicobacter spp. based on 16S
rRNA genus-specific helicobacter primers were noted in 39 of 97
(32%) DNA fecal extracts. Twenty-seven of these geese had
helicobacters isolated (27.8%) from their feces. A urease-positive
novel Helicobacter sp. C/B52 based on phenotypic and 16S rRNA
analysis previously isolated from terns on the Massachusetts
Atlantic shoreline was isolated from 21 geese from seven different
gaggles. A second novel urease-negative Helicobacter sp. was
identified in six geese. Four geese had both novel Helicobacter spp.
using the same phenotypic and molecular characterization cultured
from their feces. Whether these novel helicobacters pose a zoonotic
risk, similar to other enteric helicobacters (e.g., H. canadensis
previously isolated from diarrheic humans and from geese in
Europe) will require further studies.

Abstract no.: 15.08
Identification of “Candidatus H. heilmannii” in
Cats, Dogs, and Humans
Abstracts
8Abstract

M. Baele,* K. Van den Bulck,* P. Vandamme,†
R. Ducatelle,* F. Haesebrouck* and A. Decostere*
*Faculty
†Faculty

of Veterinary Medicine, Ghent University, Merelbeke, Belgium,
of Sciences, Ghent University, Gent, Belgium

“Candidatus Helicobacter heilmannii” (CHh) is an uncultured
spiral organism that has recently been identified in the stomach of
wild carnivores and one human being [1]. In a previous study, a
multiplex polymerase chain reaction (PCR) [2] was used to detect
and differentiate H. felis, H. bizzozeronii, and H. salomonis in
canine, feline, and human gastric samples, and a new genotype,
designated HLO135, was identified [3]. It was the aim of the
present study to determine the prevalence of CHh in cats, dogs, and
humans and to study its phylogenetic relatedness with HLO135.
Gastric canine (110) and feline (43) samples were therefore
subjected to a CHh-specific PCR [1]. Cloning and sequencing
analysis of the 16S rDNA and part of the urease gene were
performed on a HLO135-positive feline sample. Thirty-four dogs
and 29 cats tested positive for CHh. These animals were previously
found to harbor HLO135 [2]. Sequencing the 16S rRNA gene and

K. Van den Bulck, A. Decostere, M. Baele, R. Ducatelle
and F. Haesebrouck
Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium
Non-Helicobacter pylori spiral organisms (NHPSO) have
occasionally been associated with gastric disease in humans. There
are indications that animals may act as a source of infection for at
least some of these bacteria. In an attempt to obtain better insights
in the epidemiology of these infections, spiral organisms in the
gastric mucosa of cats (43), dogs (110), pet rabbits (23), and humans
(123) were identified up to the species level. All samples were
subjected to a multiplex polymerase chain reaction (PCR), enabling
the identification of H. felis, H. salomonis, H. bizzozeronii,
“Candidatus H. suis,” and “Candidatus H. heilmannii.”
H. felis and “Candidatus H. heilmannii” were identified as the
most prevalent Helicobacter species in cats (62.8% and 67.4%,
respectively), whereas H. bizzozeronii presented the main spiral
organism in the canine stomach (70%). Three pet rabbits were
found to harbor H. felis in their stomach. H. salomonis was detected
in the stomach of 1 rabbit, 1 cat, and 10 dogs. In human gastric
samples, H. felis, H. salomonis, H. bizzozeronii, “Candidatus
H. heilmannii” and “Candidatus H. suis” were identified in 14.6%,
21.1%, 4.1%, 8.1%, and 36.6% of the samples, respectively.
These results indicate that pigs and cats most probably constitute
a more important source of NHPSO infections for humans than
dogs. More research is required to determine the source of
H. salomonis infections for humans and to estimate the role of pet
rabbits in the epidemiology of NHPSO infections.
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Abstract no.: 15.10
Serum Antibodies to Helicobacter hepaticus,
Helicobacter bilis, and Helicobacter pullorum in
Patients with Chronic Liver Diseases and in a
Population with High Prevalence of
Helicobacter pylori Infection
T. Vorobjova,* I. Nilsson,† S. Terjajev,* M. Granholm,*
M. Lyyra,* T. Porkka,* T. Prükk,‡ R. Salupere,§
H. I. Maaroos,¶ T. Wadström† and R. Uibo*
*University

of Tartu, Institute of General and Molecular Pathology,
Department of Immunology, Tartu, Estonia, †University of Lund,
Division of Medical Microbiology, Department of Laboratory
Medicine, Lund, Sweden, ‡University of Tartu, Division of Infectious
Diseases, Department of Internal Medicine, Tartu, Estonia, §University
of Tartu, Division of Gastroenterology, Department of Internal
Medicine, Tartu, Estonia, ¶University of Tartu, Department of Family
Medicine, Tartu, Estonia
Objectives. Enteric Helicobacter species might be a risk factor for
chronic liver and biliary tract diseases.
Aim. To analyze serum antibody levels to three enteric
Helicobacter species in patients with various chronic liver diseases
(CLD); to compare them with corresponding parameters for
population with high prevalence of Helicobacter pylori infection
including blood donors and pediatric patients; to explore possible
association of increased serum antibody levels to enteric
Helicobacter species with chronic liver diseases.
Methods. Sera of 90 patients with various CLDs, 121 Estonian
adult persons, 68 blood donors, and 50 consecutive pediatric
patients were analyzed. Sera tested previously for H. pylori were
analyzed for IgG to H. hepaticus, H. bilis, and H. pullorum. ELISA
was initially used for screening and exclusion of negative cases.
ELISA-positive sera were analyzed by immunoblot. To remove
cross-reactive antibodies to H. pylori, sera were preabsorbed with
a lysate of H. pylori cells.
Results. Liver patients showed a significantly higher prevalence of
IgG to H. hepaticus and H. bilis, compared with those in adult
population ( p = .0001; p = .04, respectively), and to H. hepaticus,
compared with blood donors ( p = .01). Patients with autoimmune
hepatitis have no specific antibody reactivity to enteric
Helicobacter in contrast to the higher detection rate of antibodies
to H. hepaticus and H. bilis among patients with other chronic liver
diseases.
Conclusion. Use of immunoblot for defining antibody response
to the specific proteins of each Helicobacter spp. seems to be the
more promising way to establish serodiagnosis of infections with
these pathogens.
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Abstract no.: 15.11
Detection of Gastric Helicobacter-Like
Organisms (GHLOs) in Domestic and Stray Cats
in Tehran Province via PCR
B. Akhtardanesh,* M. Mohammadi,† S. Jamshidi,*
F. Sassani,* S. Bokaie* and T. Zahraii Salehi*
*Veterinary

Faculty, Tehran University, Tehran, Islamic Republic of Iran,
Research Center, Pasteur Institute of Iran, Tehran,
Islamic Republic of Iran

†Biotechnology

The presence of spiral-shaped bacteria in the feline stomach has
been recognized for over a century, but the identities and degrees
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556

of prevalence of such organisms in cats are still poorly documented.
On the other hand, reports of domestic animal-to-human
transmission and isolation of Helicobacter pylori from domestic
cats have led to speculation that cats and dogs may serve as a reservoir
for human infection. The zoonotic potential of Helicobacter
heilmannii and felis has been the subject of considerable interest as
well.
In order to investigate the presence and prevalence of gastric
Helicobacter spp., feline gastric samples underwent rapid urease
test (RUT), histopathology examinations, and genus strain-specific
polymerase chain reaction (PCR). According to 16srRNA-specific
PCR, prevalence of rate of GHLO infection in domestic and stray
cats was estimated as 100% and 56.7%, respectively. The most
commonly found GHLOs in cats are H. felis and H. Heilmannii.
According to our results H. Heilmannii is the most prevalent
infecting strain. No signs of H. pylori infection was detected in the
studied cats. Prevalence of GHLO infection was significantly
different between domestic and stray cats (81% versus 43.3%,
respectively; p < .005). The comparison between different
diagnostic tests revealed that Giemsa staining is the best method for
initial screening of GHLO infection. Furthermore, gastric body
is the best site for feline biopsy sampling. Unlike in humans,
there was no correlation found between presence and degree
of Helicobacter colonization and the development and severity of
chronic gastritis in cats ( p > .05).

Abstract no.: 15.12
PCR–DGGE Detection of Helicobacter Species in
Human Colon Biopsies of Patients with
Inflammatory Bowel Disease
8Abstract
Abstracts

W. Abu Al-Soud, E. Sturegård, Å. Ljungh, E. Hertervig
and T. Wadström
Lund University, Lund, Sweden
Background. Inflammatory bowel disease (IBD) is a chronic
inflammation of the gastrointestinal tract that exists in two forms:
Crohn’s disease (CD) and ulcerative colitis (UC). As a microbial
factor, some of Helicobacter and other bacterial species may play a
role in IBD. The aim of this study was to determine the presence of
Helicobacter species in colon biopsies of patients with IBD.
Methods. Forty-eight colonic mucosal biopsies were collected
from 24 patients undergoing colonoscopy as follows: 6 from UC,
3 from CD, 12 from other colon diseases, and 3 from patient’s colon
of normal endoscopic picture. Samples were examined by using
Helicobacter genus-specific PCR–DGGE (polymerase chain reaction–
denaturing gradient gel electrophoresis) and DNA sequencing.
Results. Helicobacter species were detected in 11% of the patients
with IBD, in 50% of the patients with other colon diseases, and in
33% of the patients with normal colon endoscopy. PCR–DGGE
analysis of Lactobacillus DNA concentration was decreased in
patients’ colon with IBD compared to other groups. Desulfovibrio
DNA was detected in 50% of patients with UC and in none of the
patients with CD.
Conclusions. The high PCR–DGGE detection of Helicobacter
DNA in other colon diseases than in IBD suggests that Helicobacter
species may not have a role at least in the late stage of this disease. A
possible link of lactic acid bacteria and Desulfovibrio was found to IBD.
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Abstract no.: 15.13
Antibodies to Bile-Tolerant Non-pylori
Helicobacter in Patients with Chronic Liver
Diseases

Antibodies to Helicobacter pylori, Helicobacter bilis, Helicobacter
hepaticus, and Helicobacter pullorum were screened using enzyme
immunoassay (EIA). Sera with positive/borderline EIA results
were analyzed by immunoblot (IB). Sera were preabsorbed with
H. pylori before EIAs and IBs with non-pylori Helicobacters.

H. Rautelin,*† I. Nilsson,‡ J. Mäkinen,§
P. Sipponen,¶ Å. Ljungh‡ and L. Veijola**

Table 1 Helicobacter antibodies demonstrated by IB in IBD patients

*Department of Bacteriology and Immunology, Haartman Institute,
University of Helsinki, Helsinki, Finland, †HUSLAB, Helsinki University
Central Hospital Laboratory, Helsinki, Finland, ‡Department of
Laboratory Medicine, Division Medical Microbiology, Lund University,
Lund, Sweden, §Department of Pathology, Peijas Hospital,Vantaa,
Finland, ¶Department of Pathology, Jorvi Hospital, Espoo, Finland,
**Malmi Hospital, Helsinki, Finland

Aim. To study the seroprevalence of enterohepatic Helicobacter
species in patients with chronic liver diseases.
Methods. Sera of 32 patients with primary biliary cirrhosis (12
cases), chronic active hepatitis (4), primary sclerosing cholangitis
(1), alcoholic cirrhosis (2), cryptogenic cirrhosis (1), fatty liver (3),
focal nodular hyperplasia (1), cholestatic hepatitis (4), hepatitis of
unknown etiology (3), and normal liver status (1) (earlier elevated
liver enzyme levels) were analyzed. Liver biopsies (29 cases) had
been classified (METAVIR) and the grade of liver fibrosis was 0 in
19 patients, 1 in 1 patient, 2 in 3, 3 in 4, and 4 in 2 patients. Liver
enzyme levels were slightly or moderately elevated (averages, ALT
46, AST 50, alkaline phosphatase 366).
Antibodies to Helicobacter pylori and enteric Helicobacter spp.
were measured by enzyme immunoassay (EIA) and sera with
positive/borderline EIA results were further analyzed by
immunoblot (IB). To minimize cross-reactivity between H. pylori
and the enteric spp. sera were absorbed with H. pylori before the
EIA and IB analyses.
Results. Seropositivity of the 32 patients to Helicobacter spp. by
EIA and IB.
Antigen/species
H. bilis
H. pullorum
H. hepaticus
H. pylori
*Patient

EIA Pos (%)

IB Pos (%)

8/32 (25)
7/32 (22)
9/32 (28)
9/32 (28)

1*/8 (12.5)
0/7
0/9
Not performed

with autoimmune cholangitis.

Conclusion. Antibodies to enteric Helicobacter spp. were uncommon
in Finnish patients with mostly mild chronic liver diseases.
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of Bacteriology and Immunology, Haartman Institute,
University of Helsinki, Helsinki, Finland, †Helsinki University Hospital,
Helsinki, Finland, ‡Department of Laboratory Medicine, Division
Medical Microbiology, Lund University, Lund, Sweden, §Department of
Surgery, Helsinki University Hospital, Helsinki, Finland
The seroprevalence of enterohepatic Helicobacter species was
studied in 61 patients with Crohn’s disease (median age 37.0 years,
median duration of disease 6.3 years) and 73 patients with
ulcerative colitis (median age 44.2 years, duration 11.4 years).

H. pylori/
CagA+

H. bilis

H.
hepaticus

H.
pullorum

13 (21%)/12

1 (1.6%)

1 (1.6%)

0

17 (23%)/15

2 (2.7%)

0

2 (2.7%)

Patients with
Crohn’s disease
(n = 61)
Ulcerative colitis
(n = 73)

The seroprevalence of H. pylori was 22%. Of the H. pyloripositive, 90% were also CagA +0. Two (3%) patients with Crohn’s
disease and four (5%) with ulcerative colitis had antibodies to
enterohepatic Helicobacter species. Both of these Crohn’s disease
patients had acute inflammatory findings in the ileum, whereas all
the four seropositive ulcerative colitis patients had inactive bowel
disease. Two of the six patients (one with H. bilis and the other with
H. hepaticus antibodies) had no evidence of H. pylori infection.
In conclusion, infection with enteric non-pylori Helicobacter
species is rarely detected in Finnish IBD patients. Our findings,
however, do not exclude colonization/infection with these species
at an earlier stage of IBD.
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Isolation of Helicobacter spp. from Seawater,
Plankton, and Oysters from Areas of the
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M. A. García-Amado,* M. Fernandez,† P. Suarez† and
P. Gueneau*
*Instituto Venezolano

de Investigaciones Cientificas, Caracas,
Venezuela, †Universidad Simon Bolivar, Caracas,Venezuela

This study aimed at culturing Helicobacter species from a marine
environment subject to fecal contamination. We collected oysters
tissue (Isognomus alatus and Crassostrea mangle), marine water
filtrates, and marine plankton from a touristic coastal area of
Venezuela. Detection was made using culture, Gram staining,
transmission electron microscopy, and genus-specific polymerase
chain reaction (PCR). Total and fecal coliforms and enterococci
were measured using classical culture methods for the assessment
of the microbiological quality of coastal recreational waters. We
obtained cultures of Gram-negative curved and spiral rods, with a
polar flagellum from marine water filtrates, plankton, and oysters
(Isognomus alatus). We confirmed the identity of the cultures by
PCR.
Our results show that viable Helicobacter species are present in
marine areas subject to fecal contamination. To our knowledge, this
is the first successful culture of Helicobacter species from the
marine environment.
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Abstract no.: 15.16
Helicobacter cinaedi Bacteremia in a Previously
Healthy Person with Cellulitis
H. Holst,* J. Blom,* J. J. Christensen,* M. Kemp,*
N. Højlyng,† K. Andresen* and K. A. Krogfelt*
*Statens

serum Institut, 2300 Copenhagen S, Denmark,
county Hospital, 4000 Roskilde, Denmark

†Roskilde

Helicobacter cinaedi is an infrequent, but well-recognized course
of gastroenteritis in immunosupressed patients. Here we report a
case of an extra-intestinal infection in a previous healthy 61-yearold heterosexual male.
The bacterium was cultured from blood twice within 1 week.
Focus for the infection was most likely cellulitis on the lower
right leg. The condition was at first considered to be erysipelas
and treated with intravenous penicillin without any clinical
response.
Five days after admission blood cultures were positive. The
bacterium grew under aerobic conditions and was isolated on horse
blood agar enriched with 5% yeast. Light microscopy and Gram
staining identified a spiral organism. Electron microscopy of the
isolate visualized bipolar flagella suggesting Helicobacter cinaedi.
Partial DNA sequencing of the 16S rRNA gene established the
species diagnosis. Fecal specimens were not available. Antibodies
reacting against H. pylori were detectable in serum.
After the isolation of H. cinaedi and the antibiotic resistance tests
performed treatment was changed to rifampicin for 2 weeks. At the
end of treatment no Helicobacter were found in blood samples and
the cellulitis had disappeared.
Source of infection is unknown; no contact to animals was
reported. The only exposition to be account for was mice
excrements, whereas cleaning the attic of his house.
Molecular bacterial identification methods have been proven
beneficial in many settings. The fact that the patient did not
respond to standard treatment regiments should always make one
consider alternative etiology.
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Bacterial Interaction Between Staphylococcus
Strains and Helicobacter pylori Clinical Isolates
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J. Díaz-Regañón Vilches, T. Alarcón, D. Domingo and
M. López-Brea
Servicio de Microbiología, H. U. de La Princesa, Madrid, Spain
Objectives. 1, To study the inhibitory effect of 6 Staphylococcus
strains against 10 Helicobacter pylori clinical isolates; 2, to
determine whether this effect is caused by the microorganism itself
or by something relapsed by it.
Methods. H. pylori strains were obtained from 10 gastric biopsies
and processed by standard microbiological methodology. Six
Staphylococcus strains were obtained from clinical specimens and
identified by Gram stain and MicroScan (Dade Behring). To
determine the effect of Staphylococcus on H. pylori we used the
“drop” method. A blood agar plate was completely inoculated with
H. pylori and 2 drops were deposited containing 10 µl of
Staphylococcus after 0.5 MacFarland concentration and after
72 hours in BHI. One Staphylococcus isolate was selected for
further studies. It was inoculated in 5 ml of BHI overnight and the
supernatant was collected by centrifugation (10 minutes at
© 2005 Blackwell Publishing Ltd, Helicobacter, 10, 458–556

13,000 g) and then filter-sterilized (0.45 µm pore size filter). It was
also sonicated and filter-sterilized again. Plates were incubated
under microaerobic atmosphere for 3–5 days.
Results. A Staphylococcus epidermidis strain showed an inhibitory
effect against all the H. pylori tested. The inhibition zone was 27–
36 mm depending on the concentration of the Staphylococcus. This
effect was seen after concentration and sonication but not after filtration.
Conclusions. In our study Staphylococcus epidermidis is able to
inhibit the growth of Helicobacter pylori in vitro. According to
these data, the effect seems to be caused by the microorganism
itself. Further studies are needed in order to confirm these results.
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Detection of Enterohepatic Helicobacter Species
and Wolinella succinogenes in Biopsy Specimens
from Children with Inflammatory Bowel Disease
(IBD) and Irritable Bowel Syndrome (IBS)
L. Zhang,* A. Day,† G. McKenzie‡ and H. M. Mitchell*
*School

of Biotechnology and Biomolecular Sciences, University of
New South Wales, Sydney, Australia, †School of Women’s and
Children’s Health, University of New South Wales, Sydney, Australia,
‡School of Medical Sciences, University of New South Wales, Sydney,
Australia
Introduction. Enterohepatic Helicobacter species can initiate
IBD in immunodeficient mice. Attempts to detect such organisms
in human IBD have resulted in divergent results.
Aim. To determine the presence and spatial distribution of
Helicobacteraceae (Helicobacter and Wolinella), in colonic biopsies
from children undergoing colonoscopy.
Methods. Three biopsies were collected from 18 children,
diagnosed with IBD (n = 12), IBS (n = 4), and two controls (without
symptoms or inflammation). DNA from one biopsy was used for
Helicobacteraceae-specific polymerase chain reaction (PCR)
and subsequent sequencing; the second to examine the spatial
distribution of Helicobacteraceae using specific rRNA fluorescent
in situ hybridization (FISH) and for PAS staining to assess the
depth of the mucus layer and the third for histology.
Results. Helicobacteraceae were detected in 12/12 children with
IBD (11 CD, 1 UC), 4/4 with IBS and 0/2 controls. Sequencing of
PCR products showed 3 children to be closely related to H. hepaticus,
6 to H. trogontum, 5 to W. succinogenes and 2 to an uncultured
Helicobacter species previously detected in UC patients. PAS
staining showed children with IBD to have a significantly thinner
( p < .001) mucus layer (0.84 ± 0.08 µm) than children with IBS
(3.30 ± 0.22 µm). Using FISH, a positive Helicobacteraceae signal
was detected in the mucus layer of 3/16 PCR positive children.
Conclusions. This is the first report of the detection of Wollinella
species in the human gastrointestinal tract (GIT) and of the
detection of Helicobacter species or W. succinogenes colonizing the
colonic mucus layer of children with IBD or IBS. Further work is
required to clarify the roles of mucus-associated bacteria in IBD.
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Isolation of Helicobacter spp. from Seawater,
Plankton, and Oysters from Areas of the
Caribbean Sea Subject to Fecal Contamination
M. A. García-Amado,* M. Fernández,† P. Suárez† and
P. Gueneau*
*Instituto Venezolano de Investigaciones Científicas, Miranda,
Venezuela, †Universidad Simón Bolìvar, Sartenejas,Venezuela

This study aimed at culturing Helicobacter species from a marine
environment to fecal contamination. We collected oysters tissue
(Isognomus alatus and Crassostrea mangle), marine water filtrates,
and marine plankton from a touristic coastal area of Venezuela.

Hepatobiliary Diseases
Detection was made using culture, Gram staining, transmission
electron microscopy and genus-specific PCR. Total and fecal
coliforms and enterococci were measured using classical culture
methods for the assessment of the microbiological quality of
coastal recreational waters. We obtained cultures of Gram-negative
curved and spiral rods, with a polar flagellum from marine water
filtrates, plankton and oysters (Isognomus alatus). We confirmed
the identity of the cultures by PCR.
Our results show that viable Helicobacter species are present
in marine areas subject to fecal contamination. To our knowledge,
this is the first culture of Helicobacter species from the marine
environment.
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Abstract no.: 16.01*
Biliary Lipid Compositions in Cholesterol
Gallstone-Prone C57L Mice Infected with
Certain Cholelithogenic Enterohepatic
Helicobacter spp. Suggest Pro-Nucleating
Organisms
K. J. Maurer,* M. R. Leonard,† J. G. Fox* and
M. C. Carey†

Abstract no.: 16.02
Unlike Some Enterohepatic Helicobacter
Species, Helicobacter pylori Does not Promote
Cholesterol Gallstone Formation in GallstoneProne C57L Mice
K. J. Maurer,* A. J. Wiese,* Z. Ge,* A. B. Rogers,*
M. C. Carey† and J. G. Fox*
*Massachusetts

Institute of Technology, Cambridge, MA, USA,
Medical School, Brigham and Womens Hospital, Boston, MA,

*Massachusetts

†Harvard

We demonstrated previously (Gastroenterology 2005; 128) that
infection with specific enterohepatic Helicobacter spp. contributes
to cholesterol cholelithogenesis in C57L mice. In particular,
coinfection with H. hepaticus and H. rodentium or monoinfection
with H. bilis induced an approximately 80% prevalence of
cholesterol gallstones compared to uninfected controls (∼10%). To
elucidate the mechanism(s) we analyzed lipids from hepatic bile of
H. hepaticus and H. rodentium coinfected and uninfected mice.
Helicobacter spp.-free male 4- to 5-week-old C57L mice were
either infected or sham dosed (n = 10/group). Four weeks after
infection, mice were fed a lithogenic diet for 6 weeks. At
laparotomy, hepatic bile was collected for 20 minutes. Bile of
infected and uninfected animals did not differ in total lipid content
(3.14 ± 0.25 and 3.16 ± 0.31 g/dl, respectively). Similarly, CSIs
(1.25 ± 0.10 and 1.25 ± 0.13) and cholesterol concentrations
(3.29 ± 0.29 mmol/l) from infected and uninfected animals were
identical, and bile salt (42.4 ± 4.3 and 41.8 ± 4.4 mmol/l) and
phospholipid (9.5 ± 0.4 and 10.1 ± 0.9 mmol/l) concentrations
were similar. The bile salt pool of infected animals demonstrated a
significant loss of muricholic acids compared to uninfected animals
(11.5 ± 0.6% and 13.7 ± 0.7%, p < .05) and consequently contained
significantly more hydrophobic bile salts ( p < .05). In vitro, bile
salt hydrophobicity changes the phase diagram of bile and alters
kinetics of cholesterol crystallization. These data, together with our
earlier observations, imply that these bacteria act by making cholesterol
monohydrate crystal formation more favorable by promoting
heterogeneous nucleation and altering the hydrophobicity of bile.

We demonstrated recently that infection with specific enterohepatic
Helicobacter spp. induces cholesterol gallstones (approximately 80%)
in gallstone-prone C57L mice fed a lithogenic diet (Gastroenterology
2005; 128). In contrast, uninfected mice do not develop gallstones with
appreciable frequency (approximately 10%). We wished to determine
whether Helicobacter pylori would exhibit similar properties.
Helicobacter-free, 4-week-old male C57L mice were infected with
H. pylori SS1 (n = 10) or sham dosed (n = 10). Mice were fed a lithogenic
diet containing 1% cholesterol and 0.5% cholic acid for 8 weeks.
At necropsy, gallbladder bile was examined microscopically, and
tissues examined histopathologically, molecularly, and by culture.
Neither control nor infected animals exhibited a high prevalence of
cholesterol gallstones (10% and 20%, respectively). Likewise neither
group progressed along the cholelithogenic pathway (10% cholesterol
monohydrate crystals and 0% sandy stones for controls, and 20%
cholesterol monohydrate crystals and 0% sandy stones for infected).
Additionally, infected mice did not differ significantly from controls
with respect to normalized gallbladder weight (0.75 ± 0.23 mg/g,
0.66 ± 0.12 mg/g) nor mucin score (0.95 ± 0.5 and 1.2 ± 0.2) and
uninfected animals demonstrated slightly more mucin gel accumulation.
Nested polymerase chain reaction (PCR) performed on the hepatobiliary tree revealed no H. pylori. Infected animals displayed moderate
to severe gastritis and H. pylori was present in the stomach. These data
demonstrate that H. pylori is not cholelithogenic and is not present
in the hepatobiliary tree of gallstone susceptible mice We hypothesize
that organisms identified previously as H. pylori in patients with
cholesterol gallstones were actually a cholelithogenic–enterohepatic
Helicobacter species with high sequence homology to H. pylori.
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Abstract no.: 16.03
Helicobacter pylori Gastric Infection and
Histologic Hepatic Lesions in Patients with
Hepatic Diseases
G. A. Rocha,* L. D. Silva,* L. P. F. Castro,* R. Dani,*
G. S. Mendes,† A. M. C. Rocha,* D. A. Silva* and
D. M. M. Queiroz*
*Universidade

Federal de Minas Gerais, Belo Horizonte, Brazil,
Horizonte, Brazil

†HGIP/IPSEMG, Belo

There are studies demonstrating association between gastric
Helicobacter pylori infection and cirrhosis in patients with hepatitis
B or C. It has been postulated that increased blood proinflammatory cytokines associated with H. pylori infection would
increase hepatic lesions predisposing to cirrhosis. Since there are no
studies evaluating the effect of H. pylori gastric infection on the
histologic hepatic lesions, we studied, prospectively, the liver
histology of 110 consecutive patients (60 men; mean age,
52.4 ± 15.9 years; range 18–93) with hepatic diseases. Liver biopsy
specimens were stained with hematoxylin and eosin (H&E),
Gomori’s trichromic and reticulin to investigate the presence of
necrosis, inflammatory cells, and fibrosis. H. pylori status was
determined by ELISA and 13C–UBT. Association between
necrosis (dependent) and H. pylori infection, liver metastasis,
alcoholic hepatic diseases (AHD), HCV, HBV, autoimmune
hepatitis (AIH) and drug-induced liver disease (DILD) was seen in
univariate analysis, but H. pylori infection ( p = .03, OR = 3.6,
95%CI = 1.1–11.0), AHD ( p = .009, OR = 6.0 95%CI = 1.6–23.0),
AIH ( p = .03, OR = 14.3, 95%CI = 1.3–158.2), DILD ( p = .02,
OR = 15.3, 95%CI = 1.6–149.3), and HCV ( p = .04, OR = 11.6,
95%CI = 1.1–120.8) remained independently associated with
necrosis in multivariate analysis. In the univariate analysis, the
presence of intra-acinar neutrophils was associated with H. pylori
infection, liver metastasis, AHD, HBV, and DILD. In the
multivariate analysis, only H. pylori infection ( p = .03, OR = 3.2,
95%CI = 1.2–9.2) and DILD (p = .03, OR = 5.2, 95%CI = 1.2–24.2)
remained independently associated with lobular neutrophils.
H. pylori infection was neither associated with mononuclear cells,
even when the analysis was topographic, nor with fibrosis ( p = .5).
We demonstrated independent associations between H. pylori gastric
infection and hepatic histologic lesions, reinforcing the hypothesis
that the infection may contribute to the course of liver diseases.

Abstract no.: 16.04
Molecular Detection of Helicobacter and Other
Bacterial Species in Liver Tissue of Patients with
Malignant Liver Disease
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W. Abu Al-Soud, H. Nilsson, Å. Ljungh, U. Stenram and
T. Wadström
Lund University, Lund, Sweden
Background. Primary liver tumors are commonly divided into
benign tumors including cavernous hemangioma, hepatocellular
nodules, focal nodular hyperplasia, and adenoma. Malignant tumors
are classified as hepatocellular carcinoma, cholangiocarcinoma, hepatoblastoma, and angiosarcoma. The aim of this study was to determine
the possible presence of Helicobacter species in the liver tissue
samples of patients with hepatocellularcarcinoma (HCC) (n = 13),
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cholangiocarcinoma (CCC) (n = 13), normal tissue surrounding the
tumor (n = 34), and as controls, focal nodular hyperplasia (n = 52).
Materials and Methods. Paraffin-embedded liver specimens (112)
were examined for the presence of Helicobacter species by a genusspecific polymerase chain reaction (PCR) assay, and other bacteria.
PCR products of positive samples were further characterized by
denaturing gradient gel electrophoresis (DGGE) and DNAsequencing.
Results. Using Helicobacter genus-specific PCR assay, helicobacter
DNA was detected in 7/13 normal tissue surrounding HCC, 8/13
normal tissue surrounding CCC, 1/34 inside the tumor, and 4/52
from the control group. DGGE analysis and DNA sequencing
showed that 90% of the detected PCR products were H. pylori-like.
Other bacterial DNA was detected in only 3% of total samples.
Conclusions. The presence of DNA of various Helicobacter
species in liver tissue samples especially of HCC and CCC may
indicate a possible role of Helicobacter species in chronic
inflammation associated with human malignant liver diseases.
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Detection of Helicobacter and Other Bacterial
DNA in Biliary Tree of Kosovan Patients with
Chronic Cholecystitis by PCR-DGGE
W. Abu Al-Soud,* F. T. Hoxha,† Å. Ljungh* and
T. Wadström*
*Lund

University, Lund, Sweden, †University Clinical Center of Kosova,
Prishtina, Serbia and Montenegro
Background. Helicobacter DNA has been detected in bile, bile
stones, and gallbladder mucosa and in association with stomach,
liver, and pancreatic cancer. However, the correlation of
Helicobacter species to some chronic biliary tree and liver diseases
is still poorly understood. The aim of this study was to investigate
the presence of Helicobacter species in bile and gallbladder biopsy
specimens of Kosovan patients with chronic cholecystitis.
Materials and Methods. DNA was extracted from gallbladder
and bile specimens, using a QIAamp DNA Kit (QIAGEN,
Hilden, Germany). All samples were examined for the presence of
Helicobacter species and other bacteria by genus-, group-, and
prokaryote-specific polymerase chain reaction (PCR) assays. PCR
products of positive samples were further characterized by DGGE
and DNA-sequencing.
Results. Helicobacter DNA was detected in 19/52 and 26/84 of
bile and gallbladder samples, respectively. DGGE analysis and
DNA sequencing identified DNA of H. pylori (9), H. pullorum (1),
H. cholecystus (4), H. muridarum (2), H. pametensis (1), and
H. hepaticus (2) in bile samples. In gallbladders, the Helicobacter
species DNA identified were H. pullorum (16), H. pylori (4),
H. cholecystus (2), and H. bilis (1), and H. pametensis (1). On the
other hand, Lactobacillus species and Escherichia coli DNA were
detected in only four and two of the bile samples, respectively.
Conclusions. The high prevalence of Helicobacter DNA in
gallbladder and bile of Kosovan patients with chronic cholecystitis
in comparison to a low prevalence of some gut microbe DNA
highlights a possible role of Helicobacter species in chronic
cholecystitis and associated cholangiocarcinoma.
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Serologic Analysis of Helicobacter hepaticus
Infection in Patients with Chronic Viral Hepatitis
Using New Monoclonal Antibodies
T. Shimoyama,* Y. Fukuda,† T. Ohmura,‡
Y. Sano-Matsuura,‡ R. Takahashi‡ and S. Fukuda*
*Hirosaki

University, Hirosaki, Japan, †Hyogo College of Medicine,
Nishinomiya, Japan, ‡Wakamoto Pharmaceutical Co., Ltd,
Minami-Ashigara, Japan
Background and Aims. Infection of Helicobacter hepaticus has
been associated with the development of hepatocellular carcinoma
in mice. In humans, however, prevalence of H. hepaticus infection has
not been studied. The aim of this study was to examine the prevalence
of H. hepaticus infection in patients with chronic hepatitis serologically.
Methods. Serum samples obtained from 182 patients with chronic
hepatitis C (106 men and 76 women, mean age 47.4) and 51 patients
with chronic hepatitis B (33 men and 18 women, mean age 35.8)
were studied. Sera were also obtained from 142 control subjects
who were not infected with hepatitis virus (69 men and 73 women,
mean age 60.0). Seropositivity of H. pylori and H. hepaticus was
tested by E-plate and antigen-capture ELISA using monoclonal
antibody to H. hepaticus antigen.
Results. H. hepaticus seropositivity was significantly higher in
patients with chronic hepatitis C (29.4%) compared to control
subjects (13.7%, p < .05), whereas H. pylori seropositivity was
not different (67.0% and 77.4%, respectively). H. hepaticus
seropositivity in patients with chronic hepatitis B was 14.0% and it
was not different from control subjects who were below 50 years
(18.8%). Higher H. hepaticus seropositivity was observed in
H. pylori-seropositive patients (32.1%) than in H. pyloriseronegative patients (15.3%, p < .01).
Conclusions. Present results suggest the possibility that
prevalence of H. hepaticus is high in patients infected with hepatitis
C virus. Association of seropositivity may suggest the presence of
similar transmission routes of H. hepaticus and H. pylori.
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The Role of Helicobacter pylori Infection in
Cirrhotic Patients: Facts or Fictions
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H. Vrazic,* M. Ticak† and B. Sabaric†
*Intensive

Care Unit, Zagreb, Croatia, †Gastroenterology, Zagreb,

Croatia
Aim. The purpose of this study was to evaluate the evidence of the
pathogenic role of Helicobacter pylori infection in liver cirrhosis (LV).
Patients and Methods. Eighty patients (68 men, 12 women) mean
age 48.5 year with LV were included in the study. All patients had
upper gastroduodenal endoscopy and gastroduodenal pathology
was identified. H. pylori infection was confirmed by gastric
histology. The patients were divided into two groups. Group A, 40
cirrhotic patients with H. pylori; and group B, 40 cirrhotic patients
without H. pylori infection. The age and sex of two studied groups
were compared. The effect variables were: stay in the ICU, peptic
ulcer disease, levels of serum ammonia, hepatic encephalopathy,
mortality, and surgery treatment.
Results. The incidence of peptic ulcer disease was significantly
higher in group A (74%) compared to group B (51%). p < .001. The
mean levels of serum ammonia in group A was significantly higher
(68%) compared to group B (39%). p < .001. The episodes of
hepatic encephalopathy were significantly lower in group B (3, 6)
compared to group A (8, 2). p < .001. The duration of stay in the
ICU in group A (6.8 days) was significantly higher compared with
group B (4.2 days). p < .001. No significant difference was found
for surgical intervention and mortality into two groups.
Student’s t-test, Friedman, and Wilcoxon Signed-Ranks tests
were used.
Conclusion. According to our results, we found that H. pylori
infection is the major risk factors for peptic ulcers in LV. The mean
levels of serum ammonia in patients with H. pylori infection were
higher than in patients without H. pylori infection.
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